id	sid	tid	token	lemma	pos
ihlr-16574	1	1	preemptive	preemptive	ADJ
ihlr-16574	1	2	legislation	legislation	NOUN
ihlr-16574	1	3	in	in	ADP
ihlr-16574	1	4	the	the	DET
ihlr-16574	1	5	european	european	PROPN
ihlr-16574	1	6	union	union	PROPN
ihlr-16574	1	7	and	and	CCONJ
ihlr-16574	1	8	the	the	DET
ihlr-16574	1	9	united	united	PROPN
ihlr-16574	1	10	states	states	PROPN
ihlr-16574	1	11	on	on	ADP
ihlr-16574	1	12	the	the	DET
ihlr-16574	1	13	topic	topic	NOUN
ihlr-16574	1	14	of	of	ADP
ihlr-16574	1	15	nanomedicine	nanomedicine	NOUN
ihlr-16574	1	16	:	:	PUNCT
ihlr-16574	1	17	examining	examine	VERB
ihlr-16574	1	18	the	the	DET
ihlr-16574	1	19	questions	question	NOUN
ihlr-16574	1	20	raised	raise	VERB
ihlr-16574	1	21	by	by	ADP
ihlr-16574	1	22	smart	smart	ADJ
ihlr-16574	1	23	medical	medical	ADJ
ihlr-16574	1	24	technology	technology	PROPN
ihlr-16574	1	25	emilee	emilee	PROPN
ihlr-16574	1	26	s.	s.	PROPN
ihlr-16574	1	27	preble	preble	PROPN
ihlr-16574	1	28	'	'	PART
ihlr-16574	1	29	"	"	PUNCT
ihlr-16574	1	30	i.	i.	NOUN
ihlr-16574	1	31	introduction	introduction	NOUN
ihlr-16574	1	32	...............................................................................	...............................................................................	PUNCT
ihlr-16574	1	33	398	398	NUM
ihlr-16574	1	34	ll	ll	NOUN
ihlr-16574	1	35	.	.	PUNCT
ihlr-16574	2	1	historical	historical	ADJ
ihlr-16574	2	2	overview	overview	NOUN
ihlr-16574	2	3	and	and	CCONJ
ihlr-16574	2	4	the	the	DET
ihlr-16574	2	5	trouble	trouble	NOUN
ihlr-16574	2	6	with	with	ADP
ihlr-16574	2	7	regulating	regulate	VERB
ihlr-16574	2	8	new	new	ADJ
ihlr-16574	2	9	technologies	technology	NOUN
ihlr-16574	2	10	......................................................................	......................................................................	PUNCT
ihlr-16574	3	1	399	399	NUM
ihlr-16574	3	2	a.	a.	NOUN
ihlr-16574	3	3	nanotechnology	nanotechnology	NOUN
ihlr-16574	3	4	and	and	CCONJ
ihlr-16574	3	5	the	the	DET
ihlr-16574	3	6	development	development	NOUN
ihlr-16574	3	7	ofnanomedicine	ofnanomedicine	NOUN
ihlr-16574	3	8	........	........	PUNCT
ihlr-16574	4	1	399	399	NUM
ihlr-16574	4	2	1	1	NUM
ihlr-16574	4	3	.	.	PUNCT
ihlr-16574	5	1	"	"	PUNCT
ihlr-16574	5	2	what	what	PRON
ihlr-16574	5	3	is	be	AUX
ihlr-16574	5	4	nanotechltology	nanotechltology	NOUN
ihlr-16574	5	5	?	?	PUNCT
ihlr-16574	6	1	..................................................	..................................................	PUNCT
ihlr-16574	7	1	399	399	NUM
ihlr-16574	7	2	2	2	NUM
ihlr-16574	7	3	.	.	PUNCT
ihlr-16574	8	1	"	"	PUNCT
ihlr-16574	8	2	what	what	PRON
ihlr-16574	8	3	is	be	AUX
ihlr-16574	8	4	nanomedicine	nanomedicine	ADJ
ihlr-16574	8	5	?	?	PUNCT
ihlr-16574	9	1	.....................................................	.....................................................	PUNCT
ihlr-16574	10	1	400	400	NUM
ihlr-16574	10	2	b.	b.	PROPN
ihlr-16574	10	3	factual	factual	ADJ
ihlr-16574	10	4	sctmario	sctmario	PROPN
ihlr-16574	10	5	of	of	ADP
ihlr-16574	10	6	patient	patient	ADJ
ihlr-16574	10	7	xtumor	xtumor	PROPN
ihlr-16574	10	8	cured	cure	VERB
ihlr-16574	10	9	by	by	ADP
ihlr-16574	10	10	nanites	nanite	NOUN
ihlr-16574	10	11	......	......	PUNCT
ihlr-16574	10	12	401	401	NUM
ihlr-16574	10	13	c.	c.	NOUN
ihlr-16574	10	14	regulating	regulate	VERB
ihlr-16574	10	15	the	the	DET
ihlr-16574	10	16	undiscoveredcontrolling	undiscoveredcontrolling	NOUN
ihlr-16574	10	17	the	the	DET
ihlr-16574	10	18	unknown	unknown	ADJ
ihlr-16574	10	19	.......	.......	PUNCT
ihlr-16574	10	20	402	402	NUM
ihlr-16574	10	21	lll	lll	NOUN
ihlr-16574	10	22	.	.	PUNCT
ihlr-16574	11	1	regulatory	regulatory	ADJ
ihlr-16574	11	2	bacic.gr.oond	bacic.gr.oond	NOUN
ihlr-16574	11	3	.........................................................	.........................................................	PUNCT
ihlr-16574	12	1	405	405	NUM
ihlr-16574	12	2	a.	a.	NOUN
ihlr-16574	12	3	regulation	regulation	NOUN
ihlr-16574	12	4	in	in	ADP
ihlr-16574	12	5	the	the	DET
ihlr-16574	12	6	united	united	PROPN
ihlr-16574	12	7	states	states	PROPN
ihlr-16574	12	8	................................................	................................................	PUNCT
ihlr-16574	13	1	405	405	NUM
ihlr-16574	13	2	1	1	NUM
ihlr-16574	13	3	.	.	PUNCT
ihlr-16574	14	1	the	the	DET
ihlr-16574	14	2	fda	fda	PROPN
ihlr-16574	14	3	takes	take	VERB
ihlr-16574	14	4	fhe	fhe	PROPN
ihlr-16574	14	5	i	i	PRON
ihlr-16574	14	6	..	..	PUNCT
ihlr-16574	14	7	ead	ead	PROPN
ihlr-16574	14	8	...................................................	...................................................	PUNCT
ihlr-16574	14	9	405	405	NUM
ihlr-16574	14	10	2	2	NUM
ihlr-16574	14	11	.	.	PUNCT
ihlr-16574	15	1	the	the	DET
ihlr-16574	15	2	nanoteclmology	nanoteclmology	PROPN
ihlr-16574	15	3	task	task	PROPN
ihlr-16574	15	4	force	force	NOUN
ihlr-16574	15	5	.......................................	.......................................	PUNCT
ihlr-16574	15	6	407	407	NUM
ihlr-16574	15	7	3	3	X
ihlr-16574	15	8	.	.	PUNCT
ihlr-16574	15	9	special	special	ADJ
ihlr-16574	15	10	interest	interest	NOUN
ihlr-16574	15	11	groups	group	NOUN
ihlr-16574	15	12	in	in	ADP
ihlr-16574	15	13	the	the	DET
ihlr-16574	15	14	united	united	PROPN
ihlr-16574	15	15	states	states	PROPN
ihlr-16574	15	16	advocating	advocate	VERB
ihlr-16574	15	17	for	for	ADP
ihlr-16574	15	18	regulation	regulation	NOUN
ihlr-16574	15	19	.........................................................................	.........................................................................	PUNCT
ihlr-16574	15	20	409	409	NUM
ihlr-16574	15	21	4	4	NUM
ihlr-16574	15	22	.	.	PUNCT
ihlr-16574	15	23	opposition	opposition	NOUN
ihlr-16574	15	24	to	to	ADP
ihlr-16574	15	25	nanotechnology	nanotechnology	PROPN
ihlr-16574	15	26	research	research	NOUN
ihlr-16574	15	27	and	and	CCONJ
ihlr-16574	15	28	development	development	NOUN
ihlr-16574	15	29	in	in	ADP
ihlr-16574	15	30	the	the	DET
ihlr-16574	15	31	united	united	PROPN
ihlr-16574	15	32	states	states	PROPN
ihlr-16574	15	33	............................................................	............................................................	PUNCT
ihlr-16574	15	34	412	412	NUM
ihlr-16574	15	35	b.	b.	NOUN
ihlr-16574	15	36	regulation	regulation	NOUN
ihlr-16574	15	37	in	in	ADP
ihlr-16574	15	38	the	the	DET
ihlr-16574	15	39	european	european	PROPN
ihlr-16574	15	40	union	union	PROPN
ihlr-16574	15	41	..........................................	..........................................	PUNCT
ihlr-16574	16	1	413	413	NUM
ihlr-16574	16	2	1	1	NUM
ihlr-16574	16	3	.	.	PUNCT
ihlr-16574	17	1	current	current	ADJ
ihlr-16574	17	2	regulatory	regulatory	ADJ
ihlr-16574	17	3	scheme	scheme	NOUN
ihlr-16574	17	4	..............................................	..............................................	PUNCT
ihlr-16574	17	5	413	413	NUM
ihlr-16574	17	6	2	2	NUM
ihlr-16574	17	7	.	.	PUNCT
ihlr-16574	17	8	designated	designate	VERB
ihlr-16574	17	9	regulatory	regulatory	ADJ
ihlr-16574	17	10	groups	group	NOUN
ihlr-16574	17	11	and	and	CCONJ
ihlr-16574	17	12	agencies	agency	NOUN
ihlr-16574	17	13	drafting	draft	VERB
ihlr-16574	17	14	policy	policy	NOUN
ihlr-16574	17	15	.................................................................................	.................................................................................	PUNCT
ihlr-16574	18	1	415	415	NUM
ihlr-16574	18	2	3	3	X
ihlr-16574	18	3	.	.	PUNCT
ihlr-16574	18	4	considering	consider	VERB
ihlr-16574	18	5	regulation	regulation	NOUN
ihlr-16574	18	6	.....................................................	.....................................................	PUNCT
ihlr-16574	18	7	416	416	NUM
ihlr-16574	18	8	4	4	NUM
ihlr-16574	18	9	.	.	PUNCT
ihlr-16574	18	10	focus	focus	NOUN
ihlr-16574	18	11	of	of	ADP
ihlr-16574	18	12	research	research	NOUN
ihlr-16574	18	13	and	and	CCONJ
ihlr-16574	18	14	development	development	NOUN
ihlr-16574	18	15	................................	................................	PUNCT
ihlr-16574	19	1	417	417	NUM
ihlr-16574	19	2	ill	ill	ADJ
ihlr-16574	19	3	.	.	PUNCT
ihlr-16574	19	4	analysis	analysis	NOUN
ihlr-16574	19	5	:	:	PUNCT
ihlr-16574	19	6	strategy	strategy	NOUN
ihlr-16574	19	7	for	for	ADP
ihlr-16574	19	8	governance	governance	NOUN
ihlr-16574	19	9	over	over	ADP
ihlr-16574	19	10	nanomedicine417	nanomedicine417	DET
ihlr-16574	19	11	a.	a.	NOUN
ihlr-16574	19	12	the	the	DET
ihlr-16574	19	13	trouble	trouble	NOUN
ihlr-16574	19	14	with	with	ADP
ihlr-16574	19	15	regulating	regulate	VERB
ihlr-16574	19	16	too	too	ADV
ihlr-16574	19	17	early	early	ADV
ihlr-16574	19	18	..................................	..................................	PUNCT
ihlr-16574	19	19	41	41	NUM
ihlr-16574	19	20	t	t	NOUN
ihlr-16574	19	21	1	1	NUM
ihlr-16574	19	22	.	.	PUNCT
ihlr-16574	20	1	in	in	ADP
ihlr-16574	20	2	the	the	DET
ihlr-16574	20	3	united	united	PROPN
ihlr-16574	20	4	states	states	PROPN
ihlr-16574	20	5	...........................................................	...........................................................	PUNCT
ihlr-16574	21	1	417	417	NUM
ihlr-16574	21	2	2	2	NUM
ihlr-16574	21	3	.	.	PUNCT
ihlr-16574	22	1	in	in	ADP
ihlr-16574	22	2	the	the	DET
ihlr-16574	22	3	european	european	PROPN
ihlr-16574	22	4	union	union	PROPN
ihlr-16574	22	5	......................................................	......................................................	PUNCT
ihlr-16574	22	6	419	419	NUM
ihlr-16574	22	7	b.	b.	NOUN
ihlr-16574	22	8	fixing	fix	VERB
ihlr-16574	22	9	the	the	DET
ihlr-16574	22	10	focus	focus	NOUN
ihlr-16574	22	11	on	on	ADP
ihlr-16574	22	12	research	research	NOUN
ihlr-16574	22	13	and	and	CCONJ
ihlr-16574	22	14	development	development	NOUN
ihlr-16574	22	15	.....................	.....................	PUNCT
ihlr-16574	22	16	421	421	NUM
ihlr-16574	22	17	c.	c.	NOUN
ihlr-16574	22	18	dealing	deal	VERB
ihlr-16574	22	19	with	with	ADP
ihlr-16574	22	20	the	the	DET
ihlr-16574	22	21	ethical	ethical	ADJ
ihlr-16574	22	22	conundrum	conundrum	NOUN
ihlr-16574	22	23	surrounding	surround	VERB
ihlr-16574	22	24	the	the	DET
ihlr-16574	22	25	unknown	unknown	ADJ
ihlr-16574	22	26	in	in	ADP
ihlr-16574	22	27	nanomedicine	nanomedicine	NOUN
ihlr-16574	22	28	......................................................................	......................................................................	PUNCT
ihlr-16574	23	1	422	422	NUM
ihlr-16574	23	2	1	1	NUM
ihlr-16574	23	3	.	.	PUNCT
ihlr-16574	24	1	contemporary	contemporary	ADJ
ihlr-16574	24	2	comparison	comparison	NOUN
ihlr-16574	24	3	to	to	ADP
ihlr-16574	24	4	a	a	DET
ihlr-16574	24	5	medical	medical	ADJ
ihlr-16574	24	6	and	and	CCONJ
ihlr-16574	24	7	ethical	ethical	ADJ
ihlr-16574	24	8	dilemma	dilemma	NOUN
ihlr-16574	24	9	............................................................................	............................................................................	PUNCT
ihlr-16574	25	1	422	422	NUM
ihlr-16574	25	2	2	2	NUM
ihlr-16574	25	3	.	.	PUNCT
ihlr-16574	25	4	creation	creation	NOUN
ihlr-16574	25	5	of	of	ADP
ihlr-16574	25	6	a	a	DET
ihlr-16574	25	7	task	task	NOUN
ihlr-16574	25	8	force	force	NOUN
ihlr-16574	25	9	on	on	ADP
ihlr-16574	25	10	ethical	ethical	ADJ
ihlr-16574	25	11	considerations	consideration	NOUN
ihlr-16574	25	12	........	........	PUNCT
ihlr-16574	25	13	424	424	NUM
ihlr-16574	25	14	•	•	NOUN
ihlr-16574	25	15	j.	j.	PROPN
ihlr-16574	25	16	d.	d.	PROPN
ihlr-16574	25	17	,	,	PUNCT
ihlr-16574	25	18	2009	2009	NUM
ihlr-16574	25	19	,	,	PUNCT
ihlr-16574	25	20	indiana	indiana	PROPN
ihlr-16574	25	21	university	university	PROPN
ihlr-16574	25	22	school	school	NOUN
ihlr-16574	25	23	of	of	ADP
ihlr-16574	25	24	law	law	NOUN
ihlr-16574	25	25	-	-	PUNCT
ihlr-16574	25	26	indianapolis	indianapolis	PROPN
ihlr-16574	25	27	;	;	PUNCT
ihlr-16574	25	28	b.a	b.a	PROPN
ihlr-16574	25	29	.	.	PROPN
ihlr-16574	25	30	,	,	PUNCT
ihlr-16574	25	31	2005	2005	NUM
ihlr-16574	25	32	,	,	PUNCT
ihlr-16574	25	33	butler	butler	PROPN
ihlr-16574	25	34	university	university	PROPN
ihlr-16574	25	35	.	.	PUNCT
ihlr-16574	26	1	398	398	NUM
ihlr-16574	26	2	indiana	indiana	PROPN
ihlr-16574	26	3	healtii	healtii	PROPN
ihlr-16574	26	4	law	law	PROPN
ihlr-16574	26	5	review	review	NOUN
ihlr-16574	26	6	[	[	X
ihlr-16574	26	7	vol	vol	NOUN
ihlr-16574	26	8	.	.	PUNCT
ihlr-16574	27	1	7:397	7:397	NUM
ihlr-16574	27	2	iv	iv	NOUN
ihlr-16574	27	3	.	.	PUNCT
ihlr-16574	27	4	conclusion	conclusion	NOUN
ihlr-16574	27	5	.••••••••••	.••••••••••	PROPN
ihlr-16574	27	6	..	..	PUNCT
ihlr-16574	27	7	••••••••••••••	••••••••••••••	NUM
ihlr-16574	27	8	...	...	PUNCT
ihlr-16574	27	9	••••	••••	NOUN
ihlr-16574	27	10	..	..	SYM
ihlr-16574	27	11	•••••••••.•••••••••••••••.•••••••.•••.•••••••.	•••••••••.•••••••••••••••.•••••••.•••.•••••••.	NOUN
ihlr-16574	27	12	424	424	NUM
ihlr-16574	27	13	every	every	DET
ihlr-16574	27	14	industry	industry	NOUN
ihlr-16574	27	15	that	that	PRON
ihlr-16574	27	16	involves	involve	VERB
ihlr-16574	27	17	manufactured	manufacture	VERB
ihlr-16574	27	18	items	item	NOUN
ihlr-16574	27	19	will	will	AUX
ihlr-16574	27	20	be	be	AUX
ihlr-16574	27	21	impacted	impact	VERB
ihlr-16574	27	22	by	by	ADP
ihlr-16574	27	23	nanotechnology	nanotechnology	NOUN
ihlr-16574	27	24	research	research	NOUN
ihlr-16574	27	25	.	.	PUNCT
ihlr-16574	28	1	everything	everything	PRON
ihlr-16574	28	2	can	can	AUX
ihlr-16574	28	3	be	be	AUX
ihlr-16574	28	4	made	make	VERB
ihlr-16574	28	5	in	in	ADP
ihlr-16574	28	6	some	some	DET
ihlr-16574	28	7	way	way	NOUN
ihlr-16574	28	8	better	well	ADV
ihlr-16574	28	9	-	-	PUNCT
ihlr-16574	28	10	stronger	strong	ADJ
ihlr-16574	28	11	,	,	PUNCT
ihlr-16574	28	12	lighter	light	ADJ
ihlr-16574	28	13	,	,	PUNCT
ihlr-16574	28	14	cheaper	cheap	ADJ
ihlr-16574	28	15	,	,	PUNCT
ihlr-16574	28	16	easier	easy	ADJ
ihlr-16574	28	17	to	to	PART
ihlr-16574	28	18	recycle	recycle	VERB
ihlr-16574	28	19	-	-	PUNCT
ihlr-16574	28	20	if	if	SCONJ
ihlr-16574	28	21	it	it	PRON
ihlr-16574	28	22	's	be	AUX
ihlr-16574	28	23	engineered	engineer	VERB
ihlr-16574	28	24	and	and	CCONJ
ihlr-16574	28	25	·	·	PUNCT
ihlr-16574	28	26	manufactured	manufacture	VERB
ihlr-16574	28	27	at	at	ADP
ihlr-16574	28	28	the	the	DET
ihlr-16574	28	29	nanometer	nanometer	NOUN
ihlr-16574	28	30	scale.1	scale.1	NUM
ihlr-16574	28	31	l	l	NOUN
ihlr-16574	28	32	introduction	introduction	NOUN
ihlr-16574	28	33	poised	poise	VERB
ihlr-16574	28	34	at	at	ADP
ihlr-16574	28	35	the	the	DET
ihlr-16574	28	36	forefront	forefront	NOUN
ihlr-16574	28	37	of	of	ADP
ihlr-16574	28	38	scientific	scientific	ADJ
ihlr-16574	28	39	and	and	CCONJ
ihlr-16574	28	40	technological	technological	ADJ
ihlr-16574	28	41	research	research	NOUN
ihlr-16574	28	42	and	and	CCONJ
ihlr-16574	28	43	ad­	ad­	ADJ
ihlr-16574	28	44	vancement	vancement	NOUN
ihlr-16574	28	45	,	,	PUNCT
ihlr-16574	28	46	nanotechnology	nanotechnology	NOUN
ihlr-16574	28	47	involves	involve	VERB
ihlr-16574	28	48	sophisticated	sophisticated	ADJ
ihlr-16574	28	49	,	,	PUNCT
ihlr-16574	28	50	microscopic	microscopic	ADJ
ihlr-16574	28	51	technolo­	technolo­	ADP
ihlr-16574	28	52	gies	gy	NOUN
ihlr-16574	28	53	that	that	PRON
ihlr-16574	28	54	seek	seek	VERB
ihlr-16574	28	55	to	to	PART
ihlr-16574	28	56	manipulate	manipulate	VERB
ihlr-16574	28	57	matter	matter	NOUN
ihlr-16574	28	58	on	on	ADP
ihlr-16574	28	59	a	a	DET
ihlr-16574	28	60	molecular	molecular	ADJ
ihlr-16574	28	61	level	level	NOUN
ihlr-16574	28	62	.	.	PUNCT
ihlr-16574	29	1	theoretically	theoretically	ADV
ihlr-16574	29	2	,	,	PUNCT
ihlr-16574	29	3	these	these	DET
ihlr-16574	29	4	bits	bit	NOUN
ihlr-16574	29	5	of	of	ADP
ihlr-16574	29	6	nanotechnology	nanotechnology	NOUN
ihlr-16574	29	7	(	(	PUNCT
ihlr-16574	29	8	nanites	nanites	PROPN
ihlr-16574	29	9	)	)	PUNCT
ihlr-16574	29	10	can	can	AUX
ihlr-16574	29	11	be	be	AUX
ihlr-16574	29	12	programmed	program	VERB
ihlr-16574	29	13	,	,	PUNCT
ihlr-16574	29	14	either	either	CCONJ
ihlr-16574	29	15	through	through	ADP
ihlr-16574	29	16	their	their	PRON
ihlr-16574	29	17	molecular	molecular	ADJ
ihlr-16574	29	18	make	make	NOUN
ihlr-16574	29	19	-	-	PUNCT
ihlr-16574	29	20	up	up	NOUN
ihlr-16574	29	21	,	,	PUNCT
ihlr-16574	29	22	chemical	chemical	NOUN
ihlr-16574	29	23	composition	composition	NOUN
ihlr-16574	29	24	,	,	PUNCT
ihlr-16574	29	25	or	or	CCONJ
ihlr-16574	29	26	through	through	ADP
ihlr-16574	29	27	instructive	instructive	ADJ
ihlr-16574	29	28	cod­	cod­	NOUN
ihlr-16574	29	29	ing	ing	ADJ
ihlr-16574	29	30	,	,	PUNCT
ihlr-16574	29	31	to	to	PART
ihlr-16574	29	32	perform	perform	VERB
ihlr-16574	29	33	many	many	ADJ
ihlr-16574	29	34	designed	design	VERB
ihlr-16574	29	35	objectives	objective	NOUN
ihlr-16574	29	36	.	.	PUNCT
ihlr-16574	30	1	essentially	essentially	ADV
ihlr-16574	30	2	,	,	PUNCT
ihlr-16574	30	3	nanites	nanite	NOUN
ihlr-16574	30	4	can	can	AUX
ihlr-16574	30	5	be	be	AUX
ihlr-16574	30	6	pro­	pro­	NOUN
ihlr-16574	30	7	grammed	gramme	VERB
ihlr-16574	30	8	to	to	PART
ihlr-16574	30	9	do	do	VERB
ihlr-16574	30	10	anything	anything	PRON
ihlr-16574	30	11	at	at	ADV
ihlr-16574	30	12	all	all	ADV
ihlr-16574	30	13	.	.	PUNCT
ihlr-16574	31	1	although	although	SCONJ
ihlr-16574	31	2	nanotechnology	nanotechnology	NOUN
ihlr-16574	31	3	could	could	AUX
ihlr-16574	31	4	be	be	AUX
ihlr-16574	31	5	useful	useful	ADJ
ihlr-16574	31	6	in	in	ADP
ihlr-16574	31	7	virtually	virtually	ADV
ihlr-16574	31	8	any	any	DET
ihlr-16574	31	9	industry	industry	NOUN
ihlr-16574	31	10	,	,	PUNCT
ihlr-16574	31	11	it	it	PRON
ihlr-16574	31	12	has	have	VERB
ihlr-16574	31	13	the	the	DET
ihlr-16574	31	14	potential	potential	NOUN
ihlr-16574	31	15	to	to	PART
ihlr-16574	31	16	be	be	AUX
ihlr-16574	31	17	extremely	extremely	ADV
ihlr-16574	31	18	valuable	valuable	ADJ
ihlr-16574	31	19	in	in	ADP
ihlr-16574	31	20	the	the	DET
ihlr-16574	31	21	medical	medical	ADJ
ihlr-16574	31	22	field	field	NOUN
ihlr-16574	31	23	.	.	PUNCT
ihlr-16574	32	1	nanites	nanite	NOUN
ihlr-16574	32	2	could	could	AUX
ihlr-16574	32	3	be	be	AUX
ihlr-16574	32	4	used	use	VERB
ihlr-16574	32	5	to	to	PART
ihlr-16574	32	6	perform	perform	VERB
ihlr-16574	32	7	countless	countless	ADJ
ihlr-16574	32	8	functions	function	NOUN
ihlr-16574	32	9	in	in	ADP
ihlr-16574	32	10	health	health	NOUN
ihlr-16574	32	11	care	care	NOUN
ihlr-16574	32	12	,	,	PUNCT
ihlr-16574	32	13	including	include	VERB
ihlr-16574	32	14	the	the	DET
ihlr-16574	32	15	eradication	eradication	NOUN
ihlr-16574	32	16	of	of	ADP
ihlr-16574	32	17	cancer	cancer	NOUN
ihlr-16574	32	18	-	-	PUNCT
ihlr-16574	32	19	causing	cause	VERB
ihlr-16574	32	20	cells	cell	NOUN
ihlr-16574	32	21	,	,	PUNCT
ihlr-16574	32	22	restoration	restoration	NOUN
ihlr-16574	32	23	of	of	ADP
ihlr-16574	32	24	eyesight	eyesight	ADJ
ihlr-16574	32	25	,	,	PUNCT
ihlr-16574	32	26	stimulation	stimulation	NOUN
ihlr-16574	32	27	of	of	ADP
ihlr-16574	32	28	the	the	DET
ihlr-16574	32	29	immtine	immtine	NOUN
ihlr-16574	32	30	system	system	NOUN
ihlr-16574	32	31	,	,	PUNCT
ihlr-16574	32	32	and	and	CCONJ
ihlr-16574	32	33	even	even	ADV
ihlr-16574	32	34	destruction	destruction	NOUN
ihlr-16574	32	35	of	of	ADP
ihlr-16574	32	36	tu­	tu­	PROPN
ihlr-16574	32	37	mors	mors	PROPN
ihlr-16574	32	38	.	.	PUNCT
ihlr-16574	33	1	nanotechnology	nanotechnology	NOUN
ihlr-16574	33	2	in	in	ADP
ihlr-16574	33	3	the	the	DET
ihlr-16574	33	4	medical	medical	ADJ
ihlr-16574	33	5	field	field	NOUN
ihlr-16574	33	6	,	,	PUNCT
ihlr-16574	33	7	termed	term	VERB
ihlr-16574	33	8	nanomedicine	nanomedicine	NOUN
ihlr-16574	33	9	,	,	PUNCT
ihlr-16574	33	10	is	be	AUX
ihlr-16574	33	11	a	a	DET
ihlr-16574	33	12	topic	topic	NOUN
ihlr-16574	33	13	with	with	ADP
ihlr-16574	33	14	which	which	PRON
ihlr-16574	33	15	many	many	ADJ
ihlr-16574	33	16	of	of	ADP
ihlr-16574	33	17	the	the	DET
ihlr-16574	33	18	world	world	NOUN
ihlr-16574	33	19	's	's	PART
ihlr-16574	33	20	leading	lead	VERB
ihlr-16574	33	21	nations	nation	NOUN
ihlr-16574	33	22	have	have	AUX
ihlr-16574	33	23	already	already	ADV
ihlr-16574	33	24	begun	begin	VERB
ihlr-16574	33	25	to	to	PART
ihlr-16574	33	26	wrestle	wrestle	VERB
ihlr-16574	33	27	.	.	PUNCT
ihlr-16574	34	1	in	in	ADP
ihlr-16574	34	2	2004	2004	NUM
ihlr-16574	34	3	,	,	PUNCT
ihlr-16574	34	4	the	the	DET
ihlr-16574	34	5	european	european	PROPN
ihlr-16574	34	6	commission	commission	PROPN
ihlr-16574	34	7	(	(	PUNCT
ihlr-16574	34	8	"	"	PUNCT
ihlr-16574	34	9	ecj	ecj	PROPN
ihlr-16574	34	10	affirmatively	affirmatively	ADV
ihlr-16574	34	11	decided	decide	VERB
ihlr-16574	34	12	to	to	PART
ihlr-16574	34	13	consider	consider	VERB
ihlr-16574	34	14	nanotechnology	nanotechnology	NOUN
ihlr-16574	34	15	and	and	CCONJ
ihlr-16574	34	16	nanomedicine	nanomedicine	NOUN
ihlr-16574	34	17	as	as	ADP
ihlr-16574	34	18	topics	topic	NOUN
ihlr-16574	34	19	of	of	ADP
ihlr-16574	34	20	the	the	DET
ihlr-16574	34	21	utmost	utmost	ADJ
ihlr-16574	34	22	im­	im­	NOUN
ihlr-16574	34	23	portance	portance	NOUN
ihlr-16574	34	24	with	with	ADP
ihlr-16574	34	25	the	the	DET
ihlr-16574	34	26	adoption	adoption	NOUN
ihlr-16574	34	27	of	of	ADP
ihlr-16574	34	28	the	the	DET
ihlr-16574	34	29	communication2	communication2	NOUN
ihlr-16574	34	30	entitled	entitle	VERB
ihlr-16574	34	31	''	''	PUNCT
ihlr-16574	34	32	towards	towards	ADP
ihlr-16574	34	33	a	a	DET
ihlr-16574	34	34	eu­	eu­	ADJ
ihlr-16574	34	35	ropean	ropean	ADJ
ihlr-16574	34	36	strategy	strategy	NOUN
ihlr-16574	34	37	for	for	ADP
ihlr-16574	34	38	nanoteclniology	nanoteclniology	NOUN
ihlr-16574	34	39	.	.	PUNCT
ihlr-16574	35	1	'.j	'.j	PROPN
ihlr-16574	35	2	the	the	DET
ihlr-16574	35	3	communication	communication	NOUN
ihlr-16574	35	4	pushed	push	VERB
ihlr-16574	35	5	the	the	DET
ihlr-16574	35	6	nanotechnology	nanotechnology	NOUN
ihlr-16574	35	7	issue	issue	NOUN
ihlr-16574	35	8	to	to	ADP
ihlr-16574	35	9	the	the	DET
ihlr-16574	35	10	institutional	institutional	ADJ
ihlr-16574	35	11	level	level	NOUN
ihlr-16574	35	12	,	,	PUNCT
ihlr-16574	35	13	facilitating	facilitate	VERB
ihlr-16574	35	14	the	the	DET
ihlr-16574	35	15	development	development	NOUN
ihlr-16574	35	16	of	of	ADP
ihlr-16574	35	17	a	a	DET
ihlr-16574	35	18	comprehensive	comprehensive	ADJ
ihlr-16574	35	19	european	european	ADJ
ihlr-16574	35	20	strategy	strategy	NOUN
ihlr-16574	35	21	for	for	ADP
ihlr-16574	35	22	dealing	deal	VERB
ihlr-16574	35	23	with	with	ADP
ihlr-16574	35	24	the	the	DET
ihlr-16574	35	25	arrival	arrival	NOUN
ihlr-16574	35	26	of	of	ADP
ihlr-16574	35	27	nano­	nano­	PROPN
ihlr-16574	35	28	technology	technology	NOUN
ihlr-16574	35	29	.	.	PUNCT
ihlr-16574	36	1	4	4	NUM
ihlr-16574	36	2	the	the	DET
ihlr-16574	36	3	formation	formation	NOUN
ihlr-16574	36	4	of	of	ADP
ihlr-16574	36	5	a	a	DET
ihlr-16574	36	6	specific	specific	ADJ
ihlr-16574	36	7	subcommittee	subcommittee	NOUN
ihlr-16574	36	8	to	to	PART
ihlr-16574	36	9	research	research	VERB
ihlr-16574	36	10	and	and	CCONJ
ihlr-16574	36	11	plan	plan	NOUN
ihlr-16574	36	12	for	for	ADP
ihlr-16574	36	13	the	the	DET
ihlr-16574	36	14	arrival	arrival	NOUN
ihlr-16574	36	15	of	of	ADP
ihlr-16574	36	16	nanotechnology	nanotechnology	PROPN
ihlr-16574	36	17	demonstrates	demonstrate	VERB
ihlr-16574	36	18	the	the	DET
ihlr-16574	36	19	considerable	considerable	ADJ
ihlr-16574	36	20	time	time	NOUN
ihlr-16574	36	21	and	and	CCONJ
ihlr-16574	36	22	manpower	manpower	NOUN
ihlr-16574	36	23	the	the	DET
ihlr-16574	36	24	ec	ec	PROPN
ihlr-16574	36	25	has	have	AUX
ihlr-16574	36	26	invested	invest	VERB
ihlr-16574	36	27	in	in	ADP
ihlr-16574	36	28	its	its	PRON
ihlr-16574	36	29	efforts	effort	NOUN
ihlr-16574	36	30	to	to	PART
ihlr-16574	36	31	anticipate	anticipate	VERB
ihlr-16574	36	32	the	the	DET
ihlr-16574	36	33	big	big	ADJ
ihlr-16574	36	34	arrival	arrival	NOUN
ihlr-16574	36	35	of	of	ADP
ihlr-16574	36	36	1	1	NUM
ihlr-16574	36	37	.	.	PUNCT
ihlr-16574	36	38	stan	stan	PROPN
ihlr-16574	36	39	williams	williams	PROPN
ihlr-16574	36	40	,	,	PUNCT
ihlr-16574	36	41	director	director	NOUN
ihlr-16574	36	42	of	of	ADP
ihlr-16574	36	43	quantum	quantum	ADJ
ihlr-16574	36	44	science	science	NOUN
ihlr-16574	36	45	research	research	NOUN
ihlr-16574	36	46	,	,	PUNCT
ihlr-16574	36	47	hp	hp	PROPN
ihlr-16574	36	48	labs	labs	PROPN
ihlr-16574	36	49	,	,	PUNCT
ihlr-16574	36	50	newbridge	newbridge	PROPN
ihlr-16574	36	51	insti­	insti­	DET
ihlr-16574	36	52	tutional	tutional	ADJ
ihlr-16574	36	53	research	research	NOUN
ihlr-16574	36	54	,	,	PUNCT
ihlr-16574	36	55	http://www.newbridgereports.com/quotes.html	http://www.newbridgereports.com/quotes.html	PROPN
ihlr-16574	36	56	(	(	PUNCT
ihlr-16574	36	57	last	last	ADV
ihlr-16574	36	58	visited	visit	VERB
ihlr-16574	36	59	nov	nov	PROPN
ihlr-16574	36	60	.	.	PROPN
ihlr-16574	36	61	1	1	NUM
ihlr-16574	36	62	,	,	PUNCT
ihlr-16574	36	63	2008	2008	NUM
ihlr-16574	36	64	)	)	PUNCT
ihlr-16574	36	65	.	.	PUNCT
ihlr-16574	37	1	2	2	X
ihlr-16574	37	2	.	.	X
ihlr-16574	37	3	the	the	DET
ihlr-16574	37	4	european	european	PROPN
ihlr-16574	37	5	commission	commission	PROPN
ihlr-16574	37	6	functions	function	NOUN
ihlr-16574	37	7	as	as	ADP
ihlr-16574	37	8	the	the	DET
ihlr-16574	37	9	executiv	executiv	NOUN
ihlr-16574	37	10	"	"	PUNCT
ihlr-16574	37	11	branch	branch	NOUN
ihlr-16574	37	12	of	of	ADP
ihlr-16574	37	13	the	the	DET
ihlr-16574	37	14	european	european	PROPN
ihlr-16574	37	15	union	union	PROPN
ihlr-16574	37	16	.	.	PUNCT
ihlr-16574	38	1	''	''	PUNCT
ihlr-16574	38	2	the	the	DET
ihlr-16574	38	3	commission	commission	NOUN
ihlr-16574	38	4	's	's	PART
ihlr-16574	38	5	job	job	NOUN
ihlr-16574	38	6	is	be	AUX
ihlr-16574	38	7	to	to	PART
ihlr-16574	38	8	represent	represent	VERB
ihlr-16574	38	9	the	the	DET
ihlr-16574	38	10	common	common	ADJ
ihlr-16574	38	11	european	european	ADJ
ihlr-16574	38	12	interest	interest	NOUN
ihlr-16574	38	13	to	to	ADP
ihlr-16574	38	14	all	all	DET
ihlr-16574	38	15	the	the	DET
ihlr-16574	38	16	eu	eu	PROPN
ihlr-16574	38	17	countries	country	NOUN
ihlr-16574	38	18	.	.	PUNCT
ihlr-16574	39	1	to	to	PART
ihlr-16574	39	2	allow	allow	VERB
ihlr-16574	39	3	it	it	PRON
ihlr-16574	39	4	to	to	PART
ihlr-16574	39	5	play	play	VERB
ihlr-16574	39	6	its	its	PRON
ihlr-16574	39	7	role	role	NOUN
ihlr-16574	39	8	as	as	ADP
ihlr-16574	39	9	'	'	PUNCT
ihlr-16574	39	10	guardian	guardian	NOUN
ihlr-16574	39	11	of	of	ADP
ihlr-16574	39	12	the	the	DET
ihlr-16574	39	13	treaties	treaty	NOUN
ihlr-16574	39	14	'	'	PART
ihlr-16574	39	15	and	and	CCONJ
ihlr-16574	39	16	defender	defender	NOUN
ihlr-16574	39	17	of	of	ADP
ihlr-16574	39	18	the	the	DET
ihlr-16574	39	19	general	general	ADJ
ihlr-16574	39	20	interest	interest	NOUN
ihlr-16574	39	21	,	,	PUNCT
ihlr-16574	39	22	the	the	DET
ihlr-16574	39	23	commission	commission	NOUN
ihlr-16574	39	24	also	also	ADV
ihlr-16574	39	25	has	have	VERB
ihlr-16574	39	26	the	the	DET
ihlr-16574	39	27	right	right	NOUN
ihlr-16574	39	28	of	of	ADP
ihlr-16574	39	29	initiative	initiative	NOUN
ihlr-16574	39	30	in	in	ADP
ihlr-16574	39	31	the	the	DET
ihlr-16574	39	32	lawmaking	lawmaking	NOUN
ihlr-16574	39	33	process	process	NOUN
ihlr-16574	39	34	.	.	PUNCT
ihlr-16574	39	35	"	"	PUNCT
ihlr-16574	40	1	the	the	DET
ihlr-16574	40	2	european	european	PROPN
ihlr-16574	40	3	commission	commission	PROPN
ihlr-16574	40	4	utilizes	utilize	VERB
ihlr-16574	40	5	communications	communication	NOUN
ihlr-16574	40	6	to	to	PART
ihlr-16574	40	7	disseminate	disseminate	VERB
ihlr-16574	40	8	policy	policy	NOUN
ihlr-16574	40	9	,	,	PUNCT
ihlr-16574	40	10	goals	goal	NOUN
ihlr-16574	40	11	,	,	PUNCT
ihlr-16574	40	12	and	and	CCONJ
ihlr-16574	40	13	directives	directive	NOUN
ihlr-16574	40	14	to	to	ADP
ihlr-16574	40	15	the	the	DET
ihlr-16574	40	16	larger	large	ADJ
ihlr-16574	40	17	european	european	ADJ
ihlr-16574	40	18	community	community	NOUN
ihlr-16574	40	19	.	.	PUNCT
ihlr-16574	41	1	the	the	DET
ihlr-16574	41	2	european	european	PROPN
ihlr-16574	41	3	commission	commission	PROPN
ihlr-16574	41	4	at	at	ADP
ihlr-16574	41	5	work	work	NOUN
ihlr-16574	41	6	,	,	PUNCT
ihlr-16574	41	7	http://ec.europa.eu/	http://ec.europa.eu/	NOUN
ihlr-16574	41	8	atwork.lblscfucts/index	atwork.lblscfucts/index	PROPN
ihlr-16574	41	9	_	_	PROPN
ihlr-16574	41	10	en.htm#comm	en.htm#comm	NOUN
ihlr-16574	41	11	(	(	PUNCT
ihlr-16574	41	12	last	last	ADV
ihlr-16574	41	13	visited	visit	VERB
ihlr-16574	41	14	jan	jan	PROPN
ihlr-16574	41	15	.	.	PROPN
ihlr-16574	41	16	18	18	NUM
ihlr-16574	41	17	,	,	PUNCT
ihlr-16574	41	18	2009	2009	NUM
ihlr-16574	41	19	)	)	PUNCT
ihlr-16574	41	20	.	.	PUNCT
ihlr-16574	42	1	3	3	X
ihlr-16574	42	2	.	.	X
ihlr-16574	42	3	the	the	DET
ihlr-16574	42	4	european	european	ADJ
ihlr-16574	42	5	strategy	strategy	NOUN
ihlr-16574	42	6	for	for	ADP
ihlr-16574	42	7	nanotechnology	nanotechnology	NOUN
ihlr-16574	42	8	and	and	CCONJ
ihlr-16574	42	9	the	the	DET
ihlr-16574	42	10	nanotechnology	nanotechnology	NOUN
ihlr-16574	42	11	action	action	NOUN
ihlr-16574	42	12	plan	plan	NOUN
ihlr-16574	42	13	,	,	PUNCT
ihlr-16574	42	14	http://cordis.europa.eu/nanotechnology/actionplan.htm	http://cordis.europa.eu/nanotechnology/actionplan.htm	PROPN
ihlr-16574	42	15	(	(	PUNCT
ihlr-16574	42	16	last	last	ADV
ihlr-16574	42	17	visited	visit	VERB
ihlr-16574	42	18	jan	jan	PROPN
ihlr-16574	42	19	.	.	PROPN
ihlr-16574	42	20	17	17	NUM
ihlr-16574	42	21	,	,	PUNCT
ihlr-16574	42	22	2009	2009	NUM
ihlr-16574	42	23	)	)	PUNCT
ihlr-16574	42	24	.	.	PUNCT
ihlr-16574	43	1	4	4	X
ihlr-16574	43	2	.	.	X
ihlr-16574	43	3	/d	/d	PUNCT
ihlr-16574	43	4	.	.	PUNCT
ihlr-16574	43	5	2010	2010	NUM
ihlr-16574	43	6	]	]	PUNCT
ihlr-16574	43	7	nanomedicine	nanomedicine	NOUN
ihlr-16574	43	8	399	399	NUM
ihlr-16574	43	9	science	science	NOUN
ihlr-16574	43	10	's	's	PART
ihlr-16574	43	11	smallest	small	ADJ
ihlr-16574	43	12	technologies	technology	NOUN
ihlr-16574	43	13	.	.	PUNCT
ihlr-16574	44	1	in	in	ADP
ihlr-16574	44	2	the	the	DET
ihlr-16574	44	3	united	united	PROPN
ihlr-16574	44	4	states	states	PROPN
ihlr-16574	44	5	,	,	PUNCT
ihlr-16574	44	6	regulatory	regulatory	ADJ
ihlr-16574	44	7	agencies	agency	NOUN
ihlr-16574	44	8	such	such	ADJ
ihlr-16574	44	9	as	as	ADP
ihlr-16574	44	10	the	the	DET
ihlr-16574	44	11	food	food	NOUN
ihlr-16574	44	12	and	and	CCONJ
ihlr-16574	44	13	drug	drug	PROPN
ihlr-16574	44	14	administration	administration	NOUN
ihlr-16574	44	15	(	(	PUNCT
ihlr-16574	44	16	"	"	PUNCT
ihlr-16574	44	17	fda	fda	PROPN
ihlr-16574	44	18	"	"	PUNCT
ihlr-16574	44	19	)	)	PUNCT
ihlr-16574	44	20	have	have	AUX
ihlr-16574	44	21	already	already	ADV
ihlr-16574	44	22	begun	begin	VERB
ihlr-16574	44	23	to	to	PART
ihlr-16574	44	24	formulate	formulate	VERB
ihlr-16574	44	25	frameworks	framework	NOUN
ihlr-16574	44	26	to	to	PART
ihlr-16574	44	27	address	address	VERB
ihlr-16574	44	28	emerging	emerge	VERB
ihlr-16574	44	29	issues	issue	NOUN
ihlr-16574	44	30	presented	present	VERB
ihlr-16574	44	31	by	by	ADP
ihlr-16574	44	32	nanomedicine	nanomedicine	PROPN
ihlr-16574	44	33	.	.	PUNCT
ihlr-16574	45	1	since	since	SCONJ
ihlr-16574	45	2	the	the	DET
ihlr-16574	45	3	beginning	beginning	NOUN
ihlr-16574	45	4	of	of	ADP
ihlr-16574	45	5	the	the	DET
ihlr-16574	45	6	george	george	PROPN
ihlr-16574	45	7	w.	w.	PROPN
ihlr-16574	45	8	bush	bush	PROPN
ihlr-16574	45	9	administration	administration	PROPN
ihlr-16574	45	10	,	,	PUNCT
ihlr-16574	45	11	a	a	DET
ihlr-16574	45	12	great	great	ADJ
ihlr-16574	45	13	deal	deal	NOUN
ihlr-16574	45	14	of	of	ADP
ihlr-16574	45	15	emphasis	emphasis	NOUN
ihlr-16574	45	16	has	have	AUX
ihlr-16574	45	17	been	be	AUX
ihlr-16574	45	18	placed	place	VERB
ihlr-16574	45	19	on	on	ADP
ihlr-16574	45	20	nanotechnology	nanotechnology	PROPN
ihlr-16574	45	21	research	research	NOUN
ihlr-16574	45	22	and	and	CCONJ
ihlr-16574	45	23	development	development	NOUN
ihlr-16574	45	24	.	.	PUNCT
ihlr-16574	46	1	notably	notably	ADV
ihlr-16574	46	2	,	,	PUNCT
ihlr-16574	46	3	the	the	DET
ihlr-16574	46	4	bush	bush	PROPN
ihlr-16574	46	5	administration	administration	NOUN
ihlr-16574	46	6	facilitated	facilitate	VERB
ihlr-16574	46	7	the	the	DET
ihlr-16574	46	8	creation	creation	NOUN
ihlr-16574	46	9	of	of	ADP
ihlr-16574	46	10	the	the	DET
ihlr-16574	46	11	national	national	ADJ
ihlr-16574	46	12	nanotechnology	nanotechnology	PROPN
ihlr-16574	46	13	in­	in­	PROPN
ihlr-16574	46	14	itiative	itiative	PROPN
ihlr-16574	46	15	5	5	NUM
ihlr-16574	46	16	which	which	PRON
ihlr-16574	46	17	receives	receive	VERB
ihlr-16574	46	18	large	large	ADJ
ihlr-16574	46	19	amounts	amount	NOUN
ihlr-16574	46	20	of	of	ADP
ihlr-16574	46	21	federal	federal	ADJ
ihlr-16574	46	22	funding	funding	NOUN
ihlr-16574	46	23	each	each	DET
ihlr-16574	46	24	year	year	NOUN
ihlr-16574	46	25	,	,	PUNCT
ihlr-16574	46	26	includ­	includ­	PROPN
ihlr-16574	46	27	ing	e	VERB
ihlr-16574	46	28	an	an	DET
ihlr-16574	46	29	estimated	estimate	VERB
ihlr-16574	46	30	budget	budget	NOUN
ihlr-16574	46	31	of$1.5	of$1.5	NOUN
ihlr-16574	46	32	billion	billion	NUM
ihlr-16574	46	33	dollars	dollar	NOUN
ihlr-16574	46	34	in	in	ADP
ihlr-16574	46	35	2009.6	2009.6	NUM
ihlr-16574	46	36	this	this	DET
ihlr-16574	46	37	note	note	NOUN
ihlr-16574	46	38	will	will	AUX
ihlr-16574	46	39	take	take	VERB
ihlr-16574	46	40	an	an	DET
ihlr-16574	46	41	in	in	ADP
ihlr-16574	46	42	-	-	PUNCT
ihlr-16574	46	43	depth	depth	NOUN
ihlr-16574	46	44	look	look	NOUN
ihlr-16574	46	45	at	at	ADP
ihlr-16574	46	46	existing	exist	VERB
ihlr-16574	46	47	regulatory	regulatory	ADJ
ihlr-16574	46	48	frameworks	framework	NOUN
ihlr-16574	46	49	concerning	concern	VERB
ihlr-16574	46	50	nanotechnology	nanotechnology	NOUN
ihlr-16574	46	51	and	and	CCONJ
ihlr-16574	46	52	nanomedicine	nanomedicine	NOUN
ihlr-16574	46	53	in	in	ADP
ihlr-16574	46	54	the	the	DET
ihlr-16574	46	55	united	united	PROPN
ihlr-16574	46	56	states	states	PROPN
ihlr-16574	46	57	(	(	PUNCT
ihlr-16574	46	58	"	"	PUNCT
ihlr-16574	46	59	u.s	u.s	PROPN
ihlr-16574	46	60	"	"	PUNCT
ihlr-16574	46	61	)	)	PUNCT
ihlr-16574	46	62	and	and	CCONJ
ihlr-16574	46	63	the	the	DET
ihlr-16574	46	64	european	european	PROPN
ihlr-16574	46	65	union	union	PROPN
ihlr-16574	46	66	(	(	PUNCT
ihlr-16574	46	67	"	"	PUNCT
ihlr-16574	46	68	eu	eu	NOUN
ihlr-16574	46	69	''	''	PUNCT
ihlr-16574	46	70	)	)	PUNCT
ihlr-16574	46	71	.	.	PUNCT
ihlr-16574	47	1	it	it	PRON
ihlr-16574	47	2	will	will	AUX
ihlr-16574	47	3	consider	consider	VERB
ihlr-16574	47	4	the	the	DET
ihlr-16574	47	5	policy	policy	NOUN
ihlr-16574	47	6	rationales	rationale	NOUN
ihlr-16574	47	7	that	that	SCONJ
ihlr-16574	47	8	both	both	DET
ihlr-16574	47	9	nations	nation	NOUN
ihlr-16574	47	10	have	have	AUX
ihlr-16574	47	11	relied	rely	VERB
ihlr-16574	47	12	upon	upon	SCONJ
ihlr-16574	47	13	to	to	PART
ihlr-16574	47	14	justify	justify	VERB
ihlr-16574	47	15	use	use	NOUN
ihlr-16574	47	16	of	of	ADP
ihlr-16574	47	17	their	their	PRON
ihlr-16574	47	18	current	current	ADJ
ihlr-16574	47	19	regulatory	regulatory	ADJ
ihlr-16574	47	20	sys­	sys­	PROPN
ihlr-16574	47	21	tems	tem	NOUN
ihlr-16574	47	22	dealing	deal	VERB
ihlr-16574	47	23	with	with	ADP
ihlr-16574	47	24	nanotechnology	nanotechnology	NOUN
ihlr-16574	47	25	and	and	CCONJ
ihlr-16574	47	26	nanomedicine	nanomedicine	NOUN
ihlr-16574	47	27	.	.	PUNCT
ihlr-16574	48	1	this	this	DET
ihlr-16574	48	2	note	note	NOUN
ihlr-16574	48	3	will	will	AUX
ihlr-16574	48	4	also	also	ADV
ihlr-16574	48	5	consider	consider	VERB
ihlr-16574	48	6	any	any	DET
ihlr-16574	48	7	additional	additional	ADJ
ihlr-16574	48	8	steps	step	NOUN
ihlr-16574	48	9	or	or	CCONJ
ihlr-16574	48	10	measures	measure	NOUN
ihlr-16574	48	11	that	that	PRON
ihlr-16574	48	12	the	the	DET
ihlr-16574	48	13	us	us	PROPN
ihlr-16574	48	14	and	and	CCONJ
ihlr-16574	48	15	the	the	DET
ihlr-16574	48	16	eu	eu	PROPN
ihlr-16574	48	17	have	have	VERB
ihlr-16574	48	18	tak­	tak­	ADV
ihlr-16574	48	19	en	en	ADV
ihlr-16574	48	20	with	with	ADP
ihlr-16574	48	21	regard	regard	NOUN
ihlr-16574	48	22	to	to	ADP
ihlr-16574	48	23	nanotechnology	nanotechnology	NOUN
ihlr-16574	48	24	.	.	PUNCT
ihlr-16574	49	1	this	this	DET
ihlr-16574	49	2	note	note	NOUN
ihlr-16574	49	3	seeks	seek	VERB
ihlr-16574	49	4	to	to	PART
ihlr-16574	49	5	evaluate	evaluate	VERB
ihlr-16574	49	6	how	how	SCONJ
ihlr-16574	49	7	regula­	regula­	ADJ
ihlr-16574	49	8	tory	tory	NOUN
ihlr-16574	49	9	schemes	scheme	NOUN
ihlr-16574	49	10	can	can	AUX
ihlr-16574	49	11	best	well	ADV
ihlr-16574	49	12	maximize	maximize	VERB
ihlr-16574	49	13	the	the	DET
ihlr-16574	49	14	benefits	benefit	NOUN
ihlr-16574	49	15	that	that	PRON
ihlr-16574	49	16	nanotechnology	nanotechnology	NOUN
ihlr-16574	49	17	and	and	CCONJ
ihlr-16574	49	18	nanomedicine	nanomedicine	NOUN
ihlr-16574	49	19	will	will	AUX
ihlr-16574	49	20	give	give	VERB
ihlr-16574	49	21	to	to	ADP
ihlr-16574	49	22	society	society	NOUN
ihlr-16574	49	23	,	,	PUNCT
ihlr-16574	49	24	while	while	SCONJ
ihlr-16574	49	25	simultaneously	simultaneously	ADV
ihlr-16574	49	26	anticipating	anticipate	VERB
ihlr-16574	49	27	and	and	CCONJ
ihlr-16574	49	28	minimizing	minimize	VERB
ihlr-16574	49	29	any	any	DET
ihlr-16574	49	30	negative	negative	ADJ
ihlr-16574	49	31	effects	effect	NOUN
ihlr-16574	49	32	such	such	ADJ
ihlr-16574	49	33	technology	technology	NOUN
ihlr-16574	49	34	might	might	AUX
ihlr-16574	49	35	have	have	VERB
ihlr-16574	49	36	.	.	PUNCT
ihlr-16574	50	1	most	most	ADJ
ihlr-16574	50	2	impor­	impor­	NOUN
ihlr-16574	50	3	tantly	tantly	ADV
ihlr-16574	50	4	,	,	PUNCT
ihlr-16574	50	5	this	this	DET
ihlr-16574	50	6	note	note	NOUN
ihlr-16574	50	7	will	will	AUX
ihlr-16574	50	8	attempt	attempt	VERB
ihlr-16574	50	9	to	to	PART
ihlr-16574	50	10	determine	determine	VERB
ihlr-16574	50	11	if	if	SCONJ
ihlr-16574	50	12	these	these	DET
ihlr-16574	50	13	regulations	regulation	NOUN
ihlr-16574	50	14	stifle	stifle	VERB
ihlr-16574	50	15	the	the	DET
ihlr-16574	50	16	ad­	ad­	PROPN
ihlr-16574	50	17	vancement	vancement	NOUN
ihlr-16574	50	18	and	and	CCONJ
ihlr-16574	50	19	development	development	NOUN
ihlr-16574	50	20	of	of	ADP
ihlr-16574	50	21	nanotechnologies	nanotechnology	NOUN
ihlr-16574	50	22	.	.	PUNCT
ihlr-16574	51	1	ii	ii	PROPN
ihlr-16574	51	2	.	.	PUNCT
ihlr-16574	51	3	historical	historical	ADJ
ihlr-16574	51	4	overview	overview	NOUN
ihlr-16574	51	5	and	and	CCONJ
ihlr-16574	51	6	the	the	DET
ihlr-16574	51	7	trouble	trouble	NOUN
ihlr-16574	51	8	with	with	ADP
ihlr-16574	51	9	regulating	regulate	VERB
ihlr-16574	51	10	new	new	ADJ
ihlr-16574	51	11	technologies	technology	NOUN
ihlr-16574	51	12	a.	a.	NOUN
ihlr-16574	51	13	nanotechnology	nanotechnology	PROPN
ihlr-16574	51	14	and	and	CCONJ
ihlr-16574	51	15	the	the	DET
ihlr-16574	51	16	development	development	NOUN
ihlr-16574	51	17	of	of	ADP
ihlr-16574	51	18	nanomedicine	nanomedicine	NOUN
ihlr-16574	51	19	1	1	NUM
ihlr-16574	51	20	.	.	PUNCT
ihlr-16574	52	1	what	what	PRON
ihlr-16574	52	2	is	be	AUX
ihlr-16574	52	3	nanotechnology	nanotechnology	NOUN
ihlr-16574	52	4	?	?	PUNCT
ihlr-16574	53	1	the	the	DET
ihlr-16574	53	2	prefix	prefix	NOUN
ihlr-16574	53	3	"	"	PUNCT
ihlr-16574	53	4	nano	nano	NOUN
ihlr-16574	53	5	"	"	PUNCT
ihlr-16574	53	6	is	be	AUX
ihlr-16574	53	7	a	a	DET
ihlr-16574	53	8	derivative	derivative	NOUN
ihlr-16574	53	9	of	of	ADP
ihlr-16574	53	10	the	the	DET
ihlr-16574	53	11	term	term	NOUN
ihlr-16574	53	12	'	'	PUNCT
ihlr-16574	53	13	nanos	nano	NOUN
ihlr-16574	53	14	'	'	PUNCT
ihlr-16574	53	15	in	in	ADP
ihlr-16574	53	16	greek	greek	NOUN
ihlr-16574	53	17	,	,	PUNCT
ihlr-16574	53	18	mean­	mean­	VERB
ihlr-16574	53	19	ing	ing	ADJ
ihlr-16574	53	20	dwarf	dwarf	NOUN
ihlr-16574	53	21	..	..	PUNCT
ihlr-16574	53	22	7	7	NUM
ihlr-16574	53	23	"	"	PUNCT
ihlr-16574	53	24	nano	nano	NOUN
ihlr-16574	53	25	''	''	PUNCT
ihlr-16574	53	26	is	be	AUX
ihlr-16574	53	27	also	also	ADV
ihlr-16574	53	28	a	a	DET
ihlr-16574	53	29	prefix	prefix	NOUN
ihlr-16574	53	30	used	use	VERB
ihlr-16574	53	31	in	in	ADP
ihlr-16574	53	32	the	the	DET
ihlr-16574	53	33	metric	metric	ADJ
ihlr-16574	53	34	system	system	NOUN
ihlr-16574	53	35	of	of	ADP
ihlr-16574	53	36	measure­	measure­	PROPN
ihlr-16574	53	37	ment	ment	NOUN
ihlr-16574	53	38	to	to	PART
ihlr-16574	53	39	describe	describe	VERB
ihlr-16574	53	40	a	a	DET
ihlr-16574	53	41	specific	specific	ADJ
ihlr-16574	53	42	unit	unit	NOUN
ihlr-16574	53	43	of	of	ADP
ihlr-16574	53	44	measure	measure	NOUN
ihlr-16574	53	45	a	a	DET
ihlr-16574	53	46	nanometer	nanometer	NOUN
ihlr-16574	53	47	is	be	AUX
ihlr-16574	53	48	one	one	NUM
ihlr-16574	53	49	billionth	billionth	NOUN
ihlr-16574	53	50	of	of	ADP
ihlr-16574	53	51	a	a	DET
ihlr-16574	53	52	meter	meter	NOUN
ihlr-16574	53	53	.	.	PUNCT
ihlr-16574	54	1	8	8	NUM
ihlr-16574	54	2	nanotechnology	nanotechnology	NOUN
ihlr-16574	54	3	is	be	AUX
ihlr-16574	54	4	technology	technology	NOUN
ihlr-16574	54	5	that	that	PRON
ihlr-16574	54	6	is	be	AUX
ihlr-16574	54	7	created	create	VERB
ihlr-16574	54	8	and	and	CCONJ
ihlr-16574	54	9	functions	function	NOUN
ihlr-16574	54	10	on	on	ADP
ihlr-16574	54	11	this	this	PRON
ihlr-16574	54	12	extremely	extremely	ADV
ihlr-16574	54	13	tiny	tiny	ADJ
ihlr-16574	54	14	,	,	PUNCT
ihlr-16574	54	15	or	or	CCONJ
ihlr-16574	54	16	dwarf	dwarf	NOUN
ihlr-16574	54	17	,	,	PUNCT
ihlr-16574	54	18	scale	scale	NOUN
ihlr-16574	54	19	(	(	PUNCT
ihlr-16574	54	20	the	the	DET
ihlr-16574	54	21	nanoscale	nanoscale	NOUN
ihlr-16574	54	22	)	)	PUNCT
ihlr-16574	54	23	.	.	PUNCT
ihlr-16574	55	1	au	au	PROPN
ihlr-16574	55	2	example	example	NOUN
ihlr-16574	55	3	of	of	ADP
ihlr-16574	55	4	the	the	DET
ihlr-16574	55	5	size	size	NOUN
ihlr-16574	55	6	of	of	ADP
ihlr-16574	55	7	the	the	DET
ihlr-16574	55	8	nanoscale	nanoscale	NOUN
ihlr-16574	55	9	would	would	AUX
ihlr-16574	55	10	be	be	AUX
ihlr-16574	55	11	something	something	PRON
ihlr-16574	55	12	"	"	PUNCT
ihlr-16574	55	13	1/80,000th	1/80,000th	NUM
ihlr-16574	55	14	of	of	ADP
ihlr-16574	55	15	the	the	DET
ihlr-16574	55	16	diameter	diameter	NOUN
ihlr-16574	55	17	of	of	ADP
ihlr-16574	55	18	a	a	DET
ihlr-16574	55	19	hu­	hu­	ADJ
ihlr-16574	55	20	man	man	NOUN
ihlr-16574	55	21	hair	hair	NOUN
ihlr-16574	55	22	,	,	PUNCT
ihlr-16574	55	23	or	or	CCONJ
ihlr-16574	55	24	10	10	NUM
ihlr-16574	55	25	times	time	NOUN
ihlr-16574	55	26	the	the	DET
ihlr-16574	55	27	diameter	diameter	NOUN
ihlr-16574	55	28	of	of	ADP
ihlr-16574	55	29	a	a	DET
ihlr-16574	55	30	hydrogen	hydrogen	NOUN
ihlr-16574	55	31	atom	atom	NOUN
ihlr-16574	55	32	.	.	PUNCT
ihlr-16574	56	1	"9	"9	PROPN
ihlr-16574	56	2	regardless	regardless	ADV
ihlr-16574	56	3	of	of	ADP
ihlr-16574	56	4	5	5	NUM
ihlr-16574	56	5	.	.	PUNCT
ihlr-16574	57	1	brian	brian	PROPN
ihlr-16574	57	2	wilhelmi	wilhelmi	PROPN
ihlr-16574	57	3	,	,	PUNCT
ihlr-16574	57	4	nanosilver	nanosilver	ADV
ihlr-16574	57	5	:	:	PUNCT
ihlr-16574	57	6	a	a	DET
ihlr-16574	57	7	test	test	NOUN
ihlr-16574	57	8	for	for	ADP
ihlr-16574	57	9	nanotech	nanotech	PROPN
ihlr-16574	57	10	regulation	regulation	NOUN
ihlr-16574	57	11	,	,	PUNCT
ihlr-16574	57	12	63	63	NUM
ihlr-16574	57	13	food	food	NOUN
ihlr-16574	57	14	&	&	CCONJ
ihlr-16574	57	15	drug	drug	PROPN
ihlr-16574	57	16	l.j	l.j	PROPN
ihlr-16574	57	17	.	.	PROPN
ihlr-16574	57	18	89	89	NUM
ihlr-16574	57	19	,	,	PUNCT
ihlr-16574	57	20	99	99	NUM
ihlr-16574	57	21	(	(	PUNCT
ihlr-16574	57	22	2008	2008	NUM
ihlr-16574	57	23	)	)	PUNCT
ihlr-16574	57	24	6	6	NUM
ihlr-16574	57	25	.	.	PUNCT
ihlr-16574	58	1	ld	ld	PROPN
ihlr-16574	58	2	.	.	PROPN
ihlr-16574	59	1	for	for	ADP
ihlr-16574	59	2	a	a	DET
ihlr-16574	59	3	closer	close	ADJ
ihlr-16574	59	4	examination	examination	NOUN
ihlr-16574	59	5	of	of	ADP
ihlr-16574	59	6	the	the	DET
ihlr-16574	59	7	2007	2007	NUM
ihlr-16574	59	8	-	-	SYM
ihlr-16574	59	9	2009	2009	NUM
ihlr-16574	59	10	funding	funding	NOUN
ihlr-16574	59	11	break	break	NOUN
ihlr-16574	59	12	-	-	PUNCT
ihlr-16574	59	13	down	down	NOUN
ihlr-16574	59	14	,	,	PUNCT
ihlr-16574	59	15	see	see	VERB
ihlr-16574	59	16	chart	chart	NOUN
ihlr-16574	59	17	,	,	PUNCT
ihlr-16574	59	18	infra	infra	VERB
ihlr-16574	59	19	part	part	NOUN
ihlr-16574	59	20	ii(a)(3	ii(a)(3	NOUN
ihlr-16574	59	21	)	)	PUNCT
ihlr-16574	59	22	.	.	PUNCT
ihlr-16574	60	1	7	7	X
ihlr-16574	60	2	.	.	X
ihlr-16574	60	3	m.	m.	PROPN
ihlr-16574	60	4	lupton	lupton	PROPN
ihlr-16574	60	5	,	,	PUNCT
ihlr-16574	60	6	nanotechnologysalvation	nanotechnologysalvation	NOUN
ihlr-16574	60	7	or	or	CCONJ
ihlr-16574	60	8	damnation	damnation	NOUN
ihlr-16574	60	9	for	for	ADP
ihlr-16574	60	10	humans	human	NOUN
ihlr-16574	60	11	?	?	PUNCT
ihlr-16574	60	12	,	,	PUNCT
ihlr-16574	60	13	26	26	NUM
ihlr-16574	60	14	med	med	ADJ
ihlr-16574	60	15	.	.	PROPN
ihlr-16574	60	16	&	&	CCONJ
ihlr-16574	60	17	l.	l.	PROPN
ihlr-16574	60	18	,	,	PUNCT
ihlr-16574	60	19	349	349	NUM
ihlr-16574	60	20	,	,	PUNCT
ihlr-16574	60	21	350	350	NUM
ihlr-16574	60	22	(	(	PUNCT
ihlr-16574	60	23	2007	2007	NUM
ihlr-16574	60	24	)	)	PUNCT
ihlr-16574	60	25	.	.	PUNCT
ihlr-16574	61	1	8	8	X
ihlr-16574	61	2	.	.	PUNCT
ihlr-16574	61	3	/d	/d	PUNCT
ihlr-16574	61	4	.	.	PUNCT
ihlr-16574	62	1	9	9	X
ihlr-16574	62	2	.	.	PUNCT
ihlr-16574	62	3	/d	/d	PUNCT
ihlr-16574	62	4	.	.	PUNCT
ihlr-16574	63	1	citing	cite	VERB
ihlr-16574	63	2	bbc	bbc	PROPN
ihlr-16574	63	3	news	news	PROPN
ihlr-16574	63	4	science	science	PROPN
ihlr-16574	63	5	/	/	SYM
ihlr-16574	63	6	nature	nature	NOUN
ihlr-16574	63	7	,	,	PUNCT
ihlr-16574	63	8	www.bbc.com	www.bbc.com	PROPN
ihlr-16574	63	9	;	;	PUNCT
ihlr-16574	63	10	"	"	PUNCT
ihlr-16574	63	11	the	the	DET
ihlr-16574	63	12	smaller	small	ADJ
ihlr-16574	63	13	is	be	AUX
ihlr-16574	63	14	better	well	ADJ
ihlr-16574	63	15	"	"	PUNCT
ihlr-16574	63	16	in	in	ADP
ihlr-16574	63	17	reason	reason	NOUN
ihlr-16574	63	18	,	,	PUNCT
ihlr-16574	63	19	www.keepmedia.com	www.keepmedia.com	PROPN
ihlr-16574	63	20	400	400	NUM
ihlr-16574	63	21	indiana	indiana	PROPN
ihlr-16574	63	22	health	health	PROPN
ihlr-16574	63	23	law	law	PROPN
ihlr-16574	63	24	review	review	NOUN
ihlr-16574	63	25	(	(	PUNCT
ihlr-16574	63	26	vol	vol	NOUN
ihlr-16574	63	27	.	.	PUNCT
ihlr-16574	64	1	7:397	7:397	NUM
ihlr-16574	64	2	how	how	SCONJ
ihlr-16574	64	3	specifically	specifically	ADV
ihlr-16574	64	4	it	it	PRON
ihlr-16574	64	5	is	be	AUX
ihlr-16574	64	6	measured	measure	VERB
ihlr-16574	64	7	,	,	PUNCT
ihlr-16574	64	8	nanotechnology	nanotechnology	NOUN
ihlr-16574	64	9	is	be	AUX
ihlr-16574	64	10	small	small	ADJ
ihlr-16574	64	11	,	,	PUNCT
ihlr-16574	64	12	very	very	ADV
ihlr-16574	64	13	small	small	ADJ
ihlr-16574	64	14	.	.	PUNCT
ihlr-16574	65	1	nanotechnology	nanotechnology	NOUN
ihlr-16574	66	1	d	d	PROPN
ihlr-16574	66	2	~	~	NOUN
ihlr-16574	66	3	velopment	velopment	NOUN
ihlr-16574	66	4	can	can	AUX
ihlr-16574	66	5	be	be	AUX
ihlr-16574	66	6	broken	break	VERB
ihlr-16574	66	7	down	down	ADP
ihlr-16574	66	8	into	into	ADP
ihlr-16574	66	9	two	two	NUM
ihlr-16574	66	10	distinct	distinct	ADJ
ihlr-16574	66	11	scientific•	scientific•	NOUN
ihlr-16574	66	12	approaches	approach	NOUN
ihlr-16574	66	13	:	:	PUNCT
ihlr-16574	66	14	the	the	DET
ihlr-16574	66	15	top	top	NOUN
ihlr-16574	66	16	down	down	ADP
ihlr-16574	66	17	approach	approach	NOUN
ihlr-16574	66	18	and	and	CCONJ
ihlr-16574	66	19	the	the	DET
ihlr-16574	66	20	bottom	bottom	NOUN
ihlr-16574	66	21	up	up	ADP
ihlr-16574	66	22	approach.10	approach.10	ADP
ihlr-16574	66	23	the	the	DET
ihlr-16574	66	24	top	top	NOUN
ihlr-16574	66	25	down	down	ADP
ihlr-16574	66	26	approach	approach	NOUN
ihlr-16574	66	27	involves	involve	VERB
ihlr-16574	66	28	the	the	DET
ihlr-16574	66	29	creation	creation	NOUN
ihlr-16574	66	30	of	of	ADP
ihlr-16574	66	31	a	a	DET
ihlr-16574	66	32	structure	structure	NOUN
ihlr-16574	66	33	on	on	ADP
ihlr-16574	66	34	the	the	DET
ihlr-16574	66	35	nanos­	nanos­	PROPN
ihlr-16574	66	36	cale.11	cale.11	NOUN
ihlr-16574	66	37	these	these	DET
ihlr-16574	66	38	creations	creation	NOUN
ihlr-16574	66	39	would	would	AUX
ihlr-16574	66	40	be	be	AUX
ihlr-16574	66	41	machines	machine	NOUN
ihlr-16574	66	42	of	of	ADP
ihlr-16574	66	43	sorts	sort	NOUN
ihlr-16574	66	44	that	that	PRON
ihlr-16574	66	45	were	be	AUX
ihlr-16574	66	46	produced	produce	VERB
ihlr-16574	66	47	by	by	ADP
ihlr-16574	66	48	other	other	ADJ
ihlr-16574	66	49	machines	machine	NOUN
ihlr-16574	66	50	or	or	CCONJ
ihlr-16574	66	51	etching	etch	VERB
ihlr-16574	66	52	techniques.12	techniques.12	NOUN
ihlr-16574	66	53	in	in	ADP
ihlr-16574	66	54	contrast	contrast	NOUN
ihlr-16574	66	55	,	,	PUNCT
ihlr-16574	66	56	the	the	DET
ihlr-16574	66	57	bottom	bottom	NOUN
ihlr-16574	66	58	up	up	ADP
ihlr-16574	66	59	approach	approach	NOUN
ihlr-16574	66	60	involves	involve	VERB
ihlr-16574	66	61	the	the	DET
ihlr-16574	66	62	construction	construction	NOUN
ihlr-16574	66	63	of	of	ADP
ihlr-16574	66	64	technology	technology	NOUN
ihlr-16574	66	65	atom	atom	NOUN
ihlr-16574	66	66	-	-	PUNCT
ihlr-16574	66	67	by	by	ADP
ihlr-16574	66	68	-	-	PUNCT
ihlr-16574	66	69	atom	atom	NOUN
ihlr-16574	66	70	or	or	CCONJ
ihlr-16574	66	71	molecule	molecule	NOUN
ihlr-16574	66	72	-	-	PUNCT
ihlr-16574	66	73	by­	by­	ADJ
ihlr-16574	66	74	molecule	molecule	NOUN
ihlr-16574	66	75	out	out	ADP
ihlr-16574	66	76	of	of	ADP
ihlr-16574	66	77	organic	organic	ADJ
ihlr-16574	66	78	and	and	CCONJ
ihlr-16574	66	79	inorganic	inorganic	ADJ
ihlr-16574	66	80	matter.13	matter.13	NOUN
ihlr-16574	66	81	this	this	DET
ihlr-16574	66	82	approach	approach	NOUN
ihlr-16574	66	83	,	,	PUNCT
ihlr-16574	66	84	also	also	ADV
ihlr-16574	66	85	re­	re­	AUX
ihlr-16574	66	86	ferred	ferre	VERB
ihlr-16574	66	87	to	to	ADP
ihlr-16574	66	88	as	as	ADP
ihlr-16574	66	89	molecular	molecular	ADJ
ihlr-16574	66	90	nanotechnology	nanotechnology	NOUN
ihlr-16574	66	91	,	,	PUNCT
ihlr-16574	66	92	is	be	AUX
ihlr-16574	66	93	more	more	ADV
ihlr-16574	66	94	firmly	firmly	ADV
ihlr-16574	66	95	rooted	rooted	ADJ
ihlr-16574	66	96	in	in	ADP
ihlr-16574	66	97	biology.14	biology.14	PROPN
ihlr-16574	66	98	not	not	PART
ihlr-16574	66	99	surprisingly	surprisingly	ADV
ihlr-16574	66	100	,	,	PUNCT
ihlr-16574	66	101	molecular	molecular	ADJ
ihlr-16574	66	102	nanotechnology	nanotechnology	NOUN
ihlr-16574	66	103	is	be	AUX
ihlr-16574	66	104	easily	easily	ADV
ihlr-16574	66	105	the	the	DET
ihlr-16574	66	106	most	most	ADV
ihlr-16574	66	107	advanced	advanced	ADJ
ihlr-16574	66	108	form	form	NOUN
ihlr-16574	66	109	of	of	ADP
ihlr-16574	66	110	nanotechnology.15	nanotechnology.15	NOUN
ihlr-16574	66	111	it	it	PRON
ihlr-16574	66	112	not	not	PART
ihlr-16574	66	113	only	only	ADV
ihlr-16574	66	114	involves	involve	VERB
ihlr-16574	66	115	the	the	DET
ihlr-16574	66	116	construction	construction	NOUN
ihlr-16574	66	117	of	of	ADP
ihlr-16574	66	118	engi­	engi­	PROPN
ihlr-16574	66	119	neered	neere	VERB
ihlr-16574	66	120	organic	organic	ADJ
ihlr-16574	66	121	matter	matter	NOUN
ihlr-16574	66	122	on	on	ADP
ihlr-16574	66	123	the	the	DET
ihlr-16574	66	124	small	small	ADJ
ihlr-16574	66	125	nanoscale	nanoscale	NOUN
ihlr-16574	66	126	,	,	PUNCT
ihlr-16574	66	127	but	but	CCONJ
ihlr-16574	66	128	also	also	ADV
ihlr-16574	66	129	the	the	DET
ihlr-16574	66	130	ability	ability	NOUN
ihlr-16574	66	131	to	to	PART
ihlr-16574	66	132	pro­	pro­	VERB
ihlr-16574	66	133	gram	gram	NOUN
ihlr-16574	66	134	and	and	CCONJ
ihlr-16574	66	135	sustain	sustain	VERB
ihlr-16574	66	136	this	this	DET
ihlr-16574	66	137	organic	organic	ADJ
ihlr-16574	66	138	matter	matter	NOUN
ihlr-16574	66	139	to	to	PART
ihlr-16574	66	140	perform	perform	VERB
ihlr-16574	66	141	specific	specific	ADJ
ihlr-16574	66	142	tasks	task	NOUN
ihlr-16574	66	143	over	over	ADP
ihlr-16574	66	144	a	a	DET
ihlr-16574	66	145	period	period	NOUN
ihlr-16574	66	146	oftime.16	oftime.16	NOUN
ihlr-16574	66	147	2	2	NUM
ihlr-16574	66	148	.	.	PUNCT
ihlr-16574	67	1	what	what	PRON
ihlr-16574	67	2	is	be	AUX
ihlr-16574	67	3	nanomedicine	nanomedicine	ADJ
ihlr-16574	67	4	?	?	PUNCT
ihlr-16574	68	1	the	the	DET
ihlr-16574	68	2	national	national	PROPN
ihlr-16574	68	3	institute	institute	PROPN
ihlr-16574	68	4	for	for	ADP
ihlr-16574	68	5	health	health	PROPN
ihlr-16574	68	6	(	(	PUNCT
ihlr-16574	68	7	nih	nih	NOUN
ihlr-16574	68	8	)	)	PUNCT
ihlr-16574	68	9	defines	define	VERB
ihlr-16574	68	10	nanomedicine	nanomedicine	NOUN
ihlr-16574	68	11	as	as	ADP
ihlr-16574	68	12	"	"	PUNCT
ihlr-16574	68	13	an	an	DET
ihlr-16574	68	14	offshoot	offshoot	NOUN
ihlr-16574	68	15	of	of	ADP
ihlr-16574	68	16	nanotechnology	nanotechnology	NOUN
ihlr-16574	68	17	,	,	PUNCT
ihlr-16574	68	18	[	[	X
ihlr-16574	68	19	that	that	PRON
ihlr-16574	68	20	]	]	PUNCT
ihlr-16574	68	21	refers	refer	VERB
ihlr-16574	68	22	to	to	ADP
ihlr-16574	68	23	highly	highly	ADV
ihlr-16574	68	24	specific	specific	ADJ
ihlr-16574	68	25	medical	medical	ADJ
ihlr-16574	68	26	inter­	inter­	NUM
ihlr-16574	68	27	vention	vention	NOUN
ihlr-16574	68	28	at	at	ADP
ihlr-16574	68	29	the	the	DET
ihlr-16574	68	30	molecular	molecular	ADJ
ihlr-16574	68	31	scale	scale	NOUN
ihlr-16574	68	32	for	for	ADP
ihlr-16574	68	33	curing	cure	VERB
ihlr-16574	68	34	disease	disease	NOUN
ihlr-16574	68	35	or	or	CCONJ
ihlr-16574	68	36	repairing	repair	VERB
ihlr-16574	68	37	damaged	damage	VERB
ihlr-16574	68	38	tis­	tis­	ADJ
ihlr-16574	68	39	sues	sue	NOUN
ihlr-16574	68	40	,	,	PUNCT
ihlr-16574	68	41	such	such	ADJ
ihlr-16574	68	42	as	as	ADP
ihlr-16574	68	43	bone	bone	NOUN
ihlr-16574	68	44	,	,	PUNCT
ihlr-16574	68	45	muscle	muscle	NOUN
ihlr-16574	68	46	,	,	PUNCT
ihlr-16574	68	47	or	or	CCONJ
ihlr-16574	68	48	nerve	nerve	NOUN
ihlr-16574	68	49	.	.	PUNCT
ihlr-16574	69	1	"17	"17	PROPN
ihlr-16574	69	2	similarly	similarly	ADV
ihlr-16574	69	3	,	,	PUNCT
ihlr-16574	69	4	the	the	DET
ihlr-16574	69	5	european	european	PROPN
ihlr-16574	69	6	technology	technology	PROPN
ihlr-16574	69	7	platform	platform	NOUN
ihlr-16574	69	8	(	(	PUNCT
ihlr-16574	69	9	etpi8	etpi8	X
ihlr-16574	69	10	defines	define	VERB
ihlr-16574	69	11	nanomedicine	nanomedicine	NOUN
ihlr-16574	69	12	as	as	ADP
ihlr-16574	69	13	technology	technology	NOUN
ihlr-16574	69	14	that	that	SCONJ
ihlr-16574	69	15	"	"	PUNCT
ihlr-16574	69	16	ex­	ex­	NOUN
ihlr-16574	69	17	ploits	ploit	VERB
ihlr-16574	69	18	the	the	DET
ihlr-16574	69	19	improved	improved	ADJ
ihlr-16574	69	20	and	and	CCONJ
ihlr-16574	69	21	often	often	ADV
ihlr-16574	69	22	novel	novel	ADJ
ihlr-16574	69	23	physical	physical	ADJ
ihlr-16574	69	24	,	,	PUNCT
ihlr-16574	69	25	chemical	chemical	NOUN
ihlr-16574	69	26	and	and	CCONJ
ihlr-16574	69	27	biological	biological	ADJ
ihlr-16574	69	28	prop­	prop­	PROPN
ihlr-16574	69	29	erties	ertie	NOUN
ihlr-16574	69	30	of	of	ADP
ihlr-16574	69	31	materials	material	NOUN
ihlr-16574	69	32	at	at	ADP
ihlr-16574	69	33	the	the	DET
ihlr-16574	69	34	nanometer	nanometer	NOUN
ihlr-16574	69	35	scale	scale	NOUN
ihlr-16574	69	36	.	.	PUNCT
ihlr-16574	70	1	nanomedicine	nanomedicine	PROPN
ihlr-16574	70	2	has	have	VERB
ihlr-16574	70	3	the	the	DET
ihlr-16574	70	4	potential	potential	NOUN
ihlr-16574	70	5	to	to	PART
ihlr-16574	70	6	enable	enable	VERB
ihlr-16574	70	7	early	early	ADJ
ihlr-16574	70	8	detection	detection	NOUN
ihlr-16574	70	9	and	and	CCONJ
ihlr-16574	70	10	prevention	prevention	NOUN
ihlr-16574	70	11	,	,	PUNCT
ihlr-16574	70	12	and	and	CCONJ
ihlr-16574	70	13	to	to	PART
ihlr-16574	70	14	essentially	essentially	ADV
ihlr-16574	70	15	improve	improve	VERB
ihlr-16574	70	16	diagno­	diagno­	PROPN
ihlr-16574	70	17	sis	sis	NOUN
ihlr-16574	70	18	,	,	PUNCT
ihlr-16574	70	19	treatment	treatment	NOUN
ihlr-16574	70	20	and	and	CCONJ
ihlr-16574	70	21	follow	follow	NOUN
ihlr-16574	70	22	-	-	PUNCT
ihlr-16574	70	23	up	up	NOUN
ihlr-16574	70	24	of	of	ADP
ihlr-16574	70	25	diseases	disease	NOUN
ihlr-16574	70	26	.	.	PUNCT
ihlr-16574	71	1	"19	"19	NOUN
ihlr-16574	72	1	unlike	unlike	ADP
ihlr-16574	72	2	conventional	conventional	ADJ
ihlr-16574	72	3	medicine	medicine	NOUN
ihlr-16574	72	4	of	of	ADP
ihlr-16574	72	5	today	today	NOUN
ihlr-16574	72	6	,	,	PUNCT
ihlr-16574	72	7	"	"	PUNCT
ihlr-16574	72	8	[	[	X
ihlr-16574	72	9	n]anomedicine	n]anomedicine	PRON
ihlr-16574	72	10	would	would	AUX
ihlr-16574	72	11	facilitate	facilitate	VERB
ihlr-16574	72	12	the	the	DET
ihlr-16574	72	13	repair	repair	NOUN
ihlr-16574	72	14	and	and	CCONJ
ihlr-16574	72	15	improvement	improvement	NOUN
ihlr-16574	72	16	of	of	ADP
ihlr-16574	72	17	the	the	DET
ihlr-16574	72	18	human	human	ADJ
ihlr-16574	72	19	body	body	NOUN
ihlr-16574	72	20	from	from	ADP
ihlr-16574	72	21	the	the	DET
ihlr-16574	72	22	inside	inside	NOUN
ihlr-16574	72	23	out	out	ADV
ihlr-16574	72	24	,	,	PUNCT
ihlr-16574	72	25	with	with	ADP
ihlr-16574	72	26	a	a	DET
ihlr-16574	72	27	precision	precision	NOUN
ihlr-16574	72	28	and	and	CCONJ
ihlr-16574	72	29	delicacy	delicacy	NOUN
ihlr-16574	72	30	far	far	ADV
ihlr-16574	72	31	greater	great	ADJ
ihlr-16574	72	32	than	than	ADP
ihlr-16574	72	33	the	the	DET
ihlr-16574	72	34	finest	fine	ADJ
ihlr-16574	72	35	surgical	surgical	ADJ
ihlr-16574	72	36	instruments	instrument	NOUN
ihlr-16574	72	37	penint	penint	NOUN
ihlr-16574	72	38	.	.	PUNCT
ihlr-16574	73	1	•	•	NUM
ihlr-16574	73	2	.2o	.2o	NOUN
ihlr-16574	73	3	·	·	PUNCT
ihlr-16574	74	1	10	10	NUM
ihlr-16574	74	2	.	.	PUNCT
ihlr-16574	75	1	lupton	lupton	PROPN
ihlr-16574	75	2	,	,	PUNCT
ihlr-16574	75	3	supra	supra	PROPN
ihlr-16574	75	4	note	note	PROPN
ihlr-16574	75	5	7	7	NUM
ihlr-16574	75	6	,	,	PUNCT
ihlr-16574	75	7	at	at	ADP
ihlr-16574	75	8	350	350	NUM
ihlr-16574	75	9	.	.	PUNCT
ihlr-16574	75	10	11	11	NUM
ihlr-16574	75	11	.	.	X
ihlr-16574	76	1	ld	ld	PROPN
ihlr-16574	76	2	at	at	ADP
ihlr-16574	76	3	351	351	NUM
ihlr-16574	76	4	.	.	PUNCT
ihlr-16574	76	5	12	12	NUM
ihlr-16574	76	6	.	.	PUNCT
ihlr-16574	77	1	this	this	DET
ihlr-16574	77	2	type	type	NOUN
ihlr-16574	77	3	of	of	ADP
ihlr-16574	77	4	nanotechnology	nanotechnology	NOUN
ihlr-16574	77	5	is	be	AUX
ihlr-16574	77	6	best	well	ADV
ihlr-16574	77	7	thought	think	VERB
ihlr-16574	77	8	of	of	ADP
ihlr-16574	77	9	as	as	ADP
ihlr-16574	77	10	akin	akin	ADJ
ihlr-16574	77	11	to	to	ADP
ihlr-16574	77	12	microscopic	microscopic	ADJ
ihlr-16574	77	13	robots	robot	NOUN
ihlr-16574	77	14	or	or	CCONJ
ihlr-16574	77	15	machines	machine	NOUN
ihlr-16574	77	16	that	that	PRON
ihlr-16574	77	17	were	be	AUX
ihlr-16574	77	18	constructed	construct	VERB
ihlr-16574	77	19	out	out	ADP
ihlr-16574	77	20	of	of	ADP
ihlr-16574	77	21	raw	raw	ADJ
ihlr-16574	77	22	materials	material	NOUN
ihlr-16574	77	23	and	and	CCONJ
ihlr-16574	77	24	assembled	assemble	VERB
ihlr-16574	77	25	by	by	ADP
ihlr-16574	77	26	other	other	ADJ
ihlr-16574	77	27	machines	machine	NOUN
ihlr-16574	77	28	.	.	PUNCT
ihlr-16574	78	1	jd	jd	PROPN
ihlr-16574	78	2	13	13	NUM
ihlr-16574	78	3	.	.	PUNCT
ihlr-16574	79	1	lupton	lupton	PROPN
ihlr-16574	79	2	,	,	PUNCT
ihlr-16574	79	3	supra	supra	PROPN
ihlr-16574	79	4	note	note	PROPN
ihlr-16574	79	5	7	7	NUM
ihlr-16574	79	6	,	,	PUNCT
ihlr-16574	79	7	at	at	ADP
ihlr-16574	79	8	351	351	NUM
ihlr-16574	79	9	.	.	PUNCT
ihlr-16574	79	10	14	14	NUM
ihlr-16574	79	11	.	.	PUNCT
ihlr-16574	80	1	jd	jd	PROPN
ihlr-16574	80	2	.	.	PROPN
ihlr-16574	80	3	15	15	NUM
ihlr-16574	80	4	.	.	PUNCT
ihlr-16574	81	1	/d	/d	PUNCT
ihlr-16574	81	2	.	.	PUNCT
ihlr-16574	82	1	16	16	NUM
ihlr-16574	82	2	.	.	X
ihlr-16574	82	3	ld	ld	PROPN
ihlr-16574	82	4	(	(	PUNCT
ihlr-16574	82	5	providing	provide	VERB
ihlr-16574	82	6	an	an	DET
ihlr-16574	82	7	example	example	NOUN
ihlr-16574	82	8	through	through	ADP
ihlr-16574	82	9	the	the	DET
ihlr-16574	82	10	creation	creation	NOUN
ihlr-16574	82	11	of	of	ADP
ihlr-16574	82	12	''	''	PUNCT
ihlr-16574	82	13	tiny	tiny	ADJ
ihlr-16574	82	14	living	living	NOUN
ihlr-16574	82	15	robots	robot	NOUN
ihlr-16574	82	16	,	,	PUNCT
ihlr-16574	82	17	called	call	VERB
ihlr-16574	82	18	bio­	bio­	NOUN
ihlr-16574	82	19	bots	bot	NOUN
ihlr-16574	82	20	.	.	PUNCT
ihlr-16574	82	21	"	"	PUNCT
ihlr-16574	83	1	/d	/d	PUNCT
ihlr-16574	83	2	.	.	PUNCT
ihlr-16574	83	3	)	)	PUNCT
ihlr-16574	84	1	17	17	NUM
ihlr-16574	84	2	.	.	PUNCT
ihlr-16574	85	1	the	the	DET
ihlr-16574	85	2	nih	nih	PROPN
ihlr-16574	85	3	common	common	PROPN
ihlr-16574	85	4	fund	fund	PROPN
ihlr-16574	85	5	,	,	PUNCT
ihlr-16574	85	6	nanomedicine	nanomedicine	NOUN
ihlr-16574	85	7	,	,	PUNCT
ihlr-16574	85	8	http://nihroadmap.nih.gov/nanomedicine/	http://nihroadmap.nih.gov/nanomedicine/	NOUN
ihlr-16574	85	9	(	(	PUNCT
ihlr-16574	85	10	last	last	ADV
ihlr-16574	85	11	visited	visit	VERB
ihlr-16574	85	12	nov	nov	PROPN
ihlr-16574	85	13	.	.	PROPN
ihlr-16574	85	14	8	8	NUM
ihlr-16574	85	15	,	,	PUNCT
ihlr-16574	85	16	2008	2008	NUM
ihlr-16574	85	17	)	)	PUNCT
ihlr-16574	85	18	.	.	PUNCT
ihlr-16574	86	1	18	18	NUM
ihlr-16574	86	2	.	.	PUNCT
ihlr-16574	86	3	''	''	PUNCT
ihlr-16574	87	1	th~	th~	PROPN
ihlr-16574	87	2	members	member	NOUN
ihlr-16574	87	3	of	of	ADP
ihlr-16574	87	4	the	the	DET
ihlr-16574	87	5	etp	etp	PROPN
ihlr-16574	87	6	are	be	AUX
ihlr-16574	87	7	stakeholder	stakeholder	NOUN
ihlr-16574	87	8	organisations	organisation	NOUN
ihlr-16574	87	9	in	in	ADP
ihlr-16574	87	10	the	the	DET
ihlr-16574	87	11	field	field	NOUN
ihlr-16574	87	12	ofnanomedi­	ofnanomedi­	PROPN
ihlr-16574	87	13	cine	cine	NOUN
ihlr-16574	87	14	including	include	VERB
ihlr-16574	87	15	large	large	ADJ
ihlr-16574	87	16	industry	industry	NOUN
ihlr-16574	87	17	,	,	PUNCT
ihlr-16574	87	18	smes	sme	NOUN
ihlr-16574	87	19	,	,	PUNCT
ihlr-16574	87	20	industrial	industrial	ADJ
ihlr-16574	87	21	associations	association	NOUN
ihlr-16574	87	22	,	,	PUNCT
ihlr-16574	87	23	research	research	NOUN
ihlr-16574	87	24	institutions	institution	NOUN
ihlr-16574	87	25	,	,	PUNCT
ihlr-16574	87	26	academia	academia	NOUN
ihlr-16574	87	27	,	,	PUNCT
ihlr-16574	87	28	hospitals	hospital	NOUN
ihlr-16574	87	29	and	and	CCONJ
ihlr-16574	87	30	others	other	NOUN
ihlr-16574	87	31	.	.	PUNCT
ihlr-16574	87	32	"	"	PUNCT
ihlr-16574	88	1	european	european	ADJ
ihlr-16574	88	2	technology	technology	NOUN
ihlr-16574	88	3	platform	platform	NOUN
ihlr-16574	88	4	,	,	PUNCT
ihlr-16574	88	5	membership	membership	NOUN
ihlr-16574	88	6	,	,	PUNCT
ihlr-16574	88	7	http://www.etp­	http://www.etp­	X
ihlr-16574	88	8	nanomedicine.eu/public/about/membership	nanomedicine.eu/public/about/membership	NOUN
ihlr-16574	88	9	(	(	PUNCT
ihlr-16574	88	10	last	last	ADV
ihlr-16574	88	11	visited	visit	VERB
ihlr-16574	88	12	mar	mar	PROPN
ihlr-16574	88	13	.	.	PROPN
ihlr-16574	88	14	14	14	NUM
ihlr-16574	88	15	,	,	PUNCT
ihlr-16574	88	16	2009	2009	NUM
ihlr-16574	88	17	)	)	PUNCT
ihlr-16574	88	18	.	.	PUNCT
ihlr-16574	89	1	19	19	NUM
ihlr-16574	89	2	.	.	PUNCT
ihlr-16574	89	3	european	european	ADJ
ihlr-16574	89	4	technology	technology	PROPN
ihlr-16574	89	5	platform	platform	NOUN
ihlr-16574	89	6	,	,	PUNCT
ihlr-16574	89	7	http://www.etp-nanomedicine.eu/public	http://www.etp-nanomedicine.eu/public	PROPN
ihlr-16574	89	8	(	(	PUNCT
ihlr-16574	89	9	last	last	ADJ
ihlr-16574	89	10	vi­	vi­	NOUN
ihlr-16574	89	11	sited	site	VERB
ihlr-16574	89	12	nov	nov	PROPN
ihlr-16574	89	13	.	.	PROPN
ihlr-16574	89	14	8	8	NUM
ihlr-16574	89	15	,	,	PUNCT
ihlr-16574	89	16	2008	2008	NUM
ihlr-16574	89	17	)	)	PUNCT
ihlr-16574	89	18	.	.	PUNCT
ihlr-16574	90	1	20	20	NUM
ihlr-16574	90	2	.	.	PUNCT
ihlr-16574	91	1	lupton	lupton	PROPN
ihlr-16574	91	2	,	,	PUNCT
ihlr-16574	91	3	supra	supra	PROPN
ihlr-16574	91	4	note	note	PROPN
ihlr-16574	91	5	7	7	NUM
ihlr-16574	91	6	,	,	PUNCT
ihlr-16574	91	7	at	at	ADP
ihlr-16574	91	8	351	351	NUM
ihlr-16574	91	9	.	.	PUNCT
ihlr-16574	91	10	2010	2010	NUM
ihlr-16574	91	11	]	]	PUNCT
ihlr-16574	91	12	nanomedicine	nanomedicine	NOUN
ihlr-16574	91	13	401	401	NUM
ihlr-16574	91	14	though	though	SCONJ
ihlr-16574	91	15	these	these	PRON
ihlr-16574	91	16	uses	use	VERB
ihlr-16574	91	17	for	for	ADP
ihlr-16574	91	18	nanomedicine	nanomedicine	NOUN
ihlr-16574	91	19	have	have	VERB
ihlr-16574	91	20	yet	yet	ADV
ihlr-16574	91	21	to	to	PART
ihlr-16574	91	22	reach	reach	VERB
ihlr-16574	91	23	beyond	beyond	ADP
ihlr-16574	91	24	the	the	DET
ihlr-16574	91	25	theoretical	theoretical	NOUN
ihlr-16574	91	26	in	in	ADP
ihlr-16574	91	27	many	many	ADJ
ihlr-16574	91	28	respects	respect	NOUN
ihlr-16574	91	29	,	,	PUNCT
ihlr-16574	91	30	there	there	PRON
ihlr-16574	91	31	are	be	VERB
ihlr-16574	91	32	current	current	ADJ
ihlr-16574	91	33	advancements	advancement	NOUN
ihlr-16574	91	34	in	in	ADP
ihlr-16574	91	35	this	this	DET
ihlr-16574	91	36	area	area	NOUN
ihlr-16574	91	37	of	of	ADP
ihlr-16574	91	38	research	research	NOUN
ihlr-16574	91	39	.	.	PUNCT
ihlr-16574	92	1	professor	professor	NOUN
ihlr-16574	92	2	carlo	carlo	PROPN
ihlr-16574	92	3	montemagno	montemagno	PROPN
ihlr-16574	92	4	,	,	PUNCT
ihlr-16574	92	5	of	of	ADP
ihlr-16574	92	6	the	the	DET
ihlr-16574	92	7	university	university	PROPN
ihlr-16574	92	8	of	of	ADP
ihlr-16574	92	9	california	california	PROPN
ihlr-16574	92	10	,	,	PUNCT
ihlr-16574	92	11	has	have	AUX
ihlr-16574	92	12	created	create	VERB
ihlr-16574	92	13	tiny	tiny	ADJ
ihlr-16574	92	14	robots	robot	NOUN
ihlr-16574	92	15	that	that	PRON
ihlr-16574	92	16	are	be	AUX
ihlr-16574	92	17	,	,	PUNCT
ihlr-16574	92	18	for	for	ADP
ihlr-16574	92	19	all	all	DET
ihlr-16574	92	20	intents	intent	NOUN
ihlr-16574	92	21	and	and	CCONJ
ihlr-16574	92	22	purposes	purpose	NOUN
ihlr-16574	92	23	,	,	PUNCT
ihlr-16574	92	24	alive?1	alive?1	ADJ
ihlr-16574	92	25	in	in	ADP
ihlr-16574	92	26	describ­	describ­	PROPN
ihlr-16574	92	27	ing	e	VERB
ihlr-16574	92	28	his	his	PRON
ihlr-16574	92	29	work	work	NOUN
ihlr-16574	92	30	,	,	PUNCT
ihlr-16574	92	31	professor	professor	NOUN
ihlr-16574	92	32	montemagno	montemagno	NOUN
ihlr-16574	92	33	stated	state	VERB
ihlr-16574	92	34	"	"	PUNCT
ihlr-16574	92	35	...	...	PUNCT
ihlr-16574	93	1	the	the	DET
ihlr-16574	93	2	cells	cell	NOUN
ihlr-16574	93	3	actually	actually	ADV
ihlr-16574	93	4	grow	grow	VERB
ihlr-16574	93	5	,	,	PUNCT
ihlr-16574	93	6	multiply	multiply	VERB
ihlr-16574	93	7	and	and	CCONJ
ihlr-16574	93	8	assemble	assemble	VERB
ihlr-16574	93	9	on	on	ADP
ihlr-16574	93	10	their	their	PRON
ihlr-16574	93	11	own	own	ADJ
ihlr-16574	93	12	.	.	PUNCT
ihlr-16574	94	1	the	the	DET
ihlr-16574	94	2	device	device	NOUN
ihlr-16574	94	3	is	be	AUX
ihlr-16574	94	4	alive	alive	ADJ
ihlr-16574	94	5	.	.	PUNCT
ihlr-16574	94	6	'.n	'.n	PART
ihlr-16574	95	1	·	·	PUNCT
ihlr-16574	95	2	professor	professor	NOUN
ihlr-16574	95	3	montemagno	montemagno	NOUN
ihlr-16574	95	4	created	create	VERB
ihlr-16574	95	5	these	these	DET
ihlr-16574	95	6	robots	robot	NOUN
ihlr-16574	95	7	by	by	ADP
ihlr-16574	95	8	growing	grow	VERB
ihlr-16574	95	9	rat	rat	NOUN
ihlr-16574	95	10	cells	cell	NOUN
ihlr-16574	95	11	onto	onto	ADP
ihlr-16574	95	12	silicon	silicon	NOUN
ihlr-16574	95	13	comput­	comput­	ADJ
ihlr-16574	95	14	er	er	INTJ
ihlr-16574	95	15	chips?3	chips?3	VERB
ihlr-16574	95	16	these	these	DET
ihlr-16574	95	17	robots	robot	NOUN
ihlr-16574	95	18	,	,	PUNCT
ihlr-16574	95	19	which	which	PRON
ihlr-16574	95	20	are	be	AUX
ihlr-16574	95	21	less	less	ADJ
ihlr-16574	95	22	than	than	ADP
ihlr-16574	95	23	a	a	DET
ihlr-16574	95	24	millimeter	millimeter	NOUN
ihlr-16574	95	25	long	long	ADV
ihlr-16574	95	26	,	,	PUNCT
ihlr-16574	95	27	can	can	AUX
ihlr-16574	95	28	move	move	VERB
ihlr-16574	95	29	themselves	themselves	PRON
ihlr-16574	95	30	around	around	ADV
ihlr-16574	95	31	without	without	ADP
ihlr-16574	95	32	any	any	DET
ihlr-16574	95	33	external	external	ADJ
ihlr-16574	95	34	power	power	NOUN
ihlr-16574	95	35	source	source	NOUN
ihlr-16574	95	36	,	,	PUNCT
ihlr-16574	95	37	and	and	CCONJ
ihlr-16574	95	38	instead	instead	ADV
ihlr-16574	95	39	power	power	VERB
ihlr-16574	95	40	themselves	themselves	PRON
ihlr-16574	95	41	through	through	ADP
ihlr-16574	95	42	the	the	DET
ihlr-16574	95	43	energy	energy	NOUN
ihlr-16574	95	44	gained	gain	VERB
ihlr-16574	95	45	by	by	ADP
ihlr-16574	95	46	contracting	contract	VERB
ihlr-16574	95	47	cells.24	cells.24	NOUN
ihlr-16574	95	48	when	when	SCONJ
ihlr-16574	95	49	viewed	view	VERB
ihlr-16574	95	50	under	under	ADP
ihlr-16574	95	51	a	a	DET
ihlr-16574	95	52	microscope	microscope	NOUN
ihlr-16574	95	53	,	,	PUNCT
ihlr-16574	95	54	professor	professor	NOUN
ihlr-16574	95	55	montemagno	montemagno	NOUN
ihlr-16574	95	56	's	's	PART
ihlr-16574	95	57	creations	creation	NOUN
ihlr-16574	95	58	look	look	VERB
ihlr-16574	95	59	like	like	ADP
ihlr-16574	95	60	"	"	PUNCT
ihlr-16574	95	61	tiny	tiny	ADJ
ihlr-16574	95	62	,	,	PUNCT
ihlr-16574	95	63	two	two	NUM
ihlr-16574	95	64	footed	footed	ADJ
ihlr-16574	95	65	'	'	PUNCT
ihlr-16574	95	66	bio	bio	NOUN
ihlr-16574	95	67	-	-	NOUN
ihlr-16574	95	68	bots	bot	NOUN
ihlr-16574	95	69	.	.	PUNCT
ihlr-16574	96	1	"'25	"'25	ADV
ihlr-16574	96	2	the	the	DET
ihlr-16574	96	3	nanotechnologies	nanotechnology	NOUN
ihlr-16574	96	4	he	he	PRON
ihlr-16574	96	5	has	have	AUX
ihlr-16574	96	6	created	create	VERB
ihlr-16574	96	7	are	be	AUX
ihlr-16574	96	8	a	a	DET
ihlr-16574	96	9	combina­	combina­	NOUN
ihlr-16574	96	10	tion	tion	NOUN
ihlr-16574	96	11	of	of	ADP
ihlr-16574	96	12	both	both	CCONJ
ihlr-16574	96	13	the	the	DET
ihlr-16574	96	14	top	top	ADJ
ihlr-16574	96	15	-	-	PUNCT
ihlr-16574	96	16	down	down	NOUN
ihlr-16574	96	17	and	and	CCONJ
ihlr-16574	96	18	bottom	bottom	ADJ
ihlr-16574	96	19	-	-	PUNCT
ihlr-16574	96	20	up	up	ADP
ihlr-16574	96	21	approaches?6	approaches?6	PROPN
ihlr-16574	96	22	nanotechnology	nanotechnology	NOUN
ihlr-16574	96	23	with	with	ADP
ihlr-16574	96	24	the	the	DET
ihlr-16574	96	25	ability	ability	NOUN
ihlr-16574	96	26	to	to	PART
ihlr-16574	96	27	power	power	VERB
ihlr-16574	96	28	itself	itself	PRON
ihlr-16574	96	29	and	and	CCONJ
ihlr-16574	96	30	perform	perform	VERB
ihlr-16574	96	31	various	various	ADJ
ihlr-16574	96	32	instructed	instructed	ADJ
ihlr-16574	96	33	tasks	task	NOUN
ihlr-16574	96	34	could	could	AUX
ihlr-16574	96	35	be	be	AUX
ihlr-16574	96	36	utilized	utilize	VERB
ihlr-16574	96	37	in	in	ADP
ihlr-16574	96	38	a	a	DET
ihlr-16574	96	39	variety	variety	NOUN
ihlr-16574	96	40	of	of	ADP
ihlr-16574	96	41	ways	way	NOUN
ihlr-16574	96	42	in	in	ADP
ihlr-16574	96	43	the	the	DET
ihlr-16574	96	44	medical	medical	ADJ
ihlr-16574	96	45	field	field	NOUN
ihlr-16574	96	46	.	.	PUNCT
ihlr-16574	97	1	multiple	multiple	ADJ
ihlr-16574	97	2	nanites	nanite	NOUN
ihlr-16574	97	3	released	release	VERB
ihlr-16574	97	4	into	into	ADP
ihlr-16574	97	5	an	an	DET
ihlr-16574	97	6	individual	individual	NOUN
ihlr-16574	97	7	could	could	AUX
ihlr-16574	97	8	theoretically	theoretically	ADV
ihlr-16574	97	9	communi­	communi­	VERB
ihlr-16574	97	10	cate	cate	NOUN
ihlr-16574	97	11	with	with	ADP
ihlr-16574	97	12	each	each	DET
ihlr-16574	97	13	other	other	ADJ
ihlr-16574	97	14	to	to	PART
ihlr-16574	97	15	determine	determine	VERB
ihlr-16574	97	16	how	how	SCONJ
ihlr-16574	97	17	to	to	PART
ihlr-16574	97	18	maneuver	maneuver	VERB
ihlr-16574	97	19	throughout	throughout	ADP
ihlr-16574	97	20	the	the	DET
ihlr-16574	97	21	very	very	ADV
ihlr-16574	97	22	complex	complex	ADJ
ihlr-16574	97	23	human	human	ADJ
ihlr-16574	97	24	body.27	body.27	NOUN
ihlr-16574	97	25	further	far	ADV
ihlr-16574	97	26	,	,	PUNCT
ihlr-16574	97	27	the	the	DET
ihlr-16574	97	28	nanites	nanite	NOUN
ihlr-16574	97	29	would	would	AUX
ihlr-16574	97	30	theoretically	theoretically	ADV
ihlr-16574	97	31	be	be	AUX
ihlr-16574	97	32	able	able	ADJ
ihlr-16574	97	33	to	to	PART
ihlr-16574	97	34	hone	hone	VERB
ihlr-16574	97	35	in	in	ADP
ihlr-16574	97	36	on	on	ADP
ihlr-16574	97	37	existing	exist	VERB
ihlr-16574	97	38	problems	problem	NOUN
ihlr-16574	97	39	and	and	CCONJ
ihlr-16574	97	40	predict	predict	VERB
ihlr-16574	97	41	where	where	SCONJ
ihlr-16574	97	42	future	future	ADJ
ihlr-16574	97	43	problems	problem	NOUN
ihlr-16574	97	44	might	might	AUX
ihlr-16574	97	45	oc­	oc­	VERB
ihlr-16574	97	46	cur.28	cur.28	NOUN
ihlr-16574	97	47	collaboration	collaboration	NOUN
ihlr-16574	97	48	between	between	ADP
ihlr-16574	97	49	nanites	nanite	NOUN
ihlr-16574	97	50	would	would	AUX
ihlr-16574	97	51	be	be	AUX
ihlr-16574	97	52	an	an	DET
ihlr-16574	97	53	unprecedented	unprecedented	ADJ
ihlr-16574	97	54	,	,	PUNCT
ihlr-16574	97	55	revolu­	revolu­	ADJ
ihlr-16574	97	56	tionary	tionary	ADJ
ihlr-16574	97	57	form	form	NOUN
ihlr-16574	97	58	of	of	ADP
ihlr-16574	97	59	medical	medical	ADJ
ihlr-16574	97	60	treatment	treatment	NOUN
ihlr-16574	97	61	.	.	PUNCT
ihlr-16574	98	1	while	while	SCONJ
ihlr-16574	98	2	performing	perform	VERB
ihlr-16574	98	3	all	all	PRON
ihlr-16574	98	4	of	of	ADP
ihlr-16574	98	5	these	these	DET
ihlr-16574	98	6	tasks	task	NOUN
ihlr-16574	98	7	the	the	DET
ihlr-16574	98	8	nanites	nanite	NOUN
ihlr-16574	98	9	would	would	AUX
ihlr-16574	98	10	be	be	AUX
ihlr-16574	98	11	able	able	ADJ
ihlr-16574	98	12	to	to	PART
ihlr-16574	98	13	communicate	communicate	VERB
ihlr-16574	98	14	with	with	ADP
ihlr-16574	98	15	one	one	NUM
ihlr-16574	98	16	another	another	DET
ihlr-16574	98	17	to	to	PART
ihlr-16574	98	18	coordinate	coordinate	VERB
ihlr-16574	98	19	their	their	PRON
ihlr-16574	98	20	efforts	effort	NOUN
ihlr-16574	98	21	in	in	ADP
ihlr-16574	98	22	the	the	DET
ihlr-16574	98	23	body;29	body;29	ADJ
ihlr-16574	98	24	an	an	DET
ihlr-16574	98	25	example	example	NOUN
ihlr-16574	98	26	of	of	ADP
ihlr-16574	98	27	this	this	DET
ihlr-16574	98	28	coordinated	coordinate	VERB
ihlr-16574	98	29	effort	effort	NOUN
ihlr-16574	98	30	is	be	AUX
ihlr-16574	98	31	explored	explore	VERB
ihlr-16574	98	32	in	in	ADP
ihlr-16574	98	33	the	the	DET
ihlr-16574	98	34	next	next	ADJ
ihlr-16574	98	35	section	section	NOUN
ihlr-16574	98	36	.	.	PUNCT
ihlr-16574	99	1	b.	b.	PROPN
ihlr-16574	99	2	factual	factual	ADJ
ihlr-16574	99	3	scenario	scenario	NOUN
ihlr-16574	99	4	of	of	ADP
ihlr-16574	99	5	patient	patient	ADJ
ihlr-16574	99	6	xtumor	xtumor	PROPN
ihlr-16574	99	7	cured	cure	VERB
ihlr-16574	99	8	by	by	ADP
ihlr-16574	99	9	nanites	nanite	NOUN
ihlr-16574	99	10	patient	patient	ADJ
ihlr-16574	99	11	x	x	VERB
ihlr-16574	99	12	is	be	AUX
ihlr-16574	99	13	currently	currently	ADV
ihlr-16574	99	14	being	be	AUX
ihlr-16574	99	15	treated	treat	VERB
ihlr-16574	99	16	for	for	ADP
ihlr-16574	99	17	a	a	DET
ihlr-16574	99	18	cancerous	cancerous	ADJ
ihlr-16574	99	19	tumor	tumor	NOUN
ihlr-16574	99	20	with	with	ADP
ihlr-16574	99	21	cur­	cur­	ADJ
ihlr-16574	99	22	rently	rently	ADV
ihlr-16574	99	23	known	know	VERB
ihlr-16574	99	24	methods	method	NOUN
ihlr-16574	99	25	,	,	PUNCT
ihlr-16574	99	26	such	such	ADJ
ihlr-16574	99	27	as	as	ADP
ihlr-16574	99	28	chemotherapy	chemotherapy	NOUN
ihlr-16574	99	29	and	and	CCONJ
ihlr-16574	99	30	radiation	radiation	NOUN
ihlr-16574	99	31	.	.	PUNCT
ihlr-16574	100	1	these	these	DET
ihlr-16574	100	2	treat­	treat­	DET
ihlr-16574	100	3	ments	ment	NOUN
ihlr-16574	100	4	are	be	AUX
ihlr-16574	100	5	only	only	ADV
ihlr-16574	100	6	moderately	moderately	ADV
ihlr-16574	100	7	helpful	helpful	ADJ
ihlr-16574	100	8	in	in	ADP
ihlr-16574	100	9	treating	treat	VERB
ihlr-16574	100	10	patient	patient	ADJ
ihlr-16574	100	11	x	x	NOUN
ihlr-16574	100	12	's	's	PART
ihlr-16574	100	13	tumor	tumor	NOUN
ihlr-16574	100	14	,	,	PUNCT
ihlr-16574	100	15	and	and	CCONJ
ihlr-16574	100	16	have	have	VERB
ihlr-16574	100	17	serious	serious	ADJ
ihlr-16574	100	18	and	and	CCONJ
ihlr-16574	100	19	undesirable	undesirable	ADJ
ihlr-16574	100	20	side	side	NOUN
ihlr-16574	100	21	effects.30	effects.30	NOUN
ihlr-16574	100	22	patient	patient	NOUN
ihlr-16574	100	23	x	x	PUNCT
ihlr-16574	100	24	may	may	AUX
ihlr-16574	100	25	ultimately	ultimately	ADV
ihlr-16574	100	26	win	win	VERB
ihlr-16574	100	27	or	or	CCONJ
ihlr-16574	100	28	lose	lose	VERB
ihlr-16574	100	29	21	21	NUM
ihlr-16574	100	30	.	.	PUNCT
ihlr-16574	101	1	i	i	PRON
ihlr-16574	101	2	d.	d.	PROPN
ihlr-16574	101	3	22	22	NUM
ihlr-16574	101	4	.	.	PUNCT
ihlr-16574	102	1	i	i	PRON
ihlr-16574	102	2	d.	d.	PROPN
ihlr-16574	102	3	23	23	NUM
ihlr-16574	102	4	.	.	PUNCT
ihlr-16574	103	1	ld	ld	PROPN
ihlr-16574	103	2	.	.	PROPN
ihlr-16574	103	3	24	24	NUM
ihlr-16574	103	4	.	.	PUNCT
ihlr-16574	104	1	ld	ld	PROPN
ihlr-16574	104	2	.	.	PROPN
ihlr-16574	104	3	25	25	NUM
ihlr-16574	104	4	.	.	PUNCT
ihlr-16574	105	1	i	i	PRON
ihlr-16574	105	2	d	d	PROPN
ihlr-16574	105	3	26	26	NUM
ihlr-16574	105	4	.	.	PUNCT
ihlr-16574	106	1	lupton	lupton	PROPN
ihlr-16574	106	2	.	.	PUNCT
ihlr-16574	107	1	supra	supra	PROPN
ihlr-16574	107	2	note	note	PROPN
ihlr-16574	107	3	7	7	NUM
ihlr-16574	107	4	,	,	PUNCT
ihlr-16574	107	5	at	at	ADP
ihlr-16574	107	6	350	350	NUM
ihlr-16574	107	7	.	.	PUNCT
ihlr-16574	107	8	27	27	NUM
ihlr-16574	107	9	.	.	PUNCT
ihlr-16574	108	1	"	"	PUNCT
ihlr-16574	108	2	[	[	X
ihlr-16574	108	3	i]n	i]n	VERB
ihlr-16574	108	4	the	the	DET
ihlr-16574	108	5	young	young	ADJ
ihlr-16574	108	6	field	field	NOUN
ihlr-16574	108	7	of	of	ADP
ihlr-16574	108	8	nanotechnology	nanotechnology	NOUN
ihlr-16574	108	9	,	,	PUNCT
ihlr-16574	108	10	scientists	scientist	NOUN
ihlr-16574	108	11	and	and	CCONJ
ihlr-16574	108	12	engineers	engineer	NOUN
ihlr-16574	108	13	are	be	AUX
ihlr-16574	108	14	taking	take	VERB
ihlr-16574	108	15	control	control	NOUN
ihlr-16574	108	16	of	of	ADP
ihlr-16574	108	17	atoms	atom	NOUN
ihlr-16574	108	18	and	and	CCONJ
ihlr-16574	108	19	molecules	molecule	NOUN
ihlr-16574	108	20	individually	individually	ADV
ihlr-16574	108	21	,	,	PUNCT
ihlr-16574	108	22	manipulating	manipulate	VERB
ihlr-16574	108	23	them	they	PRON
ihlr-16574	108	24	and	and	CCONJ
ihlr-16574	108	25	putting	put	VERB
ihlr-16574	108	26	them	they	PRON
ihlr-16574	108	27	to	to	PART
ihlr-16574	108	28	use	use	VERB
ihlr-16574	108	29	with	with	ADP
ihlr-16574	108	30	an	an	DET
ihlr-16574	108	31	extraordinary	extraordinary	ADJ
ihlr-16574	108	32	degree	degree	NOUN
ihlr-16574	108	33	of	of	ADP
ihlr-16574	108	34	precision	precision	NOUN
ihlr-16574	108	35	.	.	PUNCT
ihlr-16574	108	36	"	"	PUNCT
ihlr-16574	109	1	adam	adam	PROPN
ihlr-16574	109	2	keiper	keiper	PROPN
ihlr-16574	109	3	,	,	PUNCT
ihlr-16574	109	4	the	the	DET
ihlr-16574	109	5	nanotechnology	nanotechnology	PROPN
ihlr-16574	109	6	revolution	revolution	NOUN
ihlr-16574	109	7	,	,	PUNCT
ihlr-16574	109	8	2003	2003	NUM
ihlr-16574	109	9	the	the	DET
ihlr-16574	109	10	new	new	ADJ
ihlr-16574	109	11	atlantis	atlantis	NOUN
ihlr-16574	109	12	,	,	PUNCT
ihlr-16574	109	13	17	17	NUM
ihlr-16574	109	14	,	,	PUNCT
ihlr-16574	109	15	17	17	NUM
ihlr-16574	109	16	,	,	PUNCT
ihlr-16574	109	17	available	available	ADJ
ihlr-16574	109	18	at	at	ADP
ihlr-16574	109	19	bttp:/lwww.thenewatlantis.com	bttp:/lwww.thenewatlantis.com	PROPN
ihlr-16574	109	20	/	/	SYM
ihlr-16574	109	21	publicationslthe­	publicationslthe­	PART
ihlr-16574	109	22	nanotecbnology	nanotecbnology	NOUN
ihlr-16574	109	23	-	-	PUNCT
ihlr-16574	109	24	revolution	revolution	NOUN
ihlr-16574	109	25	.	.	PUNCT
ihlr-16574	110	1	28	28	NUM
ihlr-16574	110	2	.	.	PUNCT
ihlr-16574	111	1	i	i	PRON
ihlr-16574	111	2	d.	d.	PROPN
ihlr-16574	111	3	at	at	ADP
ihlr-16574	111	4	24	24	NUM
ihlr-16574	111	5	-	-	SYM
ihlr-16574	111	6	5	5	NUM
ihlr-16574	111	7	.	.	NOUN
ihlr-16574	111	8	29	29	NUM
ihlr-16574	111	9	.	.	PUNCT
ihlr-16574	112	1	ld	ld	PROPN
ihlr-16574	112	2	.	.	PUNCT
ihlr-16574	113	1	at	at	ADP
ihlr-16574	113	2	25	25	NUM
ihlr-16574	113	3	.	.	PUNCT
ihlr-16574	113	4	30	30	NUM
ihlr-16574	113	5	.	.	PUNCT
ihlr-16574	113	6	mayo	mayo	PROPN
ihlr-16574	113	7	clinic	clinic	PROPN
ihlr-16574	113	8	,	,	PUNCT
ihlr-16574	113	9	cancer	cancer	NOUN
ihlr-16574	113	10	survivors	survivor	NOUN
ihlr-16574	113	11	:	:	PUNCT
ihlr-16574	113	12	managing	manage	VERB
ihlr-16574	113	13	late	late	ADJ
ihlr-16574	113	14	effects	effect	NOUN
ihlr-16574	113	15	of	of	ADP
ihlr-16574	113	16	cancer	cancer	NOUN
ihlr-16574	113	17	treatment	treatment	NOUN
ihlr-16574	113	18	,	,	PUNCT
ihlr-16574	113	19	http://www.mayoclinic.com/health/cancer-survivor/ca00073	http://www.mayoclinic.com/health/cancer-survivor/ca00073	NOUN
ihlr-16574	113	20	oast	oast	PROPN
ihlr-16574	113	21	visited	visit	VERB
ihlr-16574	113	22	jan	jan	PROPN
ihlr-16574	113	23	.	.	PROPN
ihlr-16574	113	24	18	18	NUM
ihlr-16574	113	25	,	,	PUNCT
ihlr-16574	113	26	2009	2009	NUM
ihlr-16574	113	27	)	)	PUNCT
ihlr-16574	113	28	.	.	PUNCT
ihlr-16574	114	1	402	402	NUM
ihlr-16574	114	2	indiana	indiana	PROPN
ihlr-16574	114	3	health	health	PROPN
ihlr-16574	114	4	law	law	PROPN
ihlr-16574	114	5	review	review	NOUN
ihlr-16574	114	6	[	[	X
ihlr-16574	114	7	vol	vol	NOUN
ihlr-16574	114	8	.	.	PUNCT
ihlr-16574	115	1	7:397	7:397	NUM
ihlr-16574	115	2	her	her	PRON
ihlr-16574	115	3	battle	battle	NOUN
ihlr-16574	115	4	with	with	ADP
ihlr-16574	115	5	cancer	cancer	NOUN
ihlr-16574	115	6	,	,	PUNCT
ihlr-16574	115	7	but	but	CCONJ
ihlr-16574	115	8	,	,	PUNCT
ihlr-16574	115	9	regardless	regardless	ADV
ihlr-16574	115	10	of	of	ADP
ihlr-16574	115	11	the	the	DET
ihlr-16574	115	12	outcome	outcome	NOUN
ihlr-16574	115	13	,	,	PUNCT
ihlr-16574	115	14	it	it	PRON
ihlr-16574	115	15	is	be	AUX
ihlr-16574	115	16	certain	certain	ADJ
ihlr-16574	115	17	that	that	SCONJ
ihlr-16574	115	18	pa­	pa­	ADJ
ihlr-16574	115	19	tient	tient	NOUN
ihlr-16574	115	20	x	x	X
ihlr-16574	115	21	's	's	PART
ihlr-16574	115	22	battle	battle	NOUN
ihlr-16574	115	23	will	will	AUX
ihlr-16574	115	24	not	not	PART
ihlr-16574	115	25	be	be	AUX
ihlr-16574	115	26	short	short	ADJ
ihlr-16574	115	27	.	.	PUNCT
ihlr-16574	116	1	enduring·months;·even	enduring·months;·even	ADJ
ihlr-16574	116	2	years	year	NOUN
ihlr-16574	116	3	,	,	PUNCT
ihlr-16574	116	4	of	of	ADP
ihlr-16574	116	5	harsh	harsh	ADJ
ihlr-16574	116	6	and	and	CCONJ
ihlr-16574	116	7	.	.	PUNCT
ihlr-16574	117	1	potentially	potentially	ADV
ihlr-16574	117	2	damaging	damaging	ADJ
ihlr-16574	117	3	medical	medical	ADJ
ihlr-16574	117	4	treatments	treatment	NOUN
ihlr-16574	117	5	will	will	AUX
ihlr-16574	117	6	,	,	PUNCT
ihlr-16574	117	7	undoubtedly	undoubtedly	ADV
ihlr-16574	117	8	take	take	VERB
ihlr-16574	117	9	its	its	PRON
ihlr-16574	117	10	toll	toll	NOUN
ihlr-16574	117	11	on	on	ADP
ihlr-16574	117	12	patientx	patientx	NOUN
ihlr-16574	117	13	.	.	PUNCT
ihlr-16574	118	1	now	now	ADV
ihlr-16574	118	2	suppose	suppose	VERB
ihlr-16574	118	3	that	that	SCONJ
ihlr-16574	118	4	patient	patient	NOUN
ihlr-16574	118	5	x	x	PUNCT
ihlr-16574	118	6	has	have	VERB
ihlr-16574	118	7	the	the	DET
ihlr-16574	118	8	same	same	ADJ
ihlr-16574	118	9	type	type	NOUN
ihlr-16574	118	10	of	of	ADP
ihlr-16574	118	11	cancerous	cancerous	ADJ
ihlr-16574	118	12	tumor	tumor	NOUN
ihlr-16574	118	13	,	,	PUNCT
ihlr-16574	118	14	on~	on~	PROPN
ihlr-16574	118	15	ly	ly	ADP
ihlr-16574	118	16	this	this	DET
ihlr-16574	118	17	time	time	NOUN
ihlr-16574	118	18	patient	patient	NOUN
ihlr-16574	118	19	x	x	PUNCT
ihlr-16574	118	20	lives	live	VERB
ihlr-16574	118	21	in	in	ADP
ihlr-16574	118	22	a	a	DET
ihlr-16574	118	23	world	world	NOUN
ihlr-16574	118	24	where	where	SCONJ
ihlr-16574	118	25	nanomedicine	nanomedicine	NOUN
ihlr-16574	118	26	exists	exist	VERB
ihlr-16574	118	27	.	.	PUNCT
ihlr-16574	118	28	·	·	PUNCT
ihlr-16574	119	1	once	once	ADV
ihlr-16574	119	2	patient	patient	ADJ
ihlr-16574	119	3	x	x	NOUN
ihlr-16574	119	4	's	's	PART
ihlr-16574	119	5	doctor	doctor	NOUN
ihlr-16574	119	6	becomes	become	VERB
ihlr-16574	119	7	aware	aware	ADJ
ihlr-16574	119	8	of	of	ADP
ihlr-16574	119	9	the	the	DET
ihlr-16574	119	10	tumor	tumor	NOUN
ihlr-16574	119	11	,	,	PUNCT
ihlr-16574	119	12	she	she	PRON
ihlr-16574	119	13	is	be	AUX
ihlr-16574	119	14	now	now	ADV
ihlr-16574	119	15	able	able	ADJ
ihlr-16574	119	16	.	.	PUNCT
ihlr-16574	120	1	to	to	PART
ihlr-16574	120	2	rely	rely	VERB
ihlr-16574	120	3	on	on	ADP
ihlr-16574	120	4	a	a	DET
ihlr-16574	120	5	different	different	ADJ
ihlr-16574	120	6	form	form	NOUN
ihlr-16574	120	7	of	of	ADP
ihlr-16574	120	8	treatment	treatment	NOUN
ihlr-16574	120	9	for	for	ADP
ihlr-16574	120	10	patient	patient	ADJ
ihlr-16574	120	11	x	x	NOUN
ihlr-16574	120	12	's	's	PART
ihlr-16574	120	13	cancer	cancer	NOUN
ihlr-16574	120	14	,	,	PUNCT
ihlr-16574	120	15	nanomedicine	nanomedicine	NOUN
ihlr-16574	120	16	.	.	PUNCT
ihlr-16574	121	1	the	the	DET
ihlr-16574	121	2	treatment	treatment	NOUN
ihlr-16574	121	3	would	would	AUX
ihlr-16574	121	4	be	be	AUX
ihlr-16574	121	5	greatly	greatly	ADV
ihlr-16574	121	6	different	different	ADJ
ihlr-16574	121	7	than	than	ADP
ihlr-16574	121	8	chemotherapy	chemotherapy	NOUN
ihlr-16574	121	9	and	and	CCONJ
ihlr-16574	121	10	radiation	radiation	NOUN
ihlr-16574	121	11	.	.	PUNCT
ihlr-16574	122	1	it	it	PRON
ihlr-16574	122	2	would	would	AUX
ihlr-16574	122	3	involve	involve	VERB
ihlr-16574	122	4	nanites	nanite	NOUN
ihlr-16574	122	5	,	,	PUNCT
ihlr-16574	122	6	or	or	CCONJ
ihlr-16574	122	7	microscopic	microscopic	ADJ
ihlr-16574	122	8	robots	robot	NOUN
ihlr-16574	122	9	that	that	PRON
ihlr-16574	122	10	would	would	AUX
ihlr-16574	122	11	be	be	AUX
ihlr-16574	122	12	programmed	program	VERB
ihlr-16574	122	13	to	to	PART
ihlr-16574	122	14	treat	treat	VERB
ihlr-16574	122	15	and	and	CCONJ
ihlr-16574	122	16	cure	cure	VERB
ihlr-16574	122	17	the	the	DET
ihlr-16574	122	18	tumor	tumor	NOUN
ihlr-16574	122	19	.	.	PUNCT
ihlr-16574	123	1	the	the	DET
ihlr-16574	123	2	.nanites	.nanite	NOUN
ihlr-16574	123	3	would	would	AUX
ihlr-16574	123	4	be	be	AUX
ihlr-16574	123	5	instructed	instruct	VERB
ihlr-16574	123	6	to	to	PART
ihlr-16574	123	7	attack	attack	VERB
ihlr-16574	123	8	and	and	CCONJ
ihlr-16574	123	9	de­	de­	VERB
ihlr-16574	123	10	stroy	stroy	PROPN
ihlr-16574	123	11	patient	patient	ADJ
ihlr-16574	123	12	x	x	NOUN
ihlr-16574	123	13	's	's	PART
ihlr-16574	123	14	tumor	tumor	NOUN
ihlr-16574	123	15	.	.	PUNCT
ihlr-16574	124	1	once	once	SCONJ
ihlr-16574	124	2	the	the	DET
ihlr-16574	124	3	nanites	nanite	NOUN
ihlr-16574	124	4	are	be	AUX
ihlr-16574	124	5	injected	inject	VERB
ihlr-16574	124	6	into	into	ADP
ihlr-16574	124	7	patient	patient	NOUN
ihlr-16574	124	8	x	x	NOUN
ihlr-16574	124	9	they	they	PRON
ihlr-16574	124	10	begin	begin	VERB
ihlr-16574	124	11	to	to	PART
ihlr-16574	124	12	perform	perform	VERB
ihlr-16574	124	13	their	their	PRON
ihlr-16574	124	14	programmed	program	VERB
ihlr-16574	124	15	task	task	NOUN
ihlr-16574	124	16	;	;	PUNCT
ihlr-16574	124	17	·	·	PUNCT
ihlr-16574	124	18	patient	patient	NOUN
ihlr-16574	124	19	:x	:x	PUNCT
ihlr-16574	124	20	would	would	AUX
ihlr-16574	124	21	be	be	AUX
ihlr-16574	124	22	able	able	ADJ
ihlr-16574	124	23	to	to	PART
ihlr-16574	124	24	over­	over­	VERB
ihlr-16574	124	25	come	come	VERB
ihlr-16574	124	26	a	a	DET
ihlr-16574	124	27	battle	battle	NOUN
ihlr-16574	124	28	with	with	ADP
ihlr-16574	124	29	cancer	cancer	NOUN
ihlr-16574	124	30	quickly	quickly	ADV
ihlr-16574	124	31	,	,	PUNCT
ihlr-16574	124	32	and	and	CCONJ
ihlr-16574	124	33	with	with	ADP
ihlr-16574	124	34	much	much	ADJ
ihlr-16574	125	1	.tess	.tess	ADP
ihlr-16574	125	2	suffering	suffering	NOUN
ihlr-16574	125	3	than	than	ADP
ihlr-16574	125	4	pre­	pre­	PROPN
ihlr-16574	125	5	vious	vious	ADJ
ihlr-16574	125	6	known	know	VERB
ihlr-16574	125	7	medical	medical	ADJ
ihlr-16574	125	8	treatments	treatment	NOUN
ihlr-16574	125	9	.	.	PUNCT
ihlr-16574	126	1	though	though	SCONJ
ihlr-16574	126	2	the	the	DET
ihlr-16574	126	3	science	science	NOUN
ihlr-16574	126	4	has	have	VERB
ihlr-16574	126	5	yet	yet	ADV
ihlr-16574	126	6	to	to	PART
ihlr-16574	126	7	specifically	specifically	ADV
ihlr-16574	126	8	develop	develop	VERB
ihlr-16574	126	9	the	the	DET
ihlr-16574	126	10	type	type	NOUN
ihlr-16574	126	11	of	of	ADP
ihlr-16574	126	12	technol­	technol­	NOUN
ihlr-16574	126	13	ogy	ogy	NOUN
ihlr-16574	126	14	that	that	PRON
ihlr-16574	126	15	would	would	AUX
ihlr-16574	126	16	make	make	VERB
ihlr-16574	126	17	this	this	DET
ihlr-16574	126	18	factual	factual	ADJ
ihlr-16574	126	19	scenario	scenario	NOUN
ihlr-16574	126	20	·	·	SYM
ihlr-16574	126	21	possible	possible	ADJ
ihlr-16574	126	22	,	,	PUNCT
ihlr-16574	126	23	the	the	DET
ihlr-16574	126	24	.case	.case	NOUN
ihlr-16574	126	25	of	of	ADP
ihlr-16574	126	26	patient	patient	NOUN
ihlr-16574	126	27	x	x	PUNCT
ihlr-16574	126	28	is	be	AUX
ihlr-16574	126	29	a	a	DET
ihlr-16574	126	30	hypothetically	hypothetically	ADV
ihlr-16574	126	31	.	.	PUNCT
ihlr-16574	127	1	plausible	plausible	ADJ
ihlr-16574	127	2	use	use	NOUN
ihlr-16574	127	3	of	of	ADP
ihlr-16574	127	4	nanomedicine	nanomedicine	NOUN
ihlr-16574	127	5	in	in	ADP
ihlr-16574	127	6	·	·	PUNCT
ihlr-16574	127	7	medical	medical	ADJ
ihlr-16574	127	8	treatment	treatment	NOUN
ihlr-16574	127	9	.	.	PUNCT
ihlr-16574	128	1	this	this	DET
ihlr-16574	128	2	note	note	NOUN
ihlr-16574	128	3	will	will	AUX
ihlr-16574	128	4	continue	continue	VERB
ihlr-16574	128	5	to	to	PART
ihlr-16574	128	6	reference	reference	VERB
ihlr-16574	128	7	the	the	DET
ihlr-16574	128	8	above	above	ADJ
ihlr-16574	128	9	scenario	scenario	NOUN
ihlr-16574	128	10	to	to	PART
ihlr-16574	128	11	explore	explore	VERB
ihlr-16574	128	12	possible	possible	ADJ
ihlr-16574	128	13	diffi­	diffi­	NOUN
ihlr-16574	128	14	culties	cultie	NOUN
ihlr-16574	128	15	,	,	PUNCT
ihlr-16574	128	16	concerns	concern	NOUN
ihlr-16574	128	17	,	,	PUNCT
ihlr-16574	128	18	and	and	CCONJ
ihlr-16574	128	19	benefits	benefit	NOUN
ihlr-16574	128	20	surrounding	surround	VERB
ihlr-16574	128	21	implementation	implementation	NOUN
ihlr-16574	128	22	and	and	CCONJ
ihlr-16574	128	23	use	use	NOUN
ihlr-16574	128	24	of	of	ADP
ihlr-16574	128	25	na­	na­	PROPN
ihlr-16574	128	26	nomedicine	nomedicine	PROPN
ihlr-16574	128	27	.	.	PUNCT
ihlr-16574	129	1	c.	c.	PROPN
ihlr-16574	129	2	regulating	regulate	VERB
ihlr-16574	129	3	the	the	DET
ihlr-16574	129	4	undiscoveredcontrolling	undiscoveredcontrolling	NOUN
ihlr-16574	129	5	the	the	DET
ihlr-16574	129	6	unknown	unknown	ADJ
ihlr-16574	129	7	nanotechnology	nanotechnology	NOUN
ihlr-16574	129	8	and	and	CCONJ
ihlr-16574	129	9	nanomedicine	nanomedicine	NOUN
ihlr-16574	129	10	is	be	AUX
ihlr-16574	129	11	vexing	vex	VERB
ihlr-16574	129	12	to	to	ADP
ihlr-16574	129	13	governments	government	NOUN
ihlr-16574	129	14	and	and	CCONJ
ihlr-16574	129	15	reg­	reg­	VERB
ihlr-16574	129	16	ulatory	ulatory	ADJ
ihlr-16574	129	17	agencies	agency	NOUN
ihlr-16574	129	18	for	for	ADP
ihlr-16574	129	19	precisely	precisely	ADV
ihlr-16574	129	20	the	the	DET
ihlr-16574	129	21	same	same	ADJ
ihlr-16574	129	22	reason	reason	NOUN
ihlr-16574	129	23	it	it	PRON
ihlr-16574	129	24	elicits	elicit	VERB
ihlr-16574	129	25	such	such	ADJ
ihlr-16574	129	26	excitement	excitement	NOUN
ihlr-16574	129	27	among	among	ADP
ihlr-16574	129	28	innovators	innovator	NOUN
ihlr-16574	129	29	in	in	ADP
ihlr-16574	129	30	the	the	DET
ihlr-16574	129	31	scientific	scientific	ADJ
ihlr-16574	129	32	and	and	CCONJ
ihlr-16574	129	33	medical	medical	ADJ
ihlr-16574	129	34	fields	field	NOUN
ihlr-16574	129	35	:	:	PUNCT
ihlr-16574	129	36	the	the	DET
ihlr-16574	129	37	possibilities	possibility	NOUN
ihlr-16574	129	38	and	and	CCONJ
ihlr-16574	129	39	potential	potential	ADJ
ihlr-16574	129	40	risks	risk	NOUN
ihlr-16574	129	41	of	of	ADP
ihlr-16574	129	42	nanomedicine	nanomedicine	NOUN
ihlr-16574	129	43	have	have	VERB
ihlr-16574	129	44	yet	yet	ADV
ihlr-16574	129	45	to	to	PART
ihlr-16574	129	46	be	be	AUX
ihlr-16574	129	47	imagined	imagine	VERB
ihlr-16574	129	48	.	.	PUNCT
ihlr-16574	130	1	this	this	DET
ihlr-16574	130	2	section	section	NOUN
ihlr-16574	130	3	high­	high­	PROPN
ihlr-16574	130	4	lights	light	NOUN
ihlr-16574	130	5	areas	area	NOUN
ihlr-16574	130	6	of	of	ADP
ihlr-16574	130	7	concern	concern	NOUN
ihlr-16574	130	8	with	with	ADP
ihlr-16574	130	9	regard	regard	NOUN
ihlr-16574	130	10	to	to	ADP
ihlr-16574	130	11	nanotechnologies	nanotechnology	NOUN
ihlr-16574	130	12	how	how	SCONJ
ihlr-16574	130	13	the	the	DET
ihlr-16574	130	14	technolo­	technolo­	X
ihlr-16574	130	15	gy	gy	NOUN
ihlr-16574	130	16	is	be	AUX
ihlr-16574	130	17	vulnerable	vulnerable	ADJ
ihlr-16574	130	18	and	and	CCONJ
ihlr-16574	130	19	what	what	PRON
ihlr-16574	130	20	risks	risk	VERB
ihlr-16574	130	21	those	those	DET
ihlr-16574	130	22	vulnerabilities	vulnerability	NOUN
ihlr-16574	130	23	introduce	introduce	VERB
ihlr-16574	130	24	.	.	PUNCT
ihlr-16574	131	1	cosmetic	cosmetic	ADJ
ihlr-16574	131	2	companies	company	NOUN
ihlr-16574	131	3	are	be	AUX
ihlr-16574	131	4	concerned	concerned	ADJ
ihlr-16574	131	5	about	about	ADP
ihlr-16574	131	6	the	the	DET
ihlr-16574	131	7	future	future	NOUN
ihlr-16574	131	8	of	of	ADP
ihlr-16574	131	9	nanotechnolo­	nanotechnolo­	PROPN
ihlr-16574	131	10	gy	gy	PROPN
ihlr-16574	131	11	in	in	ADP
ihlr-16574	131	12	their	their	PRON
ihlr-16574	131	13	industry	industry	NOUN
ihlr-16574	131	14	because	because	SCONJ
ihlr-16574	131	15	they	they	PRON
ihlr-16574	131	16	believe	believe	VERB
ihlr-16574	131	17	it	it	PRON
ihlr-16574	131	18	is	be	AUX
ihlr-16574	131	19	possible	possible	ADJ
ihlr-16574	131	20	for	for	SCONJ
ihlr-16574	131	21	nanoparticle	nanoparticle	NOUN
ihlr-16574	131	22	con­	con­	NOUN
ihlr-16574	131	23	taminants	taminant	NOUN
ihlr-16574	131	24	to	to	PART
ihlr-16574	131	25	find	find	VERB
ihlr-16574	131	26	a	a	DET
ihlr-16574	131	27	way	way	NOUN
ihlr-16574	131	28	into	into	ADP
ihlr-16574	131	29	their	their	PRON
ihlr-16574	131	30	products	product	NOUN
ihlr-16574	131	31	and	and	CCONJ
ihlr-16574	131	32	eventually	eventually	ADV
ihlr-16574	131	33	make	make	VERB
ihlr-16574	131	34	it	it	PRON
ihlr-16574	131	35	into	into	ADP
ihlr-16574	131	36	a	a	DET
ihlr-16574	131	37	person	person	NOUN
ihlr-16574	131	38	's	's	PART
ihlr-16574	131	39	blood	blood	NOUN
ihlr-16574	131	40	stream	stream	NOUN
ihlr-16574	131	41	through	through	ADP
ihlr-16574	131	42	use	use	NOUN
ihlr-16574	131	43	of	of	ADP
ihlr-16574	131	44	their	their	PRON
ihlr-16574	131	45	cosmetics.31	cosmetics.31	NOUN
ihlr-16574	131	46	potentially	potentially	ADV
ihlr-16574	131	47	,	,	PUNCT
ihlr-16574	131	48	the	the	DET
ihlr-16574	131	49	na­	na­	PROPN
ihlr-16574	131	50	noparticle	noparticle	PROPN
ihlr-16574	131	51	contaminants	contaminant	NOUN
ihlr-16574	131	52	will	will	AUX
ihlr-16574	131	53	have	have	VERB
ihlr-16574	131	54	detrimental	detrimental	ADJ
ihlr-16574	131	55	effects?2	effects?2	NOUN
ihlr-16574	131	56	although	although	SCONJ
ihlr-16574	131	57	the	the	DET
ihlr-16574	131	58	na­	na­	PROPN
ihlr-16574	131	59	noparticle	noparticle	PROPN
ihlr-16574	131	60	contaminants	contaminant	NOUN
ihlr-16574	131	61	considered	consider	VERB
ihlr-16574	131	62	here	here	ADV
ihlr-16574	131	63	are	be	AUX
ihlr-16574	131	64	not	not	PART
ihlr-16574	131	65	necessarily	necessarily	ADV
ihlr-16574	131	66	nanites	nanite	NOUN
ihlr-16574	131	67	,	,	PUNCT
ihlr-16574	131	68	that	that	ADV
ihlr-16574	131	69	is	is	ADV
ihlr-16574	131	70	,	,	PUNCT
ihlr-16574	131	71	31	31	NUM
ihlr-16574	131	72	.	.	PUNCT
ihlr-16574	132	1	"	"	PUNCT
ihlr-16574	132	2	[	[	X
ihlr-16574	132	3	n]ew	n]ew	PROPN
ihlr-16574	132	4	nanotechnologies	nanotechnology	NOUN
ihlr-16574	132	5	are	be	AUX
ihlr-16574	132	6	being	be	AUX
ihlr-16574	132	7	widely	widely	ADV
ihlr-16574	132	8	deployed	deploy	VERB
ihlr-16574	132	9	in	in	ADP
ihlr-16574	132	10	cosmetics	cosmetic	NOUN
ihlr-16574	132	11	products	product	NOUN
ihlr-16574	132	12	,	,	PUNCT
ihlr-16574	132	13	despite	despite	SCONJ
ihlr-16574	132	14	evidence	evidence	NOUN
ihlr-16574	132	15	of	of	ADP
ihlr-16574	132	16	serious	serious	ADJ
ihlr-16574	132	17	potential	potential	ADJ
ihlr-16574	132	18	health	health	NOUN
ihlr-16574	132	19	risks	risk	NOUN
ihlr-16574	132	20	...	...	PUNCT
ihlr-16574	133	1	[	[	X
ihlr-16574	133	2	t]he	t]he	ADV
ihlr-16574	133	3	physical	physical	ADJ
ihlr-16574	133	4	application	application	NOUN
ihlr-16574	133	5	of	of	ADP
ihlr-16574	133	6	some	some	PRON
ihlr-16574	133	7	of	of	ADP
ihlr-16574	133	8	the	the	DET
ihlr-16574	133	9	nano­	nano­	PROPN
ihlr-16574	133	10	technologies	technology	NOUN
ihlr-16574	133	11	to	to	ADP
ihlr-16574	133	12	the	the	DET
ihlr-16574	133	13	body	body	NOUN
ihlr-16574	133	14	in	in	ADP
ihlr-16574	133	15	cosmetics	cosmetic	NOUN
ihlr-16574	133	16	makes	make	VERB
ihlr-16574	133	17	these	these	PRON
ihlr-16574	133	18	uses	use	VERB
ihlr-16574	133	19	uniquely	uniquely	ADV
ihlr-16574	133	20	prone	prone	ADJ
ihlr-16574	133	21	to	to	ADP
ihlr-16574	133	22	skin	skin	NOUN
ihlr-16574	133	23	penetration	penetration	NOUN
ihlr-16574	133	24	,	,	PUNCT
ihlr-16574	133	25	inhalation	inhalation	NOUN
ihlr-16574	133	26	and	and	CCONJ
ihlr-16574	133	27	ingestion	ingestion	NOUN
ihlr-16574	133	28	of	of	ADP
ihlr-16574	133	29	the	the	DET
ihlr-16574	133	30	nanotech	nanotech	NOUN
ihlr-16574	133	31	materials	material	NOUN
ihlr-16574	133	32	.	.	PUNCT
ihlr-16574	133	33	"	"	PUNCT
ihlr-16574	134	1	tim	tim	PROPN
ihlr-16574	134	2	utile	utile	PROPN
ihlr-16574	134	3	,	,	PUNCT
ihlr-16574	134	4	sanford	sanford	PROPN
ihlr-16574	134	5	lewis	lewis	PROPN
ihlr-16574	134	6	&	&	CCONJ
ihlr-16574	134	7	pamela	pamela	PROPN
ihlr-16574	134	8	lundquist	lundquist	PROPN
ihlr-16574	134	9	,	,	PUNCT
ihlr-16574	134	10	beneath	beneath	ADP
ihlr-16574	134	11	the	the	DET
ihlr-16574	134	12	skin	skin	NOUN
ihlr-16574	134	13	:	:	PUNCT
ihlr-16574	134	14	hidden	hide	VERB
ihlr-16574	134	15	llabiuties	llabiutie	NOUN
ihlr-16574	134	16	,	,	PUNCT
ihlr-16574	134	17	market	market	NOUN
ihlr-16574	134	18	risk	risk	NOUN
ihlr-16574	134	19	and	and	CCONJ
ihlr-16574	134	20	·	·	PUNCT
ihlr-16574	134	21	drivers	driver	NOUN
ihlr-16574	134	22	of	of	ADP
ihlr-16574	134	23	change	change	NOUN
ihlr-16574	134	24	in	in	ADP
ihlr-16574	134	25	the	the	DET
ihlr-16574	134	26	cosmetics	cosmetic	NOUN
ihlr-16574	134	27	and	and	CCONJ
ihlr-16574	134	28	person	person	NOUN
ihlr-16574	134	29	care	care	NOUN
ihlr-16574	134	30	products	product	NOUN
ihlr-16574	134	31	industry	industry	NOUN
ihlr-16574	134	32	2·(2007	2·(2007	NUM
ihlr-16574	134	33	)	)	PUNCT
ihlr-16574	134	34	,	,	PUNCT
ihlr-16574	134	35	available	available	ADJ
ihlr-16574	134	36	at	at	ADP
ihlr-16574	134	37	http://iebn.org/filesaltiiehncosmeticsreportfin.pdf	http://iebn.org/filesaltiiehncosmeticsreportfin.pdf	NOUN
ihlr-16574	134	38	[	[	X
ihlr-16574	134	39	hereinafter	hereinafter	NOUN
ihlr-16574	134	40	beneath	beneath	ADP
ihlr-16574	134	41	the	the	DET
ihlr-16574	134	42	skin	skin	NOUN
ihlr-16574	134	43	]	]	PUNCT
ihlr-16574	134	44	.	.	PUNCT
ihlr-16574	135	1	32	32	NUM
ihlr-16574	135	2	.	.	PUNCT
ihlr-16574	136	1	see	see	VERB
ihlr-16574	136	2	i	i	PROPN
ihlr-16574	136	3	d	d	PROPN
ihlr-16574	136	4	;	;	PUNCT
ihlr-16574	136	5	see	see	VERB
ihlr-16574	136	6	also	also	ADV
ihlr-16574	136	7	nanowerk	nanowerk	PROPN
ihlr-16574	136	8	,	,	PUNCT
ihlr-16574	136	9	new	new	ADJ
ihlr-16574	136	10	report	report	NOUN
ihlr-16574	136	11	slams	slam	VERB
ihlr-16574	136	12	naiwtechnology	naiwtechnology	NOUN
ihlr-16574	136	13	z'n	z'n	PROPN
ihlr-16574	136	14	cosmetics	cosmetic	NOUN
ihlr-16574	136	15	,	,	PUNCT
ihlr-16574	136	16	http://www.nanowerk.com/newslnewsid=l505.php	http://www.nanowerk.com/newslnewsid=l505.php	PROPN
ihlr-16574	136	17	(	(	PUNCT
ihlr-16574	136	18	last	last	ADV
ihlr-16574	136	19	visited	visit	VERB
ihlr-16574	136	20	nov	nov	PROPN
ihlr-16574	136	21	.	.	PROPN
ihlr-16574	136	22	2	2	NUM
ihlr-16574	136	23	,	,	PUNCT
ihlr-16574	136	24	2008	2008	NUM
ihlr-16574	136	25	)	)	PUNCT
ihlr-16574	136	26	.	.	PUNCT
ihlr-16574	137	1	2010	2010	NUM
ihlr-16574	137	2	]	]	PUNCT
ihlr-16574	137	3	nanomedicine	nanomedicine	NOUN
ihlr-16574	137	4	403	403	NUM
ihlr-16574	137	5	they	they	PRON
ihlr-16574	137	6	may	may	AUX
ihlr-16574	137	7	not	not	PART
ihlr-16574	137	8	be	be	AUX
ihlr-16574	137	9	programmed	program	VERB
ihlr-16574	137	10	with	with	ADP
ihlr-16574	137	11	a	a	DET
ihlr-16574	137	12	specific	specific	ADJ
ihlr-16574	137	13	purpose	purpose	NOUN
ihlr-16574	137	14	,	,	PUNCT
ihlr-16574	137	15	it	it	PRON
ihlr-16574	137	16	does	do	AUX
ihlr-16574	137	17	demonstrate	demonstrate	VERB
ihlr-16574	137	18	·	·	PUNCT
ihlr-16574	137	19	the	the	DET
ihlr-16574	137	20	fear	fear	NOUN
ihlr-16574	137	21	that	that	PRON
ihlr-16574	137	22	surrounds	surround	VERB
ihlr-16574	137	23	the	the	DET
ihlr-16574	137	24	unknown	unknown	ADJ
ihlr-16574	137	25	effects	effect	NOUN
ihlr-16574	137	26	that	that	PRON
ihlr-16574	137	27	these	these	DET
ihlr-16574	137	28	tiny	tiny	ADJ
ihlr-16574	137	29	particles	particle	NOUN
ihlr-16574	137	30	could	could	AUX
ihlr-16574	137	31	have	have	VERB
ihlr-16574	137	32	on	on	ADP
ihlr-16574	137	33	human	human	ADJ
ihlr-16574	137	34	physiology.33	physiology.33	NOUN
ihlr-16574	137	35	imagine	imagine	VERB
ihlr-16574	137	36	,	,	PUNCT
ihlr-16574	137	37	a	a	DET
ihlr-16574	137	38	woman	woman	NOUN
ihlr-16574	137	39	gets	get	VERB
ihlr-16574	137	40	up	up	ADP
ihlr-16574	137	41	in	in	ADP
ihlr-16574	137	42	the	the	DET
ihlr-16574	137	43	morning	morning	NOUN
ihlr-16574	137	44	and	and	CCONJ
ihlr-16574	137	45	applies	apply	VERB
ihlr-16574	137	46	her	her	PRON
ihlr-16574	137	47	make	make	NOUN
ihlr-16574	137	48	-	-	PUNCT
ihlr-16574	137	49	up	up	NOUN
ihlr-16574	137	50	as	as	ADP
ihlr-16574	137	51	usual	usual	ADJ
ihlr-16574	137	52	and	and	CCONJ
ihlr-16574	137	53	subsequently	subsequently	ADV
ihlr-16574	137	54	becomes	become	VERB
ihlr-16574	137	55	violently	violently	ADV
ihlr-16574	137	56	ill	ill	ADJ
ihlr-16574	137	57	due	due	ADJ
ihlr-16574	137	58	to	to	ADP
ihlr-16574	137	59	a	a	DET
ihlr-16574	137	60	nanoparticle	nanoparticle	NOUN
ihlr-16574	137	61	contaminant.34	contaminant.34	NOUN
ihlr-16574	137	62	there	there	PRON
ihlr-16574	137	63	are	be	VERB
ihlr-16574	137	64	currently	currently	ADV
ihlr-16574	137	65	no	no	DET
ihlr-16574	137	66	ways	way	NOUN
ihlr-16574	137	67	of	of	ADP
ihlr-16574	137	68	detect­	detect­	NOUN
ihlr-16574	137	69	ing	e	VERB
ihlr-16574	137	70	these	these	DET
ihlr-16574	137	71	contaminants	contaminant	NOUN
ihlr-16574	137	72	.	.	PUNCT
ihlr-16574	138	1	as	as	ADP
ihlr-16574	138	2	a	a	DET
ihlr-16574	138	3	result	result	NOUN
ihlr-16574	138	4	,	,	PUNCT
ihlr-16574	138	5	physicians	physician	NOUN
ihlr-16574	138	6	will	will	AUX
ihlr-16574	138	7	face	face	VERB
ihlr-16574	138	8	difficulty	difficulty	NOUN
ihlr-16574	138	9	in	in	ADP
ihlr-16574	138	10	treat­	treat­	PRON
ihlr-16574	138	11	ing	e	VERB
ihlr-16574	138	12	the	the	DET
ihlr-16574	138	13	woman	woman	NOUN
ihlr-16574	138	14	because	because	SCONJ
ihlr-16574	138	15	they	they	PRON
ihlr-16574	138	16	will	will	AUX
ihlr-16574	138	17	not	not	PART
ihlr-16574	138	18	be	be	AUX
ihlr-16574	138	19	able	able	ADJ
ihlr-16574	138	20	to	to	PART
ihlr-16574	138	21	determine	determine	VERB
ihlr-16574	138	22	the	the	DET
ihlr-16574	138	23	source	source	NOUN
ihlr-16574	138	24	of	of	ADP
ihlr-16574	138	25	the	the	DET
ihlr-16574	138	26	patient	patient	NOUN
ihlr-16574	138	27	's	's	PART
ihlr-16574	138	28	illness.35	illness.35	NOUN
ihlr-16574	138	29	additionally	additionally	ADV
ihlr-16574	138	30	,	,	PUNCT
ihlr-16574	138	31	even	even	ADV
ihlr-16574	138	32	if	if	SCONJ
ihlr-16574	138	33	the	the	DET
ihlr-16574	138	34	source	source	NOUN
ihlr-16574	138	35	of	of	ADP
ihlr-16574	138	36	her	her	PRON
ihlr-16574	138	37	illness	illness	NOUN
ihlr-16574	138	38	can	can	AUX
ihlr-16574	138	39	be	be	AUX
ihlr-16574	138	40	as­	as­	NOUN
ihlr-16574	138	41	certained	certaine	VERB
ihlr-16574	138	42	for	for	ADP
ihlr-16574	138	43	treatment	treatment	NOUN
ihlr-16574	138	44	purposes	purpose	NOUN
ihlr-16574	138	45	,	,	PUNCT
ihlr-16574	138	46	the	the	DET
ihlr-16574	138	47	challenge	challenge	NOUN
ihlr-16574	138	48	of	of	ADP
ihlr-16574	138	49	determining	determine	VERB
ihlr-16574	138	50	who	who	PRON
ihlr-16574	138	51	should	should	AUX
ihlr-16574	138	52	be	be	AUX
ihlr-16574	138	53	liable	liable	ADJ
ihlr-16574	138	54	for	for	SCONJ
ihlr-16574	138	55	her	her	PRON
ihlr-16574	138	56	illness	illness	NOUN
ihlr-16574	138	57	remains	remain	VERB
ihlr-16574	138	58	.	.	PUNCT
ihlr-16574	139	1	though	though	SCONJ
ihlr-16574	139	2	the	the	DET
ihlr-16574	139	3	nanoparticle	nanoparticle	NOUN
ihlr-16574	139	4	contaminants	contaminant	NOUN
ihlr-16574	139	5	are	be	AUX
ihlr-16574	139	6	not	not	PART
ihlr-16574	139	7	directly	directly	ADV
ihlr-16574	139	8	related	relate	VERB
ihlr-16574	139	9	to	to	ADP
ihlr-16574	139	10	nanomedicine	nanomedicine	NOUN
ihlr-16574	139	11	,	,	PUNCT
ihlr-16574	139	12	this	this	DET
ihlr-16574	139	13	situation	situation	NOUN
ihlr-16574	139	14	demonstrates	demonstrate	VERB
ihlr-16574	139	15	the	the	DET
ihlr-16574	139	16	poten­	poten­	PROPN
ihlr-16574	139	17	tial	tial	ADJ
ihlr-16574	139	18	risks	risk	NOUN
ihlr-16574	139	19	matter	matter	VERB
ihlr-16574	139	20	created	create	VERB
ihlr-16574	139	21	on	on	ADP
ihlr-16574	139	22	the	the	DET
ihlr-16574	139	23	nano	nano	NOUN
ihlr-16574	139	24	-	-	PUNCT
ihlr-16574	139	25	level	level	NOUN
ihlr-16574	139	26	present	present	NOUN
ihlr-16574	139	27	to	to	ADP
ihlr-16574	139	28	the	the	DET
ihlr-16574	139	29	medical	medical	ADJ
ihlr-16574	139	30	field	field	NOUN
ihlr-16574	139	31	.	.	PUNCT
ihlr-16574	140	1	another	another	DET
ihlr-16574	140	2	very	very	ADV
ihlr-16574	140	3	real	real	ADJ
ihlr-16574	140	4	fear	fear	NOUN
ihlr-16574	140	5	surrounding	surround	VERB
ihlr-16574	140	6	nanomedicine	nanomedicine	NOUN
ihlr-16574	140	7	addressed	address	VERB
ihlr-16574	140	8	the	the	DET
ihlr-16574	140	9	poten­	poten­	PROPN
ihlr-16574	140	10	tial	tial	NOUN
ihlr-16574	140	11	affects	affect	VERB
ihlr-16574	140	12	on	on	ADP
ihlr-16574	140	13	human	human	ADJ
ihlr-16574	140	14	toxicology	toxicology	NOUN
ihlr-16574	140	15	.	.	PUNCT
ihlr-16574	141	1	"	"	PUNCT
ihlr-16574	141	2	the	the	DET
ihlr-16574	141	3	lack	lack	NOUN
ihlr-16574	141	4	of	of	ADP
ihlr-16574	141	5	knowledge	knowledge	NOUN
ihlr-16574	141	6	about	about	ADP
ihlr-16574	141	7	how	how	SCONJ
ihlr-16574	141	8	nano­	nano­	NUM
ihlr-16574	141	9	particles	particle	NOUN
ihlr-16574	141	10	might	might	AUX
ihlr-16574	141	11	affect	affect	VERB
ihlr-16574	141	12	or	or	CCONJ
ihlr-16574	141	13	interfere	interfere	VERB
ihlr-16574	141	14	with	with	ADP
ihlr-16574	141	15	the	the	DET
ihlr-16574	141	16	biochemical	biochemical	ADJ
ihlr-16574	141	17	pathways	pathway	NOUN
ihlr-16574	141	18	and	and	CCONJ
ihlr-16574	141	19	processes	process	NOUN
ihlr-16574	141	20	of	of	ADP
ihlr-16574	141	21	the	the	DET
ihlr-16574	141	22	humali	humali	ADJ
ihlr-16574	141	23	body	body	NOUN
ihlr-16574	141	24	''	''	PUNCT
ihlr-16574	141	25	remains	remain	VERB
ihlr-16574	141	26	unknown	unknown	ADJ
ihlr-16574	141	27	.	.	PUNCT
ihlr-16574	142	1	36	36	NUM
ihlr-16574	143	1	it	it	PRON
ihlr-16574	143	2	is	be	AUX
ihlr-16574	143	3	possible	possible	ADJ
ihlr-16574	143	4	that	that	SCONJ
ihlr-16574	143	5	na­	na­	PROPN
ihlr-16574	143	6	nomedicine	nomedicine	NOUN
ihlr-16574	143	7	could	could	AUX
ihlr-16574	143	8	be	be	AUX
ihlr-16574	143	9	extremely	extremely	ADV
ihlr-16574	143	10	harmful	harmful	ADJ
ihlr-16574	143	11	to	to	ADP
ihlr-16574	143	12	human	human	ADJ
ihlr-16574	143	13	physiology	physiology	NOUN
ihlr-16574	143	14	.	.	PUNCT
ihlr-16574	144	1	the	the	DET
ihlr-16574	144	2	euro­	euro­	NOUN
ihlr-16574	144	3	pean	pean	ADJ
ihlr-16574	144	4	technology	technology	NOUN
ihlr-16574	144	5	platform	platform	NOUN
ihlr-16574	144	6	on	on	ADP
ihlr-16574	144	7	nanomedicine	nanomedicine	ADJ
ihlr-16574	144	8	notes	note	NOUN
ihlr-16574	144	9	some	some	DET
ihlr-16574	144	10	fears	fear	NOUN
ihlr-16574	144	11	in	in	ADP
ihlr-16574	144	12	its	its	PRON
ihlr-16574	144	13	vision	vision	NOUN
ihlr-16574	144	14	report	report	NOUN
ihlr-16574	144	15	:	:	PUNCT
ihlr-16574	144	16	"	"	PUNCT
ihlr-16574	144	17	the	the	DET
ihlr-16574	144	18	risks	risk	NOUN
ihlr-16574	144	19	and	and	CCONJ
ihlr-16574	144	20	challenges	challenge	NOUN
ihlr-16574	144	21	ofnanomedicine	ofnanomedicine	VERB
ihlr-16574	144	22	comprise	comprise	VERB
ihlr-16574	144	23	issues	issue	NOUN
ihlr-16574	144	24	of	of	ADP
ihlr-16574	144	25	tox­	tox­	NOUN
ihlr-16574	144	26	icity	icity	NOUN
ihlr-16574	144	27	and	and	CCONJ
ihlr-16574	144	28	carcinogenicity	carcinogenicity	NOUN
ihlr-16574	144	29	,	,	PUNCT
ihlr-16574	144	30	as	as	ADV
ihlr-16574	144	31	well	well	ADV
ihlr-16574	144	32	as	as	ADP
ihlr-16574	144	33	long	long	ADJ
ihlr-16574	144	34	-	-	PUNCT
ihlr-16574	144	35	term	term	NOUN
ihlr-16574	144	36	stability	stability	NOUN
ihlr-16574	144	37	and	and	CCONJ
ihlr-16574	144	38	excretion	excretion	NOUN
ihlr-16574	144	39	path­	path­	NUM
ihlr-16574	144	40	ways	way	NOUN
ihlr-16574	144	41	for	for	ADP
ihlr-16574	144	42	artificial	artificial	ADJ
ihlr-16574	144	43	nanostructures	nanostructure	NOUN
ihlr-16574	144	44	,	,	PUNCT
ihlr-16574	144	45	and	and	CCONJ
ihlr-16574	144	46	technological	technological	ADJ
ihlr-16574	144	47	challenges	challenge	NOUN
ihlr-16574	144	48	in	in	ADP
ihlr-16574	144	49	molecular	molecular	ADJ
ihlr-16574	144	50	manufacturing	manufacturing	NOUN
ihlr-16574	144	51	,	,	PUNCT
ihlr-16574	144	52	quality	quality	NOUN
ihlr-16574	144	53	assurance	assurance	NOUN
ihlr-16574	144	54	and	and	CCONJ
ihlr-16574	144	55	eventually	eventually	ADV
ihlr-16574	144	56	,	,	PUNCT
ihlr-16574	144	57	the	the	DET
ihlr-16574	144	58	programmability	programmability	NOUN
ihlr-16574	144	59	of	of	ADP
ihlr-16574	144	60	nanodevices	nanodevice	NOUN
ihlr-16574	144	61	.	.	PUNCT
ihlr-16574	145	1	"	"	PUNCT
ihlr-16574	145	2	37	37	NUM
ihlr-16574	145	3	one	one	NUM
ihlr-16574	145	4	report	report	NOUN
ihlr-16574	145	5	aptly	aptly	ADV
ihlr-16574	145	6	articulated	articulate	VERB
ihlr-16574	145	7	that	that	SCONJ
ihlr-16574	145	8	the	the	DET
ihlr-16574	145	9	danger	danger	NOUN
ihlr-16574	145	10	of	of	ADP
ihlr-16574	145	11	nanotech­	nanotech­	PROPN
ihlr-16574	145	12	nology	nology	NOUN
ihlr-16574	145	13	is	be	AUX
ihlr-16574	145	14	precisely	precisely	ADV
ihlr-16574	145	15	in	in	ADP
ihlr-16574	145	16	the	the	DET
ihlr-16574	145	17	fact	fact	NOUN
ihlr-16574	145	18	that	that	SCONJ
ihlr-16574	145	19	we	we	PRON
ihlr-16574	145	20	do	do	AUX
ihlr-16574	145	21	not	not	PART
ihlr-16574	145	22	know	know	VERB
ihlr-16574	145	23	what	what	PRON
ihlr-16574	145	24	the	the	DET
ihlr-16574	145	25	dangers	danger	NOUN
ihlr-16574	145	26	are	be	AUX
ihlr-16574	145	27	...	...	PUNCT
ihlr-16574	145	28	they	they	PRON
ihlr-16574	145	29	remain	remain	VERB
ihlr-16574	145	30	unknown.38	unknown.38	ADP
ihlr-16574	145	31	it	it	PRON
ihlr-16574	145	32	is	be	AUX
ihlr-16574	145	33	difficult	difficult	ADJ
ihlr-16574	145	34	to	to	PART
ihlr-16574	145	35	anticipate	anticipate	VERB
ihlr-16574	145	36	the	the	DET
ihlr-16574	145	37	effects	effect	NOUN
ihlr-16574	145	38	,	,	PUNCT
ihlr-16574	145	39	harms	harm	NOUN
ihlr-16574	145	40	,	,	PUNCT
ihlr-16574	145	41	33	33	NUM
ihlr-16574	145	42	.	.	PUNCT
ihlr-16574	146	1	see	see	VERB
ihlr-16574	146	2	wilhelmi	wilhelmi	PROPN
ihlr-16574	146	3	,	,	PUNCT
ihlr-16574	146	4	supra	supra	PROPN
ihlr-16574	146	5	note	note	NOUN
ihlr-16574	146	6	5	5	NUM
ihlr-16574	146	7	,	,	PUNCT
ihlr-16574	146	8	at	at	ADP
ihlr-16574	146	9	97	97	NUM
ihlr-16574	146	10	(	(	PUNCT
ihlr-16574	146	11	discussing	discuss	VERB
ihlr-16574	146	12	the	the	DET
ihlr-16574	146	13	drastically	drastically	ADV
ihlr-16574	146	14	different	different	ADJ
ihlr-16574	146	15	effects	effect	NOUN
ihlr-16574	146	16	that	that	PRON
ihlr-16574	146	17	nanoparticles	nanoparticle	VERB
ihlr-16574	146	18	with	with	ADP
ihlr-16574	146	19	even	even	ADV
ihlr-16574	146	20	the	the	DET
ihlr-16574	146	21	smallest	small	ADJ
ihlr-16574	146	22	degree	degree	NOUN
ihlr-16574	146	23	of	of	ADP
ihlr-16574	146	24	compositional	compositional	ADJ
ihlr-16574	146	25	variance	variance	NOUN
ihlr-16574	146	26	from	from	ADP
ihlr-16574	146	27	their	their	PRON
ihlr-16574	146	28	larger­	larger­	PROPN
ihlr-16574	146	29	molecule	molecule	NOUN
ihlr-16574	146	30	counterparts	counterpart	NOUN
ihlr-16574	146	31	can	can	AUX
ihlr-16574	146	32	have	have	VERB
ihlr-16574	146	33	on	on	ADP
ihlr-16574	146	34	surrounding	surround	VERB
ihlr-16574	146	35	material	material	NOUN
ihlr-16574	146	36	)	)	PUNCT
ihlr-16574	146	37	.	.	PUNCT
ihlr-16574	147	1	34	34	NUM
ihlr-16574	147	2	.	.	PUNCT
ihlr-16574	148	1	beneath	beneath	ADP
ihlr-16574	148	2	the	the	DET
ihlr-16574	148	3	skin	skin	NOUN
ihlr-16574	148	4	,	,	PUNCT
ihlr-16574	148	5	supranote31	supranote31	PROPN
ihlr-16574	148	6	,	,	PUNCT
ihlr-16574	148	7	at2	at2	PROPN
ihlr-16574	148	8	.	.	PUNCT
ihlr-16574	149	1	[	[	X
ihlr-16574	149	2	m]any	m]any	NOUN
ihlr-16574	149	3	potentially	potentially	ADV
ihlr-16574	149	4	harmful	harmful	ADJ
ihlr-16574	149	5	chemic•	chemic•	NOUN
ihlr-16574	149	6	have	have	AUX
ihlr-16574	149	7	been	be	AUX
ihlr-16574	149	8	found	find	VERB
ihlr-16574	149	9	to	to	PART
ihlr-16574	149	10	make	make	VERB
ihlr-16574	149	11	their	their	PRON
ihlr-16574	149	12	way	way	NOUN
ihlr-16574	149	13	into	into	ADP
ihlr-16574	149	14	cosmetics	cosmetic	NOUN
ihlr-16574	149	15	and	and	CCONJ
ihlr-16574	149	16	personal	personal	ADJ
ihlr-16574	149	17	care	care	NOUN
ihlr-16574	149	18	products	product	NOUN
ihlr-16574	149	19	.	.	PUNCT
ihlr-16574	150	1	the	the	DET
ihlr-16574	150	2	threats	threat	NOUN
ihlr-16574	150	3	to	to	ADP
ihlr-16574	150	4	health	health	NOUN
ihlr-16574	150	5	may	may	AUX
ihlr-16574	150	6	include	include	VERB
ihlr-16574	150	7	...	...	PUNCT
ihlr-16574	150	8	cancer	cancer	NOUN
ihlr-16574	150	9	,	,	PUNCT
ihlr-16574	150	10	harm	harm	NOUN
ihlr-16574	150	11	to	to	ADP
ihlr-16574	150	12	developing	develop	VERB
ihlr-16574	150	13	fetuses	fetus	NOUN
ihlr-16574	150	14	and	and	CCONJ
ihlr-16574	150	15	infants	infant	NOUN
ihlr-16574	150	16	exposed	expose	VERB
ihlr-16574	150	17	to	to	ADP
ihlr-16574	150	18	the	the	DET
ihlr-16574	150	19	chemicals	chemical	NOUN
ihlr-16574	150	20	through	through	ADP
ihlr-16574	150	21	baby	baby	NOUN
ihlr-16574	150	22	products	product	NOUN
ihlr-16574	150	23	or	or	CCONJ
ihlr-16574	150	24	their	their	PRON
ihlr-16574	150	25	mother	mother	NOUN
ihlr-16574	150	26	's	's	PART
ihlr-16574	150	27	cosmetics	cosmetic	NOUN
ihlr-16574	150	28	use	use	NOUN
ihlr-16574	150	29	,	,	PUNCT
ihlr-16574	150	30	and	and	CCONJ
ihlr-16574	150	31	disruptions	disruption	NOUN
ihlr-16574	150	32	of	of	ADP
ihlr-16574	150	33	various	various	ADJ
ihlr-16574	150	34	organ	organ	NOUN
ihlr-16574	150	35	or	or	CCONJ
ihlr-16574	150	36	hormonal	hormonal	ADJ
ihlr-16574	150	37	systems	system	NOUN
ihlr-16574	150	38	in	in	ADP
ihlr-16574	150	39	the	the	DET
ihlr-16574	150	40	body	body	NOUN
ihlr-16574	150	41	.	.	PUNCT
ihlr-16574	151	1	i	i	PRON
ihlr-16574	151	2	d.	d.	PROPN
ihlr-16574	151	3	35	35	NUM
ihlr-16574	151	4	.	.	PUNCT
ihlr-16574	152	1	i	i	PRON
ihlr-16574	152	2	d.	d.	PROPN
ihlr-16574	152	3	36	36	NUM
ihlr-16574	152	4	.	.	PUNCT
ihlr-16574	153	1	nanowerk	nanowerk	PROPN
ihlr-16574	153	2	,	,	PUNCT
ihlr-16574	153	3	the	the	DET
ihlr-16574	153	4	potential	potential	NOUN
ihlr-16574	153	5	and	and	CCONJ
ihlr-16574	153	6	the	the	DET
ihlr-16574	153	7	pitfalls	pitfall	NOUN
ihlr-16574	153	8	of	of	ADP
ihlr-16574	153	9	nanomedicine	nanomedicine	NOUN
ihlr-16574	153	10	(	(	PUNCT
ihlr-16574	153	11	may	may	PROPN
ihlr-16574	153	12	7	7	NUM
ihlr-16574	153	13	,	,	PUNCT
ihlr-16574	153	14	2007	2007	NUM
ihlr-16574	153	15	)	)	PUNCT
ihlr-16574	153	16	,	,	PUNCT
ihlr-16574	153	17	http://www.nanowerk.com/spodightlspotid=l891.php	http://www.nanowerk.com/spodightlspotid=l891.php	PROPN
ihlr-16574	153	18	(	(	PUNCT
ihlr-16574	153	19	last	last	ADV
ihlr-16574	153	20	visited	visit	VERB
ihlr-16574	153	21	september	september	PROPN
ihlr-16574	153	22	22	22	NUM
ihlr-16574	153	23	,	,	PUNCT
ihlr-16574	153	24	2009	2009	NUM
ihlr-16574	153	25	)	)	PUNCT
ihlr-16574	154	1	[	[	X
ihlr-16574	154	2	he­	he­	NOUN
ihlr-16574	154	3	reinafter	reinafter	ADJ
ihlr-16574	154	4	potential	potential	ADJ
ihlr-16574	154	5	pitfalls	pitfall	NOUN
ihlr-16574	154	6	]	]	PUNCT
ihlr-16574	154	7	.	.	PUNCT
ihlr-16574	155	1	37	37	NUM
ihlr-16574	155	2	.	.	PUNCT
ihlr-16574	156	1	european	european	ADJ
ihlr-16574	156	2	technology	technology	PROPN
ihlr-16574	156	3	platform	platform	NOUN
ihlr-16574	156	4	on	on	ADP
ihlr-16574	156	5	nanomedicine	nanomedicine	ADJ
ihlr-16574	156	6	,	,	PUNCT
ihlr-16574	156	7	v'jsion	v'jsion	NOUN
ihlr-16574	156	8	paper	paper	NOUN
ihlr-16574	156	9	and	and	CCONJ
ihlr-16574	156	10	basis	basis	NOUN
ihlr-16574	156	11	for	for	ADP
ihlr-16574	156	12	a	a	DET
ihlr-16574	156	13	strategic	strategic	ADJ
ihlr-16574	156	14	research	research	NOUN
ihlr-16574	156	15	agenda	agenda	NOUN
ihlr-16574	156	16	for	for	ADP
ihlr-16574	156	17	nanomedicine	nanomedicine	NOUN
ihlr-16574	156	18	,	,	PUNCT
ihlr-16574	156	19	12	12	NUM
ihlr-16574	156	20	(	(	PUNCT
ihlr-16574	156	21	sept	sept	PROPN
ihlr-16574	156	22	.	.	PROPN
ihlr-16574	156	23	2005	2005	NUM
ihlr-16574	156	24	)	)	PUNCT
ihlr-16574	156	25	available	available	ADJ
ihlr-16574	156	26	at	at	ADP
ihlr-16574	156	27	ftp://ftp.cordis.europa.eulpublnanotechnology/docs/nanomedicine_visionpaper.pdf	ftp://ftp.cordis.europa.eulpublnanotechnology/docs/nanomedicine_visionpaper.pdf	PROPN
ihlr-16574	156	28	.	.	PROPN
ihlr-16574	157	1	38	38	NUM
ihlr-16574	157	2	.	.	PUNCT
ihlr-16574	158	1	rick	rick	PROPN
ihlr-16574	158	2	weiss	weiss	PROPN
ihlr-16574	158	3	,	,	PUNCT
ihlr-16574	158	4	nanotechnology	nanotechnology	NOUN
ihlr-16574	158	5	risks	risk	VERB
ihlr-16574	158	6	unknown	unknown	ADJ
ihlr-16574	158	7	,	,	PUNCT
ihlr-16574	158	8	'	'	PUNCT
ihlr-16574	158	9	die	die	VERB
ihlr-16574	158	10	washington	washington	PROPN
ihlr-16574	158	11	post	post	PROPN
ihlr-16574	158	12	,	,	PUNCT
ihlr-16574	158	13	sept	sept	PROPN
ihlr-16574	158	14	.	.	PROPN
ihlr-16574	158	15	26	26	NUM
ihlr-16574	158	16	,	,	PUNCT
ihlr-16574	158	17	2006	2006	NUM
ihlr-16574	158	18	,	,	PUNCT
ihlr-16574	158	19	available	available	ADJ
ihlr-16574	158	20	at	at	ADP
ihlr-16574	158	21	http://www	http://www	PROPN
ihlr-16574	158	22	.	.	PUNCT
ihlr-16574	159	1	washingtonpost.com/wp-dyn/content/article/2006/09/25/	washingtonpost.com/wp-dyn/content/article/2006/09/25/	PROPN
ihlr-16574	159	2	ar200609250ll38.html	ar200609250ll38.html	PUNCT
ihlr-16574	159	3	(	(	PUNCT
ihlr-16574	159	4	noting	note	VERB
ihlr-16574	159	5	that	that	SCONJ
ihlr-16574	159	6	"	"	PUNCT
ihlr-16574	159	7	[	[	X
ihlr-16574	159	8	a]bout	a]bout	ADP
ihlr-16574	159	9	300	300	NUM
ihlr-16574	159	10	consumer	consumer	NOUN
ihlr-16574	159	11	products	product	NOUN
ihlr-16574	159	12	already	already	ADV
ihlr-16574	159	13	contain	contain	VERB
ihlr-16574	159	14	na­	na­	ADJ
ihlr-16574	159	15	noscale	noscale	NOUN
ihlr-16574	159	16	ingredients	ingredient	NOUN
ihlr-16574	159	17	...	...	PUNCT
ihlr-16574	159	18	,	,	PUNCT
ihlr-16574	159	19	including	include	VERB
ihlr-16574	159	20	several	several	ADJ
ihlr-16574	159	21	foods	food	NOUN
ihlr-16574	159	22	and	and	CCONJ
ihlr-16574	159	23	many	many	ADJ
ihlr-16574	159	24	cosmetics	cosmetic	NOUN
ihlr-16574	159	25	,	,	PUNCT
ihlr-16574	159	26	with	with	ADP
ihlr-16574	159	27	little	little	ADJ
ihlr-16574	159	28	or	or	CCONJ
ihlr-16574	159	29	no	no	PRON
ihlr-16574	159	30	research	research	NOUN
ihlr-16574	159	31	to	to	PART
ihlr-16574	159	32	document	document	VERB
ihlr-16574	159	33	their	their	PRON
ihlr-16574	159	34	safety	safety	NOUN
ihlr-16574	159	35	"	"	PUNCT
ihlr-16574	159	36	)	)	PUNCT
ihlr-16574	159	37	.	.	PUNCT
ihlr-16574	160	1	404	404	NUM
ihlr-16574	160	2	indiana	indiana	PROPN
ihlr-16574	160	3	health	health	PROPN
ihlr-16574	160	4	law	law	PROPN
ihlr-16574	160	5	review	review	NOUN
ihlr-16574	160	6	[	[	X
ihlr-16574	160	7	vol	vol	NOUN
ihlr-16574	160	8	.	.	PUNCT
ihlr-16574	160	9	7:397	7:397	NUM
ihlr-16574	160	10	and	and	CCONJ
ihlr-16574	160	11	benefits	benefit	NOUN
ihlr-16574	160	12	of	of	ADP
ihlr-16574	160	13	a	a	DET
ihlr-16574	160	14	product	product	NOUN
ihlr-16574	160	15	so	so	ADV
ihlr-16574	160	16	new	new	ADJ
ihlr-16574	160	17	in	in	ADP
ihlr-16574	160	18	its	its	PRON
ihlr-16574	160	19	conception	conception	NOUN
ihlr-16574	160	20	when	when	SCONJ
ihlr-16574	160	21	even	even	ADV
ihlr-16574	160	22	those	those	PRON
ihlr-16574	160	23	who	who	PRON
ihlr-16574	160	24	are	be	AUX
ihlr-16574	160	25	most	most	ADV
ihlr-16574	160	26	familiar	familiar	ADJ
ihlr-16574	160	27	with	with	ADP
ihlr-16574	160	28	it	it	PRON
ihlr-16574	160	29	can	can	AUX
ihlr-16574	160	30	do	do	VERB
ihlr-16574	160	31	little	little	ADJ
ihlr-16574	160	32	more	more	ADJ
ihlr-16574	160	33	than	than	SCONJ
ihlr-16574	160	34	theorize	theorize	VERB
ihlr-16574	160	35	as	as	ADP
ihlr-16574	160	36	to	to	ADP
ihlr-16574	160	37	its	its	PRON
ihlr-16574	160	38	outcomes	outcome	NOUN
ihlr-16574	160	39	and	and	CCONJ
ihlr-16574	160	40	application	application	NOUN
ihlr-16574	160	41	.	.	PUNCT
ihlr-16574	161	1	perhaps	perhaps	ADV
ihlr-16574	161	2	these	these	DET
ihlr-16574	161	3	reasons	reason	NOUN
ihlr-16574	161	4	account	account	VERB
ihlr-16574	161	5	for	for	ADP
ihlr-16574	161	6	the	the	DET
ihlr-16574	161	7	fact	fact	NOUN
ihlr-16574	161	8	that	that	SCONJ
ihlr-16574	161	9	many	many	ADJ
ihlr-16574	161	10	current	current	ADJ
ihlr-16574	161	11	discus­	discus­	NOUN
ihlr-16574	161	12	sions	sion	NOUN
ihlr-16574	161	13	on	on	ADP
ihlr-16574	161	14	nanotechnology	nanotechnology	NOUN
ihlr-16574	161	15	are	be	AUX
ihlr-16574	161	16	steeped	steep	VERB
ihlr-16574	161	17	in	in	ADP
ihlr-16574	161	18	complex	complex	ADJ
ihlr-16574	161	19	ethical	ethical	ADJ
ihlr-16574	161	20	issues	issue	NOUN
ihlr-16574	161	21	.	.	PUNCT
ihlr-16574	162	1	39	39	NUM
ihlr-16574	162	2	topping	top	VERB
ihlr-16574	162	3	this	this	DET
ihlr-16574	162	4	list	list	NOUN
ihlr-16574	162	5	of	of	ADP
ihlr-16574	162	6	ethical	ethical	ADJ
ihlr-16574	162	7	concerns	concern	NOUN
ihlr-16574	162	8	is	be	AUX
ihlr-16574	162	9	the	the	DET
ihlr-16574	162	10	way	way	NOUN
ihlr-16574	162	11	in	in	ADP
ihlr-16574	162	12	which	which	PRON
ihlr-16574	162	13	nanotechnology	nanotechnology	NOUN
ihlr-16574	162	14	will	will	AUX
ihlr-16574	162	15	likely	likely	ADV
ihlr-16574	162	16	be	be	AUX
ihlr-16574	162	17	able	able	ADJ
ihlr-16574	162	18	to	to	PART
ihlr-16574	162	19	pennit	pennit	VERB
ihlr-16574	162	20	human	human	ADJ
ihlr-16574	162	21	enhancement	enhancement	NOUN
ihlr-16574	162	22	.	.	PUNCT
ihlr-16574	163	1	the	the	DET
ihlr-16574	163	2	potential	potential	ADJ
ihlr-16574	163	3	use	use	NOUN
ihlr-16574	163	4	of	of	ADP
ihlr-16574	163	5	nanotechnolo­	nanotechnolo­	PROPN
ihlr-16574	163	6	gy	gy	PROPN
ihlr-16574	163	7	for	for	ADP
ihlr-16574	163	8	human	human	ADJ
ihlr-16574	163	9	enhancement	enhancement	NOUN
ihlr-16574	163	10	blurs	blur	VERB
ihlr-16574	163	11	the	the	DET
ihlr-16574	163	12	lines	line	NOUN
ihlr-16574	163	13	between	between	ADP
ihlr-16574	163	14	medical	medical	ADJ
ihlr-16574	163	15	and	and	CCONJ
ihlr-16574	163	16	non­	non­	PROPN
ihlr-16574	163	17	medical	medical	ADJ
ihlr-16574	163	18	uses	use	NOUN
ihlr-16574	163	19	of	of	ADP
ihlr-16574	163	20	the	the	DET
ihlr-16574	163	21	technology.40	technology.40	NOUN
ihlr-16574	163	22	nanomedicine	nanomedicine	NOUN
ihlr-16574	163	23	could	could	AUX
ihlr-16574	163	24	not	not	PART
ihlr-16574	163	25	only	only	ADV
ihlr-16574	163	26	cure	cure	VERB
ihlr-16574	163	27	pa­	pa­	ADJ
ihlr-16574	163	28	tient	tient	NOUN
ihlr-16574	163	29	x	x	X
ihlr-16574	163	30	's	's	PART
ihlr-16574	163	31	cancer	cancer	NOUN
ihlr-16574	163	32	,	,	PUNCT
ihlr-16574	163	33	it	it	PRON
ihlr-16574	163	34	could	could	AUX
ihlr-16574	163	35	make	make	VERB
ihlr-16574	163	36	her	she	PRON
ihlr-16574	163	37	stronger	strong	ADJ
ihlr-16574	163	38	,	,	PUNCT
ihlr-16574	163	39	more	more	ADV
ihlr-16574	163	40	energetic	energetic	ADJ
ihlr-16574	163	41	,	,	PUNCT
ihlr-16574	163	42	or	or	CCONJ
ihlr-16574	163	43	improve	improve	VERB
ihlr-16574	163	44	other	other	ADJ
ihlr-16574	163	45	physiological	physiological	ADJ
ihlr-16574	163	46	characteristics	characteristic	NOUN
ihlr-16574	163	47	in·ways	in·way	NOUN
ihlr-16574	163	48	that	that	PRON
ihlr-16574	163	49	stretch	stretch	VERB
ihlr-16574	163	50	far	far	ADV
ihlr-16574	163	51	beyond	beyond	ADP
ihlr-16574	163	52	the	the	DET
ihlr-16574	163	53	origi­	origi­	PROPN
ihlr-16574	163	54	nal	nal	ADJ
ihlr-16574	163	55	goal	goal	NOUN
ihlr-16574	163	56	of	of	ADP
ihlr-16574	163	57	eradicating	eradicate	VERB
ihlr-16574	163	58	her	her	PRON
ihlr-16574	163	59	cancer	cancer	NOUN
ihlr-16574	163	60	.	.	PUNCT
ihlr-16574	164	1	what	what	PRON
ihlr-16574	164	2	would	would	AUX
ihlr-16574	164	3	further	far	ADV
ihlr-16574	164	4	complicate	complicate	VERB
ihlr-16574	164	5	the	the	DET
ihlr-16574	164	6	issue	issue	NOUN
ihlr-16574	164	7	is	be	AUX
ihlr-16574	164	8	if	if	SCONJ
ihlr-16574	164	9	patient	patient	ADJ
ihlr-16574	164	10	x	x	PRON
ihlr-16574	164	11	purchased	purchase	VERB
ihlr-16574	164	12	the	the	DET
ihlr-16574	164	13	nanites	nanite	NOUN
ihlr-16574	164	14	used	use	VERB
ihlr-16574	164	15	to	to	PART
ihlr-16574	164	16	cure	cure	VERB
ihlr-16574	164	17	her	her	PRON
ihlr-16574	164	18	cancer	cancer	NOUN
ihlr-16574	164	19	.	.	PUNCT
ihlr-16574	165	1	she	she	PRON
ihlr-16574	165	2	would	would	AUX
ihlr-16574	165	3	then	then	ADV
ihlr-16574	165	4	own	own	VERB
ihlr-16574	165	5	them	they	PRON
ihlr-16574	165	6	and	and	CCONJ
ihlr-16574	165	7	could	could	AUX
ihlr-16574	165	8	theoretically	theoretically	ADV
ihlr-16574	165	9	have	have	VERB
ihlr-16574	165	10	them	they	PRON
ihlr-16574	165	11	reprogrammed	reprogramme	VERB
ihlr-16574	165	12	to	to	PART
ihlr-16574	165	13	perform	perform	VERB
ihlr-16574	165	14	any	any	DET
ihlr-16574	165	15	function	function	NOUN
ihlr-16574	165	16	she	she	PRON
ihlr-16574	165	17	desired	desire	VERB
ihlr-16574	165	18	.	.	PUNCT
ihlr-16574	166	1	suddenly	suddenly	ADV
ihlr-16574	166	2	,	,	PUNCT
ihlr-16574	166	3	the	the	DET
ihlr-16574	166	4	absence	absence	NOUN
ihlr-16574	166	5	of	of	ADP
ihlr-16574	166	6	an	an	DET
ihlr-16574	166	7	ethical	ethical	ADJ
ihlr-16574	166	8	line	line	NOUN
ihlr-16574	166	9	in	in	ADP
ihlr-16574	166	10	the	the	DET
ihlr-16574	166	11	sand	sand	NOUN
ihlr-16574	166	12	becomes	become	VERB
ihlr-16574	166	13	quite	quite	ADV
ihlr-16574	166	14	noticeable	noticeable	ADJ
ihlr-16574	166	15	.	.	PUNCT
ihlr-16574	167	1	the	the	DET
ihlr-16574	167	2	question	question	NOUN
ihlr-16574	167	3	of	of	ADP
ihlr-16574	167	4	whether	whether	SCONJ
ihlr-16574	167	5	patient	patient	NOUN
ihlr-16574	167	6	x	x	PRON
ihlr-16574	167	7	should	should	AUX
ihlr-16574	167	8	be	be	AUX
ihlr-16574	167	9	able	able	ADJ
ihlr-16574	167	10	to	to	PART
ihlr-16574	167	11	do	do	VERB
ihlr-16574	167	12	with	with	ADP
ihlr-16574	167	13	her	her	PRON
ihlr-16574	167	14	nanites	nanite	NOUN
ihlr-16574	167	15	what	what	PRON
ihlr-16574	167	16	she	she	PRON
ihlr-16574	167	17	chooses	choose	VERB
ihlr-16574	167	18	becomes	become	VERB
ihlr-16574	167	19	important	important	ADJ
ihlr-16574	167	20	to	to	PART
ihlr-16574	167	21	an­	an­	VERB
ihlr-16574	167	22	swer	swer	NOUN
ihlr-16574	167	23	.	.	PUNCT
ihlr-16574	168	1	some	some	DET
ihlr-16574	168	2	theoretical	theoretical	ADJ
ihlr-16574	168	3	applications	application	NOUN
ihlr-16574	168	4	for	for	ADP
ihlr-16574	168	5	nanomedicine	nanomedicine	NOUN
ihlr-16574	168	6	are	be	AUX
ihlr-16574	168	7	extremely	extremely	ADV
ihlr-16574	168	8	attrac­	attrac­	ADP
ihlr-16574	168	9	tive	tive	NOUN
ihlr-16574	168	10	.	.	PUNCT
ihlr-16574	169	1	consider	consider	VERB
ihlr-16574	169	2	robert	robert	PROPN
ihlr-16574	169	3	a.	a.	PROPN
ihlr-16574	169	4	freitas	freitas	PROPN
ihlr-16574	169	5	'	'	PART
ihlr-16574	169	6	41	41	NUM
ihlr-16574	169	7	proposed	propose	VERB
ihlr-16574	169	8	use	use	NOUN
ihlr-16574	169	9	of	of	ADP
ihlr-16574	169	10	artificial	artificial	ADJ
ihlr-16574	169	11	red	red	ADJ
ihlr-16574	169	12	blood	blood	NOUN
ihlr-16574	169	13	cells.42	cells.42	NOUN
ihlr-16574	169	14	his	his	PRON
ihlr-16574	169	15	fabricated	fabricate	VERB
ihlr-16574	169	16	cells	cell	NOUN
ihlr-16574	169	17	are	be	AUX
ihlr-16574	169	18	theorized	theorize	VERB
ihlr-16574	169	19	to	to	PART
ihlr-16574	169	20	"	"	PUNCT
ihlr-16574	169	21	be	be	AUX
ihlr-16574	169	22	capable	capable	ADJ
ihlr-16574	169	23	of	of	ADP
ihlr-16574	169	24	delivering	deliver	VERB
ihlr-16574	169	25	oxy­	oxy­	NOUN
ihlr-16574	169	26	gen	gen	PROPN
ihlr-16574	170	1	[	[	X
ihlr-16574	170	2	to	to	ADP
ihlr-16574	170	3	the	the	DET
ihlr-16574	170	4	human	human	ADJ
ihlr-16574	170	5	body	body	NOUN
ihlr-16574	170	6	]	]	PUNCT
ihlr-16574	170	7	many	many	ADJ
ihlr-16574	170	8	hundreds	hundred	NOUN
ihlr-16574	170	9	of	of	ADP
ihlr-16574	170	10	times	time	NOUN
ihlr-16574	170	11	more	more	ADV
ihlr-16574	170	12	efficiently	efficiently	ADV
ihlr-16574	170	13	than	than	ADP
ihlr-16574	170	14	hu­	hu­	PROPN
ihlr-16574	170	15	man	man	NOUN
ihlr-16574	170	16	red	red	ADJ
ihlr-16574	170	17	blood	blood	NOUN
ihlr-16574	170	18	cells	cell	NOUN
ihlr-16574	170	19	.	.	PUNCT
ihlr-16574	171	1	'"'3	'"'3	AUX
ihlr-16574	171	2	respiratory	respiratory	ADJ
ihlr-16574	171	3	diseases	disease	NOUN
ihlr-16574	171	4	would	would	AUX
ihlr-16574	171	5	likely	likely	ADV
ihlr-16574	171	6	be	be	AUX
ihlr-16574	171	7	eradicated	eradicate	VERB
ihlr-16574	171	8	with	with	ADP
ihlr-16574	171	9	this	this	DET
ihlr-16574	171	10	technology.44	technology.44	NOUN
ihlr-16574	171	11	transfusions	transfusion	NOUN
ihlr-16574	171	12	from	from	ADP
ihlr-16574	171	13	real	real	ADJ
ihlr-16574	171	14	blood	blood	NOUN
ihlr-16574	171	15	donors	donor	NOUN
ihlr-16574	171	16	would	would	AUX
ihlr-16574	171	17	be	be	AUX
ihlr-16574	171	18	un­	un­	ADP
ihlr-16574	171	19	necessary.45	necessary.45	NOUN
ihlr-16574	171	20	athletes	athlete	NOUN
ihlr-16574	171	21	could	could	AUX
ihlr-16574	171	22	increase	increase	VERB
ihlr-16574	171	23	their	their	PRON
ihlr-16574	171	24	endurance	endurance	NOUN
ihlr-16574	171	25	;	;	PUNCT
ihlr-16574	171	26	scuba	scuba	ADJ
ihlr-16574	171	27	divers	diver	NOUN
ihlr-16574	171	28	could	could	AUX
ihlr-16574	171	29	hold	hold	VERB
ihlr-16574	171	30	their	their	PRON
ihlr-16574	171	31	breath	breath	NOUN
ihlr-16574	171	32	underwater	underwater	NOUN
ihlr-16574	171	33	for	for	ADP
ihlr-16574	171	34	hours	hour	NOUN
ihlr-16574	171	35	at	at	ADP
ihlr-16574	171	36	a	a	DET
ihlr-16574	171	37	time.46	time.46	NOUN
ihlr-16574	171	38	this	this	PRON
ihlr-16574	171	39	would	would	AUX
ihlr-16574	171	40	all	all	PRON
ihlr-16574	171	41	be	be	AUX
ihlr-16574	171	42	possi­	possi­	PROPN
ihlr-16574	171	43	ble	ble	ADJ
ihlr-16574	171	44	because	because	SCONJ
ihlr-16574	171	45	of	of	ADP
ihlr-16574	171	46	nanomedicine	nanomedicine	NOUN
ihlr-16574	171	47	.	.	PUNCT
ihlr-16574	172	1	these	these	DET
ihlr-16574	172	2	possible	possible	ADJ
ihlr-16574	172	3	uses	use	NOUN
ihlr-16574	172	4	of	of	ADP
ihlr-16574	172	5	nanomedicine	nanomedicine	ADJ
ihlr-16574	172	6	raise	raise	VERB
ihlr-16574	172	7	ethical	ethical	ADJ
ihlr-16574	172	8	concerns	concern	NOUN
ihlr-16574	172	9	in	in	ADP
ihlr-16574	172	10	the	the	DET
ihlr-16574	172	11	form	form	NOUN
ihlr-16574	172	12	of	of	ADP
ihlr-16574	172	13	human	human	ADJ
ihlr-16574	172	14	enhancement	enhancement	NOUN
ihlr-16574	172	15	,	,	PUNCT
ihlr-16574	172	16	which	which	PRON
ihlr-16574	172	17	will	will	AUX
ihlr-16574	172	18	be	be	AUX
ihlr-16574	172	19	discussed	discuss	VERB
ihlr-16574	172	20	later	later	ADV
ihlr-16574	172	21	in	in	ADP
ihlr-16574	172	22	this	this	DET
ihlr-16574	172	23	note	note	NOUN
ihlr-16574	172	24	.	.	PUNCT
ihlr-16574	173	1	nevertheless	nevertheless	ADV
ihlr-16574	173	2	,	,	PUNCT
ihlr-16574	173	3	nanotechnology	nanotechnology	NOUN
ihlr-16574	173	4	and	and	CCONJ
ihlr-16574	173	5	nanomedicine	nanomedicine	PROPN
ihlr-16574	173	6	still	still	ADV
ihlr-16574	173	7	remain	remain	VERB
ihlr-16574	173	8	a	a	DET
ihlr-16574	173	9	hopeful	hopeful	ADJ
ihlr-16574	173	10	promise	promise	NOUN
ihlr-16574	173	11	of	of	ADP
ihlr-16574	173	12	numerous	numerous	ADJ
ihlr-16574	173	13	benefits	benefit	NOUN
ihlr-16574	173	14	slated	slate	VERB
ihlr-16574	173	15	for	for	ADP
ihlr-16574	173	16	the	the	DET
ihlr-16574	173	17	future	future	ADJ
ihlr-16574	173	18	horizon	horizon	NOUN
ihlr-16574	173	19	in	in	ADP
ihlr-16574	173	20	terms	term	NOUN
ihlr-16574	173	21	of	of	ADP
ihlr-16574	173	22	med­	med­	PROPN
ihlr-16574	173	23	ical	ical	PROPN
ihlr-16574	173	24	treatment	treatment	NOUN
ihlr-16574	173	25	.	.	PUNCT
ihlr-16574	174	1	regulators	regulator	NOUN
ihlr-16574	174	2	and	and	CCONJ
ihlr-16574	174	3	legislators	legislator	NOUN
ihlr-16574	174	4	must	must	AUX
ihlr-16574	174	5	remain	remain	VERB
ihlr-16574	174	6	ever	ever	ADV
ihlr-16574	174	7	cognizant	cognizant	ADJ
ihlr-16574	174	8	of	of	ADP
ihlr-16574	174	9	the	the	DET
ihlr-16574	174	10	ethical	ethical	ADJ
ihlr-16574	174	11	concerns	concern	NOUN
ihlr-16574	174	12	surrounding	surround	VERB
ihlr-16574	174	13	nanomedicine	nanomedicine	NOUN
ihlr-16574	174	14	.	.	PUNCT
ihlr-16574	175	1	they	they	PRON
ihlr-16574	175	2	will	will	AUX
ihlr-16574	175	3	certainly	certainly	ADV
ihlr-16574	175	4	be	be	AUX
ihlr-16574	175	5	tasked	task	VERB
ihlr-16574	175	6	39	39	NUM
ihlr-16574	175	7	.	.	PUNCT
ihlr-16574	176	1	potential	potential	ADJ
ihlr-16574	176	2	pitfalls	pitfall	NOUN
ihlr-16574	176	3	,	,	PUNCT
ihlr-16574	176	4	supra	supra	PROPN
ihlr-16574	176	5	note	note	NOUN
ihlr-16574	176	6	36	36	NUM
ihlr-16574	176	7	.	.	NUM
ihlr-16574	177	1	40	40	NUM
ihlr-16574	177	2	.	.	PUNCT
ihlr-16574	178	1	ld	ld	PROPN
ihlr-16574	178	2	.	.	PROPN
ihlr-16574	178	3	41	41	NUM
ihlr-16574	178	4	.	.	PUNCT
ihlr-16574	179	1	"	"	PUNCT
ihlr-16574	179	2	robert	robert	PROPN
ihlr-16574	179	3	a.	a.	PROPN
ihlr-16574	179	4	freitas	freitas	PROPN
ihlr-16574	179	5	jr	jr	PROPN
ihlr-16574	179	6	....	....	PUNCT
ihlr-16574	179	7	authored	author	VERB
ihlr-16574	179	8	the	the	DET
ihlr-16574	179	9	first	first	ADJ
ihlr-16574	179	10	detailed	detailed	ADJ
ihlr-16574	179	11	technical	technical	ADJ
ihlr-16574	179	12	design	design	NOUN
ihlr-16574	179	13	study	study	NOUN
ihlr-16574	179	14	of	of	ADP
ihlr-16574	179	15	a	a	DET
ihlr-16574	179	16	med­	med­	PROPN
ihlr-16574	179	17	ical	ical	PROPN
ihlr-16574	179	18	nanorobot	nanorobot	PROPN
ihlr-16574	179	19	ever	ever	ADV
ihlr-16574	179	20	published	publish	VERB
ihlr-16574	179	21	in	in	ADP
ihlr-16574	179	22	a	a	DET
ihlr-16574	179	23	peer.reviewed	peer.reviewe	VERB
ihlr-16574	179	24	mainstream	mainstream	ADJ
ihlr-16574	179	25	biomedical	biomedical	ADJ
ihlr-16574	179	26	journal	journal	NOUN
ihlr-16574	179	27	.	.	PUNCT
ihlr-16574	180	1	•.	•.	PROPN
ihlr-16574	181	1	[	[	X
ihlr-16574	181	2	and	and	CCONJ
ihlr-16574	181	3	]	]	PUNCT
ihlr-16574	181	4	is	be	AUX
ihlr-16574	181	5	the	the	DET
ihlr-16574	181	6	author	author	NOUN
ihlr-16574	181	7	ofnanomedicine	ofnanomedicine	PROPN
ihlr-16574	181	8	,	,	PUNCT
ihlr-16574	181	9	the	the	DET
ihlr-16574	181	10	first	first	ADJ
ihlr-16574	181	11	book	book	NOUN
ihlr-16574	181	12	-	-	PUNCT
ihlr-16574	181	13	length	length	NOUN
ihlr-16574	181	14	technical	technical	ADJ
ihlr-16574	181	15	discussion	discussion	NOUN
ihlr-16574	181	16	of	of	ADP
ihlr-16574	181	17	the	the	DET
ihlr-16574	181	18	potential	potential	ADJ
ihlr-16574	181	19	medi­	medi­	PROPN
ihlr-16574	181	20	cal	cal	ADJ
ihlr-16574	181	21	applications	application	NOUN
ihlr-16574	181	22	of	of	ADP
ihlr-16574	181	23	molecular	molecular	ADJ
ihlr-16574	181	24	nanotechnology	nanotechnology	NOUN
ihlr-16574	181	25	and	and	CCONJ
ihlr-16574	181	26	medical	medical	ADJ
ihlr-16574	181	27	nanorobotics	nanorobotic	NOUN
ihlr-16574	181	28	.	.	PUNCT
ihlr-16574	181	29	"	"	PUNCT
ihlr-16574	181	30	institute	institute	NOUN
ihlr-16574	181	31	for	for	ADP
ihlr-16574	181	32	mo­	mo­	PROPN
ihlr-16574	181	33	lecular	lecular	ADJ
ihlr-16574	181	34	manufacturing	manufacturing	NOUN
ihlr-16574	181	35	,	,	PUNCT
ihlr-16574	181	36	robert	robert	PROPN
ihlr-16574	181	37	a.	a.	PROPN
ihlr-16574	181	38	frietas	frietas	PROPN
ihlr-16574	181	39	jr	jr	PROPN
ihlr-16574	181	40	.	.	PROPN
ihlr-16574	181	41	,	,	PUNCT
ihlr-16574	181	42	senior	senior	ADJ
ihlr-16574	181	43	research	research	NOUN
ihlr-16574	181	44	fellow	fellow	NOUN
ihlr-16574	181	45	,	,	PUNCT
ihlr-16574	181	46	http://www.imm.oqy	http://www.imm.oqy	VERB
ihlr-16574	181	47	'	'	PUNCT
ihlr-16574	181	48	about	about	ADP
ihlr-16574	181	49	/	/	SYM
ihlr-16574	181	50	freitas/	freitas/	NUM
ihlr-16574	181	51	(	(	PUNCT
ihlr-16574	181	52	last	last	ADV
ihlr-16574	181	53	visited	visit	VERB
ihlr-16574	181	54	mar	mar	PROPN
ihlr-16574	181	55	.	.	PROPN
ihlr-16574	181	56	12	12	NUM
ihlr-16574	181	57	,	,	PUNCT
ihlr-16574	181	58	2009	2009	NUM
ihlr-16574	181	59	)	)	PUNCT
ihlr-16574	181	60	.	.	PUNCT
ihlr-16574	182	1	42	42	NUM
ihlr-16574	182	2	.	.	PUNCT
ihlr-16574	182	3	keiper	keiper	PROPN
ihlr-16574	182	4	,	,	PUNCT
ihlr-16574	182	5	supra	supra	PROPN
ihlr-16574	182	6	note	note	PROPN
ihlr-16574	182	7	27	27	NUM
ihlr-16574	182	8	,	,	PUNCT
ihlr-16574	182	9	at	at	ADP
ihlr-16574	182	10	25	25	NUM
ihlr-16574	182	11	.	.	PUNCT
ihlr-16574	182	12	·	·	PUNCT
ihlr-16574	183	1	43	43	NUM
ihlr-16574	183	2	.	.	PUNCT
ihlr-16574	184	1	i	i	PRON
ihlr-16574	184	2	d.	d.	PROPN
ihlr-16574	184	3	44	44	NUM
ihlr-16574	184	4	.	.	PUNCT
ihlr-16574	184	5	!	!	PUNCT
ihlr-16574	185	1	d.	d.	PROPN
ihlr-16574	185	2	45	45	NUM
ihlr-16574	185	3	.	.	PUNCT
ihlr-16574	186	1	/d	/d	INTJ
ihlr-16574	186	2	.	.	PUNCT
ihlr-16574	187	1	46	46	NUM
ihlr-16574	187	2	.	.	PUNCT
ihlr-16574	188	1	ld	ld	PROPN
ihlr-16574	188	2	.	.	PROPN
ihlr-16574	188	3	2010	2010	NUM
ihlr-16574	188	4	]	]	PUNCT
ihlr-16574	188	5	nanomedicine	nanomedicine	NOUN
ihlr-16574	188	6	405	405	NUM
ihlr-16574	188	7	with	with	ADP
ihlr-16574	188	8	the	the	DET
ihlr-16574	188	9	delicate	delicate	ADJ
ihlr-16574	188	10	and	and	CCONJ
ihlr-16574	188	11	difficult	difficult	ADJ
ihlr-16574	188	12	choices	choice	NOUN
ihlr-16574	188	13	that	that	PRON
ihlr-16574	188	14	determine	determine	VERB
ihlr-16574	188	15	who	who	PRON
ihlr-16574	188	16	we	we	PRON
ihlr-16574	188	17	are	be	AUX
ihlr-16574	188	18	and	and	CCONJ
ihlr-16574	188	19	what	what	PRON
ihlr-16574	188	20	we	we	PRON
ihlr-16574	188	21	ought	ought	AUX
ihlr-16574	188	22	to	to	PART
ihlr-16574	188	23	be	be	AUX
ihlr-16574	188	24	able	able	ADJ
ihlr-16574	188	25	to	to	PART
ihlr-16574	188	26	permit	permit	VERB
ihlr-16574	188	27	ourselves	ourselves	PRON
ihlr-16574	188	28	to	to	PART
ihlr-16574	188	29	become	become	VERB
ihlr-16574	188	30	.	.	PUNCT
ihlr-16574	189	1	at	at	ADP
ihlr-16574	189	2	this	this	DET
ihlr-16574	189	3	moment	moment	NOUN
ihlr-16574	189	4	,	,	PUNCT
ihlr-16574	189	5	"	"	PUNCT
ihlr-16574	189	6	[	[	X
ihlr-16574	189	7	a]s	a]	VERB
ihlr-16574	189	8	the	the	DET
ihlr-16574	189	9	science	science	NOUN
ihlr-16574	189	10	of	of	ADP
ihlr-16574	189	11	[	[	X
ihlr-16574	189	12	nanotechnology	nanotechnology	X
ihlr-16574	189	13	]	]	PUNCT
ihlr-16574	189	14	leaps	leap	VERB
ihlr-16574	189	15	ahead	ahead	ADV
ihlr-16574	189	16	,	,	PUNCT
ihlr-16574	189	17	the	the	DET
ihlr-16574	189	18	ethics	ethic	NOUN
ihlr-16574	189	19	lag	lag	VERB
ihlr-16574	189	20	[	[	X
ihlr-16574	189	21	]	]	X
ihlr-16574	189	22	behind	behind	ADV
ihlr-16574	189	23	.	.	PUNCT
ihlr-16574	190	1	"	"	PUNCT
ihlr-16574	190	2	47	47	NUM
ihlr-16574	190	3	iii	iii	NOUN
ihlr-16574	190	4	.	.	PUNCT
ihlr-16574	190	5	regulatory	regulatory	ADJ
ihlr-16574	190	6	background	background	NOUN
ihlr-16574	190	7	·	·	PUNCT
ihlr-16574	190	8	a.	a.	NOUN
ihlr-16574	190	9	regulation	regulation	NOUN
ihlr-16574	190	10	in	in	ADP
ihlr-16574	190	11	the	the	DET
ihlr-16574	190	12	united	united	PROPN
ihlr-16574	190	13	states	states	PROPN
ihlr-16574	190	14	on	on	ADP
ihlr-16574	190	15	december	december	PROPN
ihlr-16574	190	16	3	3	NUM
ihlr-16574	190	17	,	,	PUNCT
ihlr-16574	190	18	2003	2003	NUM
ihlr-16574	190	19	,	,	PUNCT
ihlr-16574	190	20	president	president	PROPN
ihlr-16574	190	21	george	george	PROPN
ihlr-16574	190	22	w.	w.	PROPN
ihlr-16574	190	23	bush	bush	PROPN
ihlr-16574	190	24	signed	sign	VERB
ihlr-16574	190	25	the	the	DET
ihlr-16574	190	26	nanote­	nanote­	PROPN
ihlr-16574	190	27	chology	chology	NOUN
ihlr-16574	190	28	research	research	NOUN
ihlr-16574	190	29	and	and	CCONJ
ihlr-16574	190	30	development	development	NOUN
ihlr-16574	190	31	act	act	PROPN
ihlr-16574	190	32	(	(	PUNCT
ihlr-16574	190	33	nrda).48	nrda).48	X
ihlr-16574	190	34	the	the	DET
ihlr-16574	190	35	nrda	nrda	PROPN
ihlr-16574	190	36	authorized	authorize	VERB
ihlr-16574	190	37	funding	funding	NOUN
ihlr-16574	190	38	for	for	ADP
ihlr-16574	190	39	nanotechnology	nanotechnology	NOUN
ihlr-16574	190	40	research	research	NOUN
ihlr-16574	190	41	for	for	ADP
ihlr-16574	190	42	a	a	DET
ihlr-16574	190	43	period	period	NOUN
ihlr-16574	190	44	of	of	ADP
ihlr-16574	190	45	four	four	NUM
ihlr-16574	190	46	years	year	NOUN
ihlr-16574	190	47	beginning	begin	VERB
ihlr-16574	190	48	in	in	ADP
ihlr-16574	190	49	fiscal	fiscal	ADJ
ihlr-16574	190	50	year	year	NOUN
ihlr-16574	190	51	2005.49	2005.49	NUM
ihlr-16574	190	52	this	this	DET
ihlr-16574	190	53	funding	funding	NOUN
ihlr-16574	190	54	was	be	AUX
ihlr-16574	190	55	spread	spread	VERB
ihlr-16574	190	56	across	across	ADP
ihlr-16574	190	57	ten	ten	NUM
ihlr-16574	190	58	federal	federal	ADJ
ihlr-16574	190	59	agencies	agency	NOUN
ihlr-16574	190	60	and	and	CCONJ
ihlr-16574	190	61	totaled	total	VERB
ihlr-16574	190	62	approximately	approximately	ADV
ihlr-16574	190	63	$	$	SYM
ihlr-16574	190	64	849	849	NUM
ihlr-16574	190	65	million.50	million.50	ADJ
ihlr-16574	190	66	nanotechnology	nanotechnology	NOUN
ihlr-16574	190	67	research	research	NOUN
ihlr-16574	190	68	and	and	CCONJ
ihlr-16574	190	69	devel­	devel­	NOUN
ihlr-16574	190	70	opment	opment	NOUN
ihlr-16574	190	71	"	"	PUNCT
ihlr-16574	190	72	has	have	AUX
ihlr-16574	190	73	been	be	AUX
ihlr-16574	190	74	a	a	DET
ihlr-16574	190	75	priority	priority	NOUN
ihlr-16574	190	76	for	for	ADP
ihlr-16574	190	77	the	the	DET
ihlr-16574	190	78	administration	administration	NOUN
ihlr-16574	190	79	for	for	ADP
ihlr-16574	190	80	the	the	DET
ihlr-16574	190	81	last	last	ADJ
ihlr-16574	190	82	three	three	NUM
ihlr-16574	190	83	years	year	NOUN
ihlr-16574	190	84	.	.	PUNCT
ihlr-16574	191	1	"51	"51	NOUN
ihlr-16574	191	2	in	in	ADP
ihlr-16574	191	3	fiscal	fiscal	ADJ
ihlr-16574	191	4	year	year	NOUN
ihlr-16574	191	5	2009	2009	NUM
ihlr-16574	191	6	,	,	PUNCT
ihlr-16574	191	7	federal	federal	ADJ
ihlr-16574	191	8	funding	funding	NOUN
ihlr-16574	191	9	for	for	ADP
ihlr-16574	191	10	this	this	DET
ihlr-16574	191	11	initiative	initiative	NOUN
ihlr-16574	191	12	totaled	total	VERB
ihlr-16574	191	13	$	$	SYM
ihlr-16574	191	14	1.5	1.5	NUM
ihlr-16574	191	15	billion	billion	NUM
ihlr-16574	191	16	dollars	dollar	NOUN
ihlr-16574	191	17	.	.	PUNCT
ihlr-16574	192	1	52	52	NUM
ihlr-16574	192	2	in	in	ADP
ihlr-16574	192	3	addition	addition	NOUN
ihlr-16574	192	4	to	to	ADP
ihlr-16574	192	5	this	this	DET
ihlr-16574	192	6	program	program	NOUN
ihlr-16574	192	7	,	,	PUNCT
ihlr-16574	192	8	other	other	ADJ
ihlr-16574	192	9	federal	federal	ADJ
ihlr-16574	192	10	agencies	agency	NOUN
ihlr-16574	192	11	have	have	AUX
ihlr-16574	192	12	stepped	step	VERB
ihlr-16574	192	13	up	up	ADP
ihlr-16574	192	14	to	to	PART
ihlr-16574	192	15	tackle	tackle	VERB
ihlr-16574	192	16	the	the	DET
ihlr-16574	192	17	topic	topic	NOUN
ihlr-16574	192	18	of	of	ADP
ihlr-16574	192	19	nanotechnology	nanotechnology	NOUN
ihlr-16574	192	20	regulations	regulation	NOUN
ihlr-16574	192	21	.	.	PUNCT
ihlr-16574	193	1	1	1	X
ihlr-16574	193	2	.	.	X
ihlr-16574	193	3	the	the	DET
ihlr-16574	193	4	fda	fda	PROPN
ihlr-16574	193	5	takes	take	VERB
ihlr-16574	193	6	the	the	DET
ihlr-16574	193	7	lead	lead	NOUN
ihlr-16574	193	8	the	the	DET
ihlr-16574	193	9	fda	fda	PROPN
ihlr-16574	193	10	is	be	AUX
ihlr-16574	193	11	a	a	DET
ihlr-16574	193	12	federal	federal	ADJ
ihlr-16574	193	13	agency	agency	NOUN
ihlr-16574	193	14	within	within	ADP
ihlr-16574	193	15	the	the	DET
ihlr-16574	193	16	united	united	PROPN
ihlr-16574	193	17	states	states	PROPN
ihlr-16574	193	18	department	department	PROPN
ihlr-16574	193	19	of	of	ADP
ihlr-16574	193	20	health	health	PROPN
ihlr-16574	193	21	and	and	CCONJ
ihlr-16574	193	22	human	human	PROPN
ihlr-16574	193	23	services.53	services.53	NOUN
ihlr-16574	193	24	it	it	PRON
ihlr-16574	193	25	is	be	AUX
ihlr-16574	193	26	charged	charge	VERB
ihlr-16574	193	27	with	with	ADP
ihlr-16574	193	28	the	the	DET
ihlr-16574	193	29	safety	safety	NOUN
ihlr-16574	193	30	regulation	regulation	NOUN
ihlr-16574	193	31	of	of	ADP
ihlr-16574	193	32	food	food	NOUN
ihlr-16574	193	33	,	,	PUNCT
ihlr-16574	193	34	drugs	drug	NOUN
ihlr-16574	193	35	,	,	PUNCT
ihlr-16574	193	36	medical	medical	ADJ
ihlr-16574	193	37	devices	device	NOUN
ihlr-16574	193	38	,	,	PUNCT
ihlr-16574	193	39	etc	etc	X
ihlr-16574	193	40	.	.	X
ihlr-16574	193	41	used	use	VERB
ihlr-16574	193	42	and	and	CCONJ
ihlr-16574	193	43	consumed	consume	VERB
ihlr-16574	193	44	by	by	ADP
ihlr-16574	193	45	the	the	DET
ihlr-16574	193	46	american	american	ADJ
ihlr-16574	193	47	po­	po­	PROPN
ihlr-16574	193	48	pulace	pulace	NOUN
ihlr-16574	193	49	.	.	PUNCT
ihlr-16574	194	1	54	54	NUM
ihlr-16574	194	2	historically	historically	ADV
ihlr-16574	194	3	,	,	PUNCT
ihlr-16574	194	4	the	the	DET
ihlr-16574	194	5	fda	fda	PROPN
ihlr-16574	194	6	has	have	AUX
ihlr-16574	194	7	been	be	AUX
ihlr-16574	194	8	successful	successful	ADJ
ihlr-16574	194	9	in	in	ADP
ihlr-16574	194	10	regulating	regulate	VERB
ihlr-16574	194	11	new	new	ADJ
ihlr-16574	194	12	tech­	tech­	NOUN
ihlr-16574	194	13	nologies	nologie	NOUN
ihlr-16574	194	14	especially	especially	ADV
ihlr-16574	194	15	in	in	ADP
ihlr-16574	194	16	the	the	DET
ihlr-16574	194	17	field	field	NOUN
ihlr-16574	194	18	of	of	ADP
ihlr-16574	194	19	biotechnology	biotechnology	NOUN
ihlr-16574	194	20	.	.	PUNCT
ihlr-16574	195	1	55	55	NUM
ihlr-16574	195	2	the	the	DET
ihlr-16574	195	3	fda	fda	PROPN
ihlr-16574	195	4	is	be	AUX
ihlr-16574	195	5	extremely	extremely	ADV
ihlr-16574	195	6	important	important	ADJ
ihlr-16574	195	7	to	to	ADP
ihlr-16574	195	8	the	the	DET
ihlr-16574	195	9	development	development	NOUN
ihlr-16574	195	10	of	of	ADP
ihlr-16574	195	11	nanotechnology	nanotechnology	NOUN
ihlr-16574	195	12	and	and	CCONJ
ihlr-16574	195	13	nanomedicine	nanomedicine	NOUN
ihlr-16574	195	14	,	,	PUNCT
ihlr-16574	195	15	be­	be­	VERB
ihlr-16574	195	16	cause	cause	SCONJ
ihlr-16574	195	17	most	most	ADJ
ihlr-16574	195	18	new	new	ADJ
ihlr-16574	195	19	products	product	NOUN
ihlr-16574	195	20	that	that	PRON
ihlr-16574	195	21	would	would	AUX
ihlr-16574	195	22	employ	employ	VERB
ihlr-16574	195	23	this	this	DET
ihlr-16574	195	24	technology	technology	NOUN
ihlr-16574	195	25	would	would	AUX
ihlr-16574	195	26	require	require	VERB
ihlr-16574	195	27	47	47	NUM
ihlr-16574	195	28	.	.	PUNCT
ihlr-16574	196	1	anisa	anisa	PROPN
ihlr-16574	196	2	mnyusiwalla	mnyusiwalla	PROPN
ihlr-16574	196	3	,	,	PUNCT
ihlr-16574	196	4	abdallah	abdallah	PROPN
ihlr-16574	196	5	s.	s.	PROPN
ihlr-16574	196	6	daar	daar	PROPN
ihlr-16574	196	7	&	&	CCONJ
ihlr-16574	196	8	peter	peter	PROPN
ihlr-16574	196	9	a.	a.	PROPN
ihlr-16574	196	10	singer	singer	PROPN
ihlr-16574	196	11	,	,	PUNCT
ihlr-16574	196	12	'	'	PUNCT
ihlr-16574	196	13	mind	mind	VERB
ihlr-16574	196	14	the	the	DET
ihlr-16574	196	15	gap	gap	NOUN
ihlr-16574	196	16	'	'	PUNCT
ihlr-16574	196	17	:	:	PUNCT
ihlr-16574	196	18	science	science	NOUN
ihlr-16574	196	19	and	and	CCONJ
ihlr-16574	196	20	ethics	ethic	NOUN
ihlr-16574	196	21	in	in	ADP
ihlr-16574	196	22	nanotechnology	nanotechnology	PROPN
ihlr-16574	196	23	,	,	PUNCT
ihlr-16574	196	24	14	14	NUM
ihlr-16574	196	25	nanotechnology	nanotechnology	NOUN
ihlr-16574	196	26	r9	r9	NOUN
ihlr-16574	196	27	,	,	PUNCT
ihlr-16574	196	28	r9	r9	NOUN
ihlr-16574	196	29	(	(	PUNCT
ihlr-16574	196	30	2003	2003	NUM
ihlr-16574	196	31	)	)	PUNCT
ihlr-16574	196	32	,	,	PUNCT
ihlr-16574	196	33	available	available	ADJ
ihlr-16574	196	34	at	at	ADP
ihlr-16574	196	35	http:/	http:/	PROPN
ihlr-16574	196	36	/www.iop.org	/www.iop.org	PUNCT
ihlr-16574	196	37	/	/	SYM
ihlr-16574	196	38	ej	ej	ADJ
ihlr-16574	196	39	/	/	SYM
ihlr-16574	196	40	article/0957	article/0957	NOUN
ihlr-16574	196	41	-4484114/3/20	-4484114/3/20	PROPN
ihlr-16574	196	42	llt303rl.pdf	llt303rl.pdf	PROPN
ihlr-16574	196	43	.	.	PUNCT
ihlr-16574	196	44	48	48	NUM
ihlr-16574	196	45	.	.	PUNCT
ihlr-16574	197	1	the	the	DET
ihlr-16574	197	2	white	white	PROPN
ihlr-16574	197	3	house	house	PROPN
ihlr-16574	197	4	,	,	PUNCT
ihlr-16574	197	5	http://www.whitehouse.gov/news/releases/2003/l2/200312037.html	http://www.whitehouse.gov/news/releases/2003/l2/200312037.html	PROPN
ihlr-16574	197	6	(	(	PUNCT
ihlr-16574	197	7	last	last	ADV
ihlr-16574	197	8	visited	visit	VERB
ihlr-16574	197	9	nov	nov	PROPN
ihlr-16574	197	10	.	.	PROPN
ihlr-16574	197	11	2	2	NUM
ihlr-16574	197	12	,	,	PUNCT
ihlr-16574	197	13	2008	2008	NUM
ihlr-16574	197	14	)	)	PUNCT
ihlr-16574	197	15	.	.	PUNCT
ihlr-16574	198	1	49	49	NUM
ihlr-16574	198	2	.	.	PUNCT
ihlr-16574	199	1	ld	ld	PROPN
ihlr-16574	199	2	.	.	PROPN
ihlr-16574	199	3	50	50	NUM
ihlr-16574	199	4	.	.	PUNCT
ihlr-16574	200	1	i	i	PRON
ihlr-16574	200	2	d.	d.	PROPN
ihlr-16574	200	3	51	51	NUM
ihlr-16574	200	4	.	.	PUNCT
ihlr-16574	201	1	the	the	DET
ihlr-16574	201	2	white	white	PROPN
ihlr-16574	201	3	house	house	PROPN
ihlr-16574	201	4	,	,	PUNCT
ihlr-16574	201	5	http://www.whitehouse.gov/news/releases/2003/12/200312037.htrnl	http://www.whitehouse.gov/news/releases/2003/12/200312037.htrnl	PROPN
ihlr-16574	201	6	(	(	PUNCT
ihlr-16574	201	7	last	last	ADV
ihlr-16574	201	8	visited	visit	VERB
ihlr-16574	201	9	nov	nov	PROPN
ihlr-16574	201	10	.	.	PROPN
ihlr-16574	201	11	2	2	NUM
ihlr-16574	201	12	,	,	PUNCT
ihlr-16574	201	13	2008	2008	NUM
ihlr-16574	201	14	)	)	PUNCT
ihlr-16574	201	15	(	(	PUNCT
ihlr-16574	201	16	noting	note	VERB
ihlr-16574	201	17	that	that	SCONJ
ihlr-16574	201	18	the	the	DET
ihlr-16574	201	19	funding	funding	NOUN
ihlr-16574	201	20	for	for	ADP
ihlr-16574	201	21	nanotechnology	nanotechnology	PROPN
ihlr-16574	201	22	research	research	NOUN
ihlr-16574	201	23	and	and	CCONJ
ihlr-16574	201	24	development	development	NOUN
ihlr-16574	201	25	has	have	AUX
ihlr-16574	201	26	gone	go	VERB
ihlr-16574	201	27	up	up	ADV
ihlr-16574	201	28	83	83	NUM
ihlr-16574	201	29	%	%	NOUN
ihlr-16574	201	30	since	since	SCONJ
ihlr-16574	201	31	2001	2001	NUM
ihlr-16574	201	32	)	)	PUNCT
ihlr-16574	201	33	.	.	PUNCT
ihlr-16574	202	1	52	52	NUM
ihlr-16574	202	2	.	.	PUNCT
ihlr-16574	202	3	national	national	PROPN
ihlr-16574	202	4	nanotechnology	nanotechnology	PROPN
ihlr-16574	202	5	initiative	initiative	PROPN
ihlr-16574	202	6	(	(	PUNCT
ihlr-16574	202	7	nni	nni	PROPN
ihlr-16574	202	8	)	)	PUNCT
ihlr-16574	202	9	,	,	PUNCT
ihlr-16574	202	10	funding	funding	NOUN
ihlr-16574	202	11	,	,	PUNCT
ihlr-16574	202	12	http://www.nano.gov/html/	http://www.nano.gov/html/	VERB
ihlr-16574	202	13	about	about	ADP
ihlr-16574	202	14	/	/	SYM
ihlr-16574	202	15	fimding.html	fimding.html	PROPN
ihlr-16574	202	16	(	(	PUNCT
ihlr-16574	202	17	last	last	ADV
ihlr-16574	202	18	visited	visit	VERB
ihlr-16574	202	19	jan	jan	PROPN
ihlr-16574	202	20	.	.	PROPN
ihlr-16574	202	21	16	16	NUM
ihlr-16574	202	22	,	,	PUNCT
ihlr-16574	202	23	2009	2009	NUM
ihlr-16574	202	24	)	)	PUNCT
ihlr-16574	202	25	.	.	PUNCT
ihlr-16574	203	1	53	53	NUM
ihlr-16574	203	2	.	.	PUNCT
ihlr-16574	203	3	u.s	u.s	PROPN
ihlr-16574	203	4	.	.	PROPN
ihlr-16574	203	5	food	food	PROPN
ihlr-16574	203	6	&	&	CCONJ
ihlr-16574	203	7	drug	drug	PROPN
ihlr-16574	203	8	administration	administration	PROPN
ihlr-16574	203	9	,	,	PUNCT
ihlr-16574	203	10	about	about	ADP
ihlr-16574	203	11	fda	fda	PROPN
ihlr-16574	203	12	:	:	PUNCT
ihlr-16574	203	13	centers	center	NOUN
ihlr-16574	203	14	&	&	CCONJ
ihlr-16574	203	15	offices	office	NOUN
ihlr-16574	203	16	,	,	PUNCT
ihlr-16574	203	17	http://	http://	PROPN
ihlr-16574	203	18	www.fda.gov/aboutfda/centersoffices/default.htm	www.fda.gov/aboutfda/centersoffices/default.htm	PROPN
ihlr-16574	203	19	(	(	PUNCT
ihlr-16574	203	20	last	last	ADV
ihlr-16574	203	21	visited	visit	VERB
ihlr-16574	203	22	sept	sept	PROPN
ihlr-16574	203	23	.	.	PROPN
ihlr-16574	203	24	24	24	NUM
ihlr-16574	203	25	,	,	PUNCT
ihlr-16574	203	26	2009	2009	NUM
ihlr-16574	203	27	)	)	PUNCT
ihlr-16574	204	1	[	[	X
ihlr-16574	204	2	hereinafter	hereinafter	NOUN
ihlr-16574	204	3	"	"	PUNCT
ihlr-16574	204	4	about	about	ADP
ihlr-16574	204	5	fda	fda	PROPN
ihlr-16574	204	6	"	"	PUNCT
ihlr-16574	204	7	]	]	X
ihlr-16574	204	8	.	.	PUNCT
ihlr-16574	205	1	54	54	NUM
ihlr-16574	205	2	.	.	PUNCT
ihlr-16574	206	1	i	i	PRON
ihlr-16574	206	2	d.	d.	PROPN
ihlr-16574	206	3	55	55	NUM
ihlr-16574	206	4	.	.	PUNCT
ihlr-16574	207	1	john	john	PROPN
ihlr-16574	207	2	miller	miller	PROPN
ihlr-16574	207	3	,	,	PUNCT
ihlr-16574	207	4	student	student	NOUN
ihlr-16574	207	5	note	note	NOUN
ihlr-16574	207	6	,	,	PUNCT
ihlr-16574	207	7	beyond	beyond	ADP
ihlr-16574	207	8	biotechnology	biotechnology	NOUN
ihlr-16574	207	9	:	:	PUNCT
ihlr-16574	207	10	fda	fda	PROPN
ihlr-16574	207	11	regulation	regulation	PROPN
ihlr-16574	207	12	ofnanomedi­	ofnanomedi­	PROPN
ihlr-16574	207	13	cine	cine	NOUN
ihlr-16574	207	14	,	,	PUNCT
ihlr-16574	207	15	4	4	NUM
ihlr-16574	207	16	colum	colum	NOUN
ihlr-16574	207	17	.	.	PUNCT
ihlr-16574	208	1	sci	sci	PROPN
ihlr-16574	208	2	.	.	PROPN
ihlr-16574	208	3	&	&	CCONJ
ihlr-16574	208	4	tech	tech	PROPN
ihlr-16574	208	5	.	.	PUNCT
ihlr-16574	209	1	l.	l.	PROPN
ihlr-16574	209	2	rev	rev	PROPN
ihlr-16574	209	3	.	.	PUNCT
ihlr-16574	210	1	l	l	NOUN
ihlr-16574	210	2	,	,	PUNCT
ihlr-16574	210	3	2	2	NUM
ihlr-16574	210	4	(	(	PUNCT
ihlr-16574	210	5	2003	2003	NUM
ihlr-16574	210	6	)	)	PUNCT
ihlr-16574	210	7	(	(	PUNCT
ihlr-16574	210	8	discussing	discuss	VERB
ihlr-16574	210	9	the	the	DET
ihlr-16574	210	10	fda	fda	PROPN
ihlr-16574	210	11	's	's	PART
ihlr-16574	210	12	past	past	ADJ
ihlr-16574	210	13	success	success	NOUN
ihlr-16574	210	14	with	with	ADP
ihlr-16574	210	15	regulations	regulation	NOUN
ihlr-16574	210	16	on	on	ADP
ihlr-16574	210	17	biotechnology	biotechnology	NOUN
ihlr-16574	210	18	,	,	PUNCT
ihlr-16574	210	19	but	but	CCONJ
ihlr-16574	210	20	noting	note	VERB
ihlr-16574	210	21	that	that	SCONJ
ihlr-16574	210	22	nanomedicine	nanomedicine	NOUN
ihlr-16574	210	23	will	will	AUX
ihlr-16574	210	24	present	present	VERB
ihlr-16574	210	25	a	a	DET
ihlr-16574	210	26	new	new	ADJ
ihlr-16574	210	27	challenge	challenge	NOUN
ihlr-16574	210	28	in	in	ADP
ihlr-16574	210	29	regulation	regulation	NOUN
ihlr-16574	210	30	)	)	PUNCT
ihlr-16574	210	31	.	.	PUNCT
ihlr-16574	211	1	406	406	NUM
ihlr-16574	211	2	indiana	indiana	PROPN
ihlr-16574	211	3	health	health	PROPN
ihlr-16574	211	4	law	law	NOUN
ihlr-16574	211	5	review	review	NOUN
ihlr-16574	211	6	[	[	X
ihlr-16574	211	7	vol	vol	NOUN
ihlr-16574	211	8	.	.	PUNCT
ihlr-16574	212	1	7:397	7:397	NUM
ihlr-16574	212	2	fda	fda	PROPN
ihlr-16574	212	3	approval	approval	NOUN
ihlr-16574	212	4	before	before	ADP
ihlr-16574	212	5	public	public	ADJ
ihlr-16574	212	6	consumption	consumption	NOUN
ihlr-16574	212	7	and	and	CCONJ
ihlr-16574	212	8	use	use	NOUN
ihlr-16574	212	9	.	.	PUNCT
ihlr-16574	213	1	56	56	NUM
ihlr-16574	213	2	the	the	DET
ihlr-16574	213	3	fda	fda	PROPN
ihlr-16574	213	4	is	be	AUX
ihlr-16574	213	5	involved	involve	VERB
ihlr-16574	213	6	in	in	ADP
ihlr-16574	213	7	the	the	DET
ihlr-16574	213	8	field	field	NOUN
ihlr-16574	213	9	of	of	ADP
ihlr-16574	213	10	nanotechnology	nanotechnology	NOUN
ihlr-16574	213	11	in	in	ADP
ihlr-16574	213	12	a	a	DET
ihlr-16574	213	13	variety	variety	NOUN
ihlr-16574	213	14	of	of	ADP
ihlr-16574	213	15	ways	way	NOUN
ihlr-16574	213	16	.	.	PUNCT
ihlr-16574	214	1	57	57	NUM
ihlr-16574	214	2	through	through	ADP
ihlr-16574	214	3	the	the	DET
ihlr-16574	214	4	use	use	NOUN
ihlr-16574	214	5	of	of	ADP
ihlr-16574	214	6	both	both	CCONJ
ihlr-16574	214	7	internal	internal	ADJ
ihlr-16574	214	8	and	and	CCONJ
ihlr-16574	214	9	external	external	ADJ
ihlr-16574	214	10	working	work	VERB
ihlr-16574	214	11	groups	group	NOUN
ihlr-16574	214	12	,	,	PUNCT
ihlr-16574	214	13	the	the	DET
ihlr-16574	214	14	fda	fda	PROPN
ihlr-16574	214	15	remains	remain	VERB
ihlr-16574	214	16	educated	educate	VERB
ihlr-16574	214	17	and	and	CCONJ
ihlr-16574	214	18	aware	aware	ADJ
ihlr-16574	214	19	of	of	ADP
ihlr-16574	214	20	the	the	DET
ihlr-16574	214	21	progress	progress	NOUN
ihlr-16574	214	22	of	of	ADP
ihlr-16574	214	23	the	the	DET
ihlr-16574	214	24	nanotech	nanotech	PROPN
ihlr-16574	214	25	indus­	indus­	PROPN
ihlr-16574	214	26	try.58	try.58	PROPN
ihlr-16574	214	27	though	though	SCONJ
ihlr-16574	214	28	a	a	DET
ihlr-16574	214	29	regulatory	regulatory	ADJ
ihlr-16574	214	30	agency	agency	NOUN
ihlr-16574	214	31	,	,	PUNCT
ihlr-16574	214	32	the	the	DET
ihlr-16574	214	33	fda	fda	PROPN
ihlr-16574	214	34	remains	remain	VERB
ihlr-16574	214	35	engaged	engaged	ADJ
ihlr-16574	214	36	in	in	ADP
ihlr-16574	214	37	areas	area	NOUN
ihlr-16574	214	38	of	of	ADP
ihlr-16574	214	39	research	research	NOUN
ihlr-16574	214	40	surrounding	surround	VERB
ihlr-16574	214	41	nanotechnology	nanotechnology	NOUN
ihlr-16574	214	42	.	.	PUNCT
ihlr-16574	215	1	this	this	DET
ihlr-16574	215	2	research	research	NOUN
ihlr-16574	215	3	is	be	AUX
ihlr-16574	215	4	not	not	PART
ihlr-16574	215	5	developmental	developmental	ADJ
ihlr-16574	215	6	in	in	ADP
ihlr-16574	215	7	nature	nature	NOUN
ihlr-16574	215	8	,	,	PUNCT
ihlr-16574	215	9	but	but	CCONJ
ihlr-16574	215	10	rather	rather	ADV
ihlr-16574	215	11	,	,	PUNCT
ihlr-16574	215	12	is	be	AUX
ihlr-16574	215	13	used	use	VERB
ihlr-16574	215	14	to	to	PART
ihlr-16574	215	15	determine	determine	VERB
ihlr-16574	215	16	the	the	DET
ihlr-16574	215	17	characteristics	characteristic	NOUN
ihlr-16574	215	18	of	of	ADP
ihlr-16574	215	19	nanotech­	nanotech­	PROPN
ihlr-16574	215	20	nology	nology	NOUN
ihlr-16574	215	21	and	and	CCONJ
ihlr-16574	215	22	focuses	focus	VERB
ihlr-16574	215	23	on	on	ADP
ihlr-16574	215	24	understanding	understanding	NOUN
ihlr-16574	215	25	how	how	SCONJ
ihlr-16574	215	26	nanotechnology	nanotechnology	NOUN
ihlr-16574	215	27	interacts	interact	VERB
ihlr-16574	215	28	with	with	ADP
ihlr-16574	215	29	other	other	ADJ
ihlr-16574	215	30	fda	fda	PROPN
ihlr-16574	215	31	-	-	PUNCT
ihlr-16574	215	32	approved	approve	VERB
ihlr-16574	215	33	products	product	NOUN
ihlr-16574	215	34	.	.	PUNCT
ihlr-16574	216	1	59	59	NUM
ihlr-16574	216	2	the	the	DET
ihlr-16574	216	3	fda	fda	PROPN
ihlr-16574	216	4	has	have	AUX
ihlr-16574	216	5	also	also	ADV
ihlr-16574	216	6	tentatively	tentatively	ADV
ihlr-16574	216	7	responded	respond	VERB
ihlr-16574	216	8	to	to	ADP
ihlr-16574	216	9	the	the	DET
ihlr-16574	216	10	question	question	NOUN
ihlr-16574	216	11	surrounding	surround	VERB
ihlr-16574	216	12	jurisdiction	jurisdiction	NOUN
ihlr-16574	216	13	over	over	ADP
ihlr-16574	216	14	nanotechnology	nanotechnology	PROPN
ihlr-16574	216	15	products.60	products.60	PROPN
ihlr-16574	216	16	categorization	categorization	NOUN
ihlr-16574	216	17	options	option	NOUN
ihlr-16574	216	18	under	under	ADP
ihlr-16574	216	19	the	the	DET
ihlr-16574	216	20	fda	fda	PROPN
ihlr-16574	216	21	are	be	AUX
ihlr-16574	216	22	drugs	drug	NOUN
ihlr-16574	216	23	,	,	PUNCT
ihlr-16574	216	24	devices	device	NOUN
ihlr-16574	216	25	,	,	PUNCT
ihlr-16574	216	26	biologics	biologic	NOUN
ihlr-16574	216	27	,	,	PUNCT
ihlr-16574	216	28	or	or	CCONJ
ihlr-16574	216	29	some	some	DET
ihlr-16574	216	30	combination	combination	NOUN
ihlr-16574	216	31	thereof.61	thereof.61	NOUN
ihlr-16574	216	32	cur­	cur­	ADJ
ihlr-16574	216	33	rently	rently	ADV
ihlr-16574	216	34	,	,	PUNCT
ihlr-16574	216	35	the	the	DET
ihlr-16574	216	36	belief	belief	NOUN
ihlr-16574	216	37	is	be	AUX
ihlr-16574	216	38	that	that	SCONJ
ihlr-16574	216	39	nanotechnologies	nanotechnology	NOUN
ihlr-16574	216	40	will	will	AUX
ihlr-16574	216	41	be	be	AUX
ihlr-16574	216	42	products	product	NOUN
ihlr-16574	216	43	comprised	comprise	VERB
ihlr-16574	216	44	of	of	ADP
ihlr-16574	216	45	a	a	DET
ihlr-16574	216	46	combination	combination	NOUN
ihlr-16574	216	47	of	of	ADP
ihlr-16574	216	48	the	the	DET
ihlr-16574	216	49	above	above	ADJ
ihlr-16574	216	50	three.62	three.62	NOUN
ihlr-16574	216	51	troublesome	troublesome	ADJ
ihlr-16574	216	52	for	for	ADP
ihlr-16574	216	53	the	the	DET
ihlr-16574	216	54	fda	fda	PROPN
ihlr-16574	216	55	is	be	AUX
ihlr-16574	216	56	that	that	SCONJ
ihlr-16574	216	57	many	many	ADJ
ihlr-16574	216	58	of	of	ADP
ihlr-16574	216	59	their	their	PRON
ihlr-16574	216	60	different	different	ADJ
ihlr-16574	216	61	centers	center	NOUN
ihlr-16574	216	62	across	across	ADP
ihlr-16574	216	63	the	the	DET
ihlr-16574	216	64	country	country	NOUN
ihlr-16574	216	65	regulate	regulate	VERB
ihlr-16574	216	66	combination	combination	NOUN
ihlr-16574	216	67	products	product	NOUN
ihlr-16574	216	68	dif­	dif­	NOUN
ihlr-16574	216	69	ferently	ferently	ADV
ihlr-16574	216	70	.	.	PUNCT
ihlr-16574	217	1	63	63	NUM
ihlr-16574	217	2	predictability	predictability	NOUN
ihlr-16574	217	3	and	and	CCONJ
ihlr-16574	217	4	consistency	consistency	NOUN
ihlr-16574	217	5	in	in	ADP
ihlr-16574	217	6	regulation	regulation	NOUN
ihlr-16574	217	7	are	be	AUX
ihlr-16574	217	8	only	only	ADV
ihlr-16574	217	9	a	a	DET
ihlr-16574	217	10	few	few	ADJ
ihlr-16574	217	11	of	of	ADP
ihlr-16574	217	12	the	the	DET
ihlr-16574	217	13	concerns	concern	NOUN
ihlr-16574	217	14	posed	pose	VERB
ihlr-16574	217	15	by	by	ADP
ihlr-16574	217	16	this	this	DET
ihlr-16574	217	17	managerial	managerial	ADJ
ihlr-16574	217	18	nightmare	nightmare	NOUN
ihlr-16574	217	19	.	.	PUNCT
ihlr-16574	218	1	64	64	NUM
ihlr-16574	218	2	since	since	SCONJ
ihlr-16574	218	3	the	the	DET
ihlr-16574	218	4	fda	fda	PROPN
ihlr-16574	218	5	stipulates	stipulate	VERB
ihlr-16574	218	6	the	the	DET
ihlr-16574	218	7	requirements	requirement	NOUN
ihlr-16574	218	8	and	and	CCONJ
ihlr-16574	218	9	guidelines	guideline	NOUN
ihlr-16574	218	10	for	for	ADP
ihlr-16574	218	11	the	the	DET
ihlr-16574	218	12	ma­	ma­	ADJ
ihlr-16574	218	13	jority	jority	NOUN
ihlr-16574	218	14	of	of	ADP
ihlr-16574	218	15	products	product	NOUN
ihlr-16574	218	16	in	in	ADP
ihlr-16574	218	17	the	the	DET
ihlr-16574	218	18	u.s	u.s	PROPN
ihlr-16574	218	19	.	.	PROPN
ihlr-16574	218	20	,	,	PUNCT
ihlr-16574	218	21	it	it	PRON
ihlr-16574	218	22	follows	follow	VERB
ihlr-16574	218	23	that	that	SCONJ
ihlr-16574	218	24	the	the	DET
ihlr-16574	218	25	fda	fda	PROPN
ihlr-16574	218	26	is	be	AUX
ihlr-16574	218	27	the	the	DET
ihlr-16574	218	28	most	most	ADV
ihlr-16574	218	29	suited	suited	ADJ
ihlr-16574	218	30	at	at	ADP
ihlr-16574	218	31	this	this	DET
ihlr-16574	218	32	time	time	NOUN
ihlr-16574	218	33	to	to	PART
ihlr-16574	218	34	tackle	tackle	VERB
ihlr-16574	218	35	nanotechnology	nanotechnology	PROPN
ihlr-16574	219	1	regulation.65	regulation.65	PROPN
ihlr-16574	219	2	the	the	DET
ihlr-16574	219	3	fda	fda	PROPN
ihlr-16574	219	4	responded	respond	VERB
ihlr-16574	219	5	to	to	ADP
ihlr-16574	219	6	a	a	DET
ihlr-16574	219	7	question	question	NOUN
ihlr-16574	219	8	about	about	ADP
ihlr-16574	219	9	the	the	DET
ihlr-16574	219	10	risks	risk	NOUN
ihlr-16574	219	11	of	of	ADP
ihlr-16574	219	12	nanotechnology	nanotechnology	NOUN
ihlr-16574	219	13	and	and	CCONJ
ihlr-16574	219	14	whether	whether	SCONJ
ihlr-16574	219	15	or	or	CCONJ
ihlr-16574	219	16	not	not	PART
ihlr-16574	219	17	these	these	DET
ihlr-16574	219	18	tech­	tech­	NOUN
ihlr-16574	219	19	nologies	nologie	NOUN
ihlr-16574	219	20	should	should	AUX
ihlr-16574	219	21	be	be	AUX
ihlr-16574	219	22	regulated	regulate	VERB
ihlr-16574	219	23	differently	differently	ADV
ihlr-16574	219	24	:	:	PUNCT
ihlr-16574	219	25	existing	exist	VERB
ihlr-16574	219	26	requirements	requirement	NOUN
ihlr-16574	219	27	may	may	AUX
ihlr-16574	219	28	be	be	AUX
ihlr-16574	219	29	adequate	adequate	ADJ
ihlr-16574	219	30	for	for	ADP
ihlr-16574	219	31	most	most	ADJ
ihlr-16574	219	32	na­	na­	ADJ
ihlr-16574	219	33	notechnology	notechnology	NOUN
ihlr-16574	219	34	products	product	NOUN
ihlr-16574	219	35	that	that	PRON
ihlr-16574	219	36	we	we	PRON
ihlr-16574	219	37	will	will	AUX
ihlr-16574	219	38	regulate	regulate	VERB
ihlr-16574	219	39	.	.	PUNCT
ihlr-16574	220	1	these	these	DET
ihlr-16574	220	2	products	product	NOUN
ihlr-16574	220	3	are	be	AUX
ihlr-16574	220	4	in	in	ADP
ihlr-16574	220	5	the	the	DET
ihlr-16574	220	6	same	same	ADJ
ihlr-16574	220	7	size	size	NOUN
ihlr-16574	220	8	-	-	PUNCT
ihlr-16574	220	9	range	range	NOUN
ihlr-16574	220	10	as	as	ADP
ihlr-16574	220	11	the	the	DET
ihlr-16574	220	12	cells	cell	NOUN
ihlr-16574	220	13	and	and	CCONJ
ihlr-16574	220	14	molecules	molecule	NOUN
ihlr-16574	220	15	with	with	ADP
ihlr-16574	220	16	which	which	PRON
ihlr-16574	220	17	fda	fda	PROPN
ihlr-16574	220	18	reviewers	reviewer	NOUN
ihlr-16574	220	19	and	and	CCONJ
ihlr-16574	220	20	scientists	scientist	NOUN
ihlr-16574	220	21	associate	associate	VERB
ihlr-16574	220	22	every	every	DET
ihlr-16574	220	23	day	day	NOUN
ihlr-16574	220	24	.	.	PUNCT
ihlr-16574	221	1	in	in	ADP
ihlr-16574	221	2	particular	particular	ADJ
ihlr-16574	221	3	,	,	PUNCT
ihlr-16574	221	4	every	every	DET
ihlr-16574	221	5	degradable	degradable	ADJ
ihlr-16574	221	6	medical	medical	ADJ
ihlr-16574	221	7	device	device	NOUN
ihlr-16574	221	8	or	or	CCONJ
ihlr-16574	221	9	injectable	injectable	ADJ
ihlr-16574	221	10	pharmaceutical	pharmaceutical	NOUN
ihlr-16574	221	11	generates	generate	VERB
ihlr-16574	221	12	particulates	particulate	NOUN
ihlr-16574	221	13	that	that	PRON
ihlr-16574	221	14	pass	pass	VERB
ihlr-16574	221	15	through	through	ADP
ihlr-16574	221	16	this	this	DET
ihlr-16574	221	17	size	size	NOUN
ihlr-16574	221	18	range	range	NOUN
ihlr-16574	221	19	during	during	ADP
ihlr-16574	221	20	the	the	DET
ihlr-16574	221	21	processes	process	NOUN
ihlr-16574	221	22	of	of	ADP
ihlr-16574	221	23	their	their	PRON
ihlr-16574	221	24	absorption	absorption	NOUN
ihlr-16574	221	25	and	and	CCONJ
ihlr-16574	221	26	elimination	elimination	NOUN
ihlr-16574	221	27	by	by	ADP
ihlr-16574	221	28	56	56	NUM
ihlr-16574	221	29	.	.	PUNCT
ihlr-16574	222	1	jessica	jessica	PROPN
ihlr-16574	222	2	k	k	PROPN
ihlr-16574	222	3	fender	fender	PROPN
ihlr-16574	222	4	,	,	PUNCT
ihlr-16574	222	5	student	student	NOUN
ihlr-16574	222	6	note	note	NOUN
ihlr-16574	222	7	,	,	PUNCT
ihlr-16574	222	8	the	the	DET
ihlr-16574	222	9	fda	fda	PROPN
ihlr-16574	222	10	and	and	CCONJ
ihlr-16574	222	11	nano	nano	PROPN
ihlr-16574	222	12	:	:	PUNCT
ihlr-16574	222	13	big	big	ADJ
ihlr-16574	222	14	problems	problem	NOUN
ihlr-16574	222	15	with	with	ADP
ihlr-16574	222	16	tiny	tiny	ADJ
ihlr-16574	222	17	technology	technology	NOUN
ihlr-16574	222	18	,	,	PUNCT
ihlr-16574	222	19	83	83	NUM
ihlr-16574	222	20	cm.-kent	cm.-kent	ADJ
ihlr-16574	222	21	l.	l.	PROPN
ihlr-16574	222	22	re	re	PROPN
ihlr-16574	222	23	:	:	PUNCT
ihlr-16574	222	24	v.	v.	PROPN
ihlr-16574	222	25	1063	1063	NUM
ihlr-16574	222	26	,	,	PUNCT
ihlr-16574	222	27	1065	1065	NUM
ihlr-16574	222	28	-	-	SYM
ihlr-16574	222	29	66	66	NUM
ihlr-16574	222	30	(	(	PUNCT
ihlr-16574	222	31	2008	2008	NUM
ihlr-16574	222	32	)	)	PUNCT
ihlr-16574	222	33	.	.	PUNCT
ihlr-16574	223	1	51	51	NUM
ihlr-16574	223	2	.	.	PUNCT
ihlr-16574	223	3	nakissa	nakissa	PROPN
ihlr-16574	223	4	sadrieh	sadrieh	PROPN
ihlr-16574	223	5	&	&	CCONJ
ihlr-16574	223	6	parvaneh	parvaneh	PROPN
ihlr-16574	223	7	espandiari	espandiari	PROPN
ihlr-16574	223	8	,	,	PUNCT
ihlr-16574	223	9	nanotechnology	nanotechnology	NOUN
ihlr-16574	223	10	and	and	CCONJ
ihlr-16574	223	11	the	the	DET
ihlr-16574	223	12	fda	fda	PROPN
ihlr-16574	223	13	:	:	PUNCT
ihlr-16574	223	14	what	what	PRON
ihlr-16574	223	15	are	be	AUX
ihlr-16574	223	16	the	the	DET
ihlr-16574	223	17	scientific	scientific	ADJ
ihlr-16574	223	18	and	and	CCONJ
ihlr-16574	223	19	regulatory	regulatory	ADJ
ihlr-16574	223	20	considerations	consideration	NOUN
ihlr-16574	223	21	for	for	ADP
ihlr-16574	223	22	products	product	NOUN
ihlr-16574	223	23	containing	contain	VERB
ihlr-16574	223	24	nanomteria	nanomteria	PROPN
ihlr-16574	223	25	/	/	SYM
ihlr-16574	223	26	s	s	PROPN
ihlr-16574	223	27	?	?	NOUN
ihlr-16574	223	28	,	,	PUNCT
ihlr-16574	223	29	3	3	NUM
ihlr-16574	223	30	nanotechnology	nanotechnology	PROPN
ihlr-16574	223	31	l.	l.	PROPN
ihlr-16574	223	32	&	&	CCONJ
ihlr-16574	223	33	bus	bus	PROPN
ihlr-16574	223	34	.	.	PUNCT
ihlr-16574	223	35	339	339	NUM
ihlr-16574	223	36	,	,	PUNCT
ihlr-16574	223	37	341	341	NUM
ihlr-16574	223	38	-	-	SYM
ihlr-16574	223	39	45	45	NUM
ihlr-16574	223	40	(	(	PUNCT
ihlr-16574	223	41	2006	2006	NUM
ihlr-16574	223	42	)	)	PUNCT
ihlr-16574	223	43	.	.	PUNCT
ihlr-16574	223	44	.	.	PUNCT
ihlr-16574	224	1	58	58	NUM
ihlr-16574	224	2	.	.	PUNCT
ihlr-16574	224	3	!	!	PUNCT
ihlr-16574	225	1	d.	d.	PROPN
ihlr-16574	225	2	at	at	ADP
ihlr-16574	225	3	341	341	NUM
ihlr-16574	225	4	-	-	SYM
ihlr-16574	225	5	42	42	NUM
ihlr-16574	225	6	.	.	PUNCT
ihlr-16574	226	1	59	59	NUM
ihlr-16574	226	2	.	.	PUNCT
ihlr-16574	227	1	i	i	PRON
ihlr-16574	227	2	d	d	PROPN
ihlr-16574	227	3	at	at	ADP
ihlr-16574	227	4	342	342	NUM
ihlr-16574	227	5	.	.	PUNCT
ihlr-16574	228	1	60	60	NUM
ihlr-16574	228	2	.	.	PUNCT
ihlr-16574	229	1	u.s	u.s	PROPN
ihlr-16574	229	2	.	.	PROPN
ihlr-16574	229	3	food	food	PROPN
ihlr-16574	229	4	&	&	CCONJ
ihlr-16574	229	5	drug	drug	PROPN
ihlr-16574	229	6	administration	administration	PROPN
ihlr-16574	229	7	,	,	PUNCT
ihlr-16574	229	8	science	science	PROPN
ihlr-16574	229	9	&	&	CCONJ
ihlr-16574	229	10	research	research	PROPN
ihlr-16574	229	11	:	:	PUNCT
ihlr-16574	229	12	frequently	frequently	ADV
ihlr-16574	229	13	asked	ask	VERB
ihlr-16574	229	14	ques­	ques­	PROPN
ihlr-16574	229	15	tions	tion	NOUN
ihlr-16574	229	16	,	,	PUNCT
ihlr-16574	229	17	http://www.fdagov/scienceresearchlspecialtopics/nanotechnology/frequentlyask:edquestions/	http://www.fdagov/scienceresearchlspecialtopics/nanotechnology/frequentlyask:edquestions/	PROPN
ihlr-16574	229	18	default.htm	default.htm	X
ihlr-16574	229	19	(	(	PUNCT
ihlr-16574	229	20	last	last	ADV
ihlr-16574	229	21	visited	visit	VERB
ihlr-16574	229	22	nov	nov	PROPN
ihlr-16574	229	23	.	.	PROPN
ihlr-16574	229	24	1	1	NUM
ihlr-16574	229	25	,	,	PUNCT
ihlr-16574	229	26	2008	2008	NUM
ihlr-16574	229	27	)	)	PUNCT
ihlr-16574	230	1	[	[	X
ihlr-16574	230	2	hereinafter	hereinafter	NOUN
ihlr-16574	230	3	fda	fda	PROPN
ihlr-16574	230	4	nanotechnology	nanotechnology	PROPN
ihlr-16574	230	5	f	f	PROPN
ihlr-16574	230	6	aq	aq	PROPN
ihlr-16574	230	7	]	]	PROPN
ihlr-16574	230	8	.	.	PUNCT
ihlr-16574	231	1	61	61	NUM
ihlr-16574	231	2	.	.	X
ihlr-16574	231	3	sadrieh	sadrieh	PROPN
ihlr-16574	231	4	&	&	CCONJ
ihlr-16574	231	5	espandiari	espandiari	PROPN
ihlr-16574	231	6	,	,	PUNCT
ihlr-16574	231	7	supra	supra	PROPN
ihlr-16574	231	8	note	note	NOUN
ihlr-16574	231	9	57	57	NUM
ihlr-16574	231	10	,	,	PUNCT
ihlr-16574	231	11	at	at	ADP
ihlr-16574	231	12	342	342	NUM
ihlr-16574	231	13	.	.	PUNCT
ihlr-16574	232	1	62	62	NUM
ihlr-16574	232	2	.	.	PUNCT
ihlr-16574	233	1	i	i	PRON
ihlr-16574	233	2	d	d	PROPN
ihlr-16574	233	3	at	at	ADP
ihlr-16574	233	4	343	343	NUM
ihlr-16574	233	5	.	.	PUNCT
ihlr-16574	234	1	63	63	NUM
ihlr-16574	234	2	.	.	PUNCT
ihlr-16574	234	3	!	!	PUNCT
ihlr-16574	235	1	d.	d.	PROPN
ihlr-16574	235	2	64	64	NUM
ihlr-16574	235	3	.	.	PUNCT
ihlr-16574	236	1	i	i	PRON
ihlr-16574	236	2	d	d	PROPN
ihlr-16574	236	3	65	65	NUM
ihlr-16574	236	4	.	.	PUNCT
ihlr-16574	237	1	i	i	PRON
ihlr-16574	237	2	d.	d.	PROPN
ihlr-16574	237	3	at	at	ADP
ihlr-16574	237	4	344	344	NUM
ihlr-16574	237	5	.	.	PUNCT
ihlr-16574	237	6	2010	2010	NUM
ihlr-16574	237	7	]	]	PUNCT
ihlr-16574	237	8	nanomedicine	nanomedicine	NOUN
ihlr-16574	237	9	the	the	DET
ihlr-16574	237	10	body	body	NOUN
ihlr-16574	237	11	.	.	PUNCT
ihlr-16574	238	1	to	to	ADP
ihlr-16574	238	2	date	date	NOUN
ihlr-16574	238	3	,	,	PUNCT
ihlr-16574	238	4	fda	fda	PROPN
ihlr-16574	238	5	has	have	VERB
ihlr-16574	238	6	no	no	DET
ihlr-16574	238	7	knowledge	knowledge	NOUN
ihlr-16574	238	8	of	of	ADP
ihlr-16574	238	9	reports	report	NOUN
ihlr-16574	238	10	of	of	ADP
ihlr-16574	238	11	adverse	adverse	ADJ
ihlr-16574	238	12	reactions	reaction	NOUN
ihlr-16574	238	13	related	relate	VERB
ihlr-16574	238	14	to	to	ADP
ihlr-16574	238	15	the	the	DET
ihlr-16574	238	16	"	"	PUNCT
ihlr-16574	238	17	nano	nano	NOUN
ihlr-16574	238	18	"	"	PUNCT
ihlr-16574	238	19	size	size	NOUN
ihlr-16574	238	20	·	·	PUNCT
ihlr-16574	238	21	of	of	ADP
ihlr-16574	238	22	re­	re­	PROPN
ihlr-16574	238	23	sorbable	sorbable	ADJ
ihlr-16574	238	24	drug	drug	NOUN
ihlr-16574	238	25	or	or	CCONJ
ihlr-16574	238	26	medical	medical	ADJ
ihlr-16574	238	27	device	device	NOUN
ihlr-16574	238	28	products	product	NOUN
ihlr-16574	238	29	.	.	PUNCT
ihlr-16574	239	1	if	if	SCONJ
ihlr-16574	239	2	new	new	ADJ
ihlr-16574	239	3	risks	risk	NOUN
ihlr-16574	239	4	are	be	AUX
ihlr-16574	239	5	identified	identify	VERB
ihlr-16574	239	6	,	,	PUNCT
ihlr-16574	239	7	arising	arise	VERB
ihlr-16574	239	8	from	from	ADP
ihlr-16574	239	9	new	new	ADJ
ihlr-16574	239	10	materials	material	NOUN
ihlr-16574	239	11	or	or	CCONJ
ihlr-16574	239	12	manufac	manufac	NOUN
ihlr-16574	239	13	.	.	PUNCT
ihlr-16574	240	1	turing	ture	VERB
ihlr-16574	240	2	techniques	technique	NOUN
ihlr-16574	240	3	·	·	PUNCT
ihlr-16574	240	4	for	for	ADP
ihlr-16574	240	5	example	example	NOUN
ihlr-16574	240	6	,	,	PUNCT
ihlr-16574	240	7	new	new	ADJ
ihlr-16574	240	8	tests	test	NOUN
ihlr-16574	240	9	or	or	CCONJ
ihlr-16574	240	10	other	other	ADJ
ihlr-16574	240	11	re­	re­	PROPN
ihlr-16574	240	12	quirements	quirement	NOUN
ihlr-16574	240	13	may	may	AUX
ihlr-16574	240	14	be	be	AUX
ihlr-16574	240	15	needed.66	needed.66	NOUN
ihlr-16574	240	16	2	2	NUM
ihlr-16574	240	17	.	.	PUNCT
ihlr-16574	241	1	the	the	DET
ihlr-16574	241	2	nanotechnology	nanotechnology	PROPN
ihlr-16574	241	3	task	task	PROPN
ihlr-16574	241	4	force	force	NOUN
ihlr-16574	241	5	407	407	NUM
ihlr-16574	241	6	in	in	ADP
ihlr-16574	241	7	2006	2006	NUM
ihlr-16574	241	8	,	,	PUNCT
ihlr-16574	241	9	the	the	DET
ihlr-16574	241	10	fda	fda	PROPN
ihlr-16574	241	11	formed	form	VERB
ihlr-16574	241	12	the	the	DET
ihlr-16574	241	13	nanotechnology	nanotechnology	PROPN
ihlr-16574	241	14	task	task	PROPN
ihlr-16574	241	15	force	force	NOUN
ihlr-16574	241	16	(	(	PUNCT
ihlr-16574	241	17	ntf),67	ntf),67	NOUN
ihlr-16574	241	18	a	a	DET
ihlr-16574	241	19	body	body	NOUN
ihlr-16574	241	20	specifically	specifically	ADV
ihlr-16574	241	21	dedicated	dedicated	ADJ
ihlr-16574	241	22	to	to	ADP
ihlr-16574	241	23	"	"	PUNCT
ihlr-16574	241	24	determining	determine	VERB
ihlr-16574	241	25	regulatory	regulatory	ADJ
ihlr-16574	241	26	approaches	approach	NOUN
ihlr-16574	241	27	that	that	PRON
ihlr-16574	241	28	en­	en­	PROPN
ihlr-16574	241	29	courage	courage	VERB
ihlr-16574	241	30	the	the	DET
ihlr-16574	241	31	continued	continue	VERB
ihlr-16574	241	32	development	development	NOUN
ihlr-16574	241	33	of	of	ADP
ihlr-16574	241	34	innovative	innovative	ADJ
ihlr-16574	241	35	,	,	PUNCT
ihlr-16574	241	36	safe	safe	ADJ
ihlr-16574	241	37	,	,	PUNCT
ihlr-16574	241	38	and	and	CCONJ
ihlr-16574	241	39	effective	effective	ADJ
ihlr-16574	241	40	fda­	fda­	NOUN
ihlr-16574	241	41	regulated	regulate	VERB
ihlr-16574	241	42	products	product	NOUN
ihlr-16574	241	43	that	that	PRON
ihlr-16574	241	44	use	use	VERB
ihlr-16574	241	45	nanotechnology	nanotechnology	NOUN
ihlr-16574	241	46	materials	material	NOUN
ihlr-16574	241	47	.	.	PUNCT
ihlr-16574	242	1	"68	"68	PROPN
ihlr-16574	243	1	the	the	DET
ihlr-16574	243	2	ntf	ntf	PROPN
ihlr-16574	243	3	is	be	AUX
ihlr-16574	243	4	com­	com­	NOUN
ihlr-16574	243	5	prised	prise	VERB
ihlr-16574	243	6	of	of	ADP
ihlr-16574	243	7	members	member	NOUN
ihlr-16574	243	8	from	from	ADP
ihlr-16574	243	9	each	each	PRON
ihlr-16574	243	10	of	of	ADP
ihlr-16574	243	11	the	the	DET
ihlr-16574	243	12	fda	fda	PROPN
ihlr-16574	243	13	centers.69	centers.69	NOUN
ihlr-16574	243	14	during	during	ADP
ihlr-16574	243	15	a	a	DET
ihlr-16574	243	16	public	public	ADJ
ihlr-16574	243	17	meet­	meet­	PROPN
ihlr-16574	243	18	ing	ing	PROPN
ihlr-16574	243	19	,	,	PUNCT
ihlr-16574	243	20	ntf	ntf	PROPN
ihlr-16574	243	21	co	co	PROPN
ihlr-16574	243	22	-	-	PROPN
ihlr-16574	243	23	chair	chair	PROPN
ihlr-16574	243	24	dr	dr	PROPN
ihlr-16574	243	25	.	.	PROPN
ihlr-16574	243	26	randall	randall	PROPN
ihlr-16574	243	27	lutter	lutter	PROPN
ihlr-16574	243	28	said	say	VERB
ihlr-16574	243	29	that	that	SCONJ
ihlr-16574	243	30	the	the	DET
ihlr-16574	243	31	ntf	ntf	PROPN
ihlr-16574	243	32	would	would	AUX
ihlr-16574	243	33	be	be	AUX
ihlr-16574	243	34	also	also	ADV
ihlr-16574	243	35	creating	create	VERB
ihlr-16574	243	36	"	"	PUNCT
ihlr-16574	243	37	guidance	guidance	NOUN
ihlr-16574	243	38	documents	document	NOUN
ihlr-16574	243	39	"	"	PUNCT
ihlr-16574	243	40	for	for	ADP
ihlr-16574	243	41	nanote.chnology	nanote.chnology	NOUN
ihlr-16574	243	42	practitioners	practitioner	NOUN
ihlr-16574	243	43	'	'	PART
ihlr-16574	243	44	use	use	NOUN
ihlr-16574	243	45	to	to	PART
ihlr-16574	243	46	facilitate	facilitate	VERB
ihlr-16574	243	47	a	a	DET
ihlr-16574	243	48	better	well	ADJ
ihlr-16574	243	49	understanding	understanding	NOUN
ihlr-16574	243	50	how	how	SCONJ
ihlr-16574	243	51	the	the	DET
ihlr-16574	243	52	fda	fda	PROPN
ihlr-16574	243	53	will	will	AUX
ihlr-16574	243	54	likely	likely	ADV
ihlr-16574	243	55	interpret	interpret	VERB
ihlr-16574	243	56	and	and	CCONJ
ihlr-16574	243	57	apply	apply	VERB
ihlr-16574	243	58	existing	exist	VERB
ihlr-16574	243	59	laws	law	NOUN
ihlr-16574	243	60	and	and	CCONJ
ihlr-16574	243	61	regulations	regulation	NOUN
ihlr-16574	243	62	to	to	ADP
ihlr-16574	243	63	the	the	DET
ihlr-16574	243	64	developing	develop	VERB
ihlr-16574	243	65	technology.70	technology.70	NOUN
ihlr-16574	243	66	the	the	DET
ihlr-16574	243	67	ntf	ntf	PROPN
ihlr-16574	243	68	has	have	AUX
ihlr-16574	243	69	arguably	arguably	ADV
ihlr-16574	243	70	adopted	adopt	VERB
ihlr-16574	243	71	a	a	DET
ihlr-16574	243	72	"	"	PUNCT
ihlr-16574	243	73	wait	wait	VERB
ihlr-16574	243	74	and	and	CCONJ
ihlr-16574	243	75	see	see	VERB
ihlr-16574	243	76	"	"	PUNCT
ihlr-16574	243	77	approach	approach	NOUN
ihlr-16574	243	78	to	to	ADP
ihlr-16574	243	79	nano­	nano­	PROPN
ihlr-16574	243	80	technology	technology	NOUN
ihlr-16574	243	81	regulation	regulation	NOUN
ihlr-16574	243	82	.	.	PUNCT
ihlr-16574	244	1	in	in	ADP
ihlr-16574	244	2	its	its	PRON
ihlr-16574	244	3	2007	2007	NUM
ihlr-16574	244	4	report	report	NOUN
ihlr-16574	244	5	,	,	PUNCT
ihlr-16574	244	6	the	the	DET
ihlr-16574	244	7	ntf	ntf	PROPN
ihlr-16574	244	8	focused	focus	VERB
ihlr-16574	244	9	on	on	ADP
ihlr-16574	244	10	the	the	DET
ihlr-16574	244	11	major	major	ADJ
ihlr-16574	244	12	issues	issue	NOUN
ihlr-16574	244	13	:	:	PUNCT
ihlr-16574	244	14	1	1	X
ihlr-16574	244	15	)	)	PUNCT
ihlr-16574	244	16	examining	examine	VERB
ihlr-16574	244	17	the	the	DET
ihlr-16574	244	18	state	state	NOUN
ihlr-16574	244	19	of	of	ADP
ihlr-16574	244	20	current	current	ADJ
ihlr-16574	244	21	knowledge	knowledge	NOUN
ihlr-16574	244	22	regarding	regard	VERB
ihlr-16574	244	23	nanotechnol­	nanotechnol­	VERB
ihlr-16574	244	24	ogy	ogy	NOUN
ihlr-16574	244	25	;	;	PUNCT
ihlr-16574	244	26	2	2	X
ihlr-16574	244	27	)	)	PUNCT
ihlr-16574	244	28	"	"	PUNCT
ihlr-16574	244	29	the	the	DET
ihlr-16574	244	30	fda	fda	PROPN
ihlr-16574	244	31	's	's	PART
ihlr-16574	244	32	ability	ability	NOUN
ihlr-16574	244	33	to	to	PART
ihlr-16574	244	34	address	address	VERB
ihlr-16574	244	35	scientific	scientific	ADJ
ihlr-16574	244	36	issues	issue	NOUN
ihlr-16574	244	37	"	"	PUNCT
ihlr-16574	244	38	in	in	ADP
ihlr-16574	244	39	products	product	NOUN
ihlr-16574	244	40	contain­	contain­	VERB
ihlr-16574	244	41	ing	ing	PROPN
ihlr-16574	244	42	nanotechnology	nanotechnology	NOUN
ihlr-16574	244	43	;	;	PUNCT
ihlr-16574	244	44	and	and	CCONJ
ihlr-16574	244	45	3	3	X
ihlr-16574	244	46	)	)	PUNCT
ihlr-16574	244	47	"	"	PUNCT
ihlr-16574	244	48	describing	describe	VERB
ihlr-16574	244	49	the	the	DET
ihlr-16574	244	50	regulatory	regulatory	ADJ
ihlr-16574	244	51	authorities	authority	NOUN
ihlr-16574	244	52	as	as	SCONJ
ihlr-16574	244	53	they	they	PRON
ihlr-16574	244	54	relate	relate	VERB
ihlr-16574	244	55	to	to	ADP
ihlr-16574	244	56	nanotechnology	nanotechnology	PROPN
ihlr-16574	244	57	in	in	ADP
ihlr-16574	244	58	fda	fda	PROPN
ihlr-16574	244	59	regulated	regulate	VERB
ihlr-16574	244	60	products	product	NOUN
ihlr-16574	244	61	.	.	PUNCT
ihlr-16574	245	1	'm	be	AUX
ihlr-16574	245	2	the	the	DET
ihlr-16574	245	3	fda	fda	PROPN
ihlr-16574	245	4	is	be	AUX
ihlr-16574	245	5	inten­	inten­	AUX
ihlr-16574	245	6	tionally	tionally	ADV
ihlr-16574	245	7	avoiding	avoid	VERB
ihlr-16574	245	8	a	a	DET
ihlr-16574	245	9	narrow	narrow	ADJ
ihlr-16574	245	10	definition	definition	NOUN
ihlr-16574	245	11	for	for	ADP
ihlr-16574	245	12	nanotechnology	nanotechnology	NOUN
ihlr-16574	245	13	at	at	ADP
ihlr-16574	245	14	this	this	DET
ihlr-16574	245	15	point	point	NOUN
ihlr-16574	245	16	and	and	CCONJ
ihlr-16574	245	17	does	do	AUX
ihlr-16574	245	18	not	not	PART
ihlr-16574	245	19	propose	propose	VERB
ihlr-16574	245	20	any	any	DET
ihlr-16574	245	21	specific	specific	ADJ
ihlr-16574	245	22	mandates	mandate	NOUN
ihlr-16574	245	23	or	or	CCONJ
ihlr-16574	245	24	regulations	regulation	NOUN
ihlr-16574	245	25	beyond	beyond	ADP
ihlr-16574	245	26	those	those	DET
ihlr-16574	245	27	cur­	cur­	ADJ
ihlr-16574	245	28	rently	rently	ADV
ihlr-16574	245	29	in	in	ADP
ihlr-16574	245	30	place	place	NOUN
ihlr-16574	245	31	to	to	PART
ihlr-16574	245	32	guide	guide	VERB
ihlr-16574	245	33	existing	exist	VERB
ihlr-16574	245	34	technology.72	technology.72	NOUN
ihlr-16574	245	35	to	to	PART
ihlr-16574	245	36	not	not	PART
ihlr-16574	245	37	completely	completely	ADV
ihlr-16574	245	38	frustrate	frustrate	VERB
ihlr-16574	245	39	those	those	PRON
ihlr-16574	245	40	hoping	hope	VERB
ihlr-16574	245	41	for	for	ADP
ihlr-16574	245	42	some	some	DET
ihlr-16574	245	43	direction	direction	NOUN
ihlr-16574	245	44	in	in	ADP
ihlr-16574	245	45	terms	term	NOUN
ihlr-16574	245	46	of	of	ADP
ihlr-16574	245	47	future	future	ADJ
ihlr-16574	245	48	nanotech	nanotech	ADJ
ihlr-16574	245	49	regulation	regulation	NOUN
ihlr-16574	245	50	,	,	PUNCT
ihlr-16574	245	51	the	the	DET
ihlr-16574	245	52	ntf	ntf	PROPN
ihlr-16574	245	53	report	report	NOUN
ihlr-16574	245	54	offered	offer	VERB
ihlr-16574	245	55	limited	limited	ADJ
ihlr-16574	245	56	guidance	guidance	NOUN
ihlr-16574	245	57	by	by	ADP
ihlr-16574	245	58	encouraging	encourage	VERB
ihlr-16574	245	59	a	a	DET
ihlr-16574	245	60	reliance	reliance	NOUN
ihlr-16574	245	61	on	on	ADP
ihlr-16574	245	62	research	research	NOUN
ihlr-16574	245	63	and	and	CCONJ
ihlr-16574	245	64	the	the	DET
ihlr-16574	245	65	"	"	PUNCT
ihlr-16574	245	66	predicative	predicative	ADJ
ihlr-16574	245	67	value	value	NOUN
ihlr-16574	245	68	of	of	ADP
ihlr-16574	245	69	scientific	scientific	ADJ
ihlr-16574	245	70	studies	study	NOUN
ihlr-16574	245	71	.	.	PUNCT
ihlr-16574	246	1	"73	"73	NOUN
ihlr-16574	247	1	this	this	PRON
ihlr-16574	247	2	is	be	AUX
ihlr-16574	247	3	arguably	arguably	ADV
ihlr-16574	247	4	insuffi­	insuffi­	ADJ
ihlr-16574	247	5	cient	cient	NOUN
ihlr-16574	247	6	guidance	guidance	NOUN
ihlr-16574	247	7	at	at	ADV
ihlr-16574	247	8	all	all	ADV
ihlr-16574	247	9	.	.	PUNCT
ihlr-16574	248	1	66	66	NUM
ihlr-16574	248	2	.	.	PUNCT
ihlr-16574	249	1	fda	fda	PROPN
ihlr-16574	249	2	nanotechnology	nanotechnology	PROPN
ihlr-16574	249	3	f	f	PROPN
ihlr-16574	249	4	aq	aq	PROPN
ihlr-16574	249	5	,	,	PUNCT
ihlr-16574	249	6	supra	supra	PROPN
ihlr-16574	249	7	note	note	NOUN
ihlr-16574	249	8	60	60	NUM
ihlr-16574	249	9	.	.	PUNCT
ihlr-16574	249	10	67	67	NUM
ihlr-16574	249	11	.	.	PUNCT
ihlr-16574	250	1	wilhelmi	wilhelmi	PROPN
ihlr-16574	250	2	,	,	PUNCT
ihlr-16574	250	3	supra	supra	PROPN
ihlr-16574	250	4	note	note	NOUN
ihlr-16574	250	5	5	5	NUM
ihlr-16574	250	6	,	,	PUNCT
ihlr-16574	250	7	at	at	ADP
ihlr-16574	250	8	100	100	NUM
ihlr-16574	250	9	.	.	PUNCT
ihlr-16574	251	1	68	68	NUM
ihlr-16574	251	2	.	.	PUNCT
ihlr-16574	252	1	u.s	u.s	PROPN
ihlr-16574	252	2	.	.	PROPN
ihlr-16574	252	3	food	food	PROPN
ihlr-16574	252	4	&	&	CCONJ
ihlr-16574	252	5	drug	drug	PROPN
ihlr-16574	252	6	administration	administration	PROPN
ihlr-16574	252	7	,	,	PUNCT
ihlr-16574	252	8	fda	fda	PROPN
ihlr-16574	252	9	nanotechnology	nanotechnology	PROPN
ihlr-16574	252	10	task	task	PROPN
ihlr-16574	252	11	force	force	NOUN
ihlr-16574	252	12	,	,	PUNCT
ihlr-16574	252	13	http://	http://	PROPN
ihlr-16574	252	14	www.fda.gov/scienceresearchlspecialtopics/nanotechnology/nanotechnologytaskforceldefault.htm	www.fda.gov/scienceresearchlspecialtopics/nanotechnology/nanotechnologytaskforceldefault.htm	PROPN
ihlr-16574	253	1	(	(	PUNCT
ihlr-16574	253	2	last	last	ADV
ihlr-16574	253	3	visited	visit	VERB
ihlr-16574	253	4	jan	jan	PROPN
ihlr-16574	253	5	.	.	PROPN
ihlr-16574	253	6	16	16	NUM
ihlr-16574	253	7	,	,	PUNCT
ihlr-16574	253	8	2009	2009	NUM
ihlr-16574	253	9	)	)	PUNCT
ihlr-16574	253	10	.	.	PUNCT
ihlr-16574	254	1	69	69	NUM
ihlr-16574	254	2	.	.	PUNCT
ihlr-16574	255	1	fda	fda	PROPN
ihlr-16574	255	2	centers	center	NOUN
ihlr-16574	255	3	include	include	VERB
ihlr-16574	255	4	:	:	PUNCT
ihlr-16574	255	5	l	l	NOUN
ihlr-16574	255	6	)	)	PUNCT
ihlr-16574	255	7	center	center	NOUN
ihlr-16574	255	8	for	for	ADP
ihlr-16574	255	9	biologics	biologic	NOUN
ihlr-16574	255	10	evaluation	evaluation	NOUN
ihlr-16574	255	11	and	and	CCONJ
ihlr-16574	255	12	research	research	NOUN
ihlr-16574	255	13	;	;	PUNCT
ihlr-16574	255	14	2	2	X
ihlr-16574	255	15	)	)	PUNCT
ihlr-16574	255	16	center	center	NOUN
ihlr-16574	255	17	for	for	ADP
ihlr-16574	255	18	devices	device	NOUN
ihlr-16574	255	19	and	and	CCONJ
ihlr-16574	255	20	radiological	radiological	ADJ
ihlr-16574	255	21	health	health	NOUN
ihlr-16574	255	22	;	;	PUNCT
ihlr-16574	255	23	3	3	X
ihlr-16574	255	24	)	)	PUNCT
ihlr-16574	255	25	center	center	NOUN
ihlr-16574	255	26	for	for	ADP
ihlr-16574	255	27	drug	drug	NOUN
ihlr-16574	255	28	evaluation	evaluation	NOUN
ihlr-16574	255	29	and	and	CCONJ
ihlr-16574	255	30	research	research	NOUN
ihlr-16574	255	31	;	;	PUNCT
ihlr-16574	255	32	4	4	X
ihlr-16574	255	33	)	)	PUNCT
ihlr-16574	255	34	center	center	NOUN
ihlr-16574	255	35	for	for	ADP
ihlr-16574	255	36	food	food	NOUN
ihlr-16574	255	37	safety	safety	NOUN
ihlr-16574	255	38	and	and	CCONJ
ihlr-16574	255	39	applied	apply	VERB
ihlr-16574	255	40	nutrition	nutrition	NOUN
ihlr-16574	255	41	;	;	PUNCT
ihlr-16574	255	42	5	5	X
ihlr-16574	255	43	)	)	PUNCT
ihlr-16574	255	44	center	center	NOUN
ihlr-16574	255	45	for	for	ADP
ihlr-16574	255	46	veterinary	veterinary	ADJ
ihlr-16574	255	47	medicine	medicine	NOUN
ihlr-16574	255	48	;	;	PUNCT
ihlr-16574	255	49	6	6	X
ihlr-16574	255	50	)	)	PUNCT
ihlr-16574	255	51	national	national	ADJ
ihlr-16574	255	52	cen­	cen­	PROPN
ihlr-16574	255	53	ter	ter	NOUN
ihlr-16574	255	54	for	for	ADP
ihlr-16574	255	55	toxicological	toxicological	ADJ
ihlr-16574	255	56	research	research	NOUN
ihlr-16574	255	57	;	;	PUNCT
ihlr-16574	255	58	7	7	X
ihlr-16574	255	59	)	)	PUNCT
ihlr-16574	255	60	office	office	NOUN
ihlr-16574	255	61	of	of	ADP
ihlr-16574	255	62	chief	chief	ADJ
ihlr-16574	255	63	counsel	counsel	NOUN
ihlr-16574	255	64	;	;	PUNCT
ihlr-16574	255	65	8)	8)	NUM
ihlr-16574	255	66	office	office	NOUN
ihlr-16574	255	67	ofthe	ofthe	NOUN
ihlr-16574	255	68	commissioner	commissioner	NOUN
ihlr-16574	255	69	;	;	PUNCT
ihlr-16574	255	70	9	9	X
ihlr-16574	255	71	)	)	PUNCT
ihlr-16574	255	72	office	office	NOUN
ihlr-16574	255	73	of	of	ADP
ihlr-16574	255	74	regulatory	regulatory	ADJ
ihlr-16574	255	75	affairs	affair	NOUN
ihlr-16574	255	76	.	.	PUNCT
ihlr-16574	256	1	about	about	ADP
ihlr-16574	256	2	fda	fda	PROPN
ihlr-16574	256	3	,	,	PUNCT
ihlr-16574	256	4	supra	supra	PROPN
ihlr-16574	256	5	note	note	PROPN
ihlr-16574	256	6	53	53	NUM
ihlr-16574	256	7	;	;	PUNCT
ihlr-16574	256	8	see	see	VERB
ihlr-16574	256	9	wilhelmi	wilhelmi	PROPN
ihlr-16574	256	10	,	,	PUNCT
ihlr-16574	256	11	supra	supra	PROPN
ihlr-16574	256	12	note	note	NOUN
ihlr-16574	256	13	5	5	NUM
ihlr-16574	256	14	,	,	PUNCT
ihlr-16574	256	15	at	at	ADP
ihlr-16574	256	16	100	100	NUM
ihlr-16574	256	17	.	.	PUNCT
ihlr-16574	257	1	70	70	NUM
ihlr-16574	257	2	.	.	PUNCT
ihlr-16574	258	1	wilhelmi	wilhelmi	PROPN
ihlr-16574	258	2	,	,	PUNCT
ihlr-16574	258	3	supra	supra	PROPN
ihlr-16574	258	4	note	note	NOUN
ihlr-16574	258	5	5	5	NUM
ihlr-16574	258	6	,	,	PUNCT
ihlr-16574	258	7	at	at	ADP
ihlr-16574	258	8	100	100	NUM
ihlr-16574	258	9	.	.	PUNCT
ihlr-16574	258	10	71	71	NUM
ihlr-16574	258	11	.	.	PUNCT
ihlr-16574	258	12	!	!	PUNCT
ihlr-16574	259	1	d.	d.	PROPN
ihlr-16574	259	2	at	at	ADP
ihlr-16574	259	3	100	100	NUM
ihlr-16574	259	4	-	-	SYM
ihlr-16574	259	5	01	01	NUM
ihlr-16574	259	6	.	.	PUNCT
ihlr-16574	259	7	72	72	NUM
ihlr-16574	259	8	.	.	PUNCT
ihlr-16574	259	9	!	!	PUNCT
ihlr-16574	260	1	d.	d.	PROPN
ihlr-16574	260	2	at	at	ADP
ihlr-16574	260	3	101	101	NUM
ihlr-16574	260	4	.	.	PUNCT
ihlr-16574	261	1	73	73	NUM
ihlr-16574	261	2	.	.	PUNCT
ihlr-16574	262	1	/d	/d	INTJ
ihlr-16574	262	2	.	.	PUNCT
ihlr-16574	263	1	408	408	NUM
ihlr-16574	263	2	indiana	indiana	PROPN
ihlr-16574	263	3	health	health	PROPN
ihlr-16574	263	4	law	law	PROPN
ihlr-16574	263	5	review	review	NOUN
ihlr-16574	263	6	[	[	X
ihlr-16574	263	7	vol	vol	NOUN
ihlr-16574	263	8	.	.	PUNCT
ihlr-16574	264	1	7:397	7:397	NUM
ihlr-16574	264	2	the	the	DET
ihlr-16574	264	3	ntf	ntf	PROPN
ihlr-16574	264	4	report	report	NOUN
ihlr-16574	264	5	also	also	ADV
ihlr-16574	264	6	contained	contain	VERB
ihlr-16574	264	7	an	an	DET
ihlr-16574	264	8	express	express	ADJ
ihlr-16574	264	9	lack	lack	NOUN
ihlr-16574	264	10	of	of	ADP
ihlr-16574	264	11	confidence	confidence	NOUN
ihlr-16574	264	12	in	in	ADP
ihlr-16574	264	13	cur­	cur­	ADJ
ihlr-16574	264	14	rent	rent	NOUN
ihlr-16574	264	15	safety	safety	NOUN
ihlr-16574	264	16	testing	testing	NOUN
ihlr-16574	264	17	methods	method	NOUN
ihlr-16574	264	18	for	for	ADP
ihlr-16574	264	19	products	product	NOUN
ihlr-16574	264	20	used	use	VERB
ihlr-16574	264	21	and	and	CCONJ
ihlr-16574	264	22	approved	approve	VERB
ihlr-16574	264	23	by	by	ADP
ihlr-16574	264	24	the	the	DET
ihlr-16574	264	25	fda	fda	PROPN
ihlr-16574	264	26	as	as	SCONJ
ihlr-16574	264	27	applied	apply	VERB
ihlr-16574	264	28	to	to	ADP
ihlr-16574	264	29	nanotechnology	nanotechnology	NOUN
ihlr-16574	264	30	.	.	PUNCT
ihlr-16574	265	1	74	74	NUM
ihlr-16574	265	2	current	current	ADJ
ihlr-16574	265	3	research	research	NOUN
ihlr-16574	265	4	that	that	PRON
ihlr-16574	265	5	has	have	AUX
ihlr-16574	265	6	shed	shed	VERB
ihlr-16574	265	7	light	light	NOUN
ihlr-16574	265	8	on	on	ADP
ihlr-16574	265	9	electr­	electr­	NOUN
ihlr-16574	265	10	ically	ically	ADV
ihlr-16574	265	11	neutral	neutral	ADJ
ihlr-16574	265	12	silver	silver	ADJ
ihlr-16574	265	13	nanoparticles	nanoparticle	NOUN
ihlr-16574	265	14	is	be	AUX
ihlr-16574	265	15	illustrative	illustrative	ADJ
ihlr-16574	265	16	of	of	ADP
ihlr-16574	265	17	this	this	DET
ihlr-16574	265	18	point.75	point.75	NOUN
ihlr-16574	265	19	previously	previously	ADV
ihlr-16574	265	20	,	,	PUNCT
ihlr-16574	265	21	it	it	PRON
ihlr-16574	265	22	was	be	AUX
ihlr-16574	265	23	believed	believe	VERB
ihlr-16574	265	24	that	that	SCONJ
ihlr-16574	265	25	nanoparticles	nanoparticle	NOUN
ihlr-16574	265	26	would	would	AUX
ihlr-16574	265	27	behave	behave	VERB
ihlr-16574	265	28	essentially	essentially	ADV
ihlr-16574	265	29	the	the	DET
ihlr-16574	265	30	same	same	ADJ
ihlr-16574	265	31	as	as	SCONJ
ihlr-16574	265	32	their	their	PRON
ihlr-16574	265	33	larger	large	ADJ
ihlr-16574	265	34	,	,	PUNCT
ihlr-16574	265	35	molecular	molecular	ADJ
ihlr-16574	265	36	sized	sized	ADJ
ihlr-16574	265	37	counterparts.76	counterparts.76	NOUN
ihlr-16574	265	38	electrically	electrically	ADV
ihlr-16574	265	39	neutral	neutral	ADJ
ihlr-16574	265	40	silver	silver	NOUN
ihlr-16574	265	41	na­	na­	PROPN
ihlr-16574	265	42	noparticles	noparticle	NOUN
ihlr-16574	265	43	have	have	AUX
ihlr-16574	265	44	been	be	AUX
ihlr-16574	265	45	found	find	VERB
ihlr-16574	265	46	,	,	PUNCT
ihlr-16574	265	47	however	however	ADV
ihlr-16574	265	48	,	,	PUNCT
ihlr-16574	265	49	to	to	PART
ihlr-16574	265	50	cross	cross	VERB
ihlr-16574	265	51	plasma	plasma	NOUN
ihlr-16574	265	52	membranes	membrane	NOUN
ihlr-16574	265	53	with	with	ADP
ihlr-16574	265	54	greater	great	ADJ
ihlr-16574	265	55	ease	ease	NOUN
ihlr-16574	265	56	than	than	ADP
ihlr-16574	265	57	their	their	PRON
ihlr-16574	265	58	charged	charge	VERB
ihlr-16574	265	59	counterparts.77	counterparts.77	ADV
ihlr-16574	265	60	this	this	DET
ihlr-16574	265	61	unexpected	unexpected	ADJ
ihlr-16574	265	62	behavior	behavior	NOUN
ihlr-16574	265	63	demonstrates	demonstrate	VERB
ihlr-16574	265	64	that	that	SCONJ
ihlr-16574	265	65	traditional	traditional	ADJ
ihlr-16574	265	66	scientific	scientific	ADJ
ihlr-16574	265	67	assumption	assumption	NOUN
ihlr-16574	265	68	may	may	AUX
ihlr-16574	265	69	not	not	PART
ihlr-16574	265	70	adequately	adequately	ADV
ihlr-16574	265	71	pre­	pre­	PROPN
ihlr-16574	265	72	dict	dict	VERB
ihlr-16574	265	73	how	how	SCONJ
ihlr-16574	265	74	even	even	ADV
ihlr-16574	265	75	a	a	DET
ihlr-16574	265	76	simple	simple	ADJ
ihlr-16574	265	77	change	change	NOUN
ihlr-16574	265	78	in	in	ADP
ihlr-16574	265	79	particle	particle	NOUN
ihlr-16574	265	80	size	size	NOUN
ihlr-16574	265	81	or	or	CCONJ
ihlr-16574	265	82	structure	structure	NOUN
ihlr-16574	265	83	could	could	AUX
ihlr-16574	265	84	alter	alter	VERB
ihlr-16574	265	85	exist­	exist­	PRON
ihlr-16574	265	86	ing	ing	ADJ
ihlr-16574	265	87	chemical	chemical	NOUN
ihlr-16574	265	88	,	,	PUNCT
ihlr-16574	265	89	biological	biological	ADJ
ihlr-16574	265	90	,	,	PUNCT
ihlr-16574	265	91	or	or	CCONJ
ihlr-16574	265	92	physiological	physiological	NOUN
ihlr-16574	265	93	structures.78	structures.78	VERB
ihlr-16574	265	94	because	because	SCONJ
ihlr-16574	265	95	of	of	ADP
ihlr-16574	265	96	the	the	DET
ihlr-16574	265	97	immense	immense	ADJ
ihlr-16574	265	98	uncertainty	uncertainty	NOUN
ihlr-16574	265	99	,	,	PUNCT
ihlr-16574	265	100	the	the	DET
ihlr-16574	265	101	ntf	ntf	PROPN
ihlr-16574	265	102	report	report	NOUN
ihlr-16574	265	103	repeatedly	repeatedly	ADV
ihlr-16574	265	104	em­	em­	X
ihlr-16574	265	105	phasizes	phasize	VERB
ihlr-16574	265	106	the	the	DET
ihlr-16574	265	107	need	need	NOUN
ihlr-16574	265	108	for	for	ADP
ihlr-16574	265	109	collaborative	collaborative	ADJ
ihlr-16574	265	110	efforts	effort	NOUN
ihlr-16574	265	111	to	to	PART
ihlr-16574	265	112	pool	pool	VERB
ihlr-16574	265	113	knowledge	knowledge	NOUN
ihlr-16574	265	114	and	and	CCONJ
ihlr-16574	265	115	resources	resource	NOUN
ihlr-16574	265	116	to	to	PART
ihlr-16574	265	117	lessen	lessen	VERB
ihlr-16574	265	118	the	the	DET
ihlr-16574	265	119	unpredictability	unpredictability	NOUN
ihlr-16574	265	120	ofnanotechnology.79	ofnanotechnology.79	NOUN
ihlr-16574	265	121	the	the	DET
ihlr-16574	265	122	ntf	ntf	PROPN
ihlr-16574	265	123	's	's	PART
ihlr-16574	265	124	emphasis	emphasis	NOUN
ihlr-16574	265	125	on	on	ADP
ihlr-16574	265	126	making	make	VERB
ihlr-16574	265	127	analyses	analysis	NOUN
ihlr-16574	265	128	on	on	ADP
ihlr-16574	265	129	"	"	PUNCT
ihlr-16574	265	130	a	a	DET
ihlr-16574	265	131	case	case	NOUN
ihlr-16574	265	132	-	-	PUNCT
ihlr-16574	265	133	by	by	ADP
ihlr-16574	265	134	-	-	PUNCT
ihlr-16574	265	135	case	case	NOUN
ihlr-16574	265	136	basis	basis	NOUN
ihlr-16574	265	137	"	"	PUNCT
ihlr-16574	265	138	in	in	ADP
ihlr-16574	265	139	the	the	DET
ihlr-16574	265	140	summary	summary	NOUN
ihlr-16574	265	141	"	"	PUNCT
ihlr-16574	265	142	recommenda­	recommenda­	ADJ
ihlr-16574	265	143	tions	tion	NOUN
ihlr-16574	265	144	for	for	ADP
ihlr-16574	265	145	considerations	consideration	NOUN
ihlr-16574	265	146	"	"	PUNCT
ihlr-16574	265	147	sections	section	NOUN
ihlr-16574	265	148	of	of	ADP
ihlr-16574	265	149	the	the	DET
ihlr-16574	265	150	report	report	NOUN
ihlr-16574	265	151	that	that	PRON
ihlr-16574	265	152	were	be	AUX
ihlr-16574	265	153	to	to	ADP
ihlr-16574	265	154	specifically	specifically	ADV
ihlr-16574	265	155	ad­	ad­	ADV
ihlr-16574	265	156	dress	dress	VERB
ihlr-16574	265	157	how	how	SCONJ
ihlr-16574	265	158	nanotechnology	nanotechnology	NOUN
ihlr-16574	265	159	would	would	AUX
ihlr-16574	265	160	or	or	CCONJ
ihlr-16574	265	161	would	would	AUX
ihlr-16574	265	162	not	not	PART
ihlr-16574	265	163	fit	fit	VERB
ihlr-16574	265	164	into	into	ADP
ihlr-16574	265	165	the	the	DET
ihlr-16574	265	166	current	current	ADJ
ihlr-16574	265	167	regulatory	regulatory	ADJ
ihlr-16574	265	168	scheme	scheme	NOUN
ihlr-16574	265	169	is	be	AUX
ihlr-16574	265	170	indicative	indicative	ADJ
ihlr-16574	265	171	of	of	ADP
ihlr-16574	265	172	this	this	DET
ihlr-16574	265	173	position	position	NOUN
ihlr-16574	265	174	.	.	PUNCT
ihlr-16574	266	1	80	80	NUM
ihlr-16574	266	2	this	this	DET
ihlr-16574	266	3	"	"	PUNCT
ihlr-16574	266	4	case	case	NOUN
ihlr-16574	266	5	-	-	PUNCT
ihlr-16574	266	6	by	by	ADP
ihlr-16574	266	7	-	-	PUNCT
ihlr-16574	266	8	case	case	NOUN
ihlr-16574	266	9	"	"	PUNCT
ihlr-16574	266	10	lan­	lan­	NOUN
ihlr-16574	266	11	guage	guage	NOUN
ihlr-16574	266	12	neatly	neatly	ADV
ihlr-16574	266	13	identifies	identify	VERB
ihlr-16574	266	14	the	the	DET
ihlr-16574	266	15	fda	fda	PROPN
ihlr-16574	266	16	's	's	PART
ihlr-16574	266	17	current	current	ADJ
ihlr-16574	266	18	approach	approach	NOUN
ihlr-16574	266	19	for	for	ADP
ihlr-16574	266	20	regulating	regulate	VERB
ihlr-16574	266	21	nano­	nano­	ADP
ihlr-16574	266	22	technology	technology	NOUN
ihlr-16574	266	23	in	in	ADP
ihlr-16574	266	24	its	its	PRON
ihlr-16574	266	25	various	various	ADJ
ihlr-16574	266	26	products	product	NOUN
ihlr-16574	266	27	as	as	ADP
ihlr-16574	266	28	one	one	NUM
ihlr-16574	266	29	of	of	ADP
ihlr-16574	266	30	"	"	PUNCT
ihlr-16574	266	31	wait	wait	VERB
ihlr-16574	266	32	and	and	CCONJ
ihlr-16574	266	33	see	see	VERB
ihlr-16574	266	34	.	.	PUNCT
ihlr-16574	266	35	"	"	PUNCT
ihlr-16574	267	1	specific	specific	ADJ
ihlr-16574	267	2	direction	direction	NOUN
ihlr-16574	267	3	as	as	SCONJ
ihlr-16574	267	4	to	to	ADP
ihlr-16574	267	5	which	which	PRON
ihlr-16574	267	6	fda	fda	PROPN
ihlr-16574	267	7	regulations	regulation	NOUN
ihlr-16574	267	8	would	would	AUX
ihlr-16574	267	9	apply	apply	VERB
ihlr-16574	267	10	to	to	ADP
ihlr-16574	267	11	nano­	nano­	PUNCT
ihlr-16574	267	12	technology	technology	NOUN
ihlr-16574	267	13	and	and	CCONJ
ihlr-16574	267	14	nanomedicine	nanomedicine	NOUN
ihlr-16574	267	15	would	would	AUX
ihlr-16574	267	16	be	be	AUX
ihlr-16574	267	17	applicable	applicable	ADJ
ihlr-16574	267	18	was	be	AUX
ihlr-16574	267	19	not	not	PART
ihlr-16574	267	20	given	give	VERB
ihlr-16574	267	21	thorough	thorough	ADJ
ihlr-16574	267	22	consideration	consideration	NOUN
ihlr-16574	267	23	in	in	ADP
ihlr-16574	267	24	the	the	DET
ihlr-16574	267	25	ntf	ntf	PROPN
ihlr-16574	267	26	report	report	NOUN
ihlr-16574	267	27	.	.	PUNCT
ihlr-16574	268	1	rather	rather	ADV
ihlr-16574	268	2	,	,	PUNCT
ihlr-16574	268	3	the	the	DET
ihlr-16574	268	4	report	report	NOUN
ihlr-16574	268	5	focused	focus	VERB
ihlr-16574	268	6	on	on	ADP
ihlr-16574	268	7	the	the	DET
ihlr-16574	268	8	many	many	ADJ
ihlr-16574	268	9	product	product	NOUN
ihlr-16574	268	10	types	type	NOUN
ihlr-16574	268	11	in	in	ADP
ihlr-16574	268	12	which	which	PRON
ihlr-16574	268	13	nanotechnology	nanotechnology	NOUN
ihlr-16574	268	14	will	will	AUX
ihlr-16574	268	15	be	be	AUX
ihlr-16574	268	16	applicable.81	applicable.81	NOUN
ihlr-16574	268	17	it	it	PRON
ihlr-16574	268	18	is	be	AUX
ihlr-16574	268	19	likely	likely	ADJ
ihlr-16574	268	20	that	that	SCONJ
ihlr-16574	268	21	this	this	DET
ihlr-16574	268	22	hesitance	hesitance	NOUN
ihlr-16574	268	23	to	to	PART
ihlr-16574	268	24	focus	focus	VERB
ihlr-16574	268	25	nanotechnology	nanotechnology	NOUN
ihlr-16574	268	26	into	into	ADP
ihlr-16574	268	27	one	one	NUM
ihlr-16574	268	28	category	category	NOUN
ihlr-16574	268	29	was	be	AUX
ihlr-16574	268	30	also	also	ADV
ihlr-16574	268	31	a	a	DET
ihlr-16574	268	32	func­	func­	NOUN
ihlr-16574	268	33	tion	tion	NOUN
ihlr-16574	268	34	of	of	ADP
ihlr-16574	268	35	the	the	DET
ihlr-16574	268	36	"	"	PUNCT
ihlr-16574	268	37	wait	wait	VERB
ihlr-16574	268	38	and	and	CCONJ
ihlr-16574	268	39	see	see	VERB
ihlr-16574	268	40	"	"	PUNCT
ihlr-16574	268	41	approach	approach	NOUN
ihlr-16574	268	42	the	the	DET
ihlr-16574	268	43	ntf	ntf	PROPN
ihlr-16574	268	44	has	have	AUX
ihlr-16574	268	45	taken	take	VERB
ihlr-16574	268	46	towards	towards	ADP
ihlr-16574	268	47	the	the	DET
ihlr-16574	268	48	develop­	develop­	ADJ
ihlr-16574	268	49	ing	ing	ADJ
ihlr-16574	268	50	technology	technology	NOUN
ihlr-16574	268	51	.	.	PUNCT
ihlr-16574	269	1	still	still	ADV
ihlr-16574	269	2	,	,	PUNCT
ihlr-16574	269	3	however	however	ADV
ihlr-16574	269	4	,	,	PUNCT
ihlr-16574	269	5	there	there	PRON
ihlr-16574	269	6	are	be	VERB
ihlr-16574	269	7	certain	certain	ADJ
ihlr-16574	269	8	categories	category	NOUN
ihlr-16574	269	9	within	within	ADP
ihlr-16574	269	10	the	the	DET
ihlr-16574	269	11	fda	fda	PROPN
ihlr-16574	269	12	that	that	PRON
ihlr-16574	269	13	do	do	AUX
ihlr-16574	269	14	po­	po­	X
ihlr-16574	269	15	tentially	tentially	ADV
ihlr-16574	269	16	seem	seem	VERB
ihlr-16574	269	17	appropriate	appropriate	ADJ
ihlr-16574	269	18	for	for	ADP
ihlr-16574	269	19	nanomedicine	nanomedicine	NOUN
ihlr-16574	269	20	as	as	SCONJ
ihlr-16574	269	21	it	it	PRON
ihlr-16574	269	22	is	be	AUX
ihlr-16574	269	23	anticipated	anticipate	VERB
ihlr-16574	269	24	to	to	PART
ihlr-16574	269	25	develop	develop	VERB
ihlr-16574	269	26	.	.	PUNCT
ihlr-16574	270	1	one	one	NUM
ihlr-16574	270	2	notable	notable	ADJ
ihlr-16574	270	3	category	category	NOUN
ihlr-16574	270	4	with	with	ADP
ihlr-16574	270	5	a	a	DET
ihlr-16574	270	6	strong	strong	ADJ
ihlr-16574	270	7	relation	relation	NOUN
ihlr-16574	270	8	to	to	ADP
ihlr-16574	270	9	nanomedicine	nanomedicine	PROPN
ihlr-16574	270	10	is	be	AUX
ihlr-16574	270	11	the	the	DET
ihlr-16574	270	12	device	device	NOUN
ihlr-16574	270	13	regulation	regulation	NOUN
ihlr-16574	270	14	category	category	NOUN
ihlr-16574	270	15	.	.	PUNCT
ihlr-16574	271	1	though	though	SCONJ
ihlr-16574	271	2	the	the	DET
ihlr-16574	271	3	use	use	NOUN
ihlr-16574	271	4	of	of	ADP
ihlr-16574	271	5	nanotechnology	nanotechnology	NOUN
ihlr-16574	271	6	in	in	ADP
ihlr-16574	271	7	pharmaceuticals	pharmaceutical	NOUN
ihlr-16574	271	8	74	74	NUM
ihlr-16574	271	9	.	.	PUNCT
ihlr-16574	272	1	/d	/d	INTJ
ihlr-16574	272	2	.	.	PUNCT
ihlr-16574	273	1	at	at	ADP
ihlr-16574	273	2	102	102	NUM
ihlr-16574	273	3	.	.	PUNCT
ihlr-16574	273	4	75	75	NUM
ihlr-16574	273	5	.	.	PUNCT
ihlr-16574	273	6	/d	/d	INTJ
ihlr-16574	273	7	.	.	PUNCT
ihlr-16574	274	1	76	76	NUM
ihlr-16574	274	2	.	.	PUNCT
ihlr-16574	275	1	wilhelmi	wilhelmi	PROPN
ihlr-16574	275	2	,	,	PUNCT
ihlr-16574	275	3	supra	supra	PROPN
ihlr-16574	275	4	note	note	NOUN
ihlr-16574	275	5	5	5	NUM
ihlr-16574	275	6	,	,	PUNCT
ihlr-16574	275	7	at	at	ADP
ihlr-16574	275	8	102	102	NUM
ihlr-16574	275	9	.	.	PUNCT
ihlr-16574	276	1	77	77	NUM
ihlr-16574	276	2	.	.	PUNCT
ihlr-16574	277	1	/d	/d	INTJ
ihlr-16574	277	2	.	.	PUNCT
ihlr-16574	278	1	(	(	PUNCT
ihlr-16574	278	2	citing	cite	VERB
ihlr-16574	278	3	chun	chun	PROPN
ihlr-16574	278	4	-	-	PUNCT
ihlr-16574	278	5	nm	nm	ADJ
ihlr-16574	278	6	lok	lok	PROPN
ihlr-16574	278	7	et	et	PROPN
ihlr-16574	278	8	al	al	PROPN
ihlr-16574	278	9	.	.	PROPN
ihlr-16574	278	10	,	,	PUNCT
ihlr-16574	278	11	silver	silver	NOUN
ihlr-16574	278	12	nanoparticles	nanoparticle	NOUN
ihlr-16574	278	13	:	:	PUNCT
ihlr-16574	278	14	partial	partial	ADJ
ihlr-16574	278	15	oxidation	oxidation	NOUN
ihlr-16574	278	16	and	and	CCONJ
ihlr-16574	278	17	antibacterial	antibacterial	ADJ
ihlr-16574	278	18	activities	activity	NOUN
ihlr-16574	278	19	,	,	PUNCT
ihlr-16574	278	20	12	12	NUM
ihlr-16574	278	21	j.	j.	NOUN
ihlr-16574	278	22	of	of	ADP
ihlr-16574	278	23	biological	biological	ADJ
ihlr-16574	278	24	inorganic	inorganic	ADJ
ihlr-16574	278	25	chem	chem	NOUN
ihlr-16574	278	26	.	.	PUNCT
ihlr-16574	279	1	527	527	NUM
ihlr-16574	279	2	(	(	PUNCT
ihlr-16574	279	3	2007	2007	NUM
ihlr-16574	279	4	)	)	PUNCT
ihlr-16574	279	5	)	)	PUNCT
ihlr-16574	279	6	.	.	PUNCT
ihlr-16574	280	1	78	78	NUM
ihlr-16574	280	2	.	.	PUNCT
ihlr-16574	281	1	wilhelmi	wilhelmi	ADJ
ihlr-16574	281	2	,	,	PUNCT
ihlr-16574	281	3	supra	supra	PROPN
ihlr-16574	281	4	note	note	NOUN
ihlr-16574	281	5	5	5	NUM
ihlr-16574	281	6	,	,	PUNCT
ihlr-16574	281	7	at	at	ADP
ihlr-16574	281	8	102	102	NUM
ihlr-16574	281	9	.	.	PUNCT
ihlr-16574	281	10	79	79	NUM
ihlr-16574	281	11	.	.	PUNCT
ihlr-16574	282	1	/d	/d	INTJ
ihlr-16574	282	2	.	.	PUNCT
ihlr-16574	283	1	at	at	ADP
ihlr-16574	283	2	103	103	NUM
ihlr-16574	283	3	.	.	PUNCT
ihlr-16574	283	4	80	80	NUM
ihlr-16574	283	5	.	.	PUNCT
ihlr-16574	284	1	u.s	u.s	PROPN
ihlr-16574	284	2	.	.	PROPN
ihlr-16574	284	3	food	food	PROPN
ihlr-16574	284	4	and	and	CCONJ
ihlr-16574	284	5	drug	drug	NOUN
ihlr-16574	284	6	administration	administration	NOUN
ihlr-16574	284	7	,	,	PUNCT
ihlr-16574	284	8	nanotechnology	nanotechnology	NOUN
ihlr-16574	284	9	:	:	PUNCT
ihlr-16574	284	10	a	a	DET
ihlr-16574	284	11	report	report	NOUN
ihlr-16574	284	12	of	of	ADP
ihlr-16574	284	13	the	the	DET
ihlr-16574	284	14	u.s	u.s	PROPN
ihlr-16574	284	15	.	.	PROPN
ihlr-16574	284	16	food	food	PROPN
ihlr-16574	284	17	and	and	CCONJ
ihlr-16574	284	18	drug	drug	NOUN
ihlr-16574	284	19	aomjnistra	aomjnistra	PROPN
ihlr-16574	284	20	tion	tion	PROPN
ihlr-16574	284	21	nanotechnology	nanotechnology	PROPN
ihlr-16574	284	22	task	task	PROPN
ihlr-16574	284	23	force	force	NOUN
ihlr-16574	284	24	35	35	NUM
ihlr-16574	284	25	(	(	PUNCT
ihlr-16574	284	26	2007	2007	NUM
ihlr-16574	284	27	)	)	PUNCT
ihlr-16574	284	28	,	,	PUNCT
ihlr-16574	284	29	available	available	ADJ
ihlr-16574	284	30	at	at	ADP
ihlr-16574	284	31	http://www.fdagov/nanotechnology/taskforcelreport2007	http://www.fdagov/nanotechnology/taskforcelreport2007	NOUN
ihlr-16574	284	32	.pdf	.pdf	PUNCT
ihlr-16574	285	1	[	[	X
ihlr-16574	285	2	hereinafter	hereinafter	NOUN
ihlr-16574	285	3	ntf	ntf	PROPN
ihlr-16574	285	4	report	report	PROPN
ihlr-16574	285	5	]	]	X
ihlr-16574	285	6	.	.	PUNCT
ihlr-16574	286	1	81	81	NUM
ihlr-16574	286	2	.	.	PUNCT
ihlr-16574	287	1	the	the	DET
ihlr-16574	287	2	list	list	NOUN
ihlr-16574	287	3	included	include	VERB
ihlr-16574	287	4	new	new	ADJ
ihlr-16574	287	5	drugs	drug	NOUN
ihlr-16574	287	6	and	and	CCONJ
ihlr-16574	287	7	biological	biological	ADJ
ihlr-16574	287	8	devices	device	NOUN
ihlr-16574	287	9	,	,	PUNCT
ihlr-16574	287	10	over	over	ADP
ihlr-16574	287	11	the	the	DET
ihlr-16574	287	12	counter	counter	PROPN
ihlr-16574	287	13	monograph	monograph	NOUN
ihlr-16574	287	14	drugs	drug	NOUN
ihlr-16574	287	15	,	,	PUNCT
ihlr-16574	287	16	animal	animal	NOUN
ihlr-16574	287	17	drugs	drug	NOUN
ihlr-16574	287	18	and	and	CCONJ
ihlr-16574	287	19	new	new	ADJ
ihlr-16574	287	20	feed	feed	NOUN
ihlr-16574	287	21	containing	contain	VERB
ihlr-16574	287	22	animal	animal	NOUN
ihlr-16574	287	23	drugs	drug	NOUN
ihlr-16574	287	24	,	,	PUNCT
ihlr-16574	287	25	devices	device	NOUN
ihlr-16574	287	26	,	,	PUNCT
ihlr-16574	287	27	food	food	NOUN
ihlr-16574	287	28	additives	additive	NOUN
ihlr-16574	287	29	and	and	CCONJ
ihlr-16574	287	30	gras	gra	NOUN
ihlr-16574	287	31	(	(	PUNCT
ihlr-16574	287	32	generally	generally	ADV
ihlr-16574	287	33	recognized	recognize	VERB
ihlr-16574	287	34	as	as	ADP
ihlr-16574	287	35	safe	safe	ADJ
ihlr-16574	287	36	)	)	PUNCT
ihlr-16574	287	37	food	food	NOUN
ihlr-16574	287	38	ingredients	ingredient	NOUN
ihlr-16574	287	39	,	,	PUNCT
ihlr-16574	287	40	color	color	NOUN
ihlr-16574	287	41	additives	additive	NOUN
ihlr-16574	287	42	,	,	PUNCT
ihlr-16574	287	43	cosmetics	cosmetic	NOUN
ihlr-16574	287	44	,	,	PUNCT
ihlr-16574	287	45	dietary	dietary	ADJ
ihlr-16574	287	46	supplements	supplement	NOUN
ihlr-16574	287	47	,	,	PUNCT
ihlr-16574	287	48	and	and	CCONJ
ihlr-16574	287	49	labeling	labeling	NOUN
ihlr-16574	287	50	and	and	CCONJ
ihlr-16574	287	51	advertising	advertising	NOUN
ihlr-16574	287	52	claims	claim	NOUN
ihlr-16574	287	53	for	for	ADP
ihlr-16574	287	54	conventional	conventional	ADJ
ihlr-16574	287	55	foods	food	NOUN
ihlr-16574	287	56	and	and	CCONJ
ihlr-16574	287	57	dietary	dietary	ADJ
ihlr-16574	287	58	supple­	supple­	NOUN
ihlr-16574	287	59	ments	ment	NOUN
ihlr-16574	287	60	.	.	PUNCT
ihlr-16574	288	1	/d	/d	INTJ
ihlr-16574	288	2	.	.	PUNCT
ihlr-16574	289	1	at	at	ADP
ihlr-16574	289	2	19	19	NUM
ihlr-16574	289	3	-	-	SYM
ihlr-16574	289	4	20	20	NUM
ihlr-16574	289	5	.	.	PUNCT
ihlr-16574	289	6	2010	2010	NUM
ihlr-16574	289	7	]	]	PUNCT
ihlr-16574	289	8	nanomedicine	nanomedicine	NOUN
ihlr-16574	289	9	409	409	NUM
ihlr-16574	289	10	is	be	AUX
ihlr-16574	289	11	also	also	ADV
ihlr-16574	289	12	extremely	extremely	ADV
ihlr-16574	289	13	.	.	PUNCT
ihlr-16574	290	1	relevant	relevant	ADJ
ihlr-16574	290	2	to	to	ADP
ihlr-16574	290	3	nanomedicine	nanomedicine	PROPN
ihlr-16574	290	4	,	,	PUNCT
ihlr-16574	290	5	it	it	PRON
ihlr-16574	290	6	remains	remain	VERB
ihlr-16574	290	7	to	to	PART
ihlr-16574	290	8	be	be	AUX
ihlr-16574	290	9	seen	see	VERB
ihlr-16574	290	10	whether	whether	SCONJ
ihlr-16574	290	11	this	this	DET
ihlr-16574	290	12	technology	technology	NOUN
ihlr-16574	290	13	will	will	AUX
ihlr-16574	290	14	be	be	AUX
ihlr-16574	290	15	governed	govern	VERB
ihlr-16574	290	16	by	by	ADP
ihlr-16574	290	17	a	a	DET
ihlr-16574	290	18	separate	separate	ADJ
ihlr-16574	290	19	section	section	NOUN
ihlr-16574	290	20	outside	outside	ADP
ihlr-16574	290	21	that	that	PRON
ihlr-16574	290	22	of	of	ADP
ihlr-16574	290	23	medi­	medi­	PROPN
ihlr-16574	290	24	cal	cal	PROPN
ihlr-16574	290	25	devices	device	NOUN
ihlr-16574	290	26	.	.	PUNCT
ihlr-16574	291	1	currently	currently	ADV
ihlr-16574	291	2	,	,	PUNCT
ihlr-16574	291	3	devices	device	NOUN
ihlr-16574	291	4	regulated	regulate	VERB
ihlr-16574	291	5	under	under	ADP
ihlr-16574	291	6	the	the	DET
ihlr-16574	291	7	fda	fda	PROPN
ihlr-16574	291	8	fall	fall	VERB
ihlr-16574	291	9	into	into	ADP
ihlr-16574	291	10	three	three	NUM
ihlr-16574	291	11	catego­	catego­	NOUN
ihlr-16574	291	12	ries	rie	NOUN
ihlr-16574	291	13	.	.	PUNCT
ihlr-16574	292	1	82	82	NUM
ihlr-16574	292	2	class	class	NOUN
ihlr-16574	292	3	i	i	NOUN
ihlr-16574	292	4	devices	device	NOUN
ihlr-16574	292	5	are	be	AUX
ihlr-16574	292	6	considered	consider	VERB
ihlr-16574	292	7	low	low	ADJ
ihlr-16574	292	8	risk	risk	NOUN
ihlr-16574	292	9	and	and	CCONJ
ihlr-16574	292	10	subject	subject	ADJ
ihlr-16574	292	11	to	to	ADP
ihlr-16574	292	12	very	very	ADV
ihlr-16574	292	13	few	few	ADJ
ihlr-16574	292	14	con­	con­	NOUN
ihlr-16574	292	15	trols	trols	X
ihlr-16574	292	16	(	(	PUNCT
ihlr-16574	292	17	labeling	labeling	NOUN
ihlr-16574	292	18	,	,	PUNCT
ihlr-16574	292	19	adverse	adverse	ADJ
ihlr-16574	292	20	event	event	NOUN
ihlr-16574	292	21	reporting	reporting	NOUN
ihlr-16574	292	22	,	,	PUNCT
ihlr-16574	292	23	etc	etc	X
ihlr-16574	292	24	.	.	X
ihlr-16574	292	25	)	)	PUNCT
ihlr-16574	292	26	.	.	PUNCT
ihlr-16574	293	1	83	83	NUM
ihlr-16574	293	2	class	class	NOUN
ihlr-16574	293	3	ll	ll	NOUN
ihlr-16574	293	4	devices	device	NOUN
ihlr-16574	293	5	have	have	VERB
ihlr-16574	293	6	a	a	DET
ihlr-16574	293	7	higher	high	ADJ
ihlr-16574	293	8	risk	risk	NOUN
ihlr-16574	293	9	to	to	ADP
ihlr-16574	293	10	the	the	DET
ihlr-16574	293	11	public	public	NOUN
ihlr-16574	293	12	and	and	CCONJ
ihlr-16574	293	13	contain	contain	VERB
ihlr-16574	293	14	more	more	ADV
ihlr-16574	293	15	complex	complex	ADJ
ihlr-16574	293	16	technology.84	technology.84	NOUN
ihlr-16574	293	17	devices	device	NOUN
ihlr-16574	293	18	under	under	ADP
ihlr-16574	293	19	this	this	DET
ihlr-16574	293	20	category	category	NOUN
ihlr-16574	293	21	must	must	AUX
ihlr-16574	293	22	follow	follow	VERB
ihlr-16574	293	23	specific	specific	ADJ
ihlr-16574	293	24	pre	pre	ADJ
ihlr-16574	293	25	-	-	ADJ
ihlr-16574	293	26	market	market	ADJ
ihlr-16574	293	27	review	review	NOUN
ihlr-16574	293	28	protocols	protocol	NOUN
ihlr-16574	293	29	wherein	wherein	SCONJ
ihlr-16574	293	30	a	a	DET
ihlr-16574	293	31	manufacturer	manufacturer	NOUN
ihlr-16574	293	32	must	must	AUX
ihlr-16574	293	33	"	"	PUNCT
ihlr-16574	293	34	demonstrate	demonstrate	VERB
ihlr-16574	293	35	that	that	SCONJ
ihlr-16574	293	36	[	[	X
ihlr-16574	293	37	its	its	PRON
ihlr-16574	293	38	]	]	X
ihlr-16574	293	39	new	new	ADJ
ihlr-16574	293	40	device	device	NOUN
ihlr-16574	293	41	is	be	AUX
ihlr-16574	293	42	'	'	PUNCT
ihlr-16574	293	43	substan­	substan­	ADV
ihlr-16574	293	44	tially	tially	ADV
ihlr-16574	293	45	equivalent	equivalent	ADJ
ihlr-16574	293	46	'	'	PUNCT
ihlr-16574	293	47	with	with	ADP
ihlr-16574	293	48	regard	regard	NOUN
ihlr-16574	293	49	to	to	ADP
ihlr-16574	293	50	safety	safety	NOUN
ihlr-16574	293	51	and	and	CCONJ
ihlr-16574	293	52	effectiveness	effectiveness	NOUN
ihlr-16574	293	53	to	to	ADP
ihlr-16574	293	54	a	a	DET
ihlr-16574	293	55	similar	similar	ADJ
ihlr-16574	293	56	device	device	NOUN
ihlr-16574	293	57	already	already	ADV
ihlr-16574	293	58	legally	legally	ADV
ihlr-16574	293	59	marketed	market	VERB
ihlr-16574	293	60	in	in	ADP
ihlr-16574	293	61	the	the	DET
ihlr-16574	293	62	united	united	PROPN
ihlr-16574	293	63	states:.ss	states:.ss	PROPN
ihlr-16574	293	64	class	class	NOUN
ihlr-16574	293	65	ill	ill	ADJ
ihlr-16574	293	66	devices	device	NOUN
ihlr-16574	293	67	are	be	AUX
ihlr-16574	293	68	com­	com­	NOUN
ihlr-16574	293	69	prised	prise	VERB
ihlr-16574	293	70	of	of	ADP
ihlr-16574	293	71	the	the	DET
ihlr-16574	293	72	most	most	ADV
ihlr-16574	293	73	complex	complex	ADJ
ihlr-16574	293	74	and	and	CCONJ
ihlr-16574	293	75	risky	risky	ADJ
ihlr-16574	293	76	devices	device	NOUN
ihlr-16574	293	77	available.86	available.86	VERB
ihlr-16574	293	78	these	these	DET
ihlr-16574	293	79	devices	device	NOUN
ihlr-16574	293	80	are	be	AUX
ihlr-16574	293	81	subject	subject	ADJ
ihlr-16574	293	82	to	to	ADP
ihlr-16574	293	83	pre	pre	ADJ
ihlr-16574	293	84	-	-	ADJ
ihlr-16574	293	85	market	market	ADJ
ihlr-16574	293	86	approval	approval	NOUN
ihlr-16574	293	87	through	through	ADP
ihlr-16574	293	88	extensive	extensive	ADJ
ihlr-16574	293	89	clinical	clinical	ADJ
ihlr-16574	293	90	testing	testing	NOUN
ihlr-16574	293	91	and	and	CCONJ
ihlr-16574	293	92	peri­	peri­	NOUN
ihlr-16574	293	93	odic	odic	ADJ
ihlr-16574	293	94	reporting	reporting	NOUN
ihlr-16574	293	95	on	on	ADP
ihlr-16574	293	96	new	new	ADJ
ihlr-16574	293	97	developments	development	NOUN
ihlr-16574	293	98	.	.	PUNCT
ihlr-16574	294	1	87	87	NUM
ihlr-16574	294	2	alterations	alteration	NOUN
ihlr-16574	294	3	to	to	ADP
ihlr-16574	294	4	any	any	DET
ihlr-16574	294	5	class	class	NOUN
ihlr-16574	294	6	ill	ill	ADJ
ihlr-16574	294	7	device	device	NOUN
ihlr-16574	294	8	require	require	VERB
ihlr-16574	294	9	further	further	ADJ
ihlr-16574	294	10	documentation	documentation	NOUN
ihlr-16574	294	11	and	and	CCONJ
ihlr-16574	294	12	testing	testing	NOUN
ihlr-16574	294	13	.	.	PUNCT
ihlr-16574	295	1	88	88	NUM
ihlr-16574	295	2	class	class	NOUN
ihlr-16574	295	3	ill	ill	ADJ
ihlr-16574	295	4	devices	device	NOUN
ihlr-16574	295	5	are	be	AUX
ihlr-16574	295	6	those	those	PRON
ihlr-16574	295	7	that	that	PRON
ihlr-16574	295	8	pose	pose	VERB
ihlr-16574	295	9	a	a	DET
ihlr-16574	295	10	"	"	PUNCT
ihlr-16574	295	11	significant	significant	ADJ
ihlr-16574	295	12	risk	risk	NOUN
ihlr-16574	295	13	"	"	PUNCT
ihlr-16574	295	14	to	to	ADP
ihlr-16574	295	15	the	the	DET
ihlr-16574	295	16	public	public	NOUN
ihlr-16574	295	17	.	.	PUNCT
ihlr-16574	296	1	89	89	NUM
ihlr-16574	296	2	if	if	SCONJ
ihlr-16574	296	3	forced	force	VERB
ihlr-16574	296	4	into	into	ADP
ihlr-16574	296	5	an	an	DET
ihlr-16574	296	6	existing	exist	VERB
ihlr-16574	296	7	category	category	NOUN
ihlr-16574	296	8	as	as	ADP
ihlr-16574	296	9	the	the	DET
ihlr-16574	296	10	fda	fda	PROPN
ihlr-16574	296	11	and	and	CCONJ
ihlr-16574	296	12	ntf	ntf	PROPN
ihlr-16574	296	13	have	have	AUX
ihlr-16574	296	14	sug­	sug­	NOUN
ihlr-16574	296	15	gested	geste	VERB
ihlr-16574	296	16	is	be	AUX
ihlr-16574	296	17	appropriate	appropriate	ADJ
ihlr-16574	296	18	,	,	PUNCT
ihlr-16574	296	19	nanomedicine	nanomedicine	ADJ
ihlr-16574	296	20	technology	technology	NOUN
ihlr-16574	296	21	will	will	AUX
ihlr-16574	296	22	likely	likely	ADV
ihlr-16574	296	23	fall	fall	VERB
ihlr-16574	296	24	into	into	ADP
ihlr-16574	296	25	the	the	DET
ihlr-16574	296	26	class	class	NOUN
ihlr-16574	296	27	ill	ill	ADJ
ihlr-16574	296	28	designation	designation	NOUN
ihlr-16574	296	29	unless	unless	SCONJ
ihlr-16574	296	30	another	another	DET
ihlr-16574	296	31	class	class	NOUN
ihlr-16574	296	32	division	division	NOUN
ihlr-16574	296	33	is	be	AUX
ihlr-16574	296	34	added	add	VERB
ihlr-16574	296	35	to	to	PART
ihlr-16574	296	36	specifically	specifically	ADV
ihlr-16574	296	37	address	address	VERB
ihlr-16574	296	38	nanotechnology	nanotechnology	NOUN
ihlr-16574	296	39	.	.	PUNCT
ihlr-16574	297	1	the	the	DET
ihlr-16574	297	2	latter	latter	ADJ
ihlr-16574	297	3	option	option	NOUN
ihlr-16574	297	4	may	may	AUX
ihlr-16574	297	5	prove	prove	VERB
ihlr-16574	297	6	the	the	DET
ihlr-16574	297	7	most	most	ADV
ihlr-16574	297	8	appropriate	appropriate	ADJ
ihlr-16574	297	9	considering	consider	VERB
ihlr-16574	297	10	the	the	DET
ihlr-16574	297	11	delicate	delicate	ADJ
ihlr-16574	297	12	and	and	CCONJ
ihlr-16574	297	13	unpredictable	unpredictable	ADJ
ihlr-16574	297	14	nature	nature	NOUN
ihlr-16574	297	15	of	of	ADP
ihlr-16574	297	16	nanotechnology.90	nanotechnology.90	ADV
ihlr-16574	297	17	at	at	ADP
ihlr-16574	297	18	this	this	DET
ihlr-16574	297	19	point	point	NOUN
ihlr-16574	297	20	,	,	PUNCT
ihlr-16574	297	21	the	the	DET
ihlr-16574	297	22	''	''	PUNCT
ihlr-16574	297	23	wait	wait	VERB
ihlr-16574	297	24	and	and	CCONJ
ihlr-16574	297	25	see	see	VERB
ihlr-16574	297	26	"	"	PUNCT
ihlr-16574	297	27	approach	approach	NOUN
ihlr-16574	297	28	still	still	ADV
ihlr-16574	297	29	applies	apply	VERB
ihlr-16574	297	30	.	.	PUNCT
ihlr-16574	298	1	3	3	X
ihlr-16574	298	2	.	.	X
ihlr-16574	298	3	special	special	ADJ
ihlr-16574	298	4	interest	interest	NOUN
ihlr-16574	298	5	groups	group	NOUN
ihlr-16574	298	6	in	in	ADP
ihlr-16574	298	7	the	the	DET
ihlr-16574	298	8	united	united	PROPN
ihlr-16574	298	9	states	states	PROPN
ihlr-16574	298	10	advocating	advocate	VERB
ihlr-16574	298	11	for	for	ADP
ihlr-16574	298	12	regulation	regulation	NOUN
ihlr-16574	298	13	in	in	ADP
ihlr-16574	298	14	addition	addition	NOUN
ihlr-16574	298	15	to	to	ADP
ihlr-16574	298	16	the	the	DET
ihlr-16574	298	17	efforts	effort	NOUN
ihlr-16574	298	18	spearheaded	spearhead	VERB
ihlr-16574	298	19	by	by	ADP
ihlr-16574	298	20	the	the	DET
ihlr-16574	298	21	fda	fda	PROPN
ihlr-16574	298	22	,	,	PUNCT
ihlr-16574	298	23	there	there	PRON
ihlr-16574	298	24	are	be	VERB
ihlr-16574	298	25	other	other	ADJ
ihlr-16574	298	26	agencies	agency	NOUN
ihlr-16574	298	27	currently	currently	ADV
ihlr-16574	298	28	operating	operate	VERB
ihlr-16574	298	29	in	in	ADP
ihlr-16574	298	30	the	the	DET
ihlr-16574	298	31	u.s	u.s	PROPN
ihlr-16574	298	32	.	.	PROPN
ihlr-16574	298	33	that	that	PRON
ihlr-16574	298	34	focus	focus	VERB
ihlr-16574	298	35	on	on	ADP
ihlr-16574	298	36	nanotechnology	nanotechnology	NOUN
ihlr-16574	298	37	.	.	PUNCT
ihlr-16574	299	1	one	one	NUM
ihlr-16574	299	2	such	such	ADJ
ihlr-16574	299	3	organization	organization	NOUN
ihlr-16574	299	4	is	be	AUX
ihlr-16574	299	5	the	the	DET
ihlr-16574	299	6	national	national	ADJ
ihlr-16574	299	7	nanotechnology	nanotechnology	PROPN
ihlr-16574	299	8	initiative	initiative	NOUN
ihlr-16574	299	9	(	(	PUNCT
ihlr-16574	299	10	nni	nni	PROPN
ihlr-16574	299	11	)	)	PUNCT
ihlr-16574	299	12	,	,	PUNCT
ihlr-16574	299	13	which	which	PRON
ihlr-16574	299	14	was	be	AUX
ihlr-16574	299	15	established	establish	VERB
ihlr-16574	299	16	in	in	ADP
ihlr-16574	299	17	2001	2001	NUM
ihlr-16574	299	18	to	to	PART
ihlr-16574	299	19	coordinate	coordinate	VERB
ihlr-16574	299	20	research	research	NOUN
ihlr-16574	299	21	and	and	CCONJ
ihlr-16574	299	22	development	development	NOUN
ihlr-16574	299	23	efforts	effort	NOUN
ihlr-16574	299	24	on	on	ADP
ihlr-16574	299	25	nanotechnology	nanotechnology	NOUN
ihlr-16574	299	26	at	at	ADP
ihlr-16574	299	27	the	the	DET
ihlr-16574	299	28	federallevel.91	federallevel.91	NOUN
ihlr-16574	299	29	the	the	DET
ihlr-16574	299	30	goals	goal	NOUN
ihlr-16574	299	31	ofnni	ofnni	VERB
ihlr-16574	299	32	are	be	AUX
ihlr-16574	299	33	to	to	ADP
ihlr-16574	299	34	"	"	PUNCT
ihlr-16574	299	35	[	[	X
ihlr-16574	299	36	a]dvance	a]dvance	VERB
ihlr-16574	299	37	a	a	DET
ihlr-16574	299	38	82	82	NUM
ihlr-16574	299	39	.	.	PUNCT
ihlr-16574	300	1	i	i	PRON
ihlr-16574	300	2	d	d	PROPN
ihlr-16574	300	3	at24	at24	PROPN
ihlr-16574	300	4	.	.	PROPN
ihlr-16574	300	5	83	83	NUM
ihlr-16574	300	6	.	.	PUNCT
ihlr-16574	300	7	!	!	PUNCT
ihlr-16574	301	1	d.	d.	PROPN
ihlr-16574	301	2	84	84	NUM
ihlr-16574	301	3	.	.	PUNCT
ihlr-16574	301	4	!	!	PUNCT
ihlr-16574	302	1	d.	d.	PROPN
ihlr-16574	302	2	85	85	NUM
ihlr-16574	302	3	.	.	PUNCT
ihlr-16574	302	4	!	!	PUNCT
ihlr-16574	303	1	d.	d.	PROPN
ihlr-16574	303	2	86	86	NUM
ihlr-16574	303	3	.	.	PUNCT
ihlr-16574	303	4	!	!	PUNCT
ihlr-16574	304	1	d.	d.	PROPN
ihlr-16574	304	2	87	87	NUM
ihlr-16574	304	3	.	.	PUNCT
ihlr-16574	305	1	ntfreport	ntfreport	PROPN
ihlr-16574	305	2	,	,	PUNCT
ihlr-16574	305	3	supranote	supranote	VERB
ihlr-16574	305	4	80	80	NUM
ihlr-16574	305	5	,	,	PUNCT
ihlr-16574	305	6	at24	at24	PROPN
ihlr-16574	305	7	-	-	PUNCT
ihlr-16574	305	8	5	5	NUM
ihlr-16574	305	9	.	.	NUM
ihlr-16574	305	10	88	88	NUM
ihlr-16574	305	11	.	.	PUNCT
ihlr-16574	305	12	!	!	PUNCT
ihlr-16574	306	1	d.	d.	PROPN
ihlr-16574	306	2	at	at	ADP
ihlr-16574	306	3	25	25	NUM
ihlr-16574	306	4	.	.	PUNCT
ihlr-16574	306	5	89	89	NUM
ihlr-16574	306	6	.	.	PUNCT
ihlr-16574	307	1	"	"	PUNCT
ihlr-16574	307	2	significant	significant	ADJ
ihlr-16574	307	3	risk	risk	NOUN
ihlr-16574	307	4	devices	device	NOUN
ihlr-16574	307	5	may	may	AUX
ihlr-16574	307	6	include	include	VERB
ihlr-16574	307	7	implants	implant	NOUN
ihlr-16574	307	8	,	,	PUNCT
ihlr-16574	307	9	devices	device	NOUN
ihlr-16574	307	10	that	that	PRON
ihlr-16574	307	11	support	support	VERB
ihlr-16574	307	12	or	or	CCONJ
ihlr-16574	307	13	sustain	sustain	VERB
ihlr-16574	307	14	human	human	ADJ
ihlr-16574	307	15	life	life	NOUN
ihlr-16574	307	16	,	,	PUNCT
ihlr-16574	307	17	and	and	CCONJ
ihlr-16574	307	18	devices	device	NOUN
ihlr-16574	307	19	that	that	PRON
ihlr-16574	307	20	are	be	AUX
ihlr-16574	307	21	substantially	substantially	ADV
ihlr-16574	307	22	important	important	ADJ
ihlr-16574	307	23	in	in	ADP
ihlr-16574	307	24	diagnosing	diagnose	VERB
ihlr-16574	307	25	,	,	PUNCT
ihlr-16574	307	26	curing	curing	NOUN
ihlr-16574	307	27	,	,	PUNCT
ihlr-16574	307	28	mitigating	mitigate	VERB
ihlr-16574	307	29	or	or	CCONJ
ihlr-16574	307	30	treating	treat	VERB
ihlr-16574	307	31	disease	disease	NOUN
ihlr-16574	307	32	or	or	CCONJ
ihlr-16574	307	33	in	in	ADP
ihlr-16574	307	34	preventing	prevent	VERB
ihlr-16574	307	35	impairment	impairment	NOUN
ihlr-16574	307	36	to	to	ADP
ihlr-16574	307	37	human	human	ADJ
ihlr-16574	307	38	health	health	NOUN
ihlr-16574	307	39	.	.	PUNCT
ihlr-16574	308	1	examples	example	NOUN
ihlr-16574	308	2	include	include	VERB
ihlr-16574	308	3	sutures	suture	NOUN
ihlr-16574	308	4	,	,	PUNCT
ihlr-16574	308	5	cardiac	cardiac	ADJ
ihlr-16574	308	6	pacemakers	pacemaker	NOUN
ihlr-16574	308	7	,	,	PUNCT
ihlr-16574	308	8	hydrocephalus	hydrocephalus	ADJ
ihlr-16574	308	9	shunts	shunt	NOUN
ihlr-16574	308	10	,	,	PUNCT
ihlr-16574	308	11	and	and	CCONJ
ihlr-16574	308	12	orthopedic	orthopedic	ADJ
ihlr-16574	308	13	implants	implant	NOUN
ihlr-16574	308	14	.	.	PUNCT
ihlr-16574	308	15	"	"	PUNCT
ihlr-16574	308	16	!	!	PUNCT
ihlr-16574	309	1	d.	d.	PROPN
ihlr-16574	309	2	90	90	NUM
ihlr-16574	309	3	.	.	PUNCT
ihlr-16574	310	1	see	see	VERB
ihlr-16574	310	2	wilhelmi	wilhelmi	PROPN
ihlr-16574	310	3	,	,	PUNCT
ihlr-16574	310	4	supra	supra	PROPN
ihlr-16574	310	5	note	note	NOUN
ihlr-16574	310	6	5	5	NUM
ihlr-16574	310	7	,	,	PUNCT
ihlr-16574	310	8	at	at	ADP
ihlr-16574	310	9	102	102	NUM
ihlr-16574	310	10	(	(	PUNCT
ihlr-16574	310	11	discussing	discuss	VERB
ihlr-16574	310	12	how	how	SCONJ
ihlr-16574	310	13	the	the	DET
ihlr-16574	310	14	smallest	small	ADJ
ihlr-16574	310	15	change	change	NOUN
ihlr-16574	310	16	in	in	ADP
ihlr-16574	310	17	the	the	DET
ihlr-16574	310	18	molecular	molecular	ADJ
ihlr-16574	310	19	structure	structure	NOUN
ihlr-16574	310	20	of	of	ADP
ihlr-16574	310	21	nanoparticles	nanoparticle	NOUN
ihlr-16574	310	22	drastically	drastically	ADV
ihlr-16574	310	23	affects	affect	VERB
ihlr-16574	310	24	the	the	DET
ihlr-16574	310	25	way	way	NOUN
ihlr-16574	310	26	nanoparticles	nanoparticle	NOUN
ihlr-16574	310	27	behave	behave	VERB
ihlr-16574	310	28	and	and	CCONJ
ihlr-16574	310	29	interact	interact	VERB
ihlr-16574	310	30	with	with	ADP
ihlr-16574	310	31	surrounding	surround	VERB
ihlr-16574	310	32	matter	matter	NOUN
ihlr-16574	310	33	)	)	PUNCT
ihlr-16574	310	34	.	.	PUNCT
ihlr-16574	311	1	91	91	NUM
ihlr-16574	311	2	.	.	PUNCT
ihlr-16574	312	1	national	national	PROPN
ihlr-16574	312	2	nanotechnology	nanotechnology	PROPN
ihlr-16574	312	3	initiative	initiative	PROPN
ihlr-16574	312	4	(	(	PUNCT
ihlr-16574	312	5	nni	nni	PROPN
ihlr-16574	312	6	)	)	PUNCT
ihlr-16574	312	7	,	,	PUNCT
ihlr-16574	312	8	http://www.nano.gov/htmvaboutlhome	http://www.nano.gov/htmvaboutlhome	X
ihlr-16574	312	9	_	_	PUNCT
ihlr-16574	313	1	about.html	about.html	PROPN
ihlr-16574	313	2	(	(	PUNCT
ihlr-16574	313	3	last	last	ADV
ihlr-16574	313	4	visited	visit	VERB
ihlr-16574	313	5	nov	nov	PROPN
ihlr-16574	313	6	.	.	PROPN
ihlr-16574	313	7	2	2	NUM
ihlr-16574	313	8	,	,	PUNCT
ihlr-16574	313	9	2008	2008	NUM
ihlr-16574	313	10	)	)	PUNCT
ihlr-16574	313	11	.	.	PUNCT
ihlr-16574	314	1	410	410	NUM
ihlr-16574	314	2	indiana	indiana	PROPN
ihlr-16574	314	3	health	health	PROPN
ihlr-16574	314	4	law	law	PROPN
ihlr-16574	314	5	review	review	NOUN
ihlr-16574	314	6	[	[	X
ihlr-16574	314	7	vol	vol	NOUN
ihlr-16574	314	8	.	.	PUNCT
ihlr-16574	315	1	7:397	7:397	NUM
ihlr-16574	315	2	world	world	NOUN
ihlr-16574	315	3	-	-	PUNCT
ihlr-16574	315	4	class	class	NOUN
ihlr-16574	315	5	nanotechnology	nanotechnology	NOUN
ihlr-16574	315	6	research	research	NOUN
ihlr-16574	315	7	and	and	CCONJ
ihlr-16574	315	8	development	development	NOUN
ihlr-16574	315	9	program	program	NOUN
ihlr-16574	315	10	[	[	X
ihlr-16574	315	11	;	;	PUNCT
ihlr-16574	315	12	]	]	X
ihlr-16574	316	1	[	[	X
ihlr-16574	316	2	f]oster	f]oster	ADP
ihlr-16574	316	3	the	the	DET
ihlr-16574	316	4	transfer	transfer	NOUN
ihlr-16574	316	5	of	of	ADP
ihlr-16574	316	6	new	new	ADJ
ihlr-16574	316	7	technologies	technology	NOUN
ihlr-16574	316	8	into	into	ADP
ihlr-16574	316	9	products	product	NOUN
ihlr-16574	316	10	for	for	ADP
ihlr-16574	316	11	commercial	commercial	ADJ
ihlr-16574	316	12	and	and	CCONJ
ihlr-16574	316	13	public	public	ADJ
ihlr-16574	316	14	.benefit	.benefit	PUNCT
ihlr-16574	316	15	[	[	X
ihlr-16574	316	16	;	;	PUNCT
ihlr-16574	316	17	]	]	PUNCT
ihlr-16574	316	18	[	[	PUNCT
ihlr-16574	316	19	d]evelop	d]evelop	X
ihlr-16574	316	20	and	and	CCONJ
ihlr-16574	316	21	sustain	sustain	VERB
ihlr-16574	316	22	educational	educational	ADJ
ihlr-16574	316	23	resources	resource	NOUN
ihlr-16574	316	24	,	,	PUNCT
ihlr-16574	316	25	a	a	DET
ihlr-16574	316	26	skilled	skilled	ADJ
ihlr-16574	316	27	workforce	workforce	NOUN
ihlr-16574	316	28	,	,	PUNCT
ihlr-16574	316	29	and	and	CCONJ
ihlr-16574	316	30	the	the	DET
ihlr-16574	316	31	supporting	support	VERB
ihlr-16574	316	32	infrastructure	infrastructure	NOUN
ihlr-16574	316	33	and	and	CCONJ
ihlr-16574	316	34	tools	tool	NOUN
ihlr-16574	316	35	to	to	PART
ihlr-16574	316	36	advance	advance	VERB
ihlr-16574	316	37	technology	technology	NOUN
ihlr-16574	316	38	[	[	X
ihlr-16574	316	39	;	;	PUNCT
ihlr-16574	316	40	and	and	CCONJ
ihlr-16574	316	41	]	]	PUNCT
ihlr-16574	316	42	[	[	X
ihlr-16574	316	43	s]upport	s]upport	VERB
ihlr-16574	316	44	responsible	responsible	ADJ
ihlr-16574	316	45	development	development	NOUN
ihlr-16574	316	46	ofnanotechnology	ofnanotechnology	NOUN
ihlr-16574	316	47	.	.	PUNCT
ihlr-16574	317	1	"92	"92	PROPN
ihlr-16574	317	2	further	far	ADV
ihlr-16574	318	1	,	,	PUNCT
ihlr-16574	318	2	the	the	DET
ihlr-16574	318	3	nni	nni	PROPN
ihlr-16574	318	4	is	be	AUX
ihlr-16574	318	5	committed	commit	VERB
ihlr-16574	318	6	to	to	ADP
ihlr-16574	318	7	the	the	DET
ihlr-16574	318	8	expansion	expansion	NOUN
ihlr-16574	318	9	of	of	ADP
ihlr-16574	318	10	"	"	PUNCT
ihlr-16574	318	11	scientific	scientific	ADJ
ihlr-16574	318	12	understanding	understanding	NOUN
ihlr-16574	318	13	of	of	ADP
ihlr-16574	318	14	the	the	DET
ihlr-16574	318	15	nano­	nano­	NUM
ihlr-16574	318	16	meter	meter	NOUN
ihlr-16574	318	17	scale	scale	NOUN
ihlr-16574	318	18	phenomena	phenomenon	NOUN
ihlr-16574	318	19	.	.	PUNCT
ihlr-16574	319	1	"93	"93	PROPN
ihlr-16574	319	2	nni	nni	PROPN
ihlr-16574	319	3	is	be	AUX
ihlr-16574	319	4	governed	govern	VERB
ihlr-16574	319	5	and	and	CCONJ
ihlr-16574	319	6	coordinated	coordinate	VERB
ihlr-16574	319	7	by	by	ADP
ihlr-16574	319	8	the	the	DET
ihlr-16574	319	9	nanoscale	nanoscale	NOUN
ihlr-16574	319	10	science	science	NOUN
ihlr-16574	319	11	,	,	PUNCT
ihlr-16574	319	12	engineer­	engineer­	PROPN
ihlr-16574	319	13	ing	ing	NOUN
ihlr-16574	319	14	and	and	CCONJ
ihlr-16574	319	15	technology	technology	NOUN
ihlr-16574	319	16	(	(	PUNCT
ihlr-16574	319	17	nset	nset	ADJ
ihlr-16574	319	18	)	)	PUNCT
ihlr-16574	319	19	subcommittee	subcommittee	NOUN
ihlr-16574	319	20	,	,	PUNCT
ihlr-16574	319	21	a	a	DET
ihlr-16574	319	22	group	group	NOUN
ihlr-16574	319	23	led	lead	VERB
ihlr-16574	319	24	by	by	ADP
ihlr-16574	319	25	a	a	DET
ihlr-16574	319	26	managing	manage	VERB
ihlr-16574	319	27	board	board	NOUN
ihlr-16574	319	28	and	and	CCONJ
ihlr-16574	319	29	representatives	representative	NOUN
ihlr-16574	319	30	from	from	ADP
ihlr-16574	319	31	over	over	ADP
ihlr-16574	319	32	25	25	NUM
ihlr-16574	319	33	of	of	ADP
ihlr-16574	319	34	the	the	DET
ihlr-16574	319	35	nation	nation	NOUN
ihlr-16574	319	36	's	's	PART
ihlr-16574	319	37	federal	federal	ADJ
ihlr-16574	319	38	agencies.94	agencies.94	NOUN
ihlr-16574	319	39	nset	nset	VERB
ihlr-16574	319	40	is	be	AUX
ihlr-16574	319	41	a	a	DET
ihlr-16574	319	42	subcommittee	subcommittee	NOUN
ihlr-16574	319	43	of	of	ADP
ihlr-16574	319	44	the	the	DET
ihlr-16574	319	45	larger	large	ADJ
ihlr-16574	319	46	national	national	ADJ
ihlr-16574	319	47	science	science	NOUN
ihlr-16574	319	48	and	and	CCONJ
ihlr-16574	319	49	technology	technology	PROPN
ihlr-16574	319	50	council	council	PROPN
ihlr-16574	319	51	committee	committee	PROPN
ihlr-16574	319	52	on	on	ADP
ihlr-16574	319	53	technology.95	technology.95	PROPN
ihlr-16574	319	54	nset	nset	PROPN
ihlr-16574	319	55	uses	use	VERB
ihlr-16574	319	56	one	one	NUM
ihlr-16574	319	57	of	of	ADP
ihlr-16574	319	58	its	its	PRON
ihlr-16574	319	59	fom	fom	NOUN
ihlr-16574	319	60	working	work	VERB
ihlr-16574	319	61	groups	group	NOUN
ihlr-16574	319	62	to	to	PART
ihlr-16574	319	63	specifically	specifically	ADV
ihlr-16574	319	64	focus	focus	VERB
ihlr-16574	319	65	on	on	ADP
ihlr-16574	319	66	health	health	NOUN
ihlr-16574	319	67	and	and	CCONJ
ihlr-16574	319	68	environmental	environmental	ADJ
ihlr-16574	319	69	concerns	concern	NOUN
ihlr-16574	319	70	sur­	sur­	ADJ
ihlr-16574	319	71	rounding	round	VERB
ihlr-16574	319	72	nanotechnology	nanotechnology	PROPN
ihlr-16574	319	73	and	and	CCONJ
ihlr-16574	319	74	nanomedicine.96	nanomedicine.96	PROPN
ihlr-16574	319	75	nni	nni	PROPN
ihlr-16574	319	76	is	be	AUX
ihlr-16574	319	77	funded	fund	VERB
ihlr-16574	319	78	by	by	ADP
ihlr-16574	319	79	the	the	DET
ihlr-16574	319	80	federal	federal	ADJ
ihlr-16574	319	81	government	government	NOUN
ihlr-16574	319	82	.	.	PUNCT
ihlr-16574	320	1	it	it	PRON
ihlr-16574	320	2	hasan	hasan	PROPN
ihlr-16574	320	3	estimated	estimate	VERB
ihlr-16574	320	4	budget	budget	NOUN
ihlr-16574	320	5	of$1.5	of$1.5	NOUN
ihlr-16574	320	6	billion	billion	NUM
ihlr-16574	320	7	for	for	ADP
ihlr-16574	320	8	the	the	DET
ihlr-16574	320	9	2009	2009	NUM
ihlr-16574	320	10	fiscal	fiscal	ADJ
ihlr-16574	320	11	year.97	year.97	NOUN
ihlr-16574	320	12	nni	nni	PROPN
ihlr-16574	320	13	invests	invest	VERB
ihlr-16574	320	14	these	these	DET
ihlr-16574	320	15	federal	federal	ADJ
ihlr-16574	320	16	funds	fund	NOUN
ihlr-16574	320	17	in	in	ADP
ihlr-16574	320	18	federal	federal	ADJ
ihlr-16574	320	19	agencies	agency	NOUN
ihlr-16574	320	20	with	with	ADP
ihlr-16574	320	21	programs	program	NOUN
ihlr-16574	320	22	and	and	CCONJ
ihlr-16574	320	23	projects	project	NOUN
ihlr-16574	320	24	specifically	specifically	ADV
ihlr-16574	320	25	related	relate	VERB
ihlr-16574	320	26	to	to	ADP
ihlr-16574	320	27	nano­	nano­	NUM
ihlr-16574	320	28	technology	technology	NOUN
ihlr-16574	320	29	research	research	NOUN
ihlr-16574	320	30	and	and	CCONJ
ihlr-16574	320	31	development	development	NOUN
ihlr-16574	320	32	.	.	PUNCT
ihlr-16574	321	1	98	98	NUM
ihlr-16574	322	1	the	the	DET
ihlr-16574	322	2	following	follow	VERB
ihlr-16574	322	3	chart	chart	NOUN
ihlr-16574	322	4	details	detail	NOUN
ihlr-16574	322	5	the	the	DET
ihlr-16574	322	6	distribution	distribution	NOUN
ihlr-16574	322	7	ofnni	ofnni	NOUN
ihlr-16574	322	8	funds	fund	NOUN
ihlr-16574	322	9	to	to	ADP
ihlr-16574	322	10	federal	federal	ADJ
ihlr-16574	322	11	agencies	agency	NOUN
ihlr-16574	322	12	.	.	PUNCT
ihlr-16574	323	1	92	92	NUM
ihlr-16574	323	2	.	.	PUNCT
ihlr-16574	324	1	/d	/d	INTJ
ihlr-16574	324	2	.	.	PUNCT
ihlr-16574	325	1	93	93	NUM
ihlr-16574	325	2	.	.	PUNCT
ihlr-16574	326	1	/d	/d	INTJ
ihlr-16574	326	2	.	.	PUNCT
ihlr-16574	327	1	94	94	NUM
ihlr-16574	327	2	.	.	PUNCT
ihlr-16574	328	1	national	national	PROPN
ihlr-16574	328	2	nanotechnology	nanotechnology	PROPN
ihlr-16574	328	3	initiative	initiative	NOUN
ihlr-16574	328	4	,	,	PUNCT
ihlr-16574	328	5	bttp:/lwww.nano.gov	bttp:/lwww.nano.gov	PROPN
ihlr-16574	328	6	/	/	SYM
ihlr-16574	328	7	btmji	btmji	ADJ
ihlr-16574	328	8	aboutlnnipartic	aboutlnnipartic	NOUN
ihlr-16574	328	9	(	(	PUNCT
ihlr-16574	328	10	last	last	ADV
ihlr-16574	328	11	visited	visit	VERB
ihlr-16574	328	12	jan	jan	PROPN
ihlr-16574	328	13	.	.	PROPN
ihlr-16574	328	14	16	16	NUM
ihlr-16574	328	15	,	,	PUNCT
ihlr-16574	328	16	2009	2009	NUM
ihlr-16574	328	17	)	)	PUNCT
ihlr-16574	328	18	.	.	PUNCT
ihlr-16574	329	1	95	95	NUM
ihlr-16574	329	2	.	.	PUNCT
ihlr-16574	330	1	/d	/d	INTJ
ihlr-16574	330	2	.	.	PUNCT
ihlr-16574	331	1	96	96	NUM
ihlr-16574	331	2	.	.	PUNCT
ihlr-16574	331	3	nanoscale	nanoscale	NOUN
ihlr-16574	331	4	science	science	NOUN
ihlr-16574	331	5	,	,	PUNCT
ihlr-16574	331	6	engineering	engineering	NOUN
ihlr-16574	331	7	and	and	CCONJ
ihlr-16574	331	8	technology	technology	NOUN
ihlr-16574	331	9	(	(	PUNCT
ihlr-16574	331	10	nset	nset	ADJ
ihlr-16574	331	11	)	)	PUNCT
ihlr-16574	331	12	subcommittee	subcommittee	NOUN
ihlr-16574	331	13	working	work	VERB
ihlr-16574	331	14	groups	group	NOUN
ihlr-16574	331	15	,	,	PUNCT
ihlr-16574	331	16	http://www.nano.gov/h1m1/about/nsetworkinggroups.html	http://www.nano.gov/h1m1/about/nsetworkinggroups.html	NUM
ihlr-16574	331	17	(	(	PUNCT
ihlr-16574	331	18	last	last	ADV
ihlr-16574	331	19	visited	visit	VERB
ihlr-16574	331	20	jan	jan	PROPN
ihlr-16574	331	21	.	.	PROPN
ihlr-16574	331	22	16	16	NUM
ihlr-16574	331	23	,	,	PUNCT
ihlr-16574	331	24	2009	2009	NUM
ihlr-16574	331	25	)	)	PUNCT
ihlr-16574	331	26	;	;	PUNCT
ihlr-16574	331	27	97	97	NUM
ihlr-16574	331	28	.	.	PUNCT
ihlr-16574	331	29	national	national	PROPN
ihlr-16574	331	30	nanotechnology	nanotechnology	PROPN
ihlr-16574	331	31	initiative	initiative	PROPN
ihlr-16574	331	32	fy	fy	PROPN
ihlr-16574	331	33	2009	2009	NUM
ihlr-16574	331	34	budget	budget	NOUN
ihlr-16574	331	35	highlights	highlight	NOUN
ihlr-16574	331	36	,	,	PUNCT
ihlr-16574	331	37	http://www.nano.gov/nni	http://www.nano.gov/nni	PROPN
ihlr-16574	331	38	_	_	PUNCT
ihlr-16574	332	1	fy09	fy09	PROPN
ihlr-16574	332	2	_	_	PUNCT
ihlr-16574	332	3	budget	budget	NOUN
ihlr-16574	332	4	_	_	PUNCT
ihlr-16574	332	5	summary	summary	NOUN
ihlr-16574	332	6	.	.	PUNCT
ihlr-16574	333	1	pdf	pdf	NOUN
ihlr-16574	333	2	{	{	PUNCT
ihlr-16574	333	3	last	last	ADV
ihlr-16574	333	4	visited	visit	VERB
ihlr-16574	333	5	april	april	PROPN
ihlr-16574	333	6	21	21	NUM
ihlr-16574	333	7	,	,	PUNCT
ihlr-16574	333	8	201	201	NUM
ihlr-16574	333	9	0	0	NUM
ihlr-16574	333	10	)	)	PUNCT
ihlr-16574	333	11	;	;	PUNCT
ihlr-16574	333	12	see	see	VERB
ihlr-16574	333	13	also	also	ADV
ihlr-16574	333	14	national	national	ADJ
ihlr-16574	333	15	science	science	NOUN
ihlr-16574	333	16	and	and	CCONJ
ihlr-16574	333	17	technology	technology	NOUN
ihlr-16574	333	18	council	council	PROPN
ihlr-16574	333	19	,	,	PUNCT
ihlr-16574	333	20	the	the	DET
ihlr-16574	333	21	national	national	ADJ
ihlr-16574	333	22	nanotechnowgy	nanotechnowgy	ADJ
ihlr-16574	333	23	initiative	initiative	NOUN
ihlr-16574	333	24	:	:	PUNCT
ihlr-16574	333	25	s1rategic	s1rategic	ADJ
ihlr-16574	333	26	plan	plan	NOUN
ihlr-16574	333	27	(	(	PUNCT
ihlr-16574	333	28	2007	2007	NUM
ihlr-16574	333	29	)	)	PUNCT
ihlr-16574	333	30	,	,	PUNCT
ihlr-16574	333	31	awjilable	awjilable	ADJ
ihlr-16574	333	32	at	at	ADP
ihlr-16574	333	33	http://www.nano.gov/nni_strategic	http://www.nano.gov/nni_strategic	NOUN
ihlr-16574	333	34	_	_	PUNCT
ihlr-16574	333	35	plan_2007.pdf	plan_2007.pdf	NOUN
ihlr-16574	333	36	.	.	PUNCT
ihlr-16574	334	1	·	·	PUNCT
ihlr-16574	335	1	98	98	X
ihlr-16574	335	2	.	.	PUNCT
ihlr-16574	335	3	national	national	PROPN
ihlr-16574	335	4	nanotechnology	nanotechnology	PROPN
ihlr-16574	335	5	initiative	initiative	NOUN
ihlr-16574	335	6	,	,	PUNCT
ihlr-16574	335	7	http://www.nano.gov/h1m1/about/funding.html	http://www.nano.gov/h1m1/about/funding.html	PUNCT
ihlr-16574	335	8	(	(	PUNCT
ihlr-16574	335	9	last	last	ADJ
ihlr-16574	335	10	visited	visit	VERB
ihlr-16574	335	11	jan	jan	PROPN
ihlr-16574	335	12	.	.	PROPN
ihlr-16574	335	13	16	16	NUM
ihlr-16574	335	14	,	,	PUNCT
ihlr-16574	335	15	2009	2009	NUM
ihlr-16574	335	16	)	)	PUNCT
ihlr-16574	335	17	.	.	PUNCT
ihlr-16574	336	1	2010	2010	NUM
ihlr-16574	336	2	]	]	PUNCT
ihlr-16574	336	3	nanomedicine	nanomedicine	PROPN
ihlr-16574	336	4	nni	nni	PROPN
ihlr-16574	336	5	budget	budget	PROPN
ihlr-16574	336	6	100'7-:z~	100'7-:z~	PROPN
ihlr-16574	336	7	services	service	NOUN
ihlr-16574	336	8	(	(	PUNCT
ihlr-16574	336	9	national	national	ADJ
ihlr-16574	336	10	institutes	institutes	PROPN
ihlr-16574	336	11	of	of	ADP
ihlr-16574	336	12	health	health	PROPN
ihlr-16574	336	13	department	department	PROPN
ihlr-16574	336	14	of	of	ADP
ihlr-16574	336	15	commerce	commerce	PROPN
ihlr-16574	336	16	(	(	PUNCT
ihlr-16574	336	17	national	national	PROPN
ihlr-16574	336	18	institute	institute	PROPN
ihlr-16574	336	19	of	of	ADP
ihlr-16574	336	20	standards	standard	NOUN
ihlr-16574	336	21	total	total	VERB
ihlr-16574	336	22	411	411	NUM
ihlr-16574	336	23	each	each	PRON
ihlr-16574	336	24	of	of	ADP
ihlr-16574	336	25	the	the	DET
ihlr-16574	336	26	above	above	ADJ
ihlr-16574	336	27	organizations	organization	NOUN
ihlr-16574	336	28	has	have	VERB
ihlr-16574	336	29	some	some	DET
ihlr-16574	336	30	budget	budget	NOUN
ihlr-16574	336	31	/	/	SYM
ihlr-16574	336	32	investment	investment	NOUN
ihlr-16574	336	33	opera­	opera­	NOUN
ihlr-16574	336	34	tions	tion	NOUN
ihlr-16574	336	35	set	set	VERB
ihlr-16574	336	36	aside	aside	ADV
ihlr-16574	336	37	for	for	ADP
ihlr-16574	336	38	nanotechnology	nanotechnology	NOUN
ihlr-16574	336	39	research	research	NOUN
ihlr-16574	336	40	and	and	CCONJ
ihlr-16574	336	41	development.100	development.100	PROPN
ihlr-16574	336	42	to	to	PART
ihlr-16574	336	43	qualify	qualify	VERB
ihlr-16574	336	44	for	for	ADP
ihlr-16574	336	45	funding	fund	VERB
ihlr-16574	336	46	an	an	DET
ihlr-16574	336	47	organization	organization	NOUN
ihlr-16574	336	48	must	must	AUX
ihlr-16574	336	49	have	have	VERB
ihlr-16574	336	50	a	a	DET
ihlr-16574	336	51	budget	budget	NOUN
ihlr-16574	336	52	/	/	SYM
ihlr-16574	336	53	investment	investment	NOUN
ihlr-16574	336	54	included	include	VERB
ihlr-16574	336	55	under	under	ADP
ihlr-16574	336	56	eight	eight	NUM
ihlr-16574	336	57	categories	category	NOUN
ihlr-16574	336	58	outlined	outline	VERB
ihlr-16574	336	59	in	in	ADP
ihlr-16574	336	60	the	the	DET
ihlr-16574	336	61	nni	nni	PROPN
ihlr-16574	336	62	strategic	strategic	ADJ
ihlr-16574	336	63	plan.101	plan.101	NOUN
ihlr-16574	336	64	in	in	ADP
ihlr-16574	336	65	addition	addition	NOUN
ihlr-16574	336	66	to	to	ADP
ihlr-16574	336	67	nni	nni	PROPN
ihlr-16574	336	68	,	,	PUNCT
ihlr-16574	336	69	there	there	PRON
ihlr-16574	336	70	are	be	VERB
ihlr-16574	336	71	other	other	ADJ
ihlr-16574	336	72	,	,	PUNCT
ihlr-16574	336	73	lesser	less	ADJ
ihlr-16574	336	74	known	know	VERB
ihlr-16574	336	75	organizations	organization	NOUN
ihlr-16574	336	76	operat99	operat99	NOUN
ihlr-16574	336	77	.	.	PUNCT
ihlr-16574	337	1	national	national	PROPN
ihlr-16574	337	2	science	science	PROPN
ihlr-16574	337	3	&	&	CCONJ
ihlr-16574	337	4	technology	technology	PROPN
ihlr-16574	337	5	council	council	PROPN
ihlr-16574	337	6	,	,	PUNCT
ihlr-16574	337	7	national	national	PROPN
ihlr-16574	337	8	nanotechnology	nanotechnology	PROPN
ihlr-16574	337	9	initiative	initiative	NOUN
ihlr-16574	337	10	:	:	PUNCT
ihlr-16574	337	11	fy	fy	PROPN
ihlr-16574	337	12	2009	2009	NUM
ihlr-16574	337	13	budget	budget	NOUN
ihlr-16574	337	14	&	&	CCONJ
ihlr-16574	337	15	highlights	highlight	NOUN
ihlr-16574	337	16	1	1	NUM
ihlr-16574	337	17	,	,	PUNCT
ihlr-16574	337	18	available	available	ADJ
ihlr-16574	337	19	at	at	ADP
ihlr-16574	337	20	ht1p:/lwww.nano.gov	ht1p:/lwww.nano.gov	VERB
ihlr-16574	337	21	/	/	SYM
ihlr-16574	337	22	nni_fy09_budget	nni_fy09_budget	NOUN
ihlr-16574	337	23	_	_	PUNCT
ihlr-16574	337	24	summary.pdf(last	summary.pdf(last	ADV
ihlr-16574	337	25	visited	visit	VERB
ihlr-16574	337	26	february	february	PROPN
ihlr-16574	337	27	14	14	NUM
ihlr-16574	337	28	,	,	PUNCT
ihlr-16574	337	29	2010	2010	NUM
ihlr-16574	337	30	)	)	PUNCT
ihlr-16574	337	31	.	.	PUNCT
ihlr-16574	338	1	100	100	NUM
ihlr-16574	338	2	.	.	X
ihlr-16574	338	3	funding	funding	NOUN
ihlr-16574	338	4	,	,	PUNCT
ihlr-16574	338	5	http://www.nano.gov/html/about/funding.html	http://www.nano.gov/html/about/funding.html	PROPN
ihlr-16574	338	6	(	(	PUNCT
ihlr-16574	338	7	last	last	ADV
ihlr-16574	338	8	visited	visit	VERB
ihlr-16574	338	9	jan	jan	PROPN
ihlr-16574	338	10	..	..	PROPN
ihlr-16574	338	11	16	16	NUM
ihlr-16574	338	12	,	,	PUNCT
ihlr-16574	338	13	2009	2009	NUM
ihlr-16574	338	14	)	)	PUNCT
ihlr-16574	338	15	.	.	PUNCT
ihlr-16574	339	1	i	i	PRON
ihlr-16574	339	2	01	01	NUM
ihlr-16574	339	3	.	.	PUNCT
ihlr-16574	340	1	the	the	DET
ihlr-16574	340	2	eight	eight	NUM
ihlr-16574	340	3	program	program	NOUN
ihlr-16574	340	4	component	component	NOUN
ihlr-16574	340	5	areas	area	NOUN
ihlr-16574	340	6	include	include	VERB
ihlr-16574	340	7	:	:	PUNCT
ihlr-16574	340	8	1	1	X
ihlr-16574	340	9	)	)	PUNCT
ihlr-16574	340	10	fundamental	fundamental	ADJ
ihlr-16574	340	11	nanoscale	nanoscale	NOUN
ihlr-16574	340	12	phenomena	phenomenon	NOUN
ihlr-16574	340	13	and	and	CCONJ
ihlr-16574	340	14	process	process	NOUN
ihlr-16574	340	15	;	;	PUNCT
ihlr-16574	340	16	2	2	X
ihlr-16574	340	17	)	)	PUNCT
ihlr-16574	340	18	nanomaterials	nanomaterial	NOUN
ihlr-16574	340	19	;	;	PUNCT
ihlr-16574	340	20	3	3	X
ihlr-16574	340	21	)	)	PUNCT
ihlr-16574	340	22	nanoscale	nanoscale	NOUN
ihlr-16574	340	23	devices	device	NOUN
ihlr-16574	340	24	and	and	CCONJ
ihlr-16574	340	25	systems	system	NOUN
ihlr-16574	340	26	;	;	PUNCT
ihlr-16574	340	27	4	4	X
ihlr-16574	340	28	)	)	PUNCT
ihlr-16574	340	29	instrumentation	instrumentation	NOUN
ihlr-16574	340	30	re­	re­	PROPN
ihlr-16574	340	31	search	search	NOUN
ihlr-16574	340	32	,	,	PUNCT
ihlr-16574	340	33	meteorology	meteorology	NOUN
ihlr-16574	340	34	and	and	CCONJ
ihlr-16574	340	35	standards	standard	NOUN
ihlr-16574	340	36	for	for	ADP
ihlr-16574	340	37	nanotechnology	nanotechnology	NOUN
ihlr-16574	340	38	;	;	PUNCT
ihlr-16574	340	39	5	5	X
ihlr-16574	340	40	)	)	PUNCT
ihlr-16574	340	41	nanomanufacturing	nanomanufacture	VERB
ihlr-16574	340	42	;	;	PUNCT
ihlr-16574	340	43	6	6	X
ihlr-16574	340	44	)	)	PUNCT
ihlr-16574	340	45	major	major	ADJ
ihlr-16574	340	46	research	research	NOUN
ihlr-16574	340	47	facilities	facility	NOUN
ihlr-16574	340	48	and	and	CCONJ
ihlr-16574	340	49	instrumentation	instrumentation	NOUN
ihlr-16574	340	50	acquisition	acquisition	NOUN
ihlr-16574	340	51	;	;	PUNCT
ihlr-16574	340	52	7	7	X
ihlr-16574	340	53	)	)	PUNCT
ihlr-16574	340	54	environmental	environmental	ADJ
ihlr-16574	340	55	health	health	NOUN
ihlr-16574	340	56	and	and	CCONJ
ihlr-16574	340	57	safety	safety	NOUN
ihlr-16574	340	58	;	;	PUNCT
ihlr-16574	340	59	8)	8)	NUM
ihlr-16574	340	60	and	and	CCONJ
ihlr-16574	340	61	educational	educational	ADJ
ihlr-16574	340	62	and	and	CCONJ
ihlr-16574	340	63	societal	societal	ADJ
ihlr-16574	340	64	dimensions	dimension	NOUN
ihlr-16574	340	65	.	.	PUNCT
ihlr-16574	341	1	funding	funding	NOUN
ihlr-16574	341	2	strategy	strategy	NOUN
ihlr-16574	341	3	:	:	PUNCT
ihlr-16574	341	4	nn1	nn1	PROPN
ihlr-16574	341	5	program	program	NOUN
ihlr-16574	341	6	component	component	NOUN
ihlr-16574	341	7	areas	area	NOUN
ihlr-16574	341	8	,	,	PUNCT
ihlr-16574	341	9	http://www.nano.gov/html/aboutlfundingstrategy.html	http://www.nano.gov/html/aboutlfundingstrategy.html	PUNCT
ihlr-16574	341	10	(	(	PUNCT
ihlr-16574	341	11	last	last	ADV
ihlr-16574	341	12	visited	visit	VERB
ihlr-16574	341	13	jan	jan	PROPN
ihlr-16574	341	14	.	.	PROPN
ihlr-16574	341	15	16	16	NUM
ihlr-16574	341	16	,	,	PUNCT
ihlr-16574	341	17	2009	2009	NUM
ihlr-16574	341	18	)	)	PUNCT
ihlr-16574	341	19	.	.	PUNCT
ihlr-16574	342	1	412	412	NUM
ihlr-16574	342	2	indiana	indiana	PROPN
ihlr-16574	342	3	health	health	PROPN
ihlr-16574	342	4	law	law	PROPN
ihlr-16574	342	5	review	review	NOUN
ihlr-16574	342	6	[	[	X
ihlr-16574	342	7	vol	vol	NOUN
ihlr-16574	342	8	.	.	PUNCT
ihlr-16574	343	1	7:397	7:397	NUM
ihlr-16574	343	2	ing	ing	NOUN
ihlr-16574	343	3	in	in	ADP
ihlr-16574	343	4	the	the	DET
ihlr-16574	343	5	united	united	PROPN
ihlr-16574	343	6	states	states	PROPN
ihlr-16574	343	7	that	that	PRON
ihlr-16574	343	8	address	address	VERB
ihlr-16574	343	9	nanotechnology	nanotechnology	NOUN
ihlr-16574	343	10	.	.	PUNCT
ihlr-16574	344	1	the	the	DET
ihlr-16574	344	2	international	international	PROPN
ihlr-16574	344	3	association	association	PROPN
ihlr-16574	344	4	of	of	ADP
ihlr-16574	344	5	nanotechnology	nanotechnology	PROPN
ihlr-16574	344	6	(	(	PUNCT
ihlr-16574	344	7	ian	ian	PROPN
ihlr-16574	344	8	)	)	PUNCT
ihlr-16574	344	9	is	be	AUX
ihlr-16574	344	10	a	a	DET
ihlr-16574	344	11	non	non	ADJ
ihlr-16574	344	12	-	-	ADJ
ihlr-16574	344	13	profit	profit	ADJ
ihlr-16574	344	14	international	international	PROPN
ihlr-16574	344	15	organi­	organi­	PROPN
ihlr-16574	344	16	zation	zation	NOUN
ihlr-16574	344	17	based	base	VERB
ihlr-16574	344	18	in	in	ADP
ihlr-16574	344	19	california	california	PROPN
ihlr-16574	344	20	that	that	PRON
ihlr-16574	344	21	focuses	focus	VERB
ihlr-16574	344	22	on	on	ADP
ihlr-16574	344	23	promotion	promotion	NOUN
ihlr-16574	344	24	of	of	ADP
ihlr-16574	344	25	scientific	scientific	ADJ
ihlr-16574	344	26	and	and	CCONJ
ihlr-16574	344	27	busi­	busi­	PROPN
ihlr-16574	344	28	ness	ness	ADJ
ihlr-16574	344	29	development	development	NOUN
ihlr-16574	344	30	in	in	ADP
ihlr-16574	344	31	nanotechnology?02	nanotechnology?02	PROPN
ihlr-16574	344	32	in	in	ADP
ihlr-16574	344	33	contrast	contrast	NOUN
ihlr-16574	344	34	to	to	ADP
ihlr-16574	344	35	ian	ian	PROPN
ihlr-16574	344	36	's	's	PART
ihlr-16574	344	37	goals	goal	NOUN
ihlr-16574	344	38	for	for	ADP
ihlr-16574	344	39	nanotechnology	nanotechnology	NOUN
ihlr-16574	344	40	advancement	advancement	NOUN
ihlr-16574	344	41	,	,	PUNCT
ihlr-16574	344	42	the	the	DET
ihlr-16574	344	43	center	center	NOUN
ihlr-16574	344	44	for	for	ADP
ihlr-16574	344	45	responsible	responsible	ADJ
ihlr-16574	344	46	nanotechnology	nanotechnology	NOUN
ihlr-16574	344	47	(	(	PUNCT
ihlr-16574	344	48	crn	crn	PROPN
ihlr-16574	344	49	)	)	PUNCT
ihlr-16574	344	50	states	state	VERB
ihlr-16574	344	51	that	that	SCONJ
ihlr-16574	344	52	their	their	PRON
ihlr-16574	344	53	purpose	purpose	NOUN
ihlr-16574	344	54	is	be	AUX
ihlr-16574	344	55	''	''	PUNCT
ihlr-16574	344	56	not	not	PART
ihlr-16574	344	57	to	to	PART
ihlr-16574	344	58	predict	predict	VERB
ihlr-16574	344	59	,	,	PUNCT
ihlr-16574	344	60	but	but	CCONJ
ihlr-16574	344	61	to	to	PART
ihlr-16574	344	62	prepare	prepare	VERB
ihlr-16574	344	63	;	;	PUNCT
ihlr-16574	344	64	not	not	PART
ihlr-16574	344	65	to	to	PART
ihlr-16574	344	66	de­	de­	VERB
ihlr-16574	344	67	termine	termine	NOUN
ihlr-16574	344	68	exactly	exactly	ADV
ihlr-16574	344	69	when	when	SCONJ
ihlr-16574	344	70	and	and	CCONJ
ihlr-16574	344	71	how	how	SCONJ
ihlr-16574	344	72	nanotechnology	nanotechnology	NOUN
ihlr-16574	344	73	will	will	AUX
ihlr-16574	344	74	enable	enable	VERB
ihlr-16574	344	75	disruptive	disruptive	ADJ
ihlr-16574	344	76	mole­	mole­	NOUN
ihlr-16574	344	77	cular	cular	ADJ
ihlr-16574	344	78	manufacturing	manufacturing	NOUN
ihlr-16574	344	79	,	,	PUNCT
ihlr-16574	344	80	but	but	CCONJ
ihlr-16574	344	81	to	to	PART
ihlr-16574	344	82	stimulate	stimulate	VERB
ihlr-16574	344	83	effective	effective	ADJ
ihlr-16574	344	84	preparation	preparation	NOUN
ihlr-16574	344	85	for	for	ADP
ihlr-16574	344	86	it	it	PRON
ihlr-16574	344	87	,	,	PUNCT
ihlr-16574	344	88	whenever	whenever	SCONJ
ihlr-16574	344	89	and	and	CCONJ
ihlr-16574	344	90	however	however	ADV
ihlr-16574	344	91	it	it	PRON
ihlr-16574	344	92	comes	come	VERB
ihlr-16574	344	93	.	.	PUNCT
ihlr-16574	345	1	"	"	PUNCT
ihlr-16574	345	2	103	103	NUM
ihlr-16574	345	3	unlike	unlike	ADP
ihlr-16574	345	4	other	other	ADJ
ihlr-16574	345	5	previously	previously	ADV
ihlr-16574	345	6	discussed	discuss	VERB
ihlr-16574	345	7	agencies	agency	NOUN
ihlr-16574	345	8	,	,	PUNCT
ihlr-16574	345	9	crn	crn	PROPN
ihlr-16574	345	10	is	be	AUX
ihlr-16574	345	11	deeply	deeply	ADV
ihlr-16574	345	12	concerned	concerned	ADJ
ihlr-16574	345	13	about	about	ADP
ihlr-16574	345	14	the	the	DET
ihlr-16574	345	15	risks	risk	NOUN
ihlr-16574	345	16	associated	associate	VERB
ihlr-16574	345	17	with	with	ADP
ihlr-16574	345	18	nanotechnolo­	nanotechnolo­	PROPN
ihlr-16574	345	19	gy	gy	PROPN
ihlr-16574	345	20	.	.	PROPN
ihlr-16574	345	21	104	104	NUM
ihlr-16574	345	22	crn	crn	NOUN
ihlr-16574	345	23	attempts	attempt	VERB
ihlr-16574	345	24	,	,	PUNCT
ihlr-16574	345	25	however	however	ADV
ihlr-16574	345	26	,	,	PUNCT
ihlr-16574	345	27	to	to	PART
ihlr-16574	345	28	balance	balance	VERB
ihlr-16574	345	29	these	these	DET
ihlr-16574	345	30	risks	risk	NOUN
ihlr-16574	345	31	against	against	ADP
ihlr-16574	345	32	the	the	DET
ihlr-16574	345	33	backdrop	backdrop	NOUN
ihlr-16574	345	34	of	of	ADP
ihlr-16574	345	35	"	"	PUNCT
ihlr-16574	345	36	cautious	cautious	ADJ
ihlr-16574	345	37	optimism	optimism	NOUN
ihlr-16574	345	38	.	.	PUNCT
ihlr-16574	346	1	"	"	PUNCT
ihlr-16574	346	2	105	105	NUM
ihlr-16574	346	3	4	4	NUM
ihlr-16574	346	4	.	.	PUNCT
ihlr-16574	347	1	opposition	opposition	NOUN
ihlr-16574	347	2	to	to	ADP
ihlr-16574	347	3	nanotechnology	nanotechnology	PROPN
ihlr-16574	347	4	research	research	NOUN
ihlr-16574	347	5	and	and	CCONJ
ihlr-16574	347	6	development	development	NOUN
ihlr-16574	347	7	in	in	ADP
ihlr-16574	347	8	the	the	DET
ihlr-16574	347	9	united	united	PROPN
ihlr-16574	347	10	states	states	PROPN
ihlr-16574	347	11	though	though	SCONJ
ihlr-16574	347	12	nanotechnology	nanotechnology	PROPN
ihlr-16574	347	13	and	and	CCONJ
ihlr-16574	347	14	nanomedicine	nanomedicine	NOUN
ihlr-16574	347	15	have	have	VERB
ihlr-16574	347	16	many	many	ADJ
ihlr-16574	347	17	supporters	supporter	NOUN
ihlr-16574	347	18	there	there	PRON
ihlr-16574	347	19	are	be	VERB
ihlr-16574	347	20	other	other	ADJ
ihlr-16574	347	21	groups	group	NOUN
ihlr-16574	347	22	in	in	ADP
ihlr-16574	347	23	the	the	DET
ihlr-16574	347	24	united	united	PROPN
ihlr-16574	347	25	states	states	PROPN
ihlr-16574	347	26	that	that	PRON
ihlr-16574	347	27	are	be	AUX
ihlr-16574	347	28	opposed	oppose	VERB
ihlr-16574	347	29	to	to	PART
ihlr-16574	347	30	nanotechnol­	nanotechnol­	VERB
ihlr-16574	347	31	ogy	ogy	NOUN
ihlr-16574	347	32	research	research	NOUN
ihlr-16574	347	33	and	and	CCONJ
ihlr-16574	347	34	development.106	development.106	PRON
ihlr-16574	347	35	at	at	ADP
ihlr-16574	347	36	the	the	DET
ihlr-16574	347	37	forefront	forefront	NOUN
ihlr-16574	347	38	of	of	ADP
ihlr-16574	347	39	opposition	opposition	NOUN
ihlr-16574	347	40	to	to	ADP
ihlr-16574	347	41	nano­	nano­	PROPN
ihlr-16574	347	42	technology	technology	NOUN
ihlr-16574	347	43	is	be	AUX
ihlr-16574	347	44	the	the	DET
ihlr-16574	347	45	etc	etc	X
ihlr-16574	347	46	group	group	NOUN
ihlr-16574	347	47	action	action	NOUN
ihlr-16574	347	48	group	group	NOUN
ihlr-16574	347	49	on	on	ADP
ihlr-16574	347	50	erosion	erosion	NOUN
ihlr-16574	347	51	,	,	PUNCT
ihlr-16574	347	52	technology	technology	NOUN
ihlr-16574	347	53	and	and	CCONJ
ihlr-16574	347	54	concentration	concentration	NOUN
ihlr-16574	347	55	(	(	PUNCT
ihlr-16574	347	56	name	name	NOUN
ihlr-16574	347	57	to	to	PART
ihlr-16574	347	58	be	be	AUX
ihlr-16574	347	59	pronounced	pronounce	VERB
ihlr-16574	347	60	"	"	PUNCT
ihlr-16574	347	61	et	et	NOUN
ihlr-16574	347	62	cetera").107	cetera").107	VERB
ihlr-16574	347	63	the	the	DET
ihlr-16574	347	64	"	"	PUNCT
ihlr-16574	347	65	etc	etc	X
ihlr-16574	347	66	group	group	NOUN
ihlr-16574	347	67	is	be	AUX
ihlr-16574	347	68	dedicated	dedicate	VERB
ihlr-16574	347	69	to	to	ADP
ihlr-16574	347	70	the	the	DET
ihlr-16574	347	71	conservation	conservation	NOUN
ihlr-16574	347	72	and	and	CCONJ
ihlr-16574	347	73	sustainable	sustainable	ADJ
ihlr-16574	347	74	advancement	advancement	NOUN
ihlr-16574	347	75	of	of	ADP
ihlr-16574	347	76	cultural	cultural	ADJ
ihlr-16574	347	77	and	and	CCONJ
ihlr-16574	347	78	ecological	ecological	ADJ
ihlr-16574	347	79	diversity	diversity	NOUN
ihlr-16574	347	80	and	and	CCONJ
ihlr-16574	347	81	human	human	ADJ
ihlr-16574	347	82	rights	right	NOUN
ihlr-16574	347	83	.	.	PUNCT
ihlr-16574	348	1	"	"	PUNCT
ihlr-16574	348	2	108	108	NUM
ihlr-16574	348	3	deeply	deeply	ADV
ihlr-16574	348	4	concerned	concerned	ADJ
ihlr-16574	348	5	about	about	ADP
ihlr-16574	348	6	the	the	DET
ihlr-16574	348	7	neg­	neg­	ADJ
ihlr-16574	348	8	ative	ative	ADJ
ihlr-16574	348	9	impacts	impact	NOUN
ihlr-16574	348	10	and	and	CCONJ
ihlr-16574	348	11	effects	effect	NOUN
ihlr-16574	348	12	of	of	ADP
ihlr-16574	348	13	nanotechnology	nanotechnology	NOUN
ihlr-16574	348	14	,	,	PUNCT
ihlr-16574	348	15	the	the	DET
ihlr-16574	348	16	etc	etc	X
ihlr-16574	348	17	group	group	NOUN
ihlr-16574	348	18	is	be	AUX
ihlr-16574	348	19	calling	call	VERB
ihlr-16574	348	20	for	for	ADP
ihlr-16574	348	21	an	an	DET
ihlr-16574	348	22	evaluation	evaluation	NOUN
ihlr-16574	348	23	of	of	ADP
ihlr-16574	348	24	the	the	DET
ihlr-16574	348	25	"	"	PUNCT
ihlr-16574	348	26	social	social	ADJ
ihlr-16574	348	27	implications	implication	NOUN
ihlr-16574	348	28	of	of	ADP
ihlr-16574	348	29	all	all	DET
ihlr-16574	348	30	nanotechnologies	nanotechnology	NOUN
ihlr-16574	348	31	,	,	PUNCT
ihlr-16574	348	32	"	"	PUNCT
ihlr-16574	348	33	and	and	CCONJ
ihlr-16574	348	34	ar­	ar­	ADJ
ihlr-16574	348	35	gues	gue	NOUN
ihlr-16574	348	36	that	that	PRON
ihlr-16574	348	37	"	"	PUNCT
ihlr-16574	348	38	in	in	ADP
ihlr-16574	348	39	the	the	DET
ihlr-16574	348	40	meantime	meantime	NOUN
ihlr-16574	348	41	•	•	NOUN
ihlr-16574	348	42	..	..	PUNCT
ihlr-16574	348	43	a	a	DET
ihlr-16574	348	44	moratorium	moratorium	NOUN
ihlr-16574	348	45	should	should	AUX
ihlr-16574	348	46	be	be	AUX
ihlr-16574	348	47	placed	place	VERB
ihlr-16574	348	48	on	on	ADP
ihlr-16574	348	49	research	research	NOUN
ihlr-16574	348	50	involving	involve	VERB
ihlr-16574	348	51	molecular	molecular	ADJ
ihlr-16574	348	52	self	self	NOUN
ihlr-16574	348	53	-	-	PUNCT
ihlr-16574	348	54	assembly	assembly	NOUN
ihlr-16574	348	55	and	and	CCONJ
ihlr-16574	348	56	self	self	NOUN
ihlr-16574	348	57	-	-	PUNCT
ihlr-16574	348	58	replication	replication	NOUN
ihlr-16574	348	59	.	.	PUNCT
ihlr-16574	349	1	"109	"109	VERB
ihlr-16574	349	2	the	the	DET
ihlr-16574	349	3	etc	etc	NOUN
ihlr-16574	349	4	group	group	NOUN
ihlr-16574	349	5	's	's	PART
ihlr-16574	349	6	skepticism	skepticism	NOUN
ihlr-16574	349	7	about	about	ADP
ihlr-16574	349	8	nanotechnology	nanotechnology	NOUN
ihlr-16574	349	9	is	be	AUX
ihlr-16574	349	10	motivated	motivate	VERB
ihlr-16574	349	11	by	by	ADP
ihlr-16574	349	12	a	a	DET
ihlr-16574	349	13	102	102	NUM
ihlr-16574	349	14	.	.	PUNCT
ihlr-16574	350	1	international	international	ADJ
ihlr-16574	350	2	association	association	PROPN
ihlr-16574	350	3	of	of	ADP
ihlr-16574	350	4	nanotechnology	nanotechnology	PROPN
ihlr-16574	350	5	,	,	PUNCT
ihlr-16574	350	6	http://www.ianano.org	http://www.ianano.org	PUNCT
ihlr-16574	350	7	(	(	PUNCT
ihlr-16574	350	8	last	last	ADV
ihlr-16574	350	9	visited	visit	VERB
ihlr-16574	350	10	nov	nov	PROPN
ihlr-16574	350	11	.	.	PROPN
ihlr-16574	350	12	2	2	NUM
ihlr-16574	350	13	,	,	PUNCT
ihlr-16574	350	14	2008	2008	NUM
ihlr-16574	350	15	)	)	PUNCT
ihlr-16574	350	16	.	.	PUNCT
ihlr-16574	351	1	103	103	NUM
ihlr-16574	351	2	.	.	PUNCT
ihlr-16574	351	3	center	center	NOUN
ihlr-16574	351	4	for	for	ADP
ihlr-16574	351	5	responsible	responsible	ADJ
ihlr-16574	351	6	nanotechnology	nanotechnology	NOUN
ihlr-16574	351	7	(	(	PUNCT
ihlr-16574	351	8	crn	crn	PROPN
ihlr-16574	351	9	)	)	PUNCT
ihlr-16574	351	10	,	,	PUNCT
ihlr-16574	351	11	http://\vww.cmano.org	http://\vww.cmano.org	PROPN
ihlr-16574	351	12	/	/	SYM
ihlr-16574	351	13	index.html	index.html	NOUN
ihlr-16574	351	14	(	(	PUNCT
ihlr-16574	351	15	last	last	ADV
ihlr-16574	351	16	visited	visit	VERB
ihlr-16574	351	17	nov	nov	PROPN
ihlr-16574	351	18	.	.	PROPN
ihlr-16574	351	19	2	2	NUM
ihlr-16574	351	20	,	,	PUNCT
ihlr-16574	351	21	2008	2008	NUM
ihlr-16574	351	22	)	)	PUNCT
ihlr-16574	351	23	.	.	PUNCT
ihlr-16574	352	1	104	104	NUM
ihlr-16574	352	2	.	.	PUNCT
ihlr-16574	353	1	i	i	PRON
ihlr-16574	354	1	d	d	PROPN
ihlr-16574	354	2	105	105	NUM
ihlr-16574	354	3	.	.	PUNCT
ihlr-16574	354	4	crn	crn	PROPN
ihlr-16574	354	5	,	,	PUNCT
ihlr-16574	354	6	"	"	PUNCT
ihlr-16574	354	7	issues	issue	NOUN
ihlr-16574	354	8	,	,	PUNCT
ihlr-16574	354	9	positions	position	NOUN
ihlr-16574	354	10	and	and	CCONJ
ihlr-16574	354	11	urgency	urgency	NOUN
ihlr-16574	354	12	in	in	ADP
ihlr-16574	354	13	nanotechnology	nanotechnology	NOUN
ihlr-16574	354	14	policy	policy	NOUN
ihlr-16574	354	15	,	,	PUNCT
ihlr-16574	354	16	"	"	PUNCT
ihlr-16574	354	17	http:/lwww.crnano.org	http:/lwww.crnano.org	PROPN
ihlr-16574	354	18	/	/	SYM
ihlr-16574	354	19	positions.htm	positions.htm	X
ihlr-16574	354	20	(	(	PUNCT
ihlr-16574	354	21	last	last	ADJ
ihlr-16574	354	22	visit	visit	NOUN
ihlr-16574	354	23	april21	april21	NOUN
ihlr-16574	354	24	,	,	PUNCT
ihlr-16574	354	25	2010	2010	NUM
ihlr-16574	354	26	)	)	PUNCT
ihlr-16574	354	27	.	.	PUNCT
ihlr-16574	355	1	106	106	NUM
ihlr-16574	355	2	.	.	PUNCT
ihlr-16574	355	3	''	''	PUNCT
ihlr-16574	356	1	[	[	X
ihlr-16574	356	2	t]he	t]he	X
ihlr-16574	356	3	prominence	prominence	NOUN
ihlr-16574	356	4	of	of	ADP
ihlr-16574	356	5	anti	anti	ADJ
ihlr-16574	356	6	-	-	ADJ
ihlr-16574	356	7	nanotechnology	nanotechnology	ADJ
ihlr-16574	356	8	activists	activist	NOUN
ihlr-16574	356	9	..	..	PUNCT
ihlr-16574	356	10	.in	.in	PUNCT
ihlr-16574	356	11	high	high	ADJ
ihlr-16574	356	12	-	-	PUNCT
ihlr-16574	356	13	level	level	NOUN
ihlr-16574	356	14	policy	policy	NOUN
ihlr-16574	356	15	debates	debate	NOUN
ihlr-16574	356	16	around	around	ADP
ihlr-16574	356	17	the	the	DET
ihlr-16574	356	18	application	application	NOUN
ihlr-16574	356	19	of	of	ADP
ihlr-16574	356	20	nano	nano	NOUN
ihlr-16574	356	21	-	-	PUNCT
ihlr-16574	356	22	engineering	engineering	NOUN
ihlr-16574	356	23	to	to	ADP
ihlr-16574	356	24	the	the	DET
ihlr-16574	356	25	fight	fight	NOUN
ihlr-16574	356	26	against	against	ADP
ihlr-16574	356	27	global	global	ADJ
ihlr-16574	356	28	warming	warming	NOUN
ihlr-16574	356	29	arguably	arguably	ADV
ihlr-16574	356	30	slowed	slow	VERB
ihlr-16574	356	31	the	the	DET
ihlr-16574	356	32	federal	federal	ADJ
ihlr-16574	356	33	government	government	NOUN
ihlr-16574	356	34	's	's	PART
ihlr-16574	356	35	willingness	willingness	NOUN
ihlr-16574	356	36	to	to	PART
ihlr-16574	356	37	underwrite	underwrite	VERB
ihlr-16574	356	38	such	such	ADJ
ihlr-16574	356	39	research	research	NOUN
ihlr-16574	356	40	.	.	PUNCT
ihlr-16574	356	41	"	"	PUNCT
ihlr-16574	357	1	nanowerk	nanowerk	NOUN
ihlr-16574	357	2	,	,	PUNCT
ihlr-16574	357	3	nano	nano	NOUN
ihlr-16574	357	4	tomorrowsscenario	tomorrowsscenario	NOUN
ihlr-16574	357	5	4	4	NUM
ihlr-16574	357	6	"	"	PUNCT
ihlr-16574	357	7	presidential	presidential	ADJ
ihlr-16574	357	8	commission	commission	NOUN
ihlr-16574	357	9	on	on	ADP
ihlr-16574	357	10	molecular	molecular	ADJ
ihlr-16574	357	11	manufacturing	manufacturing	NOUN
ihlr-16574	357	12	analysis	analysis	NOUN
ihlr-16574	357	13	:	:	PUNCT
ihlr-16574	357	14	origins	origin	NOUN
ihlr-16574	357	15	of	of	ADP
ihlr-16574	357	16	the	the	DET
ihlr-16574	357	17	present	present	ADJ
ihlr-16574	357	18	crisis	crisis	NOUN
ihlr-16574	357	19	,	,	PUNCT
ihlr-16574	357	20	"	"	PUNCT
ihlr-16574	357	21	available	available	ADJ
ihlr-16574	357	22	at	at	ADP
ihlr-16574	357	23	http://www.nanowerlc.comlnanotechnologylnano	http://www.nanowerlc.comlnanotechnologylnano	PROPN
ihlr-16574	357	24	_	_	PROPN
ihlr-16574	357	25	tomorrows_scenario4.html	tomorrows_scenario4.html	PROPN
ihlr-16574	357	26	(	(	PUNCT
ihlr-16574	357	27	last	last	ADV
ihlr-16574	357	28	visited	visit	VERB
ihlr-16574	357	29	nov	nov	PROPN
ihlr-16574	357	30	.	.	PROPN
ihlr-16574	357	31	2	2	NUM
ihlr-16574	357	32	,	,	PUNCT
ihlr-16574	357	33	2008	2008	NUM
ihlr-16574	357	34	)	)	PUNCT
ihlr-16574	357	35	.	.	PUNCT
ihlr-16574	358	1	107	107	NUM
ihlr-16574	358	2	.	.	PUNCT
ihlr-16574	359	1	etc	etc	X
ihlr-16574	359	2	group	group	NOUN
ihlr-16574	359	3	,	,	PUNCT
ihlr-16574	359	4	about	about	ADP
ihlr-16574	359	5	etc	etc	X
ihlr-16574	359	6	group	group	NOUN
ihlr-16574	359	7	,	,	PUNCT
ihlr-16574	359	8	http://www.etcgroup.orglenlabout/	http://www.etcgroup.orglenlabout/	PROPN
ihlr-16574	359	9	(	(	PUNCT
ihlr-16574	359	10	last	last	ADV
ihlr-16574	359	11	visited	visit	VERB
ihlr-16574	359	12	nov	nov	PROPN
ihlr-16574	359	13	.	.	PROPN
ihlr-16574	359	14	2	2	NUM
ihlr-16574	359	15	,	,	PUNCT
ihlr-16574	359	16	2008	2008	NUM
ihlr-16574	359	17	)	)	PUNCT
ihlr-16574	360	1	[	[	X
ihlr-16574	360	2	hereinafter	hereinafter	NOUN
ihlr-16574	360	3	about	about	ADP
ihlr-16574	360	4	etc	etc	X
ihlr-16574	360	5	]	]	X
ihlr-16574	360	6	.	.	PUNCT
ihlr-16574	360	7	·	·	PUNCT
ihlr-16574	361	1	108	108	NUM
ihlr-16574	361	2	.	.	PUNCT
ihlr-16574	362	1	i	i	PRON
ihlr-16574	362	2	d	d	PROPN
ihlr-16574	362	3	109	109	NUM
ihlr-16574	362	4	.	.	PUNCT
ihlr-16574	363	1	etc	etc	X
ihlr-16574	363	2	group	group	NOUN
ihlr-16574	363	3	,	,	PUNCT
ihlr-16574	363	4	nanotechnology	nanotechnology	NOUN
ihlr-16574	363	5	,	,	PUNCT
ihlr-16574	363	6	http	http	CCONJ
ihlr-16574	363	7	:	:	PUNCT
ihlr-16574	363	8	llwww.etcgroup.org	llwww.etcgroup.org	ADJ
ihlr-16574	363	9	/	/	SYM
ihlr-16574	363	10	enf	enf	PROPN
ihlr-16574	363	11	~	~	SYM
ihlr-16574	363	12	logy.html	logy.html	PROPN
ihlr-16574	363	13	(	(	PUNCT
ihlr-16574	363	14	last	last	ADV
ihlr-16574	363	15	visited	visit	VERB
ihlr-16574	363	16	jan	jan	PROPN
ihlr-16574	363	17	.	.	PROPN
ihlr-16574	363	18	16	16	NUM
ihlr-16574	363	19	,	,	PUNCT
ihlr-16574	363	20	2009	2009	NUM
ihlr-16574	363	21	)	)	PUNCT
ihlr-16574	363	22	.	.	PUNCT
ihlr-16574	364	1	2010	2010	NUM
ihlr-16574	364	2	]	]	PUNCT
ihlr-16574	364	3	nanomedicine	nanomedicine	NOUN
ihlr-16574	364	4	413	413	NUM
ihlr-16574	364	5	desire	desire	NOUN
ihlr-16574	364	6	to	to	PART
ihlr-16574	364	7	protect	protect	VERB
ihlr-16574	364	8	underserved	underserved	ADJ
ihlr-16574	364	9	and	and	CCONJ
ihlr-16574	364	10	underrepresented	underrepresented	ADJ
ihlr-16574	364	11	members	member	NOUN
ihlr-16574	364	12	of	of	ADP
ihlr-16574	364	13	society	society	NOUN
ihlr-16574	364	14	.	.	PUNCT
ihlr-16574	365	1	110	110	NUM
ihlr-16574	365	2	specifically	specifically	ADV
ihlr-16574	365	3	,	,	PUNCT
ihlr-16574	365	4	they	they	PRON
ihlr-16574	365	5	posit	posit	VERB
ihlr-16574	365	6	that	that	SCONJ
ihlr-16574	365	7	nanomedicine	nanomedicine	NOUN
ihlr-16574	365	8	and	and	CCONJ
ihlr-16574	365	9	the	the	DET
ihlr-16574	365	10	large	large	ADJ
ihlr-16574	365	11	amounts	amount	NOUN
ihlr-16574	365	12	of	of	ADP
ihlr-16574	365	13	money	money	NOUN
ihlr-16574	365	14	poured	pour	VERB
ihlr-16574	365	15	into	into	ADP
ihlr-16574	365	16	its	its	PRON
ihlr-16574	365	17	research	research	NOUN
ihlr-16574	365	18	and	and	CCONJ
ihlr-16574	365	19	development	development	NOUN
ihlr-16574	365	20	primarily	primarily	ADV
ihlr-16574	365	21	benefits	benefit	VERB
ihlr-16574	365	22	the	the	DET
ihlr-16574	365	23	wealthy	wealthy	ADJ
ihlr-16574	365	24	.	.	PUNCT
ihlr-16574	365	25	111	111	NUM
ihlr-16574	365	26	if	if	SCONJ
ihlr-16574	365	27	nanomedicine	nanomedicine	NOUN
ihlr-16574	365	28	is	be	AUX
ihlr-16574	365	29	pursued	pursue	VERB
ihlr-16574	365	30	too	too	ADV
ihlr-16574	365	31	zealously	zealously	ADV
ihlr-16574	365	32	,	,	PUNCT
ihlr-16574	365	33	the	the	DET
ihlr-16574	365	34	etc	etc	X
ihlr-16574	365	35	group	group	NOUN
ihlr-16574	365	36	argues	argue	VERB
ihlr-16574	365	37	,	,	PUNCT
ihlr-16574	365	38	it	it	PRON
ihlr-16574	365	39	could	could	AUX
ihlr-16574	365	40	divert	divert	VERB
ihlr-16574	365	41	important	important	ADJ
ihlr-16574	365	42	funding	funding	NOUN
ihlr-16574	365	43	away	away	ADV
ihlr-16574	365	44	from	from	ADP
ihlr-16574	365	45	programs	program	NOUN
ihlr-16574	365	46	that	that	PRON
ihlr-16574	365	47	benefit	benefit	VERB
ihlr-16574	365	48	the	the	DET
ihlr-16574	365	49	underserved	underserved	ADJ
ihlr-16574	365	50	and	and	CCONJ
ihlr-16574	365	51	reduce	reduce	VERB
ihlr-16574	365	52	essential	essential	ADJ
ihlr-16574	365	53	health	health	NOUN
ihlr-16574	365	54	services	service	NOUN
ihlr-16574	365	55	already	already	ADV
ihlr-16574	365	56	suffering	suffer	VERB
ihlr-16574	365	57	from	from	ADP
ihlr-16574	365	58	a	a	DET
ihlr-16574	365	59	scarcity	scarcity	NOUN
ihlr-16574	365	60	of	of	ADP
ihlr-16574	365	61	re­	re­	PROPN
ihlr-16574	365	62	sources.112	sources.112	PROPN
ihlr-16574	365	63	b.	b.	PROPN
ihlr-16574	365	64	regulation	regulation	NOUN
ihlr-16574	365	65	in	in	ADP
ihlr-16574	365	66	the	the	DET
ihlr-16574	365	67	european	european	PROPN
ihlr-16574	365	68	union	union	PROPN
ihlr-16574	365	69	on	on	ADP
ihlr-16574	365	70	may	may	PROPN
ihlr-16574	365	71	12	12	NUM
ihlr-16574	365	72	,	,	PUNCT
ihlr-16574	365	73	2004	2004	NUM
ihlr-16574	365	74	the	the	DET
ihlr-16574	365	75	european	european	PROPN
ihlr-16574	365	76	union	union	PROPN
ihlr-16574	365	77	(	(	PUNCT
ihlr-16574	365	78	eu	eu	PROPN
ihlr-16574	365	79	)	)	PUNCT
ihlr-16574	365	80	,	,	PUNCT
ihlr-16574	365	81	through	through	ADP
ihlr-16574	365	82	the	the	DET
ihlr-16574	365	83	ec	ec	PROPN
ihlr-16574	365	84	,	,	PUNCT
ihlr-16574	365	85	issued	issue	VERB
ihlr-16574	365	86	an	an	DET
ihlr-16574	365	87	action	action	NOUN
ihlr-16574	365	88	entitled	entitle	VERB
ihlr-16574	365	89	"	"	PUNCT
ihlr-16574	365	90	towards	towards	ADP
ihlr-16574	365	91	a	a	DET
ihlr-16574	365	92	european	european	ADJ
ihlr-16574	365	93	strategy	strategy	NOUN
ihlr-16574	365	94	for	for	ADP
ihlr-16574	365	95	nanotechnology	nanotechnology	NOUN
ihlr-16574	365	96	.	.	PUNCT
ihlr-16574	366	1	"113	"113	PROPN
ihlr-16574	366	2	this	this	DET
ihlr-16574	366	3	action	action	NOUN
ihlr-16574	366	4	was	be	AUX
ihlr-16574	366	5	created	create	VERB
ihlr-16574	366	6	to	to	PART
ihlr-16574	366	7	tackle	tackle	VERB
ihlr-16574	366	8	specific	specific	ADJ
ihlr-16574	366	9	issues	issue	NOUN
ihlr-16574	366	10	in	in	ADP
ihlr-16574	366	11	regards	regard	NOUN
ihlr-16574	366	12	to	to	ADP
ihlr-16574	366	13	nanotechnolo­	nanotechnolo­	PROPN
ihlr-16574	366	14	gy	gy	NOUN
ihlr-16574	366	15	:	:	PUNCT
ihlr-16574	366	16	offer	offer	VERB
ihlr-16574	366	17	guidelines	guideline	NOUN
ihlr-16574	366	18	for	for	ADP
ihlr-16574	366	19	future	future	ADJ
ihlr-16574	366	20	policy	policy	NOUN
ihlr-16574	366	21	,	,	PUNCT
ihlr-16574	366	22	achieve	achieve	VERB
ihlr-16574	366	23	consumer	consumer	NOUN
ihlr-16574	366	24	confidence	confidence	NOUN
ihlr-16574	366	25	in	in	ADP
ihlr-16574	366	26	nano­	nano­	PROPN
ihlr-16574	366	27	technology	technology	NOUN
ihlr-16574	366	28	products	product	NOUN
ihlr-16574	366	29	,	,	PUNCT
ihlr-16574	366	30	avoid	avoid	VERB
ihlr-16574	366	31	health	health	NOUN
ihlr-16574	366	32	risks	risk	NOUN
ihlr-16574	366	33	,	,	PUNCT
ihlr-16574	366	34	create	create	VERB
ihlr-16574	366	35	conditions	condition	NOUN
ihlr-16574	366	36	for	for	ADP
ihlr-16574	366	37	responsible	responsible	ADJ
ihlr-16574	366	38	development	development	NOUN
ihlr-16574	366	39	of	of	ADP
ihlr-16574	366	40	the	the	DET
ihlr-16574	366	41	technology	technology	NOUN
ihlr-16574	366	42	,	,	PUNCT
ihlr-16574	366	43	and	and	CCONJ
ihlr-16574	366	44	above	above	ADP
ihlr-16574	366	45	all	all	PRON
ihlr-16574	366	46	,	,	PUNCT
ihlr-16574	366	47	attain	attain	VERB
ihlr-16574	366	48	these	these	DET
ihlr-16574	366	49	goals	goal	NOUN
ihlr-16574	366	50	with	with	ADP
ihlr-16574	366	51	the	the	DET
ihlr-16574	366	52	law	law	NOUN
ihlr-16574	366	53	already	already	ADV
ihlr-16574	366	54	in	in	ADP
ihlr-16574	366	55	existence.l14	existence.l14	NOUN
ihlr-16574	366	56	the	the	DET
ihlr-16574	366	57	use	use	NOUN
ihlr-16574	366	58	of	of	ADP
ihlr-16574	366	59	"	"	PUNCT
ihlr-16574	366	60	law	law	NOUN
ihlr-16574	366	61	all	all	ADV
ihlr-16574	366	62	ready	ready	ADJ
ihlr-16574	366	63	in	in	ADP
ihlr-16574	366	64	existence	existence	NOUN
ihlr-16574	366	65	"	"	PUNCT
ihlr-16574	366	66	seems	seem	VERB
ihlr-16574	366	67	strikingly	strikingly	ADV
ihlr-16574	366	68	similar	similar	ADJ
ihlr-16574	366	69	to	to	ADP
ihlr-16574	366	70	the	the	DET
ihlr-16574	366	71	fdaintf	fdaintf	NOUN
ihlr-16574	366	72	"	"	PUNCT
ihlr-16574	366	73	wait	wait	VERB
ihlr-16574	366	74	and	and	CCONJ
ihlr-16574	366	75	see	see	VERB
ihlr-16574	366	76	"	"	PUNCT
ihlr-16574	366	77	approach	approach	NOUN
ihlr-16574	366	78	to	to	ADP
ihlr-16574	366	79	nanotechnol­	nanotechnol­	VERB
ihlr-16574	366	80	ogy	ogy	NOUN
ihlr-16574	366	81	regulation	regulation	NOUN
ihlr-16574	366	82	.	.	PUNCT
ihlr-16574	367	1	1	1	X
ihlr-16574	367	2	.	.	X
ihlr-16574	367	3	current	current	ADJ
ihlr-16574	367	4	regulatory	regulatory	ADJ
ihlr-16574	367	5	scheme	scheme	NOUN
ihlr-16574	367	6	the	the	DET
ihlr-16574	367	7	eu	eu	PROPN
ihlr-16574	367	8	uses	use	VERB
ihlr-16574	367	9	legislative	legislative	ADJ
ihlr-16574	367	10	tools	tool	NOUN
ihlr-16574	367	11	called	call	VERB
ihlr-16574	367	12	"	"	PUNCT
ihlr-16574	367	13	directives	directive	NOUN
ihlr-16574	367	14	"	"	PUNCT
ihlr-16574	367	15	to	to	PART
ihlr-16574	367	16	obtain	obtain	VERB
ihlr-16574	367	17	overarching	overarching	ADJ
ihlr-16574	367	18	goals	goal	NOUN
ihlr-16574	367	19	within	within	ADP
ihlr-16574	367	20	each	each	DET
ihlr-16574	367	21	member	member	NOUN
ihlr-16574	367	22	state.115	state.115	PROPN
ihlr-16574	367	23	directives	directive	NOUN
ihlr-16574	367	24	are	be	AUX
ihlr-16574	367	25	not	not	PART
ihlr-16574	367	26	explicative	explicative	ADJ
ihlr-16574	367	27	of	of	ADP
ihlr-16574	367	28	the	the	DET
ihlr-16574	367	29	means	mean	NOUN
ihlr-16574	367	30	by	by	ADP
ihlr-16574	367	31	which	which	PRON
ihlr-16574	367	32	these	these	DET
ihlr-16574	367	33	goals	goal	NOUN
ihlr-16574	367	34	should	should	AUX
ihlr-16574	367	35	be	be	AUX
ihlr-16574	367	36	obtained	obtain	VERB
ihlr-16574	367	37	,	,	PUNCT
ihlr-16574	367	38	but	but	CCONJ
ihlr-16574	367	39	rather	rather	ADV
ihlr-16574	367	40	focus	focus	VERB
ihlr-16574	367	41	on	on	ADP
ihlr-16574	367	42	the	the	DET
ihlr-16574	367	43	out­	out­	NOUN
ihlr-16574	367	44	comes	come	VERB
ihlr-16574	367	45	and	and	CCONJ
ihlr-16574	367	46	goal	goal	NOUN
ihlr-16574	367	47	of	of	ADP
ihlr-16574	367	48	a	a	DET
ihlr-16574	367	49	directive.116	directive.116	NOUN
ihlr-16574	367	50	as	as	ADP
ihlr-16574	367	51	a	a	DET
ihlr-16574	367	52	result	result	NOUN
ihlr-16574	367	53	,	,	PUNCT
ihlr-16574	367	54	member	member	NOUN
ihlr-16574	367	55	states	state	NOUN
ihlr-16574	367	56	implement	implement	VERB
ihlr-16574	367	57	legislation	legislation	NOUN
ihlr-16574	367	58	at	at	ADP
ihlr-16574	367	59	the	the	DET
ihlr-16574	367	60	national	national	ADJ
ihlr-16574	367	61	level	level	NOUN
ihlr-16574	367	62	to	to	PART
ihlr-16574	367	63	achieve	achieve	VERB
ihlr-16574	367	64	directive	directive	NOUN
ihlr-16574	367	65	goals	goal	NOUN
ihlr-16574	367	66	over	over	ADP
ihlr-16574	367	67	a	a	DET
ihlr-16574	367	68	period	period	NOUN
ihlr-16574	367	69	of	of	ADP
ihlr-16574	367	70	time	time	NOUN
ihlr-16574	367	71	,	,	PUNCT
ihlr-16574	367	72	usually	usually	ADV
ihlr-16574	367	73	with	with	ADP
ihlr-16574	367	74	an	an	DET
ihlr-16574	367	75	articulated	articulated	ADJ
ihlr-16574	367	76	final	final	ADJ
ihlr-16574	367	77	deadline.117	deadline.117	NOUN
ihlr-16574	367	78	directives	directive	NOUN
ihlr-16574	367	79	are	be	AUX
ihlr-16574	367	80	not	not	PART
ihlr-16574	367	81	uni­	uni­	ADJ
ihlr-16574	367	82	form	form	NOUN
ihlr-16574	367	83	to	to	ADP
ihlr-16574	367	84	the	the	DET
ihlr-16574	367	85	entire	entire	ADJ
ihlr-16574	367	86	eu	eu	PROPN
ihlr-16574	367	87	,	,	PUNCT
ihlr-16574	367	88	and	and	CCONJ
ihlr-16574	367	89	can	can	AUX
ihlr-16574	367	90	apply	apply	VERB
ihlr-16574	367	91	to	to	ADP
ihlr-16574	367	92	all	all	PRON
ihlr-16574	367	93	or	or	CCONJ
ihlr-16574	367	94	only	only	ADV
ihlr-16574	367	95	some	some	DET
ihlr-16574	367	96	member	member	NOUN
ihlr-16574	367	97	states.118	states.118	VERB
ihlr-16574	367	98	"	"	PUNCT
ihlr-16574	367	99	directives	directive	NOUN
ihlr-16574	367	100	are	be	AUX
ihlr-16574	367	101	used	use	VERB
ihlr-16574	367	102	to	to	PART
ihlr-16574	367	103	bring	bring	VERB
ihlr-16574	367	104	different	different	ADJ
ihlr-16574	367	105	national	national	ADJ
ihlr-16574	367	106	laws	law	NOUN
ihlr-16574	367	107	into	into	ADP
ihlr-16574	367	108	line	line	NOUN
ihlr-16574	367	109	with	with	ADP
ihlr-16574	367	110	each	each	DET
ihlr-16574	367	111	oth110	oth110	PROPN
ihlr-16574	367	112	.	.	PUNCT
ihlr-16574	368	1	about	about	ADP
ihlr-16574	368	2	etc	etc	X
ihlr-16574	368	3	,	,	PUNCT
ihlr-16574	368	4	supra	supra	PROPN
ihlr-16574	368	5	note	note	VERB
ihlr-16574	368	6	107	107	NUM
ihlr-16574	368	7	.	.	NOUN
ihlr-16574	368	8	111	111	NUM
ihlr-16574	368	9	.	.	PUNCT
ihlr-16574	369	1	etc	etc	X
ihlr-16574	369	2	group	group	NOUN
ihlr-16574	369	3	,	,	PUNCT
ihlr-16574	369	4	nanotech	nanotech	PROPN
ihlr-16574	369	5	rx	rx	VERB
ihlr-16574	369	6	medical	medical	ADJ
ihlr-16574	369	7	applications	application	NOUN
ihlr-16574	369	8	of	of	ADP
ihlr-16574	369	9	nand	nand	ADJ
ihlr-16574	369	10	-	-	PUNCT
ihlr-16574	369	11	scale	scale	NOUN
ihlr-16574	369	12	technologies	technology	NOUN
ihlr-16574	369	13	:	:	PUNCT
ihlr-16574	369	14	what	what	DET
ihlr-16574	369	15	impact	impact	NOUN
ihlr-16574	369	16	on	on	ADP
ihlr-16574	369	17	marginalized	marginalize	VERB
ihlr-16574	369	18	communides	communide	NOUN
ihlr-16574	369	19	?	?	PUNCT
ihlr-16574	369	20	,	,	PUNCT
ihlr-16574	369	21	33	33	NUM
ihlr-16574	369	22	(	(	PUNCT
ihlr-16574	369	23	2006	2006	NUM
ihlr-16574	369	24	)	)	PUNCT
ihlr-16574	369	25	available	available	ADJ
ihlr-16574	369	26	at	at	ADP
ihlr-16574	369	27	http://www.etcgroup.orglupload/publication!593/01/etc06nanotechrx.pdf	http://www.etcgroup.orglupload/publication!593/01/etc06nanotechrx.pdf	CCONJ
ihlr-16574	369	28	.	.	PROPN
ihlr-16574	369	29	112	112	NUM
ihlr-16574	369	30	.	.	PUNCT
ihlr-16574	370	1	/d	/d	INTJ
ihlr-16574	370	2	.	.	PUNCT
ihlr-16574	371	1	at	at	ADP
ihlr-16574	371	2	31	31	NUM
ihlr-16574	371	3	-	-	SYM
ihlr-16574	371	4	35	35	NUM
ihlr-16574	371	5	.	.	NOUN
ihlr-16574	371	6	113	113	NUM
ihlr-16574	371	7	.	.	PUNCT
ihlr-16574	372	1	giorgia	giorgia	PROPN
ihlr-16574	372	2	guerra	guerra	PROPN
ihlr-16574	372	3	,	,	PUNCT
ihlr-16574	372	4	european	european	ADJ
ihlr-16574	372	5	regulatory	regulatory	ADJ
ihlr-16574	372	6	issues	issue	NOUN
ihlr-16574	372	7	in	in	ADP
ihlr-16574	372	8	nanomedicine	nanomedicine	ADJ
ihlr-16574	372	9	,	,	PUNCT
ihlr-16574	372	10	2	2	NUM
ihlr-16574	372	11	nanoethics	nanoethic	NOUN
ihlr-16574	372	12	87	87	NUM
ihlr-16574	372	13	,	,	PUNCT
ihlr-16574	372	14	87	87	NUM
ihlr-16574	372	15	(	(	PUNCT
ihlr-16574	372	16	2008	2008	NUM
ihlr-16574	372	17	)	)	PUNCT
ihlr-16574	372	18	;	;	PUNCT
ihlr-16574	372	19	see	see	VERB
ihlr-16574	372	20	also	also	ADV
ihlr-16574	372	21	european	european	PROPN
ihlr-16574	372	22	commission	commission	PROPN
ihlr-16574	372	23	,	,	PUNCT
ihlr-16574	372	24	the	the	DET
ihlr-16574	372	25	european	european	ADJ
ihlr-16574	372	26	strategy	strategy	NOUN
ihlr-16574	372	27	for	for	ADP
ihlr-16574	372	28	nanotechnology	nanotechnology	NOUN
ihlr-16574	372	29	and	and	CCONJ
ihlr-16574	372	30	the	the	DET
ihlr-16574	372	31	nanotechnology	nanotechnology	NOUN
ihlr-16574	372	32	action	action	NOUN
ihlr-16574	372	33	plan	plan	NOUN
ihlr-16574	372	34	,	,	PUNCT
ihlr-16574	372	35	http://cordis.europa.eu/nanotechnology/actionplan.htm	http://cordis.europa.eu/nanotechnology/actionplan.htm	PROPN
ihlr-16574	372	36	(	(	PUNCT
ihlr-16574	372	37	last	last	ADV
ihlr-16574	372	38	visited	visit	VERB
ihlr-16574	372	39	jan	jan	PROPN
ihlr-16574	372	40	.	.	PROPN
ihlr-16574	372	41	17	17	NUM
ihlr-16574	372	42	,	,	PUNCT
ihlr-16574	372	43	2009	2009	NUM
ihlr-16574	372	44	)	)	PUNCT
ihlr-16574	372	45	.	.	PUNCT
ihlr-16574	373	1	114	114	NUM
ihlr-16574	373	2	.	.	PUNCT
ihlr-16574	373	3	guerra	guerra	PROPN
ihlr-16574	373	4	,	,	PUNCT
ihlr-16574	373	5	supra	supra	PROPN
ihlr-16574	373	6	note	note	PROPN
ihlr-16574	373	7	113	113	NUM
ihlr-16574	373	8	,	,	PUNCT
ihlr-16574	373	9	at	at	ADP
ihlr-16574	373	10	87	87	NUM
ihlr-16574	373	11	.	.	PUNCT
ihlr-16574	374	1	(	(	PUNCT
ihlr-16574	374	2	emphasis	emphasis	NOUN
ihlr-16574	374	3	added	add	VERB
ihlr-16574	374	4	)	)	PUNCT
ihlr-16574	374	5	.	.	PUNCT
ihlr-16574	375	1	115	115	NUM
ihlr-16574	375	2	.	.	PUNCT
ihlr-16574	376	1	european	european	PROPN
ihlr-16574	376	2	commission	commission	PROPN
ihlr-16574	376	3	,	,	PUNCT
ihlr-16574	376	4	how	how	SCONJ
ihlr-16574	376	5	eu	eu	PROPN
ihlr-16574	376	6	law	law	NOUN
ihlr-16574	376	7	is	be	AUX
ihlr-16574	376	8	appliednational	appliednational	ADJ
ihlr-16574	376	9	implementation	implementation	NOUN
ihlr-16574	376	10	ofeu	ofeu	VERB
ihlr-16574	376	11	directives	directive	NOUN
ihlr-16574	376	12	,	,	PUNCT
ihlr-16574	376	13	http	http	ADJ
ihlr-16574	376	14	:	:	PUNCT
ihlr-16574	376	15	l	l	NOUN
ihlr-16574	376	16	/	/	SYM
ihlr-16574	376	17	ec.europa.eulcommunity	ec.europa.eulcommunity	NOUN
ihlr-16574	376	18	_	_	NOUN
ihlr-16574	376	19	law	law	NOUN
ihlr-16574	376	20	/	/	SYM
ihlr-16574	376	21	directives	directive	NOUN
ihlr-16574	376	22	/	/	SYM
ihlr-16574	376	23	directives	directive	NOUN
ihlr-16574	376	24	_	_	SYM
ihlr-16574	377	1	en.htm	en.htm	PROPN
ihlr-16574	377	2	(	(	PUNCT
ihlr-16574	377	3	last	last	ADV
ihlr-16574	377	4	visited	visit	VERB
ihlr-16574	377	5	jan	jan	PROPN
ihlr-16574	377	6	.	.	PROPN
ihlr-16574	377	7	1"7	1"7	NUM
ihlr-16574	377	8	,	,	PUNCT
ihlr-16574	377	9	2009	2009	NUM
ihlr-16574	377	10	)	)	PUNCT
ihlr-16574	377	11	(	(	PUNCT
ihlr-16574	377	12	explaining	explain	VERB
ihlr-16574	377	13	the	the	DET
ihlr-16574	377	14	function	function	NOUN
ihlr-16574	377	15	and	and	CCONJ
ihlr-16574	377	16	purpose	purpose	NOUN
ihlr-16574	377	17	of	of	ADP
ihlr-16574	377	18	eu	eu	PROPN
ihlr-16574	377	19	directives	directive	NOUN
ihlr-16574	377	20	)	)	PUNCT
ihlr-16574	377	21	.	.	PUNCT
ihlr-16574	378	1	116	116	NUM
ihlr-16574	378	2	.	.	PUNCT
ihlr-16574	378	3	!	!	PUNCT
ihlr-16574	379	1	d.	d.	PROPN
ihlr-16574	379	2	117	117	NUM
ihlr-16574	379	3	.	.	PUNCT
ihlr-16574	380	1	/d	/d	PUNCT
ihlr-16574	380	2	.	.	PUNCT
ihlr-16574	381	1	118	118	NUM
ihlr-16574	381	2	.	.	PUNCT
ihlr-16574	382	1	/d	/d	PUNCT
ihlr-16574	382	2	.	.	PUNCT
ihlr-16574	383	1	414	414	NUM
ihlr-16574	383	2	indiana	indiana	PROPN
ihlr-16574	383	3	health	health	PROPN
ihlr-16574	383	4	law	law	PROPN
ihlr-16574	383	5	review	review	NOUN
ihlr-16574	383	6	[	[	X
ihlr-16574	383	7	vol	vol	NOUN
ihlr-16574	383	8	.	.	PUNCT
ihlr-16574	384	1	7:397	7:397	NUM
ihlr-16574	384	2	er	er	INTJ
ihlr-16574	384	3	,	,	PUNCT
ihlr-16574	384	4	and	and	CCONJ
ihlr-16574	384	5	are	be	AUX
ihlr-16574	384	6	particularly	particularly	ADV
ihlr-16574	384	7	common	common	ADJ
ihlr-16574	384	8	in	in	ADP
ihlr-16574	384	9	matters	matter	NOUN
ihlr-16574	384	10	that	that	PRON
ihlr-16574	384	11	affect	affect	VERB
ihlr-16574	384	12	the	the	DET
ihlr-16574	384	13	operation	operation	NOUN
ihlr-16574	384	14	of	of	ADP
ihlr-16574	384	15	the	the	DET
ihlr-16574	384	16	single	single	ADJ
ihlr-16574	384	17	market	market	NOUN
ihlr-16574	384	18	(	(	PUNCT
ihlr-16574	384	19	e.g.	e.g.	ADV
ihlr-16574	384	20	product	product	NOUN
ihlr-16574	384	21	safety	safety	NOUN
ihlr-16574	384	22	standards)."119	standards)."119	NOUN
ihlr-16574	384	23	"	"	PUNCT
ihlr-16574	384	24	nanobiotechnological	nanobiotechnological	ADJ
ihlr-16574	384	25	''	''	PUNCT
ihlr-16574	384	26	compositions	composition	NOUN
ihlr-16574	384	27	(	(	PUNCT
ihlr-16574	384	28	as	as	SCONJ
ihlr-16574	384	29	they	they	PRON
ihlr-16574	384	30	are	be	AUX
ihlr-16574	384	31	called	call	VERB
ihlr-16574	384	32	in	in	ADP
ihlr-16574	384	33	the	the	DET
ihlr-16574	384	34	eu	eu	NOUN
ihlr-16574	384	35	)	)	PUNCT
ihlr-16574	384	36	generally	generally	ADV
ihlr-16574	384	37	are	be	AUX
ihlr-16574	384	38	considered	consider	VERB
ihlr-16574	384	39	to	to	PART
ihlr-16574	384	40	fall	fall	VERB
ihlr-16574	384	41	under	under	ADP
ihlr-16574	384	42	three	three	NUM
ihlr-16574	384	43	preexisting	preexist	VERB
ihlr-16574	384	44	directive	directive	NOUN
ihlr-16574	384	45	frame­	frame­	NOUN
ihlr-16574	384	46	works.120	works.120	PRON
ihlr-16574	384	47	the	the	DET
ihlr-16574	384	48	first	first	ADJ
ihlr-16574	384	49	is	be	AUX
ihlr-16574	384	50	directive	directive	ADJ
ihlr-16574	384	51	90/385	90/385	NUM
ihlr-16574	384	52	/	/	SYM
ihlr-16574	384	53	eec	eec	PROPN
ihlr-16574	384	54	which	which	PRON
ihlr-16574	384	55	relates	relate	VERB
ihlr-16574	384	56	to	to	ADP
ihlr-16574	384	57	active	active	ADJ
ihlr-16574	384	58	implan­	implan­	NOUN
ihlr-16574	384	59	table	table	NOUN
ihlr-16574	384	60	medical	medical	ADJ
ihlr-16574	384	61	devices.121	devices.121	VERB
ihlr-16574	384	62	a	a	DET
ihlr-16574	384	63	product	product	NOUN
ihlr-16574	384	64	falls	fall	VERB
ihlr-16574	384	65	under	under	ADP
ihlr-16574	384	66	this	this	DET
ihlr-16574	384	67	directive	directive	NOUN
ihlr-16574	384	68	if	if	SCONJ
ihlr-16574	384	69	it	it	PRON
ihlr-16574	384	70	is	be	AUX
ihlr-16574	384	71	a	a	DET
ihlr-16574	384	72	"	"	PUNCT
ihlr-16574	384	73	medical	medical	ADJ
ihlr-16574	384	74	device	device	NOUN
ihlr-16574	384	75	"	"	PUNCT
ihlr-16574	384	76	and	and	CCONJ
ihlr-16574	384	77	both	both	PRON
ihlr-16574	384	78	"	"	PUNCT
ihlr-16574	384	79	active	active	ADJ
ihlr-16574	384	80	"	"	PUNCT
ihlr-16574	384	81	and	and	CCONJ
ihlr-16574	384	82	"	"	PUNCT
ihlr-16574	384	83	implantable".122	implantable".122	VERB
ihlr-16574	384	84	the	the	DET
ihlr-16574	384	85	applicability	applicability	NOUN
ihlr-16574	384	86	of	of	ADP
ihlr-16574	384	87	this	this	DET
ihlr-16574	384	88	regulation	regulation	NOUN
ihlr-16574	384	89	is	be	AUX
ihlr-16574	384	90	particularly	particularly	ADV
ihlr-16574	384	91	interesting	interesting	ADJ
ihlr-16574	384	92	because	because	SCONJ
ihlr-16574	384	93	nanomedicine	nanomedicine	ADJ
ihlr-16574	384	94	technol­	technol­	NOUN
ihlr-16574	384	95	ogies	ogie	NOUN
ihlr-16574	384	96	will	will	AUX
ihlr-16574	384	97	be	be	AUX
ihlr-16574	384	98	implanted	implant	VERB
ihlr-16574	384	99	into	into	ADP
ihlr-16574	384	100	the	the	DET
ihlr-16574	384	101	human	human	ADJ
ihlr-16574	384	102	body	body	NOUN
ihlr-16574	384	103	in	in	ADP
ihlr-16574	384	104	some	some	DET
ihlr-16574	384	105	circumstances	circumstance	NOUN
ihlr-16574	384	106	.	.	PUNCT
ihlr-16574	385	1	''	''	PUNCT
ihlr-16574	385	2	im­	im­	PROPN
ihlr-16574	385	3	planted	plant	VERB
ihlr-16574	385	4	"	"	PUNCT
ihlr-16574	385	5	means	mean	VERB
ihlr-16574	385	6	"	"	PUNCT
ihlr-16574	385	7	totally	totally	ADV
ihlr-16574	385	8	or	or	CCONJ
ihlr-16574	385	9	partly	partly	ADV
ihlr-16574	385	10	introduced	introduce	VERB
ihlr-16574	385	11	,	,	PUNCT
ihlr-16574	385	12	surgically	surgically	ADV
ihlr-16574	385	13	or	or	CCONJ
ihlr-16574	385	14	medically	medically	ADV
ihlr-16574	385	15	,	,	PUNCT
ihlr-16574	385	16	into	into	ADP
ihlr-16574	385	17	the	the	DET
ihlr-16574	385	18	human	human	ADJ
ihlr-16574	385	19	body	body	NOUN
ihlr-16574	385	20	or	or	CCONJ
ihlr-16574	385	21	by	by	ADP
ihlr-16574	385	22	medical	medical	ADJ
ihlr-16574	385	23	intervention	intervention	NOUN
ihlr-16574	385	24	into	into	ADP
ihlr-16574	385	25	a	a	DET
ihlr-16574	385	26	natural	natural	ADJ
ihlr-16574	385	27	orifice	orifice	NOUN
ihlr-16574	385	28	,	,	PUNCT
ihlr-16574	385	29	and	and	CCONJ
ihlr-16574	385	30	which	which	PRON
ihlr-16574	385	31	is	be	AUX
ihlr-16574	385	32	intended	intend	VERB
ihlr-16574	385	33	to	to	PART
ihlr-16574	385	34	remain	remain	VERB
ihlr-16574	385	35	after	after	ADP
ihlr-16574	385	36	the	the	DET
ihlr-16574	385	37	procedure	procedure	NOUN
ihlr-16574	385	38	.	.	PUNCT
ihlr-16574	385	39	"	"	PUNCT
ihlr-16574	386	1	123	123	NUM
ihlr-16574	386	2	some	some	DET
ihlr-16574	386	3	types	type	NOUN
ihlr-16574	386	4	of	of	ADP
ihlr-16574	386	5	nanomedicine	nanomedicine	NOUN
ihlr-16574	386	6	could	could	AUX
ihlr-16574	386	7	potentially	potentially	ADV
ihlr-16574	386	8	fall	fall	VERB
ihlr-16574	386	9	under	under	ADP
ihlr-16574	386	10	this	this	DET
ihlr-16574	386	11	"	"	PUNCT
ihlr-16574	386	12	im­	im­	NOUN
ihlr-16574	386	13	plant	plant	NOUN
ihlr-16574	386	14	"	"	PUNCT
ihlr-16574	386	15	category	category	NOUN
ihlr-16574	386	16	,	,	PUNCT
ihlr-16574	386	17	but	but	CCONJ
ihlr-16574	386	18	ultimately	ultimately	ADV
ihlr-16574	386	19	that	that	PRON
ihlr-16574	386	20	will	will	AUX
ihlr-16574	386	21	depend	depend	VERB
ihlr-16574	386	22	on	on	ADP
ihlr-16574	386	23	how	how	SCONJ
ihlr-16574	386	24	nanomedicine	nanomedicine	ADJ
ihlr-16574	386	25	de­	de­	ADJ
ihlr-16574	386	26	velops	velop	NOUN
ihlr-16574	386	27	.	.	PUNCT
ihlr-16574	387	1	as	as	ADP
ihlr-16574	387	2	in	in	ADP
ihlr-16574	387	3	the	the	DET
ihlr-16574	387	4	patient	patient	NOUN
ihlr-16574	387	5	x	x	PROPN
ihlr-16574	387	6	scenario	scenario	NOUN
ihlr-16574	387	7	described	describe	VERB
ihlr-16574	387	8	earlier	early	ADV
ihlr-16574	387	9	,	,	PUNCT
ihlr-16574	387	10	for	for	ADP
ihlr-16574	387	11	example	example	NOUN
ihlr-16574	387	12	,	,	PUNCT
ihlr-16574	387	13	some	some	DET
ihlr-16574	387	14	types	type	NOUN
ihlr-16574	387	15	of	of	ADP
ihlr-16574	387	16	nanomedicine	nanomedicine	NOUN
ihlr-16574	387	17	now	now	ADV
ihlr-16574	387	18	being	be	AUX
ihlr-16574	387	19	researched	research	VERB
ihlr-16574	387	20	involve	involve	VERB
ihlr-16574	387	21	the	the	DET
ihlr-16574	387	22	introduction	introduction	NOUN
ihlr-16574	387	23	of	of	ADP
ihlr-16574	387	24	microscopic	microscopic	ADJ
ihlr-16574	387	25	nanites	nanite	NOUN
ihlr-16574	387	26	into	into	ADP
ihlr-16574	387	27	the	the	DET
ihlr-16574	387	28	body	body	NOUN
ihlr-16574	387	29	to	to	PART
ihlr-16574	387	30	perform	perform	VERB
ihlr-16574	387	31	a	a	DET
ihlr-16574	387	32	specific	specific	ADJ
ihlr-16574	387	33	task	task	NOUN
ihlr-16574	387	34	(	(	PUNCT
ihlr-16574	387	35	as	as	ADP
ihlr-16574	387	36	in	in	ADP
ihlr-16574	387	37	patient	patient	ADJ
ihlr-16574	387	38	x	x	NOUN
ihlr-16574	387	39	's	's	PART
ihlr-16574	387	40	case	case	NOUN
ihlr-16574	387	41	,	,	PUNCT
ihlr-16574	387	42	to	to	PART
ihlr-16574	387	43	remove	remove	VERB
ihlr-16574	387	44	a	a	DET
ihlr-16574	387	45	tumor	tumor	NOUN
ihlr-16574	387	46	)	)	PUNCT
ihlr-16574	387	47	.	.	PUNCT
ihlr-16574	388	1	once	once	SCONJ
ihlr-16574	388	2	that	that	DET
ihlr-16574	388	3	task	task	NOUN
ihlr-16574	388	4	has	have	AUX
ihlr-16574	388	5	been	be	AUX
ihlr-16574	388	6	completed	complete	VERB
ihlr-16574	388	7	,	,	PUNCT
ihlr-16574	388	8	the	the	DET
ihlr-16574	388	9	na­	na­	PROPN
ihlr-16574	388	10	nites	nites	PROPN
ihlr-16574	388	11	would	would	AUX
ihlr-16574	388	12	have	have	AUX
ihlr-16574	388	13	performed	perform	VERB
ihlr-16574	388	14	the	the	DET
ihlr-16574	388	15	task	task	NOUN
ihlr-16574	388	16	for	for	ADP
ihlr-16574	388	17	which	which	PRON
ihlr-16574	388	18	they	they	PRON
ihlr-16574	388	19	were	be	AUX
ihlr-16574	388	20	programmed	program	VERB
ihlr-16574	388	21	and	and	CCONJ
ihlr-16574	388	22	would	would	AUX
ihlr-16574	388	23	at	at	ADP
ihlr-16574	388	24	this	this	DET
ihlr-16574	388	25	point	point	NOUN
ihlr-16574	388	26	shut	shut	VERB
ihlr-16574	388	27	down	down	ADP
ihlr-16574	388	28	and	and	CCONJ
ihlr-16574	388	29	leave	leave	VERB
ihlr-16574	388	30	the	the	DET
ihlr-16574	388	31	body	body	NOUN
ihlr-16574	388	32	.	.	PUNCT
ihlr-16574	389	1	thus	thus	ADV
ihlr-16574	389	2	,	,	PUNCT
ihlr-16574	389	3	the	the	DET
ihlr-16574	389	4	question	question	NOUN
ihlr-16574	389	5	be­	be­	VERB
ihlr-16574	389	6	comes	come	VERB
ihlr-16574	389	7	whether	whether	SCONJ
ihlr-16574	389	8	the	the	DET
ihlr-16574	389	9	nanites	nanite	NOUN
ihlr-16574	389	10	would	would	AUX
ihlr-16574	389	11	qualify	qualify	VERB
ihlr-16574	389	12	as	as	ADP
ihlr-16574	389	13	sufficiently	sufficiently	ADV
ihlr-16574	389	14	"	"	PUNCT
ihlr-16574	389	15	intended	intend	VERB
ihlr-16574	389	16	to	to	PART
ihlr-16574	389	17	remain	remain	VERB
ihlr-16574	389	18	after	after	ADP
ihlr-16574	389	19	the	the	DET
ihlr-16574	389	20	procedure	procedure	NOUN
ihlr-16574	389	21	"	"	PUNCT
ihlr-16574	389	22	to	to	PART
ihlr-16574	389	23	fit	fit	VERB
ihlr-16574	389	24	within	within	ADP
ihlr-16574	389	25	the	the	DET
ihlr-16574	389	26	"	"	PUNCT
ihlr-16574	389	27	implant	implant	ADJ
ihlr-16574	389	28	"	"	PUNCT
ihlr-16574	389	29	category	category	NOUN
ihlr-16574	389	30	.	.	PUNCT
ihlr-16574	390	1	124	124	NUM
ihlr-16574	390	2	further	far	ADV
ihlr-16574	390	3	,	,	PUNCT
ihlr-16574	390	4	it	it	PRON
ihlr-16574	390	5	is	be	AUX
ihlr-16574	390	6	possible	possible	ADJ
ihlr-16574	390	7	that	that	SCONJ
ihlr-16574	390	8	certain	certain	ADJ
ihlr-16574	390	9	nanotechnologies	nanotechnology	NOUN
ihlr-16574	390	10	will	will	AUX
ihlr-16574	390	11	be	be	AUX
ihlr-16574	390	12	developed	develop	VERB
ihlr-16574	390	13	that	that	PRON
ihlr-16574	390	14	are	be	AUX
ihlr-16574	390	15	intended	intend	VERB
ihlr-16574	390	16	or	or	CCONJ
ihlr-16574	390	17	able	able	ADJ
ihlr-16574	390	18	to	to	PART
ihlr-16574	390	19	remain	remain	VERB
ihlr-16574	390	20	in	in	ADP
ihlr-16574	390	21	the	the	DET
ihlr-16574	390	22	body	body	NOUN
ihlr-16574	390	23	indefinitely	indefinitely	ADV
ihlr-16574	390	24	after	after	SCONJ
ihlr-16574	390	25	they	they	PRON
ihlr-16574	390	26	are	be	AUX
ihlr-16574	390	27	inserted.125	inserted.125	NOUN
ihlr-16574	390	28	the	the	DET
ihlr-16574	390	29	second	second	ADJ
ihlr-16574	390	30	directive	directive	NOUN
ihlr-16574	390	31	framework	framework	NOUN
ihlr-16574	390	32	that	that	PRON
ihlr-16574	390	33	nanotechnology	nanotechnology	NOUN
ihlr-16574	390	34	falls	fall	VERB
ihlr-16574	390	35	under	under	ADP
ihlr-16574	390	36	is	be	AUX
ihlr-16574	390	37	di­	di­	PROPN
ihlr-16574	390	38	rective	rective	ADJ
ihlr-16574	390	39	93/42	93/42	NUM
ihlr-16574	390	40	/	/	SYM
ihlr-16574	390	41	eec	eec	PROPN
ihlr-16574	390	42	-medical	-medical	PROPN
ihlr-16574	390	43	devices.126	devices.126	NOUN
ihlr-16574	390	44	this	this	DET
ihlr-16574	390	45	medical	medical	ADJ
ihlr-16574	390	46	device	device	NOUN
ihlr-16574	390	47	directive	directive	NOUN
ihlr-16574	390	48	has	have	VERB
ihlr-16574	390	49	the	the	DET
ihlr-16574	390	50	most	most	ADV
ihlr-16574	390	51	general	general	ADJ
ihlr-16574	390	52	applicability	applicability	NOUN
ihlr-16574	390	53	to	to	ADP
ihlr-16574	390	54	nanotechnology.127	nanotechnology.127	PROPN
ihlr-16574	390	55	"	"	PUNCT
ihlr-16574	390	56	medical	medical	ADJ
ihlr-16574	390	57	device	device	NOUN
ihlr-16574	390	58	"	"	PUNCT
ihlr-16574	390	59	is	be	AUX
ihlr-16574	390	60	defined	define	VERB
ihlr-16574	390	61	as	as	ADP
ihlr-16574	390	62	"	"	PUNCT
ihlr-16574	390	63	any	any	DET
ihlr-16574	390	64	instrument	instrument	NOUN
ihlr-16574	390	65	,	,	PUNCT
ihlr-16574	390	66	apparatus	apparatus	NOUN
ihlr-16574	390	67	,	,	PUNCT
ihlr-16574	390	68	appliance	appliance	NOUN
ihlr-16574	390	69	,	,	PUNCT
ihlr-16574	390	70	software	software	NOUN
ihlr-16574	390	71	,	,	PUNCT
ihlr-16574	390	72	material	material	NOUN
ihlr-16574	390	73	or	or	CCONJ
ihlr-16574	390	74	other	other	ADJ
ihlr-16574	390	75	article	article	NOUN
ihlr-16574	390	76	,	,	PUNCT
ihlr-16574	390	77	whether	whether	SCONJ
ihlr-16574	390	78	used	use	VERB
ihlr-16574	390	79	alone	alone	ADV
ihlr-16574	390	80	or	or	CCONJ
ihlr-16574	390	81	in	in	ADP
ihlr-16574	390	82	combination	combination	NOUN
ihlr-16574	390	83	,	,	PUNCT
ihlr-16574	390	84	including	include	VERB
ihlr-16574	390	85	the	the	DET
ihlr-16574	390	86	software	software	NOUN
ihlr-16574	390	87	in­	in­	NOUN
ihlr-16574	390	88	tended	tend	VERB
ihlr-16574	390	89	by	by	ADP
ihlr-16574	390	90	its	its	PRON
ihlr-16574	390	91	manufacturer	manufacturer	NOUN
ihlr-16574	390	92	to	to	PART
ihlr-16574	390	93	be	be	AUX
ihlr-16574	390	94	used	use	VERB
ihlr-16574	390	95	specifically	specifically	ADV
ihlr-16574	390	96	for	for	ADP
ihlr-16574	390	97	diagnostic	diagnostic	ADJ
ihlr-16574	390	98	and/or	and/or	CCONJ
ihlr-16574	390	99	the119	the119	PROPN
ihlr-16574	390	100	.	.	PUNCT
ihlr-16574	391	1	i	i	PROPN
ihlr-16574	391	2	d	d	PROPN
ihlr-16574	391	3	120	120	NUM
ihlr-16574	391	4	.	.	PUNCT
ihlr-16574	392	1	giorgia	giorgia	PROPN
ihlr-16574	392	2	guerra	guerra	PROPN
ihlr-16574	392	3	,	,	PUNCT
ihlr-16574	392	4	a	a	DET
ihlr-16574	392	5	model	model	NOUN
ihlr-16574	392	6	for	for	ADP
ihlr-16574	392	7	regulation	regulation	NOUN
ihlr-16574	392	8	of	of	ADP
ihlr-16574	392	9	medical	medical	ADJ
ihlr-16574	392	10	nanobiotechnology	nanobiotechnology	NOUN
ihlr-16574	392	11	:	:	PUNCT
ihlr-16574	392	12	the	the	DET
ihlr-16574	392	13	eu­	eu­	ADJ
ihlr-16574	392	14	ropean	ropean	ADJ
ihlr-16574	392	15	status	status	PROPN
ihlr-16574	392	16	quo	quo	NOUN
ihlr-16574	392	17	,	,	PUNCT
ihlr-16574	392	18	3	3	NUM
ihlr-16574	392	19	nanotechnology	nanotechnology	PROPN
ihlr-16574	392	20	l.	l.	PROPN
ihlr-16574	392	21	&	&	CCONJ
ihlr-16574	392	22	bus	bus	PROPN
ihlr-16574	392	23	.	.	PUNCT
ihlr-16574	392	24	84	84	NUM
ihlr-16574	392	25	,	,	PUNCT
ihlr-16574	392	26	87	87	NUM
ihlr-16574	392	27	-	-	SYM
ihlr-16574	392	28	88	88	NUM
ihlr-16574	392	29	(	(	PUNCT
ihlr-16574	392	30	2006	2006	NUM
ihlr-16574	392	31	)	)	PUNCT
ihlr-16574	393	1	[	[	X
ihlr-16574	393	2	hereinafter	hereinafter	NOUN
ihlr-16574	393	3	guerra	guerra	NOUN
ihlr-16574	393	4	,	,	PUNCT
ihlr-16574	393	5	a	a	DET
ihlr-16574	393	6	model	model	NOUN
ihlr-16574	393	7	]	]	X
ihlr-16574	393	8	.	.	PUNCT
ihlr-16574	394	1	121	121	NUM
ihlr-16574	394	2	.	.	PUNCT
ihlr-16574	394	3	/d.at	/d.at	PROPN
ihlr-16574	394	4	87	87	NUM
ihlr-16574	394	5	.	.	PUNCT
ihlr-16574	395	1	122	122	NUM
ihlr-16574	395	2	.	.	PUNCT
ihlr-16574	396	1	council	council	NOUN
ihlr-16574	396	2	directive	directive	NOUN
ihlr-16574	396	3	90/385	90/385	NUM
ihlr-16574	396	4	,	,	PUNCT
ihlr-16574	396	5	the	the	DET
ihlr-16574	396	6	approximation	approximation	NOUN
ihlr-16574	396	7	of	of	ADP
ihlr-16574	396	8	the	the	DET
ihlr-16574	396	9	laws	law	NOUN
ihlr-16574	396	10	of	of	ADP
ihlr-16574	396	11	the	the	DET
ihlr-16574	396	12	member	member	NOUN
ihlr-16574	396	13	states	state	NOUN
ihlr-16574	396	14	relating	relate	VERB
ihlr-16574	396	15	to	to	ADP
ihlr-16574	396	16	active	active	ADJ
ihlr-16574	396	17	implantable	implantable	ADJ
ihlr-16574	396	18	medical	medical	ADJ
ihlr-16574	396	19	devices	device	NOUN
ihlr-16574	396	20	,	,	PUNCT
ihlr-16574	396	21	art	art	NOUN
ihlr-16574	396	22	.	.	PUNCT
ihlr-16574	397	1	l	l	NOUN
ihlr-16574	397	2	,	,	PUNCT
ihlr-16574	397	3	1990	1990	NUM
ihlr-16574	397	4	o.j	o.j	PROPN
ihlr-16574	397	5	.	.	PUNCT
ihlr-16574	398	1	(	(	PUNCT
ihlr-16574	398	2	l	l	NOUN
ihlr-16574	398	3	189	189	NUM
ihlr-16574	398	4	)	)	PUNCT
ihlr-16574	398	5	1,3	1,3	NUM
ihlr-16574	398	6	(	(	PUNCT
ihlr-16574	398	7	en	en	X
ihlr-16574	398	8	)	)	PUNCT
ihlr-16574	398	9	,	,	PUNCT
ihlr-16574	398	10	availa­	availa­	VERB
ihlr-16574	398	11	ble	ble	ADJ
ihlr-16574	398	12	at	at	ADP
ihlr-16574	398	13	http://eur	http://eur	ADJ
ihlr-16574	398	14	-	-	PUNCT
ihlr-16574	398	15	lex.europaeu!lexuriserv!lexuriserv.do?uri	lex.europaeu!lexuriserv!lexuriserv.do?uri	ADJ
ihlr-16574	398	16	=	=	NOUN
ihlr-16574	398	17	consleg	consleg	NOUN
ihlr-16574	398	18	:	:	PUNCT
ihlr-16574	398	19	1990l0385:20071	1990l0385:20071	NUM
ihlr-16574	398	20	011	011	NUM
ihlr-16574	398	21	:	:	PUNCT
ihlr-16574	398	22	en	en	ADJ
ihlr-16574	398	23	:	:	PUNCT
ihlr-16574	398	24	pdf	pdf	NOUN
ihlr-16574	398	25	(	(	PUNCT
ihlr-16574	398	26	last	last	ADV
ihlr-16574	398	27	visited	visit	VERB
ihlr-16574	398	28	feb	feb	PROPN
ihlr-16574	398	29	.	.	PROPN
ihlr-16574	398	30	24	24	NUM
ihlr-16574	398	31	,	,	PUNCT
ihlr-16574	398	32	201	201	NUM
ihlr-16574	398	33	0	0	NUM
ihlr-16574	398	34	)	)	PUNCT
ihlr-16574	398	35	.	.	PUNCT
ihlr-16574	399	1	123	123	NUM
ihlr-16574	399	2	.	.	PUNCT
ihlr-16574	400	1	i	i	PRON
ihlr-16574	400	2	d.	d.	PROPN
ihlr-16574	400	3	124	124	NUM
ihlr-16574	400	4	.	.	PUNCT
ihlr-16574	400	5	!	!	PUNCT
ihlr-16574	401	1	d.	d.	PROPN
ihlr-16574	401	2	125	125	NUM
ihlr-16574	401	3	.	.	PUNCT
ihlr-16574	402	1	see	see	VERB
ihlr-16574	402	2	keiper	keiper	NOUN
ihlr-16574	402	3	,	,	PUNCT
ihlr-16574	402	4	supra	supra	PROPN
ihlr-16574	402	5	note	note	PROPN
ihlr-16574	402	6	27	27	NUM
ihlr-16574	402	7	,	,	PUNCT
ihlr-16574	402	8	at	at	ADP
ihlr-16574	402	9	20	20	NUM
ihlr-16574	402	10	-	-	SYM
ihlr-16574	402	11	1	1	NUM
ihlr-16574	402	12	(	(	PUNCT
ihlr-16574	402	13	discussing	discuss	VERB
ihlr-16574	402	14	theories	theory	NOUN
ihlr-16574	402	15	of	of	ADP
ihlr-16574	402	16	nanotechnology	nanotechnology	PROPN
ihlr-16574	402	17	applica­	applica­	PROPN
ihlr-16574	402	18	tion	tion	NOUN
ihlr-16574	402	19	by	by	ADP
ihlr-16574	402	20	scientist	scientist	NOUN
ihlr-16574	402	21	,	,	PUNCT
ihlr-16574	402	22	kim	kim	PROPN
ihlr-16574	402	23	eric	eric	PROPN
ihlr-16574	402	24	drexler	drexler	PROPN
ihlr-16574	402	25	,	,	PUNCT
ihlr-16574	402	26	who	who	PRON
ihlr-16574	402	27	posits	posit	VERB
ihlr-16574	402	28	that	that	SCONJ
ihlr-16574	402	29	nanotechnology	nanotechnology	NOUN
ihlr-16574	402	30	will	will	AUX
ihlr-16574	402	31	eventually	eventually	ADV
ihlr-16574	402	32	be	be	AUX
ihlr-16574	402	33	used	use	VERB
ihlr-16574	402	34	in	in	ADP
ihlr-16574	402	35	ways	way	NOUN
ihlr-16574	402	36	that	that	PRON
ihlr-16574	402	37	would	would	AUX
ihlr-16574	402	38	alter	alter	VERB
ihlr-16574	402	39	human	human	ADJ
ihlr-16574	402	40	appearance	appearance	NOUN
ihlr-16574	402	41	on	on	ADP
ihlr-16574	402	42	a	a	DET
ihlr-16574	402	43	permanent	permanent	ADJ
ihlr-16574	402	44	basis	basis	NOUN
ihlr-16574	402	45	if	if	SCONJ
ihlr-16574	402	46	desired	desire	VERB
ihlr-16574	402	47	)	)	PUNCT
ihlr-16574	402	48	.	.	PUNCT
ihlr-16574	403	1	126	126	NUM
ihlr-16574	403	2	.	.	PUNCT
ihlr-16574	404	1	guerra	guerra	PROPN
ihlr-16574	404	2	,	,	PUNCT
ihlr-16574	404	3	supra	supra	PROPN
ihlr-16574	404	4	note	note	PROPN
ihlr-16574	404	5	113	113	NUM
ihlr-16574	404	6	,	,	PUNCT
ihlr-16574	404	7	at	at	ADP
ihlr-16574	404	8	88	88	NUM
ihlr-16574	404	9	.	.	PUNCT
ihlr-16574	405	1	127	127	NUM
ihlr-16574	405	2	.	.	PUNCT
ihlr-16574	406	1	i	i	PRON
ihlr-16574	406	2	d	d	PROPN
ihlr-16574	406	3	2010	2010	NUM
ihlr-16574	406	4	]	]	PUNCT
ihlr-16574	406	5	nanomedicine	nanomedicine	NOUN
ihlr-16574	406	6	415	415	NUM
ihlr-16574	406	7	rapeutic	rapeutic	ADJ
ihlr-16574	406	8	purposes	purpose	NOUN
ihlr-16574	406	9	and	and	CCONJ
ihlr-16574	406	10	necessary	necessary	ADJ
ihlr-16574	406	11	for	for	ADP
ihlr-16574	406	12	its	its	PRON
ihlr-16574	406	13	proper	proper	ADJ
ihlr-16574	406	14	application	application	NOUN
ihlr-16574	406	15	,	,	PUNCT
ihlr-16574	406	16	intended	intend	VERB
ihlr-16574	406	17	by	by	ADP
ihlr-16574	406	18	the	the	DET
ihlr-16574	406	19	manufacturer	manufacturer	NOUN
ihlr-16574	406	20	to	to	PART
ihlr-16574	406	21	be	be	AUX
ihlr-16574	406	22	used	use	VERB
ihlr-16574	406	23	for	for	ADP
ihlr-16574	406	24	human	human	ADJ
ihlr-16574	406	25	beings	being	NOUN
ihlr-16574	406	26	.	.	PUNCT
ihlr-16574	406	27	"	"	PUNCT
ihlr-16574	407	1	128	128	NUM
ihlr-16574	407	2	the	the	DET
ihlr-16574	407	3	purpose	purpose	NOUN
ihlr-16574	407	4	of	of	ADP
ihlr-16574	407	5	the	the	DET
ihlr-16574	407	6	medical	medical	ADJ
ihlr-16574	407	7	device	device	NOUN
ihlr-16574	407	8	directive	directive	NOUN
ihlr-16574	407	9	is	be	AUX
ihlr-16574	407	10	·	·	PUNCT
ihlr-16574	407	11	defined	define	VERB
ihlr-16574	407	12	,	,	PUNCT
ihlr-16574	407	13	in	in	ADP
ihlr-16574	407	14	pertinent	pertinent	ADJ
ihlr-16574	407	15	part	part	NOUN
ihlr-16574	407	16	,	,	PUNCT
ihlr-16574	407	17	as	as	ADP
ihlr-16574	407	18	the	the	DET
ihlr-16574	407	19	"	"	PUNCT
ihlr-16574	407	20	...	...	PUNCT
ihlr-16574	407	21	alleviation	alleviation	NOUN
ihlr-16574	407	22	of	of	ADP
ihlr-16574	407	23	dis­	dis­	ADJ
ihlr-16574	407	24	ease	ease	NOUN
ihlr-16574	407	25	,	,	PUNCT
ihlr-16574	407	26	"	"	PUNCT
ihlr-16574	407	27	"	"	PUNCT
ihlr-16574	407	28	...	...	PUNCT
ihlr-16574	407	29	alleviation	alleviation	NOUN
ihlr-16574	407	30	of	of	ADP
ihlr-16574	407	31	or	or	CCONJ
ihlr-16574	407	32	compensation	compensation	NOUN
ihlr-16574	407	33	for	for	ADP
ihlr-16574	407	34	an	an	DET
ihlr-16574	407	35	injury	injury	NOUN
ihlr-16574	407	36	or	or	CCONJ
ihlr-16574	407	37	handicap	handicap	NOUN
ihlr-16574	407	38	,	,	PUNCT
ihlr-16574	407	39	"	"	PUNCT
ihlr-16574	407	40	and	and	CCONJ
ihlr-16574	407	41	"	"	PUNCT
ihlr-16574	407	42	...	...	PUNCT
ihlr-16574	408	1	modification	modification	NOUN
ihlr-16574	408	2	of	of	ADP
ihlr-16574	408	3	the	the	DET
ihlr-16574	408	4	anatomy	anatomy	NOUN
ihlr-16574	408	5	or	or	CCONJ
ihlr-16574	408	6	of	of	ADP
ihlr-16574	408	7	a	a	DET
ihlr-16574	408	8	physiological	physiological	ADJ
ihlr-16574	408	9	process	process	NOUN
ihlr-16574	408	10	.	.	PUNCT
ihlr-16574	409	1	"129	"129	PROPN
ihlr-16574	410	1	most	most	ADJ
ihlr-16574	410	2	nanomedicine	nanomedicine	ADJ
ihlr-16574	410	3	applications	application	NOUN
ihlr-16574	410	4	would	would	AUX
ihlr-16574	410	5	fall	fall	VERB
ihlr-16574	410	6	squarely	squarely	ADV
ihlr-16574	410	7	within	within	ADP
ihlr-16574	410	8	the	the	DET
ihlr-16574	410	9	guidelines	guideline	NOUN
ihlr-16574	410	10	of	of	ADP
ihlr-16574	410	11	di­	di­	PROPN
ihlr-16574	410	12	rective	rective	ADJ
ihlr-16574	410	13	93/42	93/42	NUM
ihlr-16574	410	14	/	/	SYM
ihlr-16574	410	15	eec	eec	PROPN
ihlr-16574	410	16	.	.	PUNCT
ihlr-16574	411	1	the	the	DET
ihlr-16574	411	2	third	third	ADJ
ihlr-16574	411	3	regulation	regulation	NOUN
ihlr-16574	411	4	applicable	applicable	ADJ
ihlr-16574	411	5	to	to	ADP
ihlr-16574	411	6	nanomedicine	nanomedicine	PROPN
ihlr-16574	411	7	is	be	AUX
ihlr-16574	411	8	directive	directive	ADJ
ihlr-16574	411	9	98/79ec	98/79ec	PROPN
ihlr-16574	411	10	in	in	ADP
ihlr-16574	411	11	vitro	vitro	X
ihlr-16574	411	12	diagnostic	diagnostic	ADJ
ihlr-16574	411	13	medical	medical	ADJ
ihlr-16574	411	14	devices	device	NOUN
ihlr-16574	411	15	.	.	PUNCT
ihlr-16574	412	1	130	130	NUM
ihlr-16574	412	2	an	an	DET
ihlr-16574	412	3	in	in	ADP
ihlr-16574	412	4	vitro	vitro	X
ihlr-16574	412	5	diagnostic	diagnostic	ADJ
ihlr-16574	412	6	medical	medical	ADJ
ihlr-16574	412	7	de­	de­	ADJ
ihlr-16574	412	8	vice	vice	NOUN
ihlr-16574	412	9	includes	include	VERB
ihlr-16574	412	10	those	those	PRON
ihlr-16574	412	11	which	which	PRON
ihlr-16574	412	12	are	be	AUX
ihlr-16574	412	13	:	:	PUNCT
ihlr-16574	412	14	a	a	DET
ihlr-16574	412	15	reagent	reagent	ADJ
ihlr-16574	412	16	,	,	PUNCT
ihlr-16574	412	17	reagent	reagent	ADJ
ihlr-16574	412	18	product	product	NOUN
ihlr-16574	412	19	,	,	PUNCT
ihlr-16574	412	20	calibrator	calibrator	NOUN
ihlr-16574	412	21	,	,	PUNCT
ihlr-16574	412	22	control	control	PROPN
ihlr-16574	412	23	materi­	materi­	PROPN
ihlr-16574	412	24	al	al	PROPN
ihlr-16574	412	25	,	,	PUNCT
ihlr-16574	412	26	kit	kit	PROPN
ihlr-16574	412	27	,	,	PUNCT
ihlr-16574	412	28	instrument	instrument	NOUN
ihlr-16574	412	29	,	,	PUNCT
ihlr-16574	412	30	apparatus	apparatus	NOUN
ihlr-16574	412	31	,	,	PUNCT
ihlr-16574	412	32	equipment	equipment	NOUN
ihlr-16574	412	33	,	,	PUNCT
ihlr-16574	412	34	or	or	CCONJ
ihlr-16574	412	35	system	system	NOUN
ihlr-16574	412	36	,	,	PUNCT
ihlr-16574	412	37	whether	whether	SCONJ
ihlr-16574	412	38	used	use	VERB
ihlr-16574	412	39	alone	alone	ADV
ihlr-16574	412	40	or	or	CCONJ
ihlr-16574	412	41	in	in	ADP
ihlr-16574	412	42	combination	combination	NOUN
ihlr-16574	412	43	,	,	PUNCT
ihlr-16574	412	44	intended	intend	VERB
ihlr-16574	412	45	by	by	ADP
ihlr-16574	412	46	the	the	DET
ihlr-16574	412	47	manufacturer	manufacturer	NOUN
ihlr-16574	412	48	to	to	PART
ihlr-16574	412	49	be	be	AUX
ihlr-16574	412	50	used	use	VERB
ihlr-16574	412	51	in	in	ADP
ihlr-16574	412	52	vitro	vitro	X
ihlr-16574	412	53	for	for	ADP
ihlr-16574	412	54	the	the	DET
ihlr-16574	412	55	examination	examination	NOUN
ihlr-16574	412	56	of	of	ADP
ihlr-16574	412	57	specimens	specimen	NOUN
ihlr-16574	412	58	,	,	PUNCT
ihlr-16574	412	59	.	.	PUNCT
ihlr-16574	413	1	including	include	VERB
ihlr-16574	413	2	blood	blood	NOUN
ihlr-16574	413	3	and	and	CCONJ
ihlr-16574	413	4	tissue	tissue	NOUN
ihlr-16574	413	5	donations	donation	NOUN
ihlr-16574	413	6	,	,	PUNCT
ihlr-16574	413	7	derived	derive	VERB
ihlr-16574	413	8	from	from	ADP
ihlr-16574	413	9	the	the	DET
ihlr-16574	413	10	human	human	ADJ
ihlr-16574	413	11	body	body	NOUN
ihlr-16574	413	12	,	,	PUNCT
ihlr-16574	413	13	solely	solely	ADV
ihlr-16574	413	14	or	or	CCONJ
ihlr-16574	413	15	principally	principally	ADV
ihlr-16574	413	16	for	for	ADP
ihlr-16574	413	17	the	the	DET
ihlr-16574	413	18	purpose	purpose	NOUN
ihlr-16574	413	19	of	of	ADP
ihlr-16574	413	20	providing	provide	VERB
ihlr-16574	413	21	information.131	information.131	PROPN
ihlr-16574	413	22	in	in	ADP
ihlr-16574	413	23	vitro	vitro	X
ihlr-16574	413	24	is	be	AUX
ihlr-16574	413	25	a	a	DET
ihlr-16574	413	26	technique	technique	NOUN
ihlr-16574	413	27	in	in	ADP
ihlr-16574	413	28	which	which	PRON
ihlr-16574	413	29	procedures	procedure	NOUN
ihlr-16574	413	30	are	be	AUX
ihlr-16574	413	31	performed	perform	VERB
ihlr-16574	413	32	on	on	ADP
ihlr-16574	413	33	living	live	VERB
ihlr-16574	413	34	matter	matter	NOUN
ihlr-16574	413	35	outside	outside	ADP
ihlr-16574	413	36	the	the	DET
ihlr-16574	413	37	controlled	control	VERB
ihlr-16574	413	38	environment	environment	NOUN
ihlr-16574	413	39	of	of	ADP
ihlr-16574	413	40	the	the	DET
ihlr-16574	413	41	living	live	VERB
ihlr-16574	413	42	organism	organism	NOUN
ihlr-16574	413	43	(	(	PUNCT
ihlr-16574	413	44	or	or	CCONJ
ihlr-16574	413	45	,	,	PUNCT
ihlr-16574	413	46	in	in	ADP
ihlr-16574	413	47	lay	lay	NOUN
ihlr-16574	413	48	terms	term	NOUN
ihlr-16574	413	49	,	,	PUNCT
ihlr-16574	413	50	in	in	ADP
ihlr-16574	413	51	a	a	DET
ihlr-16574	413	52	test	test	NOUN
ihlr-16574	413	53	tube).132	tube).132	NOUN
ihlr-16574	413	54	as	as	SCONJ
ihlr-16574	413	55	discussed	discuss	VERB
ihlr-16574	413	56	in	in	ADP
ihlr-16574	413	57	further	further	ADJ
ihlr-16574	413	58	depth	depth	NOUN
ihlr-16574	413	59	below	below	ADV
ihlr-16574	413	60	,	,	PUNCT
ihlr-16574	413	61	nanomedicine	nanomedicine	PROPN
ihlr-16574	413	62	is	be	AUX
ihlr-16574	413	63	ex­	ex­	NOUN
ihlr-16574	413	64	pected	pecte	VERB
ihlr-16574	413	65	to	to	PART
ihlr-16574	413	66	have	have	VERB
ihlr-16574	413	67	many	many	ADJ
ihlr-16574	413	68	applications	application	NOUN
ihlr-16574	413	69	for	for	ADP
ihlr-16574	413	70	in	in	ADP
ihlr-16574	413	71	vitro	vitro	X
ihlr-16574	413	72	research	research	NOUN
ihlr-16574	413	73	and	and	CCONJ
ihlr-16574	413	74	treatment	treatment	NOUN
ihlr-16574	413	75	.	.	PUNCT
ihlr-16574	414	1	133	133	NUM
ihlr-16574	414	2	the	the	DET
ihlr-16574	414	3	eu	eu	PROPN
ihlr-16574	414	4	is	be	AUX
ihlr-16574	414	5	currently	currently	ADV
ihlr-16574	414	6	considering	consider	VERB
ihlr-16574	414	7	nanotechnology	nanotechnology	NOUN
ihlr-16574	414	8	and	and	CCONJ
ihlr-16574	414	9	its	its	PRON
ihlr-16574	414	10	applications	application	NOUN
ihlr-16574	414	11	under	under	ADP
ihlr-16574	414	12	these	these	DET
ihlr-16574	414	13	directives.u4	directives.u4	PROPN
ihlr-16574	414	14	.	.	PUNCT
ihlr-16574	415	1	2	2	X
ihlr-16574	415	2	.	.	NUM
ihlr-16574	415	3	designated	designate	VERB
ihlr-16574	415	4	regulatory	regulatory	ADJ
ihlr-16574	415	5	groups	group	NOUN
ihlr-16574	415	6	and	and	CCONJ
ihlr-16574	415	7	agencies	agency	NOUN
ihlr-16574	415	8	drafting	draft	VERB
ihlr-16574	415	9	policy	policy	NOUN
ihlr-16574	415	10	the	the	DET
ihlr-16574	415	11	european	european	PROPN
ihlr-16574	415	12	technology	technology	PROPN
ihlr-16574	415	13	platform	platform	NOUN
ihlr-16574	415	14	on	on	ADP
ihlr-16574	415	15	nanomedicine	nanomedicine	PROPN
ihlr-16574	415	16	(	(	PUNCT
ihlr-16574	415	17	etp	etp	PROPN
ihlr-16574	415	18	)	)	PUNCT
ihlr-16574	415	19	is	be	AUX
ihlr-16574	415	20	spear­	spear­	NUM
ihlr-16574	415	21	heading	head	VERB
ihlr-16574	415	22	the	the	DET
ihlr-16574	415	23	nanotechnology	nanotechnology	NOUN
ihlr-16574	415	24	movement	movement	NOUN
ihlr-16574	415	25	in	in	ADP
ihlr-16574	415	26	europe.135	europe.135	PROPN
ihlr-16574	415	27	the	the	DET
ihlr-16574	415	28	etp	etp	PROPN
ihlr-16574	415	29	website	website	NOUN
ihlr-16574	415	30	de128	de128	PROPN
ihlr-16574	415	31	.	.	PUNCT
ihlr-16574	416	1	council	council	NOUN
ihlr-16574	416	2	directive	directive	NOUN
ihlr-16574	416	3	93/42	93/42	NUM
ihlr-16574	416	4	,	,	PUNCT
ihlr-16574	416	5	concerning	concern	VERB
ihlr-16574	416	6	medical	medical	ADJ
ihlr-16574	416	7	devices	device	NOUN
ihlr-16574	416	8	,	,	PUNCT
ihlr-16574	416	9	art	art	NOUN
ihlr-16574	416	10	.	.	PUNCT
ihlr-16574	417	1	1,1993	1,1993	NUM
ihlr-16574	417	2	o.j	o.j	PROPN
ihlr-16574	417	3	.	.	PUNCT
ihlr-16574	417	4	(	(	PUNCT
ihlr-16574	417	5	l	l	NOUN
ihlr-16574	417	6	169	169	NUM
ihlr-16574	417	7	)	)	PUNCT
ihlr-16574	417	8	1	1	NUM
ihlr-16574	417	9	,	,	PUNCT
ihlr-16574	417	10	5	5	NUM
ihlr-16574	417	11	(	(	PUNCT
ihlr-16574	417	12	en	en	X
ihlr-16574	417	13	)	)	PUNCT
ihlr-16574	417	14	,	,	PUNCT
ihlr-16574	417	15	available	available	ADJ
ihlr-16574	417	16	at	at	ADP
ihlr-16574	417	17	http://eur	http://eur	NOUN
ihlr-16574	417	18	-	-	PUNCT
ihlr-16574	417	19	lex.europaeu!lexuriserv	lex.europaeu!lexuriserv	NOUN
ihlr-16574	417	20	/	/	SYM
ihlr-16574	417	21	lexuriserv.do?uri	lexuriserv.do?uri	NOUN
ihlr-16574	417	22	=	=	NOUN
ihlr-16574	417	23	consleg	consleg	NOUN
ihlr-16574	417	24	:	:	PUNCT
ihlr-16574	417	25	l993l	l993l	PROPN
ihlr-16574	417	26	0042:20071011	0042:20071011	NUM
ihlr-16574	417	27	:	:	PUNCT
ihlr-16574	417	28	en	en	X
ihlr-16574	417	29	:	:	PUNCT
ihlr-16574	417	30	pdf	pdf	NOUN
ihlr-16574	417	31	(	(	PUNCT
ihlr-16574	417	32	last	last	ADV
ihlr-16574	417	33	visited	visit	VERB
ihlr-16574	417	34	nov	nov	PROPN
ihlr-16574	417	35	.	.	PROPN
ihlr-16574	417	36	8	8	NUM
ihlr-16574	417	37	,	,	PUNCT
ihlr-16574	417	38	2008	2008	NUM
ihlr-16574	417	39	)	)	PUNCT
ihlr-16574	417	40	.	.	PUNCT
ihlr-16574	418	1	129	129	NUM
ihlr-16574	418	2	.	.	PUNCT
ihlr-16574	419	1	i	i	PRON
ihlr-16574	419	2	d.	d.	PROPN
ihlr-16574	419	3	130	130	NUM
ihlr-16574	419	4	.	.	PUNCT
ihlr-16574	420	1	guerra	guerra	PROPN
ihlr-16574	420	2	,	,	PUNCT
ihlr-16574	420	3	supra	supra	PROPN
ihlr-16574	420	4	note	note	PROPN
ihlr-16574	420	5	113	113	NUM
ihlr-16574	420	6	,	,	PUNCT
ihlr-16574	420	7	at	at	ADP
ihlr-16574	420	8	87	87	NUM
ihlr-16574	420	9	-	-	SYM
ihlr-16574	420	10	88	88	NUM
ihlr-16574	420	11	.	.	PUNCT
ihlr-16574	421	1	131	131	NUM
ihlr-16574	421	2	.	.	PUNCT
ihlr-16574	422	1	directive	directive	NOUN
ihlr-16574	422	2	98/79	98/79	NUM
ihlr-16574	422	3	,	,	PUNCT
ihlr-16574	422	4	in	in	ADP
ihlr-16574	422	5	vitro	vitro	X
ihlr-16574	422	6	diagnostic	diagnostic	ADJ
ihlr-16574	422	7	medical	medical	ADJ
ihlr-16574	422	8	devices	device	NOUN
ihlr-16574	422	9	,	,	PUNCT
ihlr-16574	422	10	art	art	NOUN
ihlr-16574	422	11	.	.	PUNCT
ihlr-16574	423	1	1	1	NUM
ihlr-16574	423	2	,	,	PUNCT
ihlr-16574	423	3	1998	1998	NUM
ihlr-16574	423	4	o.j	o.j	PROPN
ihlr-16574	423	5	.	.	PUNCT
ihlr-16574	424	1	(	(	PUNCT
ihlr-16574	424	2	l	l	NOUN
ihlr-16574	424	3	331	331	NUM
ihlr-16574	424	4	)	)	PUNCT
ihlr-16574	424	5	1	1	NUM
ihlr-16574	424	6	,	,	PUNCT
ihlr-16574	424	7	7	7	NUM
ihlr-16574	424	8	(	(	PUNCT
ihlr-16574	424	9	en	en	X
ihlr-16574	424	10	)	)	PUNCT
ihlr-16574	424	11	,	,	PUNCT
ihlr-16574	424	12	available	available	ADJ
ihlr-16574	424	13	at	at	ADP
ihlr-16574	424	14	http://eur-lex.europa.eu/lexuriserv/lexuriserv.do?uri=consleg:1998l	http://eur-lex.europa.eu/lexuriserv/lexuriserv.do?uri=consleg:1998l	PROPN
ihlr-16574	424	15	0079:20031120	0079:20031120	PUNCT
ihlr-16574	424	16	:	:	PUNCT
ihlr-16574	424	17	en	en	ADJ
ihlr-16574	424	18	:	:	PUNCT
ihlr-16574	424	19	pdf	pdf	NOUN
ihlr-16574	424	20	(	(	PUNCT
ihlr-16574	424	21	last	last	ADV
ihlr-16574	424	22	visited	visit	VERB
ihlr-16574	424	23	nov	nov	PROPN
ihlr-16574	424	24	.	.	PROPN
ihlr-16574	424	25	8	8	NUM
ihlr-16574	424	26	,	,	PUNCT
ihlr-16574	424	27	2008	2008	NUM
ihlr-16574	424	28	)	)	PUNCT
ihlr-16574	424	29	.	.	PUNCT
ihlr-16574	425	1	132	132	NUM
ihlr-16574	425	2	.	.	PUNCT
ihlr-16574	426	1	i	i	PROPN
ihlr-16574	426	2	d	d	PROPN
ihlr-16574	426	3	133	133	NUM
ihlr-16574	426	4	.	.	PUNCT
ihlr-16574	427	1	european	european	ADJ
ihlr-16574	427	2	technology	technology	PROPN
ihlr-16574	427	3	platform	platform	NOUN
ihlr-16574	427	4	on	on	ADP
ihlr-16574	427	5	nanomedicine	nanomedicine	ADJ
ihlr-16574	427	6	,	,	PUNCT
ihlr-16574	427	7	vision	vision	NOUN
ihlr-16574	427	8	paper	paper	NOUN
ihlr-16574	427	9	and	and	CCONJ
ihlr-16574	427	10	basis	basis	NOUN
ihlr-16574	427	11	for	for	ADP
ihlr-16574	427	12	a	a	DET
ihlr-16574	427	13	strategic	strategic	ADJ
ihlr-16574	427	14	research	research	NOUN
ihlr-16574	427	15	agenda	agenda	NOUN
ihlr-16574	427	16	for	for	ADP
ihlr-16574	427	17	nanomedicine	nanomedicine	NOUN
ihlr-16574	427	18	,	,	PUNCT
ihlr-16574	427	19	15	15	NUM
ihlr-16574	427	20	(	(	PUNCT
ihlr-16574	427	21	sept	sept	PROPN
ihlr-16574	427	22	.	.	PROPN
ihlr-16574	427	23	2005	2005	NUM
ihlr-16574	427	24	)	)	PUNCT
ihlr-16574	427	25	available	available	ADJ
ihlr-16574	427	26	at	at	ADP
ihlr-16574	427	27	http://www.etp­	http://www.etp­	PROPN
ihlr-16574	427	28	nanomedicine.eu/public/about/press-documentslpublicationsletp-nanomedicine-visionpaper	nanomedicine.eu/public/about/press-documentslpublicationsletp-nanomedicine-visionpaper	NOUN
ihlr-16574	428	1	[	[	X
ihlr-16574	428	2	hereinafter	hereinafter	NOUN
ihlr-16574	428	3	etpstrategic	etpstrategic	ADJ
ihlr-16574	428	4	research	research	NOUN
ihlr-16574	428	5	agenda	agenda	NOUN
ihlr-16574	428	6	]	]	PUNCT
ihlr-16574	428	7	.	.	PUNCT
ihlr-16574	429	1	134	134	NUM
ihlr-16574	429	2	.	.	PUNCT
ihlr-16574	430	1	guerra	guerra	PROPN
ihlr-16574	430	2	,	,	PUNCT
ihlr-16574	430	3	supra	supra	PROPN
ihlr-16574	430	4	note	note	PROPN
ihlr-16574	430	5	113	113	NUM
ihlr-16574	430	6	,	,	PUNCT
ihlr-16574	430	7	at	at	ADP
ihlr-16574	430	8	.	.	PUNCT
ihlr-16574	431	1	87	87	NUM
ihlr-16574	431	2	-	-	SYM
ihlr-16574	431	3	88	88	NUM
ihlr-16574	431	4	.	.	PUNCT
ihlr-16574	432	1	135	135	NUM
ihlr-16574	432	2	.	.	PUNCT
ihlr-16574	433	1	the	the	DET
ihlr-16574	433	2	europeantechnology	europeantechnology	NOUN
ihlr-16574	433	3	platforms	platform	NOUN
ihlr-16574	433	4	"	"	PUNCT
ihlr-16574	434	1	[	[	X
ihlr-16574	434	2	p]rovide	p]rovide	NOUN
ihlr-16574	434	3	a	a	DET
ihlr-16574	434	4	framework	framework	NOUN
ihlr-16574	434	5	for	for	ADP
ihlr-16574	434	6	stakeholders	stakeholder	NOUN
ihlr-16574	434	7	,	,	PUNCT
ihlr-16574	434	8	led	lead	VERB
ihlr-16574	434	9	by	by	ADP
ihlr-16574	434	10	industry	industry	NOUN
ihlr-16574	434	11	,	,	PUNCT
ihlr-16574	434	12	to	to	PART
ihlr-16574	434	13	define	define	VERB
ihlr-16574	434	14	research	research	NOUN
ihlr-16574	434	15	and	and	CCONJ
ihlr-16574	434	16	development	development	NOUN
ihlr-16574	434	17	priorities	priority	NOUN
ihlr-16574	434	18	,	,	PUNCT
ihlr-16574	434	19	timeframes	timeframe	NOUN
ihlr-16574	434	20	and	and	CCONJ
ihlr-16574	434	21	action	action	NOUN
ihlr-16574	434	22	plans	plan	NOUN
ihlr-16574	434	23	on	on	ADP
ihlr-16574	434	24	a	a	DET
ihlr-16574	434	25	number	number	NOUN
ihlr-16574	434	26	of	of	ADP
ihlr-16574	434	27	strategically	strategically	ADV
ihlr-16574	434	28	important	important	ADJ
ihlr-16574	434	29	issues	issue	NOUN
ihlr-16574	434	30	where	where	SCONJ
ihlr-16574	434	31	achieving	achieve	VERB
ihlr-16574	434	32	europe	europe	PROPN
ihlr-16574	434	33	's	's	PART
ihlr-16574	434	34	future	future	ADJ
ihlr-16574	434	35	growth	growth	NOUN
ihlr-16574	434	36	,	,	PUNCT
ihlr-16574	434	37	competi416	competi416	PROPN
ihlr-16574	434	38	indiana	indiana	PROPN
ihlr-16574	434	39	health	health	PROPN
ihlr-16574	434	40	law	law	PROPN
ihlr-16574	434	41	review	review	NOUN
ihlr-16574	434	42	scribes	scribe	VERB
ihlr-16574	434	43	the	the	DET
ihlr-16574	434	44	group	group	NOUN
ihlr-16574	434	45	's	's	PART
ihlr-16574	434	46	inception	inception	NOUN
ihlr-16574	434	47	and	and	CCONJ
ihlr-16574	434	48	objectives	objective	NOUN
ihlr-16574	434	49	:	:	PUNCT
ihlr-16574	434	50	can	can	AUX
ihlr-16574	434	51	important	important	ADJ
ihlr-16574	434	52	initiative	initiative	NOUN
ihlr-16574	434	53	,	,	PUNCT
ihlr-16574	434	54	.	.	PUNCT
ihlr-16574	435	1	led	lead	VERB
ihlr-16574	435	2	by	by	ADP
ihlr-16574	435	3	.industry	.industry	NOUN
ihlr-16574	435	4	;	;	PUNCT
ihlr-16574	435	5	has	have	AUX
ihlr-16574	435	6	been	be	AUX
ihlr-16574	435	7	set	set	VERB
ihlr-16574	435	8	up	up	ADP
ihlr-16574	435	9	together	together	ADV
ihlr-16574	435	10	with	with	ADP
ihlr-16574	435	11	the	the	DET
ihlr-16574	435	12	european	european	PROPN
ihlr-16574	435	13	commission	commission	PROPN
ihlr-16574	435	14	.	.	PUNCT
ihlr-16574	436	1	a	a	DET
ihlr-16574	436	2	group	group	NOUN
ihlr-16574	436	3	of	of	ADP
ihlr-16574	436	4	53	53	NUM
ihlr-16574	436	5	european	european	ADJ
ihlr-16574	436	6	stakeholders	stakeholder	NOUN
ihlr-16574	436	7	,	,	PUNCT
ihlr-16574	436	8	composed	compose	VERB
ihlr-16574	436	9	of	of	ADP
ihlr-16574	436	10	industrial	industrial	ADJ
ihlr-16574	436	11	·	·	SYM
ihlr-16574	436	12	and	and	CCONJ
ihlr-16574	436	13	academic	academic	ADJ
ihlr-16574	436	14	experts	expert	NOUN
ihlr-16574	436	15	,	,	PUNCT
ihlr-16574	436	16	has	have	AUX
ihlr-16574	436	17	established	establish	VERB
ihlr-16574	436	18	a	a	DET
ihlr-16574	436	19	european	european	ADJ
ihlr-16574	436	20	technology	technology	NOUN
ihlr-16574	436	21	platform	platform	NOUN
ihlr-16574	436	22	on	on	ADP
ihlr-16574	436	23	nanomedicine	nanomedicine	NOUN
ihlr-16574	436	24	.	.	PUNCT
ihlr-16574	437	1	the	the	DET
ihlr-16574	437	2	first	first	ADJ
ihlr-16574	437	3	task	task	NOUN
ihlr-16574	437	4	of	of	ADP
ihlr-16574	437	5	this	this	DET
ihlr-16574	437	6	high	high	ADJ
ihlr-16574	437	7	level	level	NOUN
ihlr-16574	437	8	group	group	NOUN
ihlr-16574	437	9	was	be	AUX
ihlr-16574	437	10	to	to	PART
ihlr-16574	437	11	write	write	VERB
ihlr-16574	437	12	a	a	DET
ihlr-16574	437	13	vision	vision	NOUN
ihlr-16574	437	14	docu­	docu­	NOUN
ihlr-16574	437	15	ment	ment	NOUN
ihlr-16574	437	16	for	for	ADP
ihlr-16574	437	17	this	this	DET
ihlr-16574	437	18	highly	highly	ADV
ihlr-16574	437	19	future	future	ADJ
ihlr-16574	437	20	-	-	PUNCT
ihlr-16574	437	21	oriented	orient	VERB
ihlr-16574	437	22	area	area	NOUN
ihlr-16574	437	23	of	of	ADP
ihlr-16574	437	24	nanotech­	nanotech­	PROPN
ihlr-16574	437	25	nology	nology	NOUN
ihlr-16574	437	26	-	-	PUNCT
ihlr-16574	437	27	based	base	VERB
ihlr-16574	437	28	healthcare	healthcare	NOUN
ihlr-16574	437	29	in	in	ADP
ihlr-16574	437	30	which	which	PRON
ihlr-16574	437	31	experts	expert	NOUN
ihlr-16574	437	32	describe	describe	VERB
ihlr-16574	437	33	an	an	DET
ihlr-16574	437	34	extrapolation	extrapolation	NOUN
ihlr-16574	437	35	of	of	ADP
ihlr-16574	437	36	needs	need	NOUN
ihlr-16574	437	37	and	and	CCONJ
ihlr-16574	437	38	possibilities	possibility	NOUN
ihlr-16574	437	39	until	until	ADP
ihlr-16574	437	40	2020	2020	NUM
ihlr-16574	437	41	.	.	PUNCT
ihlr-16574	438	1	beginning	begin	VERB
ihlr-16574	438	2	of	of	ADP
ihlr-16574	438	3	2006	2006	NUM
ihlr-16574	438	4	this	this	DET
ihlr-16574	438	5	platform	platform	NOUN
ihlr-16574	438	6	has	have	AUX
ihlr-16574	438	7	been	be	AUX
ihlr-16574	438	8	opened	open	VERB
ihlr-16574	438	9	to	to	ADP
ihlr-16574	438	10	a	a	DET
ihlr-16574	438	11	wider	wide	ADJ
ihlr-16574	438	12	participation	participation	NOUN
ihlr-16574	438	13	(	(	PUNCT
ihlr-16574	438	14	december	december	PROPN
ihlr-16574	438	15	2006	2006	NUM
ihlr-16574	438	16	:	:	PUNCT
ihlr-16574	438	17	150	150	NUM
ihlr-16574	438	18	·	·	PUNCT
ihlr-16574	438	19	member	member	NOUN
ihlr-16574	438	20	or	or	CCONJ
ihlr-16574	438	21	.	.	PUNCT
ihlr-16574	439	1	ganisations	ganisation	NOUN
ihlr-16574	439	2	)	)	PUNCT
ihlr-16574	440	1	and	and	CCONJ
ihlr-16574	440	2	has	have	AUX
ihlr-16574	440	3	delivered	deliver	VERB
ihlr-16574	440	4	a	a	DET
ihlr-16574	440	5	so	so	ADV
ihlr-16574	440	6	-	-	PUNCT
ihlr-16574	440	7	called	call	VERB
ihlr-16574	440	8	strategic	strategic	ADJ
ihlr-16574	440	9	research	research	NOUN
ihlr-16574	440	10	agenda	agenda	NOUN
ihlr-16574	440	11	showing	show	VERB
ihlr-16574	440	12	a	a	DET
ihlr-16574	440	13	well	well	ADV
ihlr-16574	440	14	elabqrated	elabqrate	VERB
ihlr-16574	440	15	common	common	ADJ
ihlr-16574	440	16	european	european	ADJ
ihlr-16574	440	17	way	way	NOUN
ihlr-16574	440	18	of	of	ADP
ihlr-16574	440	19	working	work	VERB
ihlr-16574	440	20	together	together	ADV
ihlr-16574	440	21	for	for	ADP
ihlr-16574	440	22	the	the	DET
ihlr-16574	440	23	healthcare	healthcare	NOUN
ihlr-16574	440	24	of	of	ADP
ihlr-16574	440	25	the	the	DET
ihlr-16574	440	26	future	future	NOUN
ihlr-16574	440	27	trying	try	VERB
ihlr-16574	440	28	to	to	PART
ihlr-16574	440	29	match	match	VERB
ihlr-16574	440	30	the	the	DET
ihlr-16574	440	31	high	high	ADJ
ihlr-16574	440	32	expectations	expectation	NOUN
ihlr-16574	440	33	that	that	PRON
ihlr-16574	440	34	nanomedicine	nanomedicine	NOUN
ihlr-16574	440	35	has	have	AUX
ihlr-16574	440	36	raised	raise	VERB
ihlr-16574	440	37	so	so	ADV
ihlr-16574	440	38	far	far	ADV
ihlr-16574	440	39	.	.	PUNCT
ihlr-16574	441	1	[	[	X
ihlr-16574	441	2	vol	vol	NOUN
ihlr-16574	441	3	.	.	PUNCT
ihlr-16574	442	1	7:397	7:397	NUM
ihlr-16574	442	2	the	the	DET
ihlr-16574	442	3	etp	etp	PROPN
ihlr-16574	442	4	's	's	PART
ihlr-16574	442	5	2005	2005	NUM
ihlr-16574	442	6	vision	vision	NOUN
ihlr-16574	442	7	document	document	NOUN
ihlr-16574	442	8	focuses	focus	VERB
ihlr-16574	442	9	on	on	ADP
ihlr-16574	442	10	three	three	NUM
ihlr-16574	442	11	specific	specific	ADJ
ihlr-16574	442	12	areas	area	NOUN
ihlr-16574	442	13	of	of	ADP
ihlr-16574	442	14	nanomedicine	nanomedicine	NOUN
ihlr-16574	442	15	:	:	PUNCT
ihlr-16574	442	16	1	1	NUM
ihlr-16574	442	17	)	)	PUNCT
ihlr-16574	442	18	in	in	ADP
ihlr-16574	442	19	vitro	vitro	X
ihlr-16574	442	20	diagnostics	diagnostic	NOUN
ihlr-16574	442	21	,	,	PUNCT
ihlr-16574	442	22	2	2	NUM
ihlr-16574	442	23	)	)	PUNCT
ihlr-16574	442	24	targeted	target	VERB
ihlr-16574	442	25	drug	drug	NOUN
ihlr-16574	442	26	delivery	delivery	NOUN
ihlr-16574	442	27	and	and	CCONJ
ihlr-16574	442	28	release	release	NOUN
ihlr-16574	442	29	(	(	PUNCT
ihlr-16574	442	30	currently	currently	ADV
ihlr-16574	442	31	in	in	ADP
ihlr-16574	442	32	public	public	ADJ
ihlr-16574	442	33	use	use	NOUN
ihlr-16574	442	34	)	)	PUNCT
ihlr-16574	442	35	,	,	PUNCT
ihlr-16574	442	36	and	and	CCONJ
ihlr-16574	442	37	3	3	X
ihlr-16574	442	38	)	)	PUNCT
ihlr-16574	442	39	regenerative	regenerative	ADJ
ihlr-16574	442	40	medicine;136	medicine;136	PROPN
ihlr-16574	442	41	the	the	DET
ihlr-16574	442	42	vision	vision	PROPN
ihlr-16574	442	43	doc­	doc­	PROPN
ihlr-16574	442	44	ument	ument	NOUN
ihlr-16574	442	45	sets	set	VERB
ihlr-16574	442	46	forth	forth	ADP
ihlr-16574	442	47	specific	specific	ADJ
ihlr-16574	442	48	goals	goal	NOUN
ihlr-16574	442	49	in	in	ADP
ihlr-16574	442	50	each	each	PRON
ihlr-16574	442	51	of	of	ADP
ihlr-16574	442	52	the	the	DET
ihlr-16574	442	53	three	three	NUM
ihlr-16574	442	54	defined	define	VERB
ihlr-16574	442	55	areas	area	NOUN
ihlr-16574	442	56	,	,	PUNCT
ihlr-16574	442	57	to	to	PART
ihlr-16574	442	58	be	be	AUX
ihlr-16574	442	59	achieved	achieve	VERB
ihlr-16574	442	60	by	by	ADP
ihlr-16574	442	61	the	the	DET
ihlr-16574	442	62	year	year	NOUN
ihlr-16574	442	63	2020	2020	NUM
ihlr-16574	442	64	:	:	PUNCT
ihlr-16574	442	65	1	1	X
ihlr-16574	442	66	)	)	PUNCT
ihlr-16574	442	67	nanodiagnostics"[m]ultimodal	nanodiagnostics"[m]ultimodal	NOUN
ihlr-16574	442	68	~eras	~eras	PUNCT
ihlr-16574	442	69	for	for	ADP
ihlr-16574	442	70	medical	medical	ADJ
ihlr-16574	442	71	imaging	imaging	NOUN
ihlr-16574	442	72	,	,	PUNCT
ihlr-16574	442	73	"	"	PUNCT
ihlr-16574	442	74	2	2	X
ihlr-16574	442	75	)	)	PUNCT
ihlr-16574	442	76	targeted	target	VERB
ihlr-16574	442	77	drug	drug	NOUN
ihlr-16574	442	78	delivery	delivery	NOUN
ihlr-16574	442	79	"	"	PUNCT
ihlr-16574	443	1	[	[	PUNCT
ihlr-16574	443	2	m]ulti	m]ulti	NOUN
ihlr-16574	443	3	-	-	ADJ
ihlr-16574	443	4	reservoir	reservoir	NOUN
ihlr-16574	443	5	drug	drug	NOUN
ihlr-16574	443	6	deli­	deli­	PROPN
ihlr-16574	443	7	very	very	ADJ
ihlr-16574	443	8	microchips	microchip	NOUN
ihlr-16574	443	9	,	,	PUNCT
ihlr-16574	443	10	"	"	PUNCT
ihlr-16574	443	11	3	3	X
ihlr-16574	443	12	)	)	PUNCT
ihlr-16574	443	13	regenerative	regenerative	ADJ
ihlr-16574	443	14	medicine	medicine	NOUN
ihlr-16574	443	15	"	"	PUNCT
ihlr-16574	443	16	[	[	X
ihlr-16574	443	17	n]erve	n]erve	NOUN
ihlr-16574	443	18	regeneration	regeneration	NOUN
ihlr-16574	443	19	for	for	ADP
ihlr-16574	443	20	spinal	spinal	NOUN
ihlr-16574	443	21	and	and	CCONJ
ihlr-16574	443	22	limb	limb	NOUN
ihlr-16574	443	23	repair	repair	NOUN
ihlr-16574	443	24	.	.	PUNCT
ihlr-16574	444	1	"137	"137	NOUN
ihlr-16574	444	2	3	3	NUM
ihlr-16574	444	3	.	.	PUNCT
ihlr-16574	445	1	considering	consider	VERB
ihlr-16574	445	2	regulation	regulation	NOUN
ihlr-16574	445	3	in	in	ADP
ihlr-16574	445	4	its	its	PRON
ihlr-16574	445	5	2005	2005	NUM
ihlr-16574	445	6	vision	vision	NOUN
ihlr-16574	445	7	document	document	NOUN
ihlr-16574	445	8	the	the	DET
ihlr-16574	445	9	etp	etp	PROPN
ihlr-16574	445	10	discussed	discuss	VERB
ihlr-16574	445	11	the	the	DET
ihlr-16574	445	12	need	need	NOUN
ihlr-16574	445	13	for	for	ADP
ihlr-16574	445	14	more	more	ADJ
ihlr-16574	445	15	re­	re­	NOUN
ihlr-16574	445	16	search	search	NOUN
ihlr-16574	445	17	and	and	CCONJ
ihlr-16574	445	18	development	development	NOUN
ihlr-16574	445	19	of	of	ADP
ihlr-16574	445	20	nanomedicine	nanomedicine	NOUN
ihlr-16574	445	21	before	before	ADP
ihlr-16574	445	22	incorporating	incorporate	VERB
ihlr-16574	445	23	new	new	ADJ
ihlr-16574	445	24	lan­	lan­	NOUN
ihlr-16574	445	25	guage	guage	NOUN
ihlr-16574	445	26	into	into	ADP
ihlr-16574	445	27	regulation.138	regulation.138	NOUN
ihlr-16574	445	28	it	it	PRON
ihlr-16574	445	29	stated	state	VERB
ihlr-16574	445	30	:	:	PUNCT
ihlr-16574	445	31	[	[	X
ihlr-16574	445	32	i]t	i]t	NOUN
ihlr-16574	445	33	is	be	AUX
ihlr-16574	445	34	necessary	necessary	ADJ
ihlr-16574	445	35	to	to	PART
ihlr-16574	445	36	put	put	VERB
ihlr-16574	445	37	into	into	ADP
ihlr-16574	445	38	place	place	NOUN
ihlr-16574	445	39	measures	measure	NOUN
ihlr-16574	445	40	that	that	PRON
ihlr-16574	445	41	identify	identify	VERB
ihlr-16574	445	42	the	the	DET
ihlr-16574	445	43	hazards	hazard	NOUN
ihlr-16574	445	44	as­	as­	NOUN
ihlr-16574	445	45	sociated	sociate	VERB
ihlr-16574	445	46	with	with	ADP
ihlr-16574	445	47	novel	novel	ADJ
ihlr-16574	445	48	nanotechnology	nanotechnology	NOUN
ihlr-16574	445	49	-	-	PUNCT
ihlr-16574	445	50	based	base	VERB
ihlr-16574	445	51	therapies	therapy	NOUN
ihlr-16574	445	52	,	,	PUNCT
ihlr-16574	445	53	characterize	characterize	VERB
ihlr-16574	445	54	the	the	DET
ihlr-16574	445	55	asso­	asso­	PROPN
ihlr-16574	445	56	ciated	ciate	VERB
ihlr-16574	445	57	risks	risk	NOUN
ihlr-16574	445	58	,	,	PUNCT
ihlr-16574	445	59	reduce	reduce	VERB
ihlr-16574	445	60	those	those	DET
ihlr-16574	445	61	risks	risk	NOUN
ihlr-16574	445	62	as	as	ADV
ihlr-16574	445	63	far	far	ADV
ihlr-16574	445	64	as	as	SCONJ
ihlr-16574	445	65	reasonably	reasonably	ADV
ihlr-16574	445	66	practicable	practicable	ADJ
ihlr-16574	445	67	,	,	PUNCT
ihlr-16574	445	68	establish	establish	VERB
ihlr-16574	445	69	a	a	DET
ihlr-16574	445	70	positive	positive	ADJ
ihlr-16574	445	71	risk	risk	NOUN
ihlr-16574	445	72	/	/	SYM
ihlr-16574	445	73	benefit	benefit	NOUN
ihlr-16574	445	74	balance	balance	NOUN
ihlr-16574	445	75	,	,	PUNCT
ihlr-16574	445	76	and	and	CCONJ
ihlr-16574	445	77	communicate	communicate	VERB
ihlr-16574	445	78	the	the	DET
ihlr-16574	445	79	nature	nature	NOUN
ihlr-16574	445	80	of	of	ADP
ihlr-16574	445	81	any	any	DET
ihlr-16574	445	82	residual	residual	ADJ
ihlr-16574	445	83	risks	risk	NOUN
ihlr-16574	445	84	and	and	CCONJ
ihlr-16574	445	85	other	other	ADJ
ihlr-16574	445	86	relevant	relevant	ADJ
ihlr-16574	445	87	safety	safety	NOUN
ihlr-16574	445	88	information	information	NOUN
ihlr-16574	445	89	to	to	ADP
ihlr-16574	445	90	doctors	doctor	NOUN
ihlr-16574	445	91	,	,	PUNCT
ihlr-16574	445	92	patients	patient	NOUN
ihlr-16574	445	93	and	and	CCONJ
ihlr-16574	445	94	other	other	ADJ
ihlr-16574	445	95	key	key	ADJ
ihlr-16574	445	96	tiveness	tiveness	ADJ
ihlr-16574	445	97	and	and	CCONJ
ihlr-16574	445	98	sustainability	sustainability	NOUN
ihlr-16574	445	99	objectives	objective	NOUN
ihlr-16574	445	100	is	be	AUX
ihlr-16574	445	101	dependent	dependent	ADJ
ihlr-16574	445	102	upon	upon	SCONJ
ihlr-16574	445	103	major	major	ADJ
ihlr-16574	445	104	research	research	NOUN
ihlr-16574	445	105	and	and	CCONJ
ihlr-16574	445	106	technological	technological	ADJ
ihlr-16574	445	107	advances	advance	NOUN
ihlr-16574	445	108	in	in	ADP
ihlr-16574	445	109	the	the	DET
ihlr-16574	445	110	medium	medium	NOUN
ihlr-16574	445	111	to	to	ADP
ihlr-16574	445	112	long	long	ADJ
ihlr-16574	445	113	term.~	term.~	NOUN
ihlr-16574	446	1	european	european	PROPN
ihlr-16574	446	2	technology	technology	PROPN
ihlr-16574	446	3	platforms	platform	NOUN
ihlr-16574	446	4	,	,	PUNCT
ihlr-16574	446	5	welcome	welcome	VERB
ihlr-16574	446	6	to	to	ADP
ihlr-16574	446	7	th_e	th_e	NUM
ihlr-16574	446	8	european	european	ADJ
ihlr-16574	446	9	technology	technology	NOUN
ihlr-16574	446	10	platforms	platform	NOUN
ihlr-16574	446	11	,	,	PUNCT
ihlr-16574	446	12	available	available	ADJ
ihlr-16574	446	13	at	at	ADP
ihlr-16574	446	14	http://cordis.europa.eu/technology-platforms/	http://cordis.europa.eu/technology-platforms/	X
ihlr-16574	446	15	(	(	PUNCT
ihlr-16574	446	16	last	last	ADJ
ihlr-16574	446	17	visited	visit	VERB
ihlr-16574	446	18	mar	mar	PROPN
ihlr-16574	446	19	.	.	PROPN
ihlr-16574	446	20	12	12	NUM
ihlr-16574	446	21	,	,	PUNCT
ihlr-16574	446	22	2009	2009	NUM
ihlr-16574	446	23	)	)	PUNCT
ihlr-16574	446	24	.	.	PUNCT
ihlr-16574	447	1	136	136	NUM
ihlr-16574	447	2	.	.	PUNCT
ihlr-16574	448	1	etp	etp	PROPN
ihlr-16574	448	2	strategic	strategic	PROPN
ihlr-16574	448	3	researcha.genda	researcha.genda	PROPN
ihlr-16574	448	4	,	,	PUNCT
ihlr-16574	448	5	supranote	supranote	VERB
ihlr-16574	448	6	133	133	NUM
ihlr-16574	448	7	,	,	PUNCT
ihlr-16574	448	8	at4	at4	PROPN
ihlr-16574	448	9	.	.	PROPN
ihlr-16574	448	10	137	137	NUM
ihlr-16574	448	11	.	.	PUNCT
ihlr-16574	449	1	i	i	PRON
ihlr-16574	449	2	d	d	PROPN
ihlr-16574	449	3	138	138	NUM
ihlr-16574	449	4	.	.	PUNCT
ihlr-16574	450	1	i	i	PRON
ihlr-16574	450	2	d	d	PROPN
ihlr-16574	450	3	2010	2010	NUM
ihlr-16574	450	4	]	]	PUNCT
ihlr-16574	450	5	nanomedicine	nanomedicine	NOUN
ihlr-16574	450	6	417	417	NUM
ihlr-16574	450	7	stakeholders.139	stakeholders.139	NOUN
ihlr-16574	450	8	this	this	DET
ihlr-16574	450	9	language	language	NOUN
ihlr-16574	450	10	seems	seem	VERB
ihlr-16574	450	11	to	to	PART
ihlr-16574	450	12	indicate	indicate	VERB
ihlr-16574	450	13	a	a	DET
ihlr-16574	450	14	framework	framework	NOUN
ihlr-16574	450	15	for	for	ADP
ihlr-16574	450	16	analysis	analysis	NOUN
ihlr-16574	450	17	of	of	ADP
ihlr-16574	450	18	regulato­	regulato­	ADP
ihlr-16574	450	19	ry	ry	NOUN
ihlr-16574	450	20	issues	issue	NOUN
ihlr-16574	450	21	that	that	PRON
ihlr-16574	450	22	begins	begin	VERB
ihlr-16574	450	23	with	with	ADP
ihlr-16574	450	24	the	the	DET
ihlr-16574	450	25	identification	identification	NOUN
ihlr-16574	450	26	of	of	ADP
ihlr-16574	450	27	risks	risk	NOUN
ihlr-16574	450	28	and	and	CCONJ
ihlr-16574	450	29	ends	end	VERB
ihlr-16574	450	30	with	with	ADP
ihlr-16574	450	31	a	a	DET
ihlr-16574	450	32	reduc­	reduc­	NOUN
ihlr-16574	450	33	tion	tion	NOUN
ihlr-16574	450	34	of	of	ADP
ihlr-16574	450	35	those	those	DET
ihlr-16574	450	36	risks	risk	NOUN
ihlr-16574	450	37	.	.	PUNCT
ihlr-16574	451	1	140	140	NUM
ihlr-16574	451	2	crucial	crucial	ADJ
ihlr-16574	451	3	to	to	ADP
ihlr-16574	451	4	this	this	DET
ihlr-16574	451	5	framework	framework	NOUN
ihlr-16574	451	6	is	be	AUX
ihlr-16574	451	7	the	the	DET
ihlr-16574	451	8	dissemination	dissemination	NOUN
ihlr-16574	451	9	of	of	ADP
ihlr-16574	451	10	the	the	DET
ihlr-16574	451	11	risk	risk	NOUN
ihlr-16574	451	12	/	/	SYM
ihlr-16574	451	13	benefit	benefit	NOUN
ihlr-16574	451	14	analysis	analysis	NOUN
ihlr-16574	451	15	to	to	ADP
ihlr-16574	451	16	patients	patient	NOUN
ihlr-16574	451	17	,	,	PUNCT
ihlr-16574	451	18	doctors	doctor	NOUN
ihlr-16574	451	19	,	,	PUNCT
ihlr-16574	451	20	and	and	CCONJ
ihlr-16574	451	21	decision	decision	NOUN
ihlr-16574	451	22	makers	maker	NOUN
ihlr-16574	451	23	.	.	PUNCT
ihlr-16574	452	1	·	·	PUNCT
ihlr-16574	452	2	this	this	DET
ihlr-16574	452	3	point	point	NOUN
ihlr-16574	452	4	touches	touch	VERB
ihlr-16574	452	5	back	back	ADV
ihlr-16574	452	6	upon	upon	SCONJ
ihlr-16574	452	7	the	the	DET
ihlr-16574	452	8	ethical	ethical	ADJ
ihlr-16574	452	9	concerns	concern	NOUN
ihlr-16574	452	10	posed	pose	VERB
ihlr-16574	452	11	by	by	ADP
ihlr-16574	452	12	some	some	PRON
ihlr-16574	452	13	who	who	PRON
ihlr-16574	452	14	deal	deal	VERB
ihlr-16574	452	15	with	with	ADP
ihlr-16574	452	16	in­	in­	NOUN
ihlr-16574	452	17	formed	form	VERB
ihlr-16574	452	18	consent	consent	NOUN
ihlr-16574	452	19	and	and	CCONJ
ihlr-16574	452	20	a	a	DET
ihlr-16574	452	21	patient	patient	NOUN
ihlr-16574	452	22	's	's	PART
ihlr-16574	452	23	ability	ability	NOUN
ihlr-16574	452	24	to	to	PART
ihlr-16574	452	25	give	give	VERB
ihlr-16574	452	26	such	such	ADJ
ihlr-16574	452	27	consent	consent	NOUN
ihlr-16574	452	28	if	if	SCONJ
ihlr-16574	452	29	the	the	DET
ihlr-16574	452	30	risks	risk	NOUN
ihlr-16574	452	31	of	of	ADP
ihlr-16574	452	32	nanomedicine	nanomedicine	NOUN
ihlr-16574	452	33	are	be	AUX
ihlr-16574	452	34	largely	largely	ADV
ihlr-16574	452	35	unpredictable	unpredictable	ADJ
ihlr-16574	452	36	or	or	CCONJ
ihlr-16574	452	37	altogether	altogether	ADV
ihlr-16574	452	38	unknown.141	unknown.141	ADJ
ihlr-16574	452	39	4	4	NUM
ihlr-16574	452	40	.	.	PUNCT
ihlr-16574	452	41	focus	focus	NOUN
ihlr-16574	452	42	of	of	ADP
ihlr-16574	452	43	research	research	NOUN
ihlr-16574	452	44	and	and	CCONJ
ihlr-16574	452	45	development	development	NOUN
ihlr-16574	452	46	the	the	DET
ihlr-16574	452	47	etc	etc	NOUN
ihlr-16574	452	48	has	have	AUX
ihlr-16574	452	49	chosen	choose	VERB
ihlr-16574	452	50	a	a	DET
ihlr-16574	452	51	list	list	NOUN
ihlr-16574	452	52	of	of	ADP
ihlr-16574	452	53	diseases	disease	NOUN
ihlr-16574	452	54	on	on	ADP
ihlr-16574	452	55	which	which	PRON
ihlr-16574	452	56	to	to	PART
ihlr-16574	452	57	focus	focus	VERB
ihlr-16574	452	58	research	research	NOUN
ihlr-16574	452	59	and	and	CCONJ
ihlr-16574	452	60	development	development	NOUN
ihlr-16574	452	61	of	of	ADP
ihlr-16574	452	62	nanomedicine	nanomedicine	NOUN
ihlr-16574	452	63	.	.	PUNCT
ihlr-16574	453	1	it	it	PRON
ihlr-16574	453	2	states	state	VERB
ihlr-16574	453	3	,	,	PUNCT
ihlr-16574	453	4	"	"	PUNCT
ihlr-16574	453	5	[	[	X
ihlr-16574	453	6	t]his	t]his	DET
ihlr-16574	453	7	strategic	strategic	ADJ
ihlr-16574	453	8	research	research	NOUN
ihlr-16574	453	9	agenda	agenda	NOUN
ihlr-16574	453	10	addresses	address	VERB
ihlr-16574	453	11	a	a	DET
ihlr-16574	453	12	choice	choice	NOUN
ihlr-16574	453	13	of	of	ADP
ihlr-16574	453	14	diseases	disease	NOUN
ihlr-16574	453	15	,	,	PUNCT
ihlr-16574	453	16	selected	select	VERB
ihlr-16574	453	17	by	by	ADP
ihlr-16574	453	18	their	their	PRON
ihlr-16574	453	19	impact	impact	NOUN
ihlr-16574	453	20	on	on	ADP
ihlr-16574	453	21	patients	patient	NOUN
ihlr-16574	453	22	,	,	PUNCT
ihlr-16574	453	23	their	their	PRON
ihlr-16574	453	24	prevalence	prevalence	NOUN
ihlr-16574	453	25	and	and	CCONJ
ihlr-16574	453	26	burden	burden	NOUN
ihlr-16574	453	27	to	to	ADP
ihlr-16574	453	28	society	society	NOUN
ihlr-16574	453	29	,	,	PUNCT
ihlr-16574	453	30	and	and	CCONJ
ihlr-16574	453	31	by	by	ADP
ihlr-16574	453	32	the	the	DET
ihlr-16574	453	33	expected	expect	VERB
ihlr-16574	453	34	beneficial	beneficial	ADJ
ihlr-16574	453	35	impact	impact	NOUN
ihlr-16574	453	36	nanomedicine	nanomedicine	NOUN
ihlr-16574	453	37	is	be	AUX
ihlr-16574	453	38	likely	likely	ADJ
ihlr-16574	453	39	to	to	PART
ihlr-16574	453	40	have	have	VERB
ihlr-16574	453	41	on	on	ADP
ihlr-16574	453	42	them	they	PRON
ihlr-16574	453	43	in	in	ADP
ihlr-16574	453	44	the	the	DET
ihlr-16574	453	45	near	near	ADJ
ihlr-16574	453	46	future	future	NOUN
ihlr-16574	453	47	.	.	PUNCT
ihlr-16574	454	1	"142	"142	PROPN
ihlr-16574	454	2	this	this	DET
ihlr-16574	454	3	pointed	point	VERB
ihlr-16574	454	4	commitment	commitment	NOUN
ihlr-16574	454	5	to	to	ADP
ihlr-16574	454	6	nanomedicine	nanomedicine	ADJ
ihlr-16574	454	7	research	research	NOUN
ihlr-16574	454	8	and	and	CCONJ
ihlr-16574	454	9	development	development	NOUN
ihlr-16574	454	10	is	be	AUX
ihlr-16574	454	11	decidedly	decidedly	ADV
ihlr-16574	454	12	absent	absent	ADJ
ihlr-16574	454	13	from	from	ADP
ihlr-16574	454	14	efforts	effort	NOUN
ihlr-16574	454	15	in	in	ADP
ihlr-16574	454	16	the	the	DET
ihlr-16574	454	17	u.s	u.s	PROPN
ihlr-16574	454	18	.	.	PROPN
ihlr-16574	454	19	iii	iii	PROPN
ihlr-16574	454	20	.	.	PUNCT
ihlr-16574	454	21	analysis	analysis	NOUN
ihlr-16574	454	22	:	:	PUNCT
ihlr-16574	454	23	strategy	strategy	NOUN
ihlr-16574	454	24	for	for	ADP
ihlr-16574	454	25	governance	governance	NOUN
ihlr-16574	454	26	overnanomedicine	overnanomedicine	NOUN
ihlr-16574	454	27	a.	a.	NOUN
ihlr-16574	454	28	the	the	DET
ihlr-16574	454	29	trouble	trouble	NOUN
ihlr-16574	454	30	with	with	ADP
ihlr-16574	454	31	regulating	regulate	VERB
ihlr-16574	454	32	too	too	ADV
ihlr-16574	454	33	early	early	ADV
ihlr-16574	454	34	the	the	DET
ihlr-16574	454	35	first	first	ADJ
ihlr-16574	454	36	step	step	NOUN
ihlr-16574	454	37	for	for	ADP
ihlr-16574	454	38	providing	provide	VERB
ihlr-16574	454	39	meaningful	meaningful	ADJ
ihlr-16574	454	40	regulation	regulation	NOUN
ihlr-16574	454	41	of	of	ADP
ihlr-16574	454	42	nanomedicine	nanomedicine	NOUN
ihlr-16574	454	43	in	in	ADP
ihlr-16574	454	44	the	the	DET
ihlr-16574	454	45	future	future	NOUN
ihlr-16574	454	46	will	will	AUX
ihlr-16574	454	47	be	be	AUX
ihlr-16574	454	48	a	a	DET
ihlr-16574	454	49	restraint	restraint	NOUN
ihlr-16574	454	50	on	on	ADP
ihlr-16574	454	51	regulating	regulate	VERB
ihlr-16574	454	52	the	the	DET
ihlr-16574	454	53	technology	technology	NOUN
ihlr-16574	454	54	too	too	ADV
ihlr-16574	454	55	early	early	ADV
ihlr-16574	454	56	.	.	PUNCT
ihlr-16574	455	1	regula­	regula­	PROPN
ihlr-16574	455	2	tion	tion	NOUN
ihlr-16574	455	3	that	that	PRON
ihlr-16574	455	4	arrives	arrive	VERB
ihlr-16574	455	5	before	before	SCONJ
ihlr-16574	455	6	the	the	DET
ihlr-16574	455	7	technology	technology	NOUN
ihlr-16574	455	8	is	be	AUX
ihlr-16574	455	9	even	even	ADV
ihlr-16574	455	10	fully	fully	ADV
ihlr-16574	455	11	understood	understand	VERB
ihlr-16574	455	12	or	or	CCONJ
ihlr-16574	455	13	its	its	PRON
ihlr-16574	455	14	poten­	poten­	PROPN
ihlr-16574	455	15	tial	tial	NOUN
ihlr-16574	455	16	fully	fully	ADV
ihlr-16574	455	17	realized	realize	VERB
ihlr-16574	455	18	will	will	AUX
ihlr-16574	455	19	function	function	VERB
ihlr-16574	455	20	to	to	PART
ihlr-16574	455	21	hinder	hinder	VERB
ihlr-16574	455	22	the	the	DET
ihlr-16574	455	23	further	further	ADJ
ihlr-16574	455	24	development	development	NOUN
ihlr-16574	455	25	of	of	ADP
ihlr-16574	455	26	the	the	DET
ihlr-16574	455	27	technologystifling	technologystifle	VERB
ihlr-16574	455	28	it	it	PRON
ihlr-16574	455	29	at	at	ADP
ihlr-16574	455	30	the	the	DET
ihlr-16574	455	31	outset	outset	NOUN
ihlr-16574	455	32	.	.	PUNCT
ihlr-16574	456	1	1	1	X
ihlr-16574	456	2	.	.	X
ihlr-16574	456	3	in	in	ADP
ihlr-16574	456	4	the	the	DET
ihlr-16574	456	5	united	united	PROPN
ihlr-16574	456	6	states	states	PROPN
ihlr-16574	456	7	currently	currently	ADV
ihlr-16574	456	8	,	,	PUNCT
ihlr-16574	456	9	nanotechnology	nanotechnology	NOUN
ihlr-16574	456	10	in	in	ADP
ihlr-16574	456	11	the	the	DET
ihlr-16574	456	12	u.s	u.s	PROPN
ihlr-16574	456	13	.	.	PROPN
ihlr-16574	456	14	is	be	AUX
ihlr-16574	456	15	regulated	regulate	VERB
ihlr-16574	456	16	exclusively	exclusively	ADV
ihlr-16574	456	17	under	under	ADP
ihlr-16574	456	18	the	the	DET
ihlr-16574	456	19	rubric	rubric	NOUN
ihlr-16574	456	20	and	and	CCONJ
ihlr-16574	456	21	guidance	guidance	NOUN
ihlr-16574	456	22	of	of	ADP
ihlr-16574	456	23	the	the	DET
ihlr-16574	456	24	fda.143	fda.143	NOUN
ihlr-16574	456	25	"	"	PUNCT
ihlr-16574	456	26	potential	potential	ADJ
ihlr-16574	456	27	applications	application	NOUN
ihlr-16574	456	28	[	[	X
ihlr-16574	456	29	for	for	ADP
ihlr-16574	456	30	fda	fda	PROPN
ihlr-16574	456	31	approval	approval	PROPN
ihlr-16574	456	32	]	]	PUNCT
ihlr-16574	456	33	are	be	AUX
ihlr-16574	456	34	expected	expect	VERB
ihlr-16574	456	35	to	to	PART
ihlr-16574	456	36	include	include	VERB
ihlr-16574	456	37	products	product	NOUN
ihlr-16574	456	38	such	such	ADJ
ihlr-16574	456	39	as	as	ADP
ihlr-16574	456	40	drugs	drug	NOUN
ihlr-16574	456	41	,	,	PUNCT
ihlr-16574	456	42	medical	medical	ADJ
ihlr-16574	456	43	devices	device	NOUN
ihlr-16574	456	44	,	,	PUNCT
ihlr-16574	456	45	biotechnology	biotechnology	NOUN
ihlr-16574	456	46	products	product	NOUN
ihlr-16574	456	47	,	,	PUNCT
ihlr-16574	456	48	tissue	tissue	NOUN
ihlr-16574	456	49	engineering	engineering	NOUN
ihlr-16574	456	50	products	product	NOUN
ihlr-16574	456	51	,	,	PUNCT
ihlr-16574	456	52	vaccines	vaccine	NOUN
ihlr-16574	456	53	,	,	PUNCT
ihlr-16574	456	54	cosmetics	cosmetic	NOUN
ihlr-16574	456	55	,	,	PUNCT
ihlr-16574	456	56	139	139	NUM
ihlr-16574	456	57	.	.	PUNCT
ihlr-16574	457	1	/d	/d	INTJ
ihlr-16574	457	2	.	.	PUNCT
ihlr-16574	458	1	140	140	NUM
ihlr-16574	458	2	.	.	PUNCT
ihlr-16574	459	1	i	i	PRON
ihlr-16574	459	2	d	d	PROPN
ihlr-16574	459	3	141	141	NUM
ihlr-16574	459	4	.	.	PUNCT
ihlr-16574	460	1	potential	potential	ADJ
ihlr-16574	460	2	pitfalls	pitfall	NOUN
ihlr-16574	460	3	,	,	PUNCT
ihlr-16574	460	4	supra	supra	PROPN
ihlr-16574	460	5	note	note	NOUN
ihlr-16574	460	6	36	36	NUM
ihlr-16574	460	7	.	.	PUNCT
ihlr-16574	460	8	142	142	NUM
ihlr-16574	460	9	.	.	PUNCT
ihlr-16574	461	1	the	the	DET
ihlr-16574	461	2	six	six	NUM
ihlr-16574	461	3	diseases	disease	NOUN
ihlr-16574	461	4	mentioned	mention	VERB
ihlr-16574	461	5	in	in	ADP
ihlr-16574	461	6	the	the	DET
ihlr-16574	461	7	strategic	strategic	ADJ
ihlr-16574	461	8	research	research	NOUN
ihlr-16574	461	9	agenda	agenda	NOUN
ihlr-16574	461	10	include	include	VERB
ihlr-16574	461	11	;	;	PUNCT
ihlr-16574	461	12	cardiovas­	cardiovas­	VERB
ihlr-16574	461	13	cular	cular	ADJ
ihlr-16574	461	14	disease	disease	NOUN
ihlr-16574	461	15	,	,	PUNCT
ihlr-16574	461	16	cancer	cancer	NOUN
ihlr-16574	461	17	,	,	PUNCT
ihlr-16574	461	18	musculoskeletal	musculoskeletal	ADJ
ihlr-16574	461	19	disorders	disorder	NOUN
ihlr-16574	461	20	,	,	PUNCT
ihlr-16574	461	21	neurodegenerative	neurodegenerative	ADJ
ihlr-16574	461	22	diseases	disease	NOUN
ihlr-16574	461	23	and	and	CCONJ
ihlr-16574	461	24	psychiatric	psychiatric	ADJ
ihlr-16574	461	25	conditions	condition	NOUN
ihlr-16574	461	26	,	,	PUNCT
ihlr-16574	461	27	diabetes	diabetes	NOUN
ihlr-16574	461	28	,	,	PUNCT
ihlr-16574	461	29	and	and	CCONJ
ihlr-16574	461	30	bacterial	bacterial	ADJ
ihlr-16574	461	31	and	and	CCONJ
ihlr-16574	461	32	viral	viral	ADJ
ihlr-16574	461	33	infections	infection	NOUN
ihlr-16574	461	34	diseases	disease	NOUN
ihlr-16574	461	35	.	.	PUNCT
ihlr-16574	462	1	etp	etp	PROPN
ihlr-16574	462	2	strategic	strategic	ADJ
ihlr-16574	462	3	research	research	NOUN
ihlr-16574	462	4	agenda	agenda	NOUN
ihlr-16574	462	5	,	,	PUNCT
ihlr-16574	462	6	supra	supra	PROPN
ihlr-16574	462	7	note	note	NOUN
ihlr-16574	462	8	133	133	NUM
ihlr-16574	462	9	at	at	ADP
ihlr-16574	462	10	i	i	PRON
ihlr-16574	462	11	0	0	NUM
ihlr-16574	462	12	.	.	PUNCT
ihlr-16574	462	13	.	.	PUNCT
ihlr-16574	463	1	143	143	X
ihlr-16574	463	2	.	.	PUNCT
ihlr-16574	464	1	sadrieh	sadrieh	PROPN
ihlr-16574	464	2	&	&	CCONJ
ihlr-16574	464	3	espandiari	espandiari	PROPN
ihlr-16574	464	4	,	,	PUNCT
ihlr-16574	464	5	supra	supra	PROPN
ihlr-16574	464	6	note	note	NOUN
ihlr-16574	464	7	57	57	NUM
ihlr-16574	464	8	,	,	PUNCT
ihlr-16574	464	9	at	at	ADP
ihlr-16574	464	10	340	340	NUM
ihlr-16574	464	11	(	(	PUNCT
ihlr-16574	464	12	noting	note	VERB
ihlr-16574	464	13	that	that	SCONJ
ihlr-16574	464	14	nanotechnology	nanotechnology	NOUN
ihlr-16574	464	15	will	will	AUX
ihlr-16574	464	16	be	be	AUX
ihlr-16574	464	17	particularly	particularly	ADV
ihlr-16574	464	18	applicable	applicable	ADJ
ihlr-16574	464	19	in	in	ADP
ihlr-16574	464	20	medicine	medicine	NOUN
ihlr-16574	464	21	and	and	CCONJ
ihlr-16574	464	22	health	health	NOUN
ihlr-16574	464	23	,	,	PUNCT
ihlr-16574	464	24	consumer	consumer	NOUN
ihlr-16574	464	25	products	product	NOUN
ihlr-16574	464	26	,	,	PUNCT
ihlr-16574	464	27	as	as	ADV
ihlr-16574	464	28	well	well	ADV
ihlr-16574	464	29	as	as	ADP
ihlr-16574	464	30	transportation	transportation	NOUN
ihlr-16574	464	31	and	and	CCONJ
ihlr-16574	464	32	agriculture	agriculture	NOUN
ihlr-16574	464	33	)	)	PUNCT
ihlr-16574	464	34	.	.	PUNCT
ihlr-16574	465	1	418	418	NUM
ihlr-16574	465	2	indiana	indiana	PROPN
ihlr-16574	465	3	heal1h	heal1h	PROPN
ihlr-16574	465	4	law	law	NOUN
ihlr-16574	465	5	review	review	NOUN
ihlr-16574	465	6	[	[	X
ihlr-16574	465	7	vol	vol	NOUN
ihlr-16574	465	8	.	.	PUNCT
ihlr-16574	466	1	7:397	7:397	NUM
ihlr-16574	466	2	and	and	CCONJ
ihlr-16574	466	3	combination	combination	NOUN
ihlr-16574	466	4	products	product	NOUN
ihlr-16574	466	5	.	.	PUNCT
ihlr-16574	467	1	"144	"144	PROPN
ihlr-16574	467	2	the	the	DET
ihlr-16574	467	3	fda	fda	PROPN
ihlr-16574	467	4	's	's	PART
ihlr-16574	467	5	regulatory	regulatory	ADJ
ihlr-16574	467	6	power	power	NOUN
ihlr-16574	467	7	is	be	AUX
ihlr-16574	467	8	far	far	ADV
ihlr-16574	467	9	-	-	PUNCT
ihlr-16574	467	10	reaching	reach	VERB
ihlr-16574	467	11	,	,	PUNCT
ihlr-16574	467	12	encompassing	encompass	VERB
ihlr-16574	467	13	products	product	NOUN
ihlr-16574	467	14	which	which	PRON
ihlr-16574	467	15	"	"	PUNCT
ihlr-16574	467	16	account	account	VERB
ihlr-16574	467	17	for	for	ADP
ihlr-16574	467	18	twenty	twenty	NUM
ihlr-16574	467	19	-	-	PUNCT
ihlr-16574	467	20	five	five	NUM
ihlr-16574	467	21	cents	cent	NOUN
ihlr-16574	467	22	out	out	ADP
ihlr-16574	467	23	of	of	ADP
ihlr-16574	467	24	each	each	DET
ihlr-16574	467	25	dollar	dollar	NOUN
ihlr-16574	467	26	that	that	PRON
ihlr-16574	467	27	each	each	DET
ihlr-16574	467	28	american	american	ADJ
ihlr-16574	467	29	spends	spend	VERB
ihlr-16574	467	30	.	.	PUNCT
ihlr-16574	468	1	"145	"145	AUX
ihlr-16574	468	2	given	give	VERB
ihlr-16574	468	3	the	the	DET
ihlr-16574	468	4	fda	fda	PROPN
ihlr-16574	468	5	's	's	PART
ihlr-16574	468	6	broad	broad	ADJ
ihlr-16574	468	7	regulatory	regulatory	ADJ
ihlr-16574	468	8	authority	authority	NOUN
ihlr-16574	468	9	,	,	PUNCT
ihlr-16574	468	10	new	new	ADJ
ihlr-16574	468	11	nanotechnology	nanotechnology	NOUN
ihlr-16574	468	12	will	will	AUX
ihlr-16574	468	13	undoubtedly	undoubtedly	ADV
ihlr-16574	468	14	be	be	AUX
ihlr-16574	468	15	subject	subject	ADJ
ihlr-16574	468	16	to	to	ADP
ihlr-16574	468	17	fda	fda	PROPN
ihlr-16574	468	18	authori­	authori­	VERB
ihlr-16574	468	19	ty	ty	PRON
ihlr-16574	468	20	,	,	PUNCT
ihlr-16574	468	21	regardless	regardless	ADV
ihlr-16574	468	22	of	of	ADP
ihlr-16574	468	23	how	how	SCONJ
ihlr-16574	468	24	it	it	PRON
ihlr-16574	468	25	develops	develop	VERB
ihlr-16574	468	26	.	.	PUNCT
ihlr-16574	469	1	as	as	ADP
ihlr-16574	469	2	such	such	ADJ
ihlr-16574	469	3	,	,	PUNCT
ihlr-16574	469	4	the	the	DET
ihlr-16574	469	5	fda	fda	PROPN
ihlr-16574	469	6	's	's	PART
ihlr-16574	469	7	approach	approach	NOUN
ihlr-16574	469	8	to	to	ADP
ihlr-16574	469	9	nano­	nano­	PROPN
ihlr-16574	469	10	technology	technology	NOUN
ihlr-16574	469	11	regulation	regulation	NOUN
ihlr-16574	469	12	is	be	AUX
ihlr-16574	469	13	of	of	ADP
ihlr-16574	469	14	utmost	utmost	ADJ
ihlr-16574	469	15	importance	importance	NOUN
ihlr-16574	469	16	as	as	SCONJ
ihlr-16574	469	17	nanomedicine	nanomedicine	NOUN
ihlr-16574	469	18	develops	develop	VERB
ihlr-16574	469	19	and	and	CCONJ
ihlr-16574	469	20	therefore	therefore	ADV
ihlr-16574	469	21	its	its	PRON
ihlr-16574	469	22	policies	policy	NOUN
ihlr-16574	469	23	and	and	CCONJ
ihlr-16574	469	24	systems	system	NOUN
ihlr-16574	469	25	of	of	ADP
ihlr-16574	469	26	regulation	regulation	NOUN
ihlr-16574	469	27	should	should	AUX
ihlr-16574	469	28	be	be	AUX
ihlr-16574	469	29	given	give	VERB
ihlr-16574	469	30	careful	careful	ADJ
ihlr-16574	469	31	scrutiny	scrutiny	NOUN
ihlr-16574	469	32	.	.	PUNCT
ihlr-16574	470	1	after	after	ADP
ihlr-16574	470	2	careful	careful	ADJ
ihlr-16574	470	3	monitoring	monitoring	NOUN
ihlr-16574	470	4	of	of	ADP
ihlr-16574	470	5	current	current	ADJ
ihlr-16574	470	6	nanotechnology	nanotechnology	NOUN
ihlr-16574	470	7	advancement	advancement	NOUN
ihlr-16574	470	8	,	,	PUNCT
ihlr-16574	470	9	the	the	DET
ihlr-16574	470	10	fda	fda	PROPN
ihlr-16574	470	11	maintains	maintain	VERB
ihlr-16574	470	12	that	that	SCONJ
ihlr-16574	470	13	its	its	PRON
ihlr-16574	470	14	"	"	PUNCT
ihlr-16574	470	15	existing	exist	VERB
ihlr-16574	470	16	requirements	requirement	NOUN
ihlr-16574	470	17	may	may	AUX
ihlr-16574	470	18	be	be	AUX
ihlr-16574	470	19	adequate	adequate	ADJ
ihlr-16574	470	20	for	for	ADP
ihlr-16574	470	21	most	most	ADJ
ihlr-16574	470	22	nanotechnology	nanotechnology	NOUN
ihlr-16574	470	23	products	product	NOUN
ihlr-16574	470	24	"	"	PUNCT
ihlr-16574	470	25	they	they	PRON
ihlr-16574	470	26	would	would	AUX
ihlr-16574	470	27	regulate.146	regulate.146	VERB
ihlr-16574	470	28	·	·	PUNCT
ihlr-16574	470	29	the	the	DET
ihlr-16574	470	30	results	result	NOUN
ihlr-16574	470	31	of	of	ADP
ihlr-16574	470	32	recent	recent	ADJ
ihlr-16574	470	33	re	re	NOUN
ihlr-16574	470	34	,	,	PUNCT
ihlr-16574	470	35	.	.	PUNCT
ihlr-16574	471	1	search	search	NOUN
ihlr-16574	471	2	in	in	ADP
ihlr-16574	471	3	nano	nano	NOUN
ihlr-16574	471	4	-	-	PUNCT
ihlr-16574	471	5	sized	sized	ADJ
ihlr-16574	471	6	particles	particle	NOUN
ihlr-16574	471	7	,	,	PUNCT
ihlr-16574	471	8	however	however	ADV
ihlr-16574	471	9	,	,	PUNCT
ihlr-16574	471	10	indicate	indicate	VERB
ihlr-16574	471	11	that	that	SCONJ
ihlr-16574	471	12	the	the	DET
ihlr-16574	471	13	fda	fda	PROPN
ihlr-16574	471	14	's	's	PART
ihlr-16574	471	15	existing	exist	VERB
ihlr-16574	471	16	regulatory	regulatory	ADJ
ihlr-16574	471	17	structures	structure	NOUN
ihlr-16574	471	18	may	may	AUX
ihlr-16574	471	19	not	not	PART
ihlr-16574	471	20	adequately	adequately	ADV
ihlr-16574	471	21	address	address	VERB
ihlr-16574	471	22	the	the	DET
ihlr-16574	471	23	novel	novel	ADJ
ihlr-16574	471	24	problems	problem	NOUN
ihlr-16574	471	25	that	that	PRON
ihlr-16574	471	26	nanotechnology	nanotechnology	NOUN
ihlr-16574	471	27	will	will	AUX
ihlr-16574	471	28	likely	likely	ADV
ihlr-16574	471	29	pose	pose	VERB
ihlr-16574	471	30	.	.	PUNCT
ihlr-16574	472	1	the	the	DET
ihlr-16574	472	2	unexpected	unexpected	ADJ
ihlr-16574	472	3	behavior	behavior	NOUN
ihlr-16574	472	4	of	of	ADP
ihlr-16574	472	5	silver	silver	NOUN
ihlr-16574	472	6	nano­	nano­	NUM
ihlr-16574	472	7	particles	particle	NOUN
ihlr-16574	472	8	discussed	discuss	VERB
ihlr-16574	472	9	earlier	early	ADV
ihlr-16574	472	10	demonstrates	demonstrate	VERB
ihlr-16574	472	11	one	one	NUM
ihlr-16574	472	12	of	of	ADP
ihlr-16574	472	13	the	the	DET
ihlr-16574	472	14	potential	potential	ADJ
ihlr-16574	472	15	weaknesses	weakness	NOUN
ihlr-16574	472	16	in	in	ADP
ihlr-16574	472	17	the	the	DET
ihlr-16574	472	18	fda	fda	PROPN
ihlr-16574	472	19	's	's	PART
ihlr-16574	472	20	existing	exist	VERB
ihlr-16574	472	21	regulations	regulation	NOUN
ihlr-16574	472	22	for	for	ADP
ihlr-16574	472	23	nanotechnology.147	nanotechnology.147	NOUN
ihlr-16574	472	24	in	in	ADP
ihlr-16574	472	25	the	the	DET
ihlr-16574	472	26	silver	silver	ADJ
ihlr-16574	472	27	nano­	nano­	PROPN
ihlr-16574	472	28	particles	particle	NOUN
ihlr-16574	472	29	research	research	NOUN
ihlr-16574	472	30	,	,	PUNCT
ihlr-16574	472	31	it	it	PRON
ihlr-16574	472	32	was	be	AUX
ihlr-16574	472	33	discovered	discover	VERB
ihlr-16574	472	34	that	that	SCONJ
ihlr-16574	472	35	electrically	electrically	ADV
ihlr-16574	472	36	neutral	neutral	ADJ
ihlr-16574	472	37	silver	silver	NOUN
ihlr-16574	472	38	nanopar­	nanopar­	PROPN
ihlr-16574	472	39	ticles	ticle	NOUN
ihlr-16574	472	40	are	be	AUX
ihlr-16574	472	41	able	able	ADJ
ihlr-16574	472	42	to	to	PART
ihlr-16574	472	43	traverse	traverse	VERB
ihlr-16574	472	44	plasma	plasma	NOUN
ihlr-16574	472	45	membranes	membrane	NOUN
ihlr-16574	472	46	with	with	ADP
ihlr-16574	472	47	greater	great	ADJ
ihlr-16574	472	48	ease	ease	NOUN
ihlr-16574	472	49	than	than	ADP
ihlr-16574	472	50	:	:	PUNCT
ihlr-16574	472	51	their	their	PRON
ihlr-16574	472	52	electrically	electrically	ADV
ihlr-16574	472	53	-	-	PUNCT
ihlr-16574	472	54	charged	charge	VERB
ihlr-16574	472	55	counterparts	counterpart	NOUN
ihlr-16574	472	56	a	a	DET
ihlr-16574	472	57	distinction	distinction	NOUN
ihlr-16574	472	58	not	not	PART
ihlr-16574	472	59	exhibited	exhibit	VERB
ihlr-16574	472	60	in	in	ADP
ihlr-16574	472	61	larger	large	ADJ
ihlr-16574	472	62	elec­	elec­	NOUN
ihlr-16574	472	63	trically	trically	ADV
ihlr-16574	472	64	neutral	neutral	ADJ
ihlr-16574	472	65	molecules.148	molecules.148	PROPN
ihlr-16574	472	66	the	the	DET
ihlr-16574	472	67	fact	fact	NOUN
ihlr-16574	472	68	that	that	SCONJ
ihlr-16574	472	69	these	these	DET
ihlr-16574	472	70	nanoparticles	nanoparticle	NOUN
ihlr-16574	472	71	·	·	PUNCT
ihlr-16574	472	72	which	which	PRON
ihlr-16574	472	73	,	,	PUNCT
ihlr-16574	472	74	aside	aside	ADV
ihlr-16574	472	75	from	from	ADP
ihlr-16574	472	76	their	their	PRON
ihlr-16574	472	77	size	size	NOUN
ihlr-16574	472	78	-otherwise	-otherwise	PROPN
ihlr-16574	472	79	share	share	VERB
ihlr-16574	472	80	the	the	DET
ihlr-16574	472	81	characteristics	characteristic	NOUN
ihlr-16574	472	82	of	of	ADP
ihlr-16574	472	83	larger	large	ADJ
ihlr-16574	472	84	mole­	mole­	NOUN
ihlr-16574	472	85	cules	cule	NOUN
ihlr-16574	472	86	behave	behave	VERB
ihlr-16574	472	87	differently	differently	ADV
ihlr-16574	472	88	than	than	ADP
ihlr-16574	472	89	larger	large	ADJ
ihlr-16574	472	90	molecules	molecule	NOUN
ihlr-16574	472	91	indicates	indicate	VERB
ihlr-16574	472	92	that	that	SCONJ
ihlr-16574	472	93	traditional	traditional	ADJ
ihlr-16574	472	94	predictive	predictive	ADJ
ihlr-16574	472	95	assumptions	assumption	NOUN
ihlr-16574	472	96	about	about	ADP
ihlr-16574	472	97	the	the	DET
ihlr-16574	472	98	behavior	behavior	NOUN
ihlr-16574	472	99	of	of	ADP
ihlr-16574	472	100	new	new	ADJ
ihlr-16574	472	101	technology	technology	NOUN
ihlr-16574	472	102	may	may	AUX
ihlr-16574	472	103	not	not	PART
ihlr-16574	472	104	ap­	ap­	AUX
ihlr-16574	472	105	ply	ply	VERB
ihlr-16574	472	106	to	to	ADP
ihlr-16574	472	107	nanotechnology	nanotechnology	NOUN
ihlr-16574	472	108	.	.	PUNCT
ihlr-16574	473	1	this	this	DET
ihlr-16574	473	2	uncertainty	uncertainty	NOUN
ihlr-16574	473	3	regarding	regard	VERB
ihlr-16574	473	4	the	the	DET
ihlr-16574	473	5	unpredictability	unpredictability	NOUN
ihlr-16574	473	6	of	of	ADP
ihlr-16574	473	7	nanoparticles	nanoparticle	NOUN
ihlr-16574	473	8	simply	simply	ADV
ihlr-16574	473	9	due	due	ADJ
ihlr-16574	473	10	to	to	ADP
ihlr-16574	473	11	the	the	DET
ihlr-16574	473	12	newness	newness	NOUN
ihlr-16574	473	13	of	of	ADP
ihlr-16574	473	14	the	the	DET
ihlr-16574	473	15	research	research	NOUN
ihlr-16574	473	16	in	in	ADP
ihlr-16574	473	17	the	the	DET
ihlr-16574	473	18	field	field	NOUN
ihlr-16574	473	19	prompt­	prompt­	NOUN
ihlr-16574	473	20	ed	ed	NOUN
ihlr-16574	473	21	.	.	PUNCT
ihlr-16574	474	1	the	the	DET
ihlr-16574	474	2	ntf	ntf	PROPN
ihlr-16574	474	3	to	to	PART
ihlr-16574	474	4	express	express	VERB
ihlr-16574	474	5	"	"	PUNCT
ihlr-16574	474	6	a	a	DET
ihlr-16574	474	7	lack	lack	NOUN
ihlr-16574	474	8	of	of	ADP
ihlr-16574	474	9	confidence	confidence	NOUN
ihlr-16574	474	10	in	in	ADP
ihlr-16574	474	11	currently	currently	ADV
ihlr-16574	474	12	used	use	VERB
ihlr-16574	474	13	fda	fda	PROPN
ihlr-16574	474	14	product	product	NOUN
ihlr-16574	474	15	testing	testing	NOUN
ihlr-16574	474	16	methods	method	NOUN
ihlr-16574	474	17	for	for	ADP
ihlr-16574	474	18	safety	safety	NOUN
ihlr-16574	474	19	and	and	CCONJ
ihlr-16574	474	20	efficacy	efficacy	NOUN
ihlr-16574	474	21	.	.	PUNCT
ihlr-16574	475	1	"149	"149	NOUN
ihlr-16574	476	1	others	other	NOUN
ihlr-16574	476	2	believe	believe	VERB
ihlr-16574	476	3	that	that	SCONJ
ihlr-16574	476	4	current	current	ADJ
ihlr-16574	476	5	regulations	regulation	NOUN
ihlr-16574	476	6	,	,	PUNCT
ihlr-16574	476	7	in	in	ADP
ihlr-16574	476	8	particular	particular	ADJ
ihlr-16574	476	9	those	those	PRON
ihlr-16574	476	10	for	for	ADP
ihlr-16574	476	11	combi­	combi­	NOUN
ihlr-16574	476	12	nation	nation	NOUN
ihlr-16574	476	13	products	product	NOUN
ihlr-16574	476	14	(	(	PUNCT
ihlr-16574	476	15	the	the	DET
ihlr-16574	476	16	category	category	NOUN
ihlr-16574	476	17	into	into	ADP
ihlr-16574	476	18	which	which	PRON
ihlr-16574	476	19	nanotechnology	nanotechnology	NOUN
ihlr-16574	476	20	is	be	AUX
ihlr-16574	476	21	likely	likely	ADJ
ihlr-16574	476	22	to	to	PART
ihlr-16574	476	23	fall	fall	VERB
ihlr-16574	476	24	within	within	ADP
ihlr-16574	476	25	the	the	DET
ihlr-16574	476	26	fda	fda	PROPN
ihlr-16574	476	27	's	's	PART
ihlr-16574	476	28	regulatory	regulatory	ADJ
ihlr-16574	476	29	guidelines	guideline	NOUN
ihlr-16574	476	30	)	)	PUNCT
ihlr-16574	476	31	;	;	PUNCT
ihlr-16574	476	32	,	,	PUNCT
ihlr-16574	476	33	are	be	AUX
ihlr-16574	476	34	adequate	adequate	ADJ
ihlr-16574	476	35	to	to	PART
ihlr-16574	476	36	meet	meet	VERB
ihlr-16574	476	37	the	the	DET
ihlr-16574	476	38	needs	need	NOUN
ihlr-16574	476	39	of	of	ADP
ihlr-16574	476	40	this	this	DET
ihlr-16574	476	41	emerging	emerge	VERB
ihlr-16574	476	42	technology	technology	NOUN
ihlr-16574	476	43	for	for	ADP
ihlr-16574	476	44	the	the	DET
ihlr-16574	476	45	following	follow	VERB
ihlr-16574	476	46	reasons	reason	NOUN
ihlr-16574	476	47	:	:	PUNCT
ihlr-16574	476	48	"	"	PUNCT
ihlr-16574	476	49	high	high	ADJ
ihlr-16574	476	50	dose	dose	NOUN
ihlr-16574	476	51	multiples	multiple	NOUN
ihlr-16574	476	52	are	be	AUX
ihlr-16574	476	53	used	use	VERB
ihlr-16574	476	54	in	in	ADP
ihlr-16574	476	55	all	all	DET
ihlr-16574	476	56	studies	study	NOUN
ihlr-16574	476	57	...	...	PUNCT
ihlr-16574	476	58	;	;	PUNCT
ihlr-16574	476	59	at	at	ADV
ihlr-16574	476	60	least	least	ADV
ihlr-16574	476	61	two	two	NUM
ihlr-16574	476	62	animal	animal	NOUN
ihlr-16574	476	63	species	specie	NOUN
ihlr-16574	476	64	are	be	AUX
ihlr-16574	476	65	used	use	VERB
ihlr-16574	476	66	...	...	PUNCT
ihlr-16574	476	67	;	;	PUNCT
ihlr-16574	476	68	extensive	extensive	ADJ
ihlr-16574	476	69	histophathology	histophathology	NOUN
ihlr-16574	476	70	is	be	AUX
ihlr-16574	476	71	conducted	conduct	VERB
ihlr-16574	476	72	on	on	ADP
ihlr-16574	476	73	most	most	ADJ
ihlr-16574	476	74	organs	organ	NOUN
ihlr-16574	476	75	...	...	PUNCT
ihlr-16574	476	76	;	;	PUNCT
ihlr-16574	476	77	functional	functional	ADJ
ihlr-16574	476	78	test	test	NOUN
ihlr-16574	476	79	to	to	PART
ihlr-16574	476	80	assess	assess	VERB
ihlr-16574	476	81	if	if	SCONJ
ihlr-16574	476	82	there	there	PRON
ihlr-16574	476	83	are	be	VERB
ihlr-16574	476	84	effects	effect	NOUN
ihlr-16574	476	85	on	on	ADP
ihlr-16574	476	86	specific	specific	ADJ
ihlr-16574	476	87	organ	organ	NOUN
ihlr-16574	476	88	systems	system	NOUN
ihlr-16574	476	89	...	...	PUNCT
ihlr-16574	476	90	;	;	PUNCT
ihlr-16574	476	91	and	and	CCONJ
ihlr-16574	476	92	drug	drug	NOUN
ihlr-16574	476	93	treatments	treatment	NOUN
ihlr-16574	476	94	in	in	ADP
ihlr-16574	476	95	animals	animal	NOUN
ihlr-16574	476	96	can	can	AUX
ihlr-16574	476	97	be	be	AUX
ihlr-16574	476	98	for	for	ADP
ihlr-16574	476	99	extended	extended	ADJ
ihlr-16574	476	100	periods	period	NOUN
ihlr-16574	476	101	of	of	ADP
ihlr-16574	476	102	time	time	NOUN
ihlr-16574	476	103	.	.	PUNCT
ihlr-16574	477	1	"	"	PUNCT
ihlr-16574	477	2	15l	15l	NUM
ihlr-16574	477	3	>	>	X
ihlr-16574	477	4	these	these	DET
ihlr-16574	477	5	testing	testing	NOUN
ihlr-16574	477	6	requirements	requirement	NOUN
ihlr-16574	477	7	for	for	ADP
ihlr-16574	477	8	combination	combination	NOUN
ihlr-16574	477	9	products	product	NOUN
ihlr-16574	477	10	are	be	AUX
ihlr-16574	477	11	thought	think	VERB
ihlr-16574	477	12	to	to	PART
ihlr-16574	477	13	be	be	AUX
ihlr-16574	477	14	rigorous	rigorous	ADJ
ihlr-16574	477	15	enough	enough	ADV
ihlr-16574	477	16	to	to	PART
ihlr-16574	477	17	evaluate	evaluate	VERB
ihlr-16574	477	18	na144	na144	PROPN
ihlr-16574	477	19	.	.	PUNCT
ihlr-16574	478	1	i	i	PRON
ihlr-16574	478	2	d.	d.	PROPN
ihlr-16574	478	3	145	145	NUM
ihlr-16574	478	4	.	.	PUNCT
ihlr-16574	479	1	/d	/d	INTJ
ihlr-16574	479	2	.	.	PUNCT
ihlr-16574	480	1	146	146	NUM
ihlr-16574	480	2	.	.	PUNCT
ihlr-16574	481	1	fda	fda	PROPN
ihlr-16574	481	2	nanotechnology	nanotechnology	PROPN
ihlr-16574	481	3	faq	faq	PROPN
ihlr-16574	481	4	,	,	PUNCT
ihlr-16574	481	5	supra	supra	PROPN
ihlr-16574	481	6	note	note	NOUN
ihlr-16574	481	7	60	60	NUM
ihlr-16574	481	8	.	.	PUNCT
ihlr-16574	482	1	14	14	NUM
ihlr-16574	482	2	7	7	NUM
ihlr-16574	482	3	.	.	PUNCT
ihlr-16574	482	4	wilhelmi	wilhelmi	PROPN
ihlr-16574	482	5	,	,	PUNCT
ihlr-16574	482	6	supra	supra	PROPN
ihlr-16574	482	7	note	note	NOUN
ihlr-16574	482	8	5	5	NUM
ihlr-16574	482	9	,	,	PUNCT
ihlr-16574	482	10	at	at	ADP
ihlr-16574	482	11	102	102	NUM
ihlr-16574	482	12	.	.	NOUN
ihlr-16574	482	13	148	148	NUM
ihlr-16574	482	14	.	.	PUNCT
ihlr-16574	483	1	i	i	PRON
ihlr-16574	483	2	d.	d.	PROPN
ihlr-16574	483	3	149	149	NUM
ihlr-16574	483	4	.	.	PUNCT
ihlr-16574	484	1	ld	ld	PROPN
ihlr-16574	484	2	.	.	PUNCT
ihlr-16574	484	3	(	(	PUNCT
ihlr-16574	484	4	citing	cite	VERB
ihlr-16574	484	5	fda	fda	PROPN
ihlr-16574	484	6	,	,	PUNCT
ihlr-16574	484	7	nanotechnology	nanotechnology	NOUN
ihlr-16574	484	8	:	:	PUNCT
ihlr-16574	484	9	a	a	DET
ihlr-16574	484	10	report	report	NOUN
ihlr-16574	484	11	of	of	ADP
ihlr-16574	484	12	the	the	DET
ihlr-16574	484	13	u.s	u.s	PROPN
ihlr-16574	484	14	.	.	PROPN
ihlr-16574	484	15	food	food	PROPN
ihlr-16574	484	16	and	and	CCONJ
ihlr-16574	484	17	drug	drug	PROPN
ihlr-16574	484	18	administration	administration	PROPN
ihlr-16574	484	19	nanotechnology	nanotechnology	PROPN
ihlr-16574	484	20	task	task	PROPN
ihlr-16574	484	21	force	force	NOUN
ihlr-16574	484	22	16	16	NUM
ihlr-16574	484	23	(	(	PUNCT
ihlr-16574	484	24	2007	2007	NUM
ihlr-16574	484	25	)	)	PUNCT
ihlr-16574	484	26	,	,	PUNCT
ihlr-16574	484	27	available	available	ADJ
ihlr-16574	484	28	at	at	ADP
ihlr-16574	484	29	http://www.fda.gov/	http://www.fda.gov/	PROPN
ihlr-16574	484	30	nanotecbnologyltaskforcelreport2007	nanotecbnologyltaskforcelreport2007	PROPN
ihlr-16574	484	31	.pdf	.pdf	PUNCT
ihlr-16574	484	32	150	150	NUM
ihlr-16574	484	33	.	.	PUNCT
ihlr-16574	484	34	sadreih	sadreih	PROPN
ihlr-16574	484	35	&	&	CCONJ
ihlr-16574	484	36	espandiari	espandiari	PROPN
ihlr-16574	484	37	,	,	PUNCT
ihlr-16574	484	38	supra	supra	PROPN
ihlr-16574	484	39	note	note	NOUN
ihlr-16574	484	40	57	57	NUM
ihlr-16574	484	41	,	,	PUNCT
ihlr-16574	484	42	at	at	ADP
ihlr-16574	484	43	344	344	NUM
ihlr-16574	484	44	.	.	PUNCT
ihlr-16574	484	45	2010	2010	NUM
ihlr-16574	484	46	]	]	PUNCT
ihlr-16574	484	47	nanomedicine	nanomedicine	NOUN
ihlr-16574	484	48	419	419	NUM
ihlr-16574	484	49	notechnology	notechnology	NOUN
ihlr-16574	484	50	products	product	NOUN
ihlr-16574	484	51	in	in	ADP
ihlr-16574	484	52	the	the	DET
ihlr-16574	484	53	foreseeable	foreseeable	ADJ
ihlr-16574	484	54	future	future	NOUN
ihlr-16574	484	55	.	.	PUNCT
ihlr-16574	485	1	"	"	PUNCT
ihlr-16574	485	2	as	as	ADP
ihlr-16574	485	3	such	such	ADJ
ihlr-16574	485	4	,	,	PUNCT
ihlr-16574	485	5	we	we	PRON
ihlr-16574	485	6	do	do	AUX
ihlr-16574	485	7	not	not	PART
ihlr-16574	485	8	ex­	ex­	NOUN
ihlr-16574	485	9	pect	pect	VERB
ihlr-16574	485	10	that	that	SCONJ
ihlr-16574	485	11	the	the	DET
ihlr-16574	485	12	fda	fda	PROPN
ihlr-16574	485	13	will	will	AUX
ihlr-16574	485	14	be	be	AUX
ihlr-16574	485	15	·	·	PUNCT
ihlr-16574	485	16	issuing	issue	VERB
ihlr-16574	485	17	any	any	DET
ihlr-16574	485	18	new	new	ADJ
ihlr-16574	485	19	guidance	guidance	NOUN
ihlr-16574	485	20	to	to	PART
ihlr-16574	485	21	specifically	specifically	ADV
ihlr-16574	485	22	focus	focus	VERB
ihlr-16574	485	23	on	on	ADP
ihlr-16574	485	24	nanotechnology	nanotechnology	NOUN
ihlr-16574	485	25	products	product	NOUN
ihlr-16574	485	26	,	,	PUNCT
ihlr-16574	485	27	as	as	SCONJ
ihlr-16574	485	28	these	these	DET
ihlr-16574	485	29	products	product	NOUN
ihlr-16574	485	30	will	will	AUX
ihlr-16574	485	31	be	be	AUX
ihlr-16574	485	32	covered	cover	VERB
ihlr-16574	485	33	by	by	ADP
ihlr-16574	485	34	the	the	DET
ihlr-16574	485	35	existing	exist	VERB
ihlr-16574	485	36	guidance	guidance	NOUN
ihlr-16574	485	37	documents	document	NOUN
ihlr-16574	485	38	.	.	PUNCT
ihlr-16574	486	1	"m	"m	NOUN
ihlr-16574	487	1	2	2	NUM
ihlr-16574	487	2	.	.	PUNCT
ihlr-16574	488	1	in	in	ADP
ihlr-16574	488	2	the	the	DET
ihlr-16574	488	3	european	european	PROPN
ihlr-16574	488	4	union	union	PROPN
ihlr-16574	488	5	discussion	discussion	NOUN
ihlr-16574	488	6	on	on	ADP
ihlr-16574	488	7	the	the	DET
ihlr-16574	488	8	topic	topic	NOUN
ihlr-16574	488	9	.	.	PUNCT
ihlr-16574	489	1	of	of	ADP
ihlr-16574	489	2	nanotechnology	nanotechnology	NOUN
ihlr-16574	489	3	is	be	AUX
ihlr-16574	489	4	moving	move	VERB
ihlr-16574	489	5	swiftly	swiftly	ADV
ihlr-16574	489	6	in	in	ADP
ihlr-16574	489	7	the	the	DET
ihlr-16574	489	8	eu	eu	PROPN
ihlr-16574	489	9	as	as	SCONJ
ihlr-16574	489	10	it	it	PRON
ihlr-16574	489	11	works	work	VERB
ihlr-16574	489	12	toward	toward	ADP
ihlr-16574	489	13	developing	develop	VERB
ihlr-16574	489	14	a	a	DET
ihlr-16574	489	15	strategy	strategy	NOUN
ihlr-16574	489	16	for	for	ADP
ihlr-16574	489	17	addressing	address	VERB
ihlr-16574	489	18	issues	issue	NOUN
ihlr-16574	489	19	that	that	PRON
ihlr-16574	489	20	arise	arise	VERB
ihlr-16574	489	21	with	with	ADP
ihlr-16574	489	22	the	the	DET
ihlr-16574	489	23	emerging	emerge	VERB
ihlr-16574	489	24	technology	technology	NOUN
ihlr-16574	489	25	.	.	PUNCT
ihlr-16574	490	1	"	"	PUNCT
ihlr-16574	490	2	while	while	SCONJ
ihlr-16574	490	3	knowledge	knowledge	NOUN
ihlr-16574	490	4	gaps	gap	NOUN
ihlr-16574	490	5	remain	remain	VERB
ihlr-16574	490	6	regarding	regard	VERB
ihlr-16574	490	7	the	the	DET
ihlr-16574	490	8	potential	potential	ADJ
ihlr-16574	490	9	risks	risk	NOUN
ihlr-16574	490	10	of	of	ADP
ihlr-16574	490	11	nanotechnologies	nanotechnology	NOUN
ihlr-16574	490	12	,	,	PUNCT
ihlr-16574	490	13	the	the	PRON
ihlr-16574	490	14	[	[	X
ihlr-16574	490	15	ec	ec	X
ihlr-16574	490	16	]	]	PUNCT
ihlr-16574	490	17	again	again	ADV
ihlr-16574	490	18	expressed	express	VERB
ihlr-16574	490	19	confi­	confi­	NOUN
ihlr-16574	490	20	dence	dence	NOUN
ihlr-16574	490	21	that	that	SCONJ
ihlr-16574	490	22	existing	exist	VERB
ihlr-16574	490	23	eu	eu	PROPN
ihlr-16574	490	24	regulation	regulation	NOUN
ihlr-16574	490	25	can	can	AUX
ihlr-16574	490	26	be	be	AUX
ihlr-16574	490	27	applied	apply	VERB
ihlr-16574	490	28	to	to	ADP
ihlr-16574	490	29	this	this	DET
ihlr-16574	490	30	emerging	emerge	VERB
ihlr-16574	490	31	sector	sector	NOUN
ihlr-16574	490	32	,	,	PUNCT
ihlr-16574	490	33	stressing	stress	VERB
ihlr-16574	490	34	that	that	SCONJ
ihlr-16574	490	35	the	the	DET
ihlr-16574	490	36	challenge	challenge	NOUN
ihlr-16574	490	37	ahead	ahead	ADV
ihlr-16574	490	38	lies	lie	VERB
ihlr-16574	490	39	in	in	ADP
ihlr-16574	490	40	their	their	PRON
ihlr-16574	490	41	implementation	implementation	NOUN
ihlr-16574	490	42	.	.	PUNCT
ihlr-16574	491	1	"152	"152	NOUN
ihlr-16574	491	2	the	the	DET
ihlr-16574	491	3	con­	con­	NOUN
ihlr-16574	491	4	fidence	fidence	NOUN
ihlr-16574	491	5	that	that	PRON
ihlr-16574	491	6	the	the	DET
ihlr-16574	491	7	eu	eu	PROPN
ihlr-16574	491	8	places	place	NOUN
ihlr-16574	491	9	in	in	ADP
ihlr-16574	491	10	the	the	DET
ihlr-16574	491	11	current	current	ADJ
ihlr-16574	491	12	regulation	regulation	NOUN
ihlr-16574	491	13	is	be	AUX
ihlr-16574	491	14	not	not	PART
ihlr-16574	491	15	,	,	PUNCT
ihlr-16574	491	16	however	however	ADV
ihlr-16574	491	17	,	,	PUNCT
ihlr-16574	491	18	given	give	VERB
ihlr-16574	491	19	without	without	ADP
ihlr-16574	491	20	pause	pause	NOUN
ihlr-16574	491	21	.	.	PUNCT
ihlr-16574	492	1	"	"	PUNCT
ihlr-16574	492	2	knowledge	knowledge	NOUN
ihlr-16574	492	3	on	on	ADP
ihlr-16574	492	4	essential	essential	ADJ
ihlr-16574	492	5	questions	question	NOUN
ihlr-16574	492	6	such	such	ADJ
ihlr-16574	492	7	as	as	ADP
ihlr-16574	492	8	characterisation	characterisation	NOUN
ihlr-16574	492	9	of	of	ADP
ihlr-16574	492	10	nanomaterials	nanomaterial	NOUN
ihlr-16574	492	11	,	,	PUNCT
ihlr-16574	492	12	their	their	PRON
ihlr-16574	492	13	hazards	hazard	NOUN
ihlr-16574	492	14	,	,	PUNCT
ihlr-16574	492	15	exposure	exposure	NOUN
ihlr-16574	492	16	,	,	PUNCT
ihlr-16574	492	17	risk	risk	NOUN
ihlr-16574	492	18	assessment	assessment	NOUN
ihlr-16574	492	19	and	and	CCONJ
ihlr-16574	492	20	risk	risk	NOUN
ihlr-16574	492	21	man­	man­	NOUN
ihlr-16574	492	22	agement	agement	NOUN
ihlr-16574	492	23	should	should	AUX
ihlr-16574	492	24	be	be	AUX
ihlr-16574	492	25	improved	improve	VERB
ihlr-16574	492	26	.	.	PUNCT
ihlr-16574	493	1	"	"	PUNCT
ihlr-16574	493	2	153	153	NUM
ihlr-16574	493	3	this	this	DET
ihlr-16574	493	4	improvement	improvement	NOUN
ihlr-16574	493	5	,	,	PUNCT
ihlr-16574	493	6	the	the	DET
ihlr-16574	493	7	eu	eu	PROPN
ihlr-16574	493	8	states	state	NOUN
ihlr-16574	493	9	,	,	PUNCT
ihlr-16574	493	10	will	will	AUX
ihlr-16574	493	11	likely	likely	ADV
ihlr-16574	493	12	stem	stem	VERB
ihlr-16574	493	13	from	from	ADP
ihlr-16574	493	14	the	the	DET
ihlr-16574	493	15	implemen­	implemen­	PROPN
ihlr-16574	493	16	tation	tation	NOUN
ihlr-16574	493	17	of	of	ADP
ihlr-16574	493	18	the	the	DET
ihlr-16574	493	19	regulations	regulation	NOUN
ihlr-16574	493	20	to	to	ADP
ihlr-16574	493	21	nanotechnology	nanotechnology	NOUN
ihlr-16574	493	22	,	,	PUNCT
ihlr-16574	493	23	not	not	PART
ihlr-16574	493	24	the	the	DET
ihlr-16574	493	25	regulatory	regulatory	ADJ
ihlr-16574	493	26	language	language	NOUN
ihlr-16574	493	27	itself.154	itself.154	VERB
ihlr-16574	493	28	"	"	PUNCT
ihlr-16574	493	29	current	current	ADJ
ihlr-16574	493	30	legislation	legislation	NOUN
ihlr-16574	493	31	covers	cover	VERB
ihlr-16574	493	32	in	in	ADP
ihlr-16574	493	33	principle	principle	NOUN
ihlr-16574	493	34	the	the	DET
ihlr-16574	493	35	potential	potential	ADJ
ihlr-16574	493	36	health	health	NOUN
ihlr-16574	493	37	,	,	PUNCT
ihlr-16574	493	38	safety	safety	NOUN
ihlr-16574	493	39	and	and	CCONJ
ihlr-16574	493	40	environmental	environmental	ADJ
ihlr-16574	493	41	.	.	PUNCT
ihlr-16574	494	1	risks	risk	NOUN
ihlr-16574	494	2	in	in	ADP
ihlr-16574	494	3	relation	relation	NOUN
ihlr-16574	494	4	to	to	ADP
ihlr-16574	494	5	nanomaterials	nanomaterial	NOUN
ihlr-16574	494	6	.	.	PUNCT
ihlr-16574	495	1	the	the	DET
ihlr-16574	495	2	protection	protection	NOUN
ihlr-16574	495	3	of	of	ADP
ihlr-16574	495	4	health	health	NOUN
ihlr-16574	495	5	,	,	PUNCT
ihlr-16574	495	6	safety	safety	NOUN
ihlr-16574	495	7	and	and	CCONJ
ihlr-16574	495	8	the	the	DET
ihlr-16574	495	9	environment	environment	NOUN
ihlr-16574	495	10	needs	need	VERB
ihlr-16574	495	11	mostly	mostly	ADV
ihlr-16574	495	12	to	to	PART
ihlr-16574	495	13	be	be	AUX
ihlr-16574	495	14	enhanced	enhance	VERB
ihlr-16574	495	15	by	by	ADP
ihlr-16574	495	16	improv­	improv­	PROPN
ihlr-16574	495	17	ing	ing	NOUN
ihlr-16574	495	18	the	the	DET
ihlr-16574	495	19	implementation	implementation	NOUN
ihlr-16574	495	20	of	of	ADP
ihlr-16574	495	21	current	current	ADJ
ihlr-16574	495	22	legislation	legislation	NOUN
ihlr-16574	495	23	.	.	PUNCT
ihlr-16574	496	1	"155	"155	PROPN
ihlr-16574	496	2	recognizing	recognize	VERB
ihlr-16574	496	3	that	that	SCONJ
ihlr-16574	496	4	the	the	DET
ihlr-16574	496	5	cur­	cur­	ADJ
ihlr-16574	496	6	rent	rent	VERB
ihlr-16574	496	7	regulatory	regulatory	ADJ
ihlr-16574	496	8	language	language	NOUN
ihlr-16574	496	9	as	as	SCONJ
ihlr-16574	496	10	applied	apply	VERB
ihlr-16574	496	11	to	to	ADP
ihlr-16574	496	12	nanotechnology	nanotechnology	NOUN
ihlr-16574	496	13	may	may	AUX
ihlr-16574	496	14	be	be	AUX
ihlr-16574	496	15	lacking	lack	VERB
ihlr-16574	496	16	in	in	ADP
ihlr-16574	496	17	some	some	DET
ihlr-16574	496	18	cases	case	NOUN
ihlr-16574	496	19	,	,	PUNCT
ihlr-16574	496	20	it	it	PRON
ihlr-16574	496	21	articulates	articulate	VERB
ihlr-16574	496	22	that	that	SCONJ
ihlr-16574	496	23	"	"	PUNCT
ihlr-16574	496	24	commission	commission	NOUN
ihlr-16574	496	25	working	work	VERB
ihlr-16574	496	26	groups	group	NOUN
ihlr-16574	496	27	in	in	ADP
ihlr-16574	496	28	charge	charge	NOUN
ihlr-16574	496	29	of	of	ADP
ihlr-16574	496	30	coordinating	coordinate	VERB
ihlr-16574	496	31	implementation	implementation	NOUN
ihlr-16574	496	32	.	.	PUNCT
ihlr-16574	497	1	of	of	ADP
ihlr-16574	497	2	legislation	legislation	NOUN
ihlr-16574	497	3	are	be	AUX
ihlr-16574	497	4	examining	examine	VERB
ihlr-16574	497	5	on	on	ADP
ihlr-16574	497	6	an	an	DET
ihlr-16574	497	7	ongoing	ongoing	ADJ
ihlr-16574	497	8	basis	basis	NOUN
ihlr-16574	497	9	whether	whether	SCONJ
ihlr-16574	497	10	regulatory	regulatory	ADJ
ihlr-16574	497	11	change	change	NOUN
ihlr-16574	497	12	on	on	ADP
ihlr-16574	497	13	specific	specific	ADJ
ihlr-16574	497	14	aspects	aspect	NOUN
ihlr-16574	497	15	is	be	AUX
ihlr-16574	497	16	necessary	necessary	ADJ
ihlr-16574	497	17	,	,	PUNCT
ihlr-16574	497	18	taking	take	VERB
ihlr-16574	497	19	into	into	ADP
ihlr-16574	497	20	account	account	NOUN
ihlr-16574	497	21	the	the	DET
ihlr-16574	497	22	continuously	continuously	ADV
ihlr-16574	497	23	generated	generate	VERB
ihlr-16574	497	24	information	information	NOUN
ihlr-16574	497	25	linked	link	VERB
ihlr-16574	497	26	with	with	ADP
ihlr-16574	497	27	the	the	DET
ihlr-16574	497	28	identified	identify	VERB
ihlr-16574	497	29	knowledge	knowledge	NOUN
ihlr-16574	497	30	gaps	gap	NOUN
ihlr-16574	497	31	.	.	PUNCT
ihlr-16574	498	1	"156	"156	PROPN
ihlr-16574	498	2	complementing	complement	VERB
ihlr-16574	498	3	the	the	DET
ihlr-16574	498	4	above	above	ADJ
ihlr-16574	498	5	guidelines	guideline	NOUN
ihlr-16574	498	6	for	for	ADP
ihlr-16574	498	7	nanotechnology	nanotechnology	NOUN
ihlr-16574	498	8	regulation	regulation	NOUN
ihlr-16574	498	9	in	in	ADP
ihlr-16574	498	10	the	the	DET
ihlr-16574	498	11	eu	eu	PROPN
ihlr-16574	498	12	,	,	PUNCT
ihlr-16574	498	13	the	the	DET
ihlr-16574	498	14	etc	etc	NOUN
ihlr-16574	498	15	has	have	AUX
ihlr-16574	498	16	articulated	articulate	VERB
ihlr-16574	498	17	additional	additional	ADJ
ihlr-16574	498	18	concerns	concern	NOUN
ihlr-16574	498	19	specifically	specifically	ADV
ihlr-16574	498	20	related	relate	VERB
ihlr-16574	498	21	to	to	ADP
ihlr-16574	498	22	nanomedicine	nanomedicine	NOUN
ihlr-16574	498	23	in	in	ADP
ihlr-16574	498	24	its	its	PRON
ihlr-16574	498	25	"	"	PUNCT
ihlr-16574	498	26	strategic	strategic	ADJ
ihlr-16574	498	27	research	research	NOUN
ihlr-16574	498	28	agenda	agenda	NOUN
ihlr-16574	498	29	for	for	ADP
ihlr-16574	498	30	nanomedicine	nanomedicine	NOUN
ihlr-16574	498	31	.	.	PUNCT
ihlr-16574	499	1	"157	"157	NOUN
ihlr-16574	499	2	the	the	DET
ihlr-16574	499	3	concerns	concern	NOUN
ihlr-16574	499	4	are	be	AUX
ihlr-16574	499	5	listed	list	VERB
ihlr-16574	499	6	under	under	ADP
ihlr-16574	499	7	the	the	DET
ihlr-16574	499	8	heading	heading	NOUN
ihlr-16574	499	9	"	"	PUNCT
ihlr-16574	499	10	providing	provide	VERB
ihlr-16574	499	11	the	the	DET
ihlr-16574	499	12	environment	environment	NOUN
ihlr-16574	499	13	to	to	ADP
ihlr-16574	499	14	151	151	NUM
ihlr-16574	499	15	.	.	PUNCT
ihlr-16574	500	1	i	i	PRON
ihlr-16574	500	2	d	d	PROPN
ihlr-16574	500	3	at	at	ADP
ihlr-16574	500	4	349	349	NUM
ihlr-16574	500	5	(	(	PUNCT
ihlr-16574	500	6	both	both	DET
ihlr-16574	500	7	authors	author	NOUN
ihlr-16574	500	8	of	of	ADP
ihlr-16574	500	9	this	this	DET
ihlr-16574	500	10	article	article	NOUN
ihlr-16574	500	11	are	be	AUX
ihlr-16574	500	12	employed	employ	VERB
ihlr-16574	500	13	by	by	ADP
ihlr-16574	500	14	the	the	DET
ihlr-16574	500	15	fda	fda	PROPN
ihlr-16574	500	16	;	;	PUNCT
ihlr-16574	500	17	as	as	ADP
ihlr-16574	500	18	such	such	ADJ
ihlr-16574	500	19	,	,	PUNCT
ihlr-16574	500	20	their	their	PRON
ihlr-16574	500	21	opinions	opinion	NOUN
ihlr-16574	500	22	are	be	AUX
ihlr-16574	500	23	unique	unique	ADJ
ihlr-16574	500	24	and	and	CCONJ
ihlr-16574	500	25	particularly	particularly	ADV
ihlr-16574	500	26	interesting	interesting	ADJ
ihlr-16574	500	27	to	to	ADP
ihlr-16574	500	28	this	this	DET
ihlr-16574	500	29	topic	topic	NOUN
ihlr-16574	500	30	)	)	PUNCT
ihlr-16574	500	31	.	.	PUNCT
ihlr-16574	501	1	152	152	NUM
ihlr-16574	501	2	.	.	PUNCT
ihlr-16574	501	3	nanowerk	nanowerk	PROPN
ihlr-16574	501	4	,	,	PUNCT
ihlr-16574	501	5	european	european	PROPN
ihlr-16574	501	6	commission	commission	PROPN
ihlr-16574	501	7	sees	see	VERB
ihlr-16574	501	8	no	no	DET
ihlr-16574	501	9	regulatory	regulatory	ADJ
ihlr-16574	501	10	void	void	NOUN
ihlr-16574	501	11	on	on	ADP
ihlr-16574	501	12	nanotechnology	nanotechnology	PROPN
ihlr-16574	501	13	.	.	PUNCT
ihlr-16574	502	1	oct	oct	PROPN
ihlr-16574	502	2	.	.	PROPN
ihlr-16574	502	3	7	7	NUM
ihlr-16574	502	4	,	,	PUNCT
ihlr-16574	502	5	2008	2008	NUM
ihlr-16574	502	6	,	,	PUNCT
ihlr-16574	502	7	available	available	ADJ
ihlr-16574	502	8	at	at	ADP
ihlr-16574	502	9	http:/lwww.nanowerk.com	http:/lwww.nanowerk.com	PROPN
ihlr-16574	502	10	/	/	SYM
ihlr-16574	502	11	newslnewsid=7617.php	newslnewsid=7617.php	PRON
ihlr-16574	502	12	(	(	PUNCT
ihlr-16574	502	13	last	last	ADV
ihlr-16574	502	14	visited	visit	VERB
ihlr-16574	502	15	sept	sept	PROPN
ihlr-16574	502	16	.	.	PROPN
ihlr-16574	502	17	29	29	NUM
ihlr-16574	502	18	,	,	PUNCT
ihlr-16574	502	19	2009	2009	NUM
ihlr-16574	502	20	)	)	PUNCT
ihlr-16574	502	21	.	.	PUNCT
ihlr-16574	503	1	153	153	NUM
ihlr-16574	503	2	.	.	PUNCT
ihlr-16574	504	1	communication	communication	NOUN
ihlr-16574	504	2	from	from	ADP
ihlr-16574	504	3	the	the	DET
ihlr-16574	504	4	commission	commission	NOUN
ihlr-16574	504	5	to	to	ADP
ihlr-16574	504	6	the	the	DET
ihlr-16574	504	7	european	european	ADJ
ihlr-16574	504	8	parliament	parliament	NOUN
ihlr-16574	504	9	,	,	PUNCT
ihlr-16574	504	10	the	the	DET
ihlr-16574	504	11	council	council	NOUN
ihlr-16574	504	12	and	and	CCONJ
ihlr-16574	504	13	the	the	DET
ihlr-16574	504	14	european	european	ADJ
ihlr-16574	504	15	economic	economic	ADJ
ihlr-16574	504	16	and	and	CCONJ
ihlr-16574	504	17	social	social	ADJ
ihlr-16574	504	18	committee	committee	NOUN
ihlr-16574	504	19	,	,	PUNCT
ihlr-16574	504	20	regulatory	regulatory	ADJ
ihlr-16574	504	21	aspects	aspect	NOUN
ihlr-16574	504	22	of	of	ADP
ihlr-16574	504	23	nanomaterials	nanomaterial	NOUN
ihlr-16574	504	24	,	,	PUNCT
ihlr-16574	504	25	com	com	NOUN
ihlr-16574	504	26	(	(	PUNCT
ihlr-16574	504	27	2008	2008	NUM
ihlr-16574	504	28	)	)	PUNCT
ihlr-16574	504	29	366	366	NUM
ihlr-16574	504	30	final	final	ADJ
ihlr-16574	504	31	,	,	PUNCT
ihlr-16574	504	32	at	at	ADP
ihlr-16574	504	33	1l	1l	PROPN
ihlr-16574	504	34	(	(	PUNCT
ihlr-16574	504	35	june	june	PROPN
ihlr-16574	504	36	17	17	NUM
ihlr-16574	504	37	,	,	PUNCT
ihlr-16574	504	38	2008	2008	NUM
ihlr-16574	504	39	)	)	PUNCT
ihlr-16574	505	1	[	[	X
ihlr-16574	505	2	hereinafter	hereinafter	NOUN
ihlr-16574	505	3	regulatory	regulatory	ADJ
ihlr-16574	505	4	aspects	aspect	NOUN
ihlr-16574	505	5	]	]	PUNCT
ihlr-16574	505	6	.	.	PUNCT
ihlr-16574	506	1	154	154	NUM
ihlr-16574	506	2	.	.	PUNCT
ihlr-16574	507	1	i	i	PRON
ihlr-16574	507	2	d.	d.	PROPN
ihlr-16574	507	3	155	155	NUM
ihlr-16574	507	4	.	.	PUNCT
ihlr-16574	507	5	!	!	PUNCT
ihlr-16574	508	1	d.	d.	PROPN
ihlr-16574	508	2	156	156	NUM
ihlr-16574	508	3	.	.	PUNCT
ihlr-16574	509	1	i	i	PRON
ihlr-16574	509	2	d.	d.	PROPN
ihlr-16574	509	3	157	157	NUM
ihlr-16574	509	4	.	.	PUNCT
ihlr-16574	510	1	etp	etp	PROPN
ihlr-16574	510	2	strategic	strategic	ADJ
ihlr-16574	510	3	research	research	NOUN
ihlr-16574	510	4	agenda	agenda	NOUN
ihlr-16574	510	5	,	,	PUNCT
ihlr-16574	510	6	supra	supra	PROPN
ihlr-16574	510	7	note	note	PROPN
ihlr-16574	510	8	133	133	NUM
ihlr-16574	510	9	.	.	PUNCT
ihlr-16574	511	1	420	420	NUM
ihlr-16574	511	2	indiana	indiana	PROPN
ihlr-16574	511	3	health	health	PROPN
ihlr-16574	511	4	law	law	NOUN
ihlr-16574	511	5	review	review	NOUN
ihlr-16574	511	6	[	[	X
ihlr-16574	511	7	vol	vol	NOUN
ihlr-16574	511	8	.	.	PUNCT
ihlr-16574	512	1	7:397	7:397	NUM
ihlr-16574	512	2	facilitate	facilitate	NOUN
ihlr-16574	512	3	nanomedicine	nanomedicine	NOUN
ihlr-16574	512	4	"	"	PUNCT
ihlr-16574	512	5	in	in	ADP
ihlr-16574	512	6	the	the	DET
ihlr-16574	512	7	report	report	NOUN
ihlr-16574	512	8	.	.	PUNCT
ihlr-16574	513	1	158	158	NUM
ihlr-16574	513	2	including	include	VERB
ihlr-16574	513	3	this	this	DET
ihlr-16574	513	4	section	section	NOUN
ihlr-16574	513	5	in	in	ADP
ihlr-16574	513	6	the	the	DET
ihlr-16574	513	7	overall	overall	ADJ
ihlr-16574	513	8	"	"	PUNCT
ihlr-16574	513	9	strategic	strategic	ADJ
ihlr-16574	513	10	research	research	NOUN
ihlr-16574	513	11	agenda	agenda	NOUN
ihlr-16574	513	12	"	"	PUNCT
ihlr-16574	513	13	suggests	suggest	VERB
ihlr-16574	513	14	that	that	SCONJ
ihlr-16574	513	15	the	the	PRON
ihlr-16574	513	16	.	.	PUNCT
ihlr-16574	514	1	eu	eu	PROPN
ihlr-16574	514	2	is	be	AUX
ihlr-16574	514	3	aw.are	aw.are	NOUN
ihlr-16574	514	4	that	that	SCONJ
ihlr-16574	514	5	na­	na­	PROPN
ihlr-16574	514	6	nomedicine	nomedicine	NOUN
ihlr-16574	514	7	may	may	AUX
ihlr-16574	514	8	not	not	PART
ihlr-16574	514	9	fit	fit	VERB
ihlr-16574	514	10	well	well	ADV
ihlr-16574	514	11	within	within	ADP
ihlr-16574	514	12	the	the	DET
ihlr-16574	514	13	·	·	SYM
ihlr-16574	514	14	current	current	ADJ
ihlr-16574	514	15	regulatory	regulatory	ADJ
ihlr-16574	514	16	guidelines.159	guidelines.159	NOUN
ihlr-16574	514	17	further	far	ADV
ihlr-16574	514	18	,	,	PUNCT
ihlr-16574	514	19	the	the	DET
ihlr-16574	514	20	report	report	NOUN
ihlr-16574	514	21	specifically	specifically	ADV
ihlr-16574	514	22	addresses	address	VERB
ihlr-16574	514	23	the	the	DET
ihlr-16574	514	24	importance	importance	NOUN
ihlr-16574	514	25	of	of	ADP
ihlr-16574	514	26	public	public	ADJ
ihlr-16574	514	27	opinion	opinion	NOUN
ihlr-16574	514	28	and	and	CCONJ
ihlr-16574	514	29	reception	reception	NOUN
ihlr-16574	514	30	of	of	ADP
ihlr-16574	514	31	nanomedicine.160	nanomedicine.160	PROPN
ihlr-16574	514	32	another	another	DET
ihlr-16574	514	33	important	important	ADJ
ihlr-16574	514	34	building	building	NOUN
ihlr-16574	514	35	block	block	NOUN
ihlr-16574	514	36	for	for	ADP
ihlr-16574	514	37	an	an	DET
ihlr-16574	514	38	environment	environment	NOUN
ihlr-16574	514	39	in	in	ADP
ihlr-16574	514	40	favour	favour	NOUN
ihlr-16574	514	41	of	of	ADP
ihlr-16574	514	42	nanomedicine	nanomedicine	NOUN
ihlr-16574	514	43	is	be	AUX
ihlr-16574	514	44	the	the	DET
ihlr-16574	514	45	public	public	ADJ
ihlr-16574	514	46	acceptance	acceptance	NOUN
ihlr-16574	514	47	of	of	ADP
ihlr-16574	514	48	this	this	DET
ihlr-16574	514	49	novel	novel	ADJ
ihlr-16574	514	50	technology	technology	NOUN
ihlr-16574	514	51	.	.	PUNCT
ihlr-16574	515	1	so	so	ADV
ihlr-16574	515	2	far	far	ADV
ihlr-16574	515	3	european	european	ADJ
ihlr-16574	515	4	public	public	ADJ
ihlr-16574	515	5	opinion	opinion	NOUN
ihlr-16574	515	6	as	as	SCONJ
ihlr-16574	515	7	expressed	express	VERB
ihlr-16574	515	8	by	by	ADP
ihlr-16574	515	9	the	the	DET
ihlr-16574	515	10	media	medium	NOUN
ihlr-16574	515	11	and	and	CCONJ
ihlr-16574	515	12	focus	focus	NOUN
ihlr-16574	515	13	groups	group	NOUN
ihlr-16574	515	14	is	be	AUX
ihlr-16574	515	15	largely	largely	ADV
ihlr-16574	515	16	·	·	PUNCT
ihlr-16574	515	17	·	·	PUNCT
ihlr-16574	515	18	positive	positive	ADJ
ihlr-16574	515	19	because	because	SCONJ
ihlr-16574	515	20	nanotechnology	nanotechnology	NOUN
ihlr-16574	515	21	promises	promise	VERB
ihlr-16574	515	22	great	great	ADJ
ihlr-16574	515	23	ben	ben	PROPN
ihlr-16574	515	24	,	,	PUNCT
ihlr-16574	515	25	.	.	PUNCT
ihlr-16574	516	1	efits	efit	NOUN
ihlr-16574	516	2	for	for	ADP
ihlr-16574	516	3	the	the	DET
ihlr-16574	516	4	health	health	NOUN
ihlr-16574	516	5	and	and	CCONJ
ihlr-16574	516	6	everyday	everyday	ADJ
ihlr-16574	516	7	life	life	NOUN
ihlr-16574	516	8	of	of	ADP
ihlr-16574	516	9	people	people	NOUN
ihlr-16574	516	10	in	in	ADP
ihlr-16574	516	11	ad­	ad­	PROPN
ihlr-16574	516	12	dition	dition	NOUN
ihlr-16574	516	13	to	to	ADP
ihlr-16574	516	14	economic	economic	ADJ
ihlr-16574	516	15	success	success	NOUN
ihlr-16574	516	16	.	.	PUNCT
ihlr-16574	517	1	however	however	ADV
ihlr-16574	517	2	,	,	PUNCT
ihlr-16574	517	3	one	one	PRON
ihlr-16574	517	4	has	have	VERB
ihlr-16574	517	5	to	to	PART
ihlr-16574	517	6	be	be	AUX
ihlr-16574	517	7	cautious	cautious	ADJ
ihlr-16574	517	8	not	not	PART
ihlr-16574	517	9	to	to	PART
ihlr-16574	517	10	fuel	fuel	VERB
ihlr-16574	517	11	the	the	DET
ihlr-16574	517	12	hype	hype	NOUN
ihlr-16574	517	13	about	about	ADP
ihlr-16574	517	14	the	the	DET
ihlr-16574	517	15	technology	technology	NOUN
ihlr-16574	517	16	,	,	PUNCT
ihlr-16574	517	17	which	which	PRON
ihlr-16574	517	18	in	in	ADP
ihlr-16574	517	19	this	this	DET
ihlr-16574	517	20	regulated	regulate	VERB
ihlr-16574	517	21	sector	sector	NOUN
ihlr-16574	517	22	will	will	AUX
ihlr-16574	517	23	have	have	VERB
ihlr-16574	517	24	«	«	PUNCT
ihlr-16574	517	25	>	>	X
ihlr-16574	517	26	mature	mature	VERB
ihlr-16574	517	27	over	over	ADP
ihlr-16574	517	28	a	a	DET
ihlr-16574	517	29	prolonged	prolonged	ADJ
ihlr-16574	517	30	period	period	NOUN
ihlr-16574	517	31	of	of	ADP
ihlr-16574	517	32	time.161	time.161	VERB
ihlr-16574	517	33	the	the	DET
ihlr-16574	517	34	etc	etc	NOUN
ihlr-16574	517	35	further	further	ADJ
ihlr-16574	517	36	couches	couch	NOUN
ihlr-16574	517	37	this	this	DET
ihlr-16574	517	38	public	public	ADJ
ihlr-16574	517	39	opinion	opinion	NOUN
ihlr-16574	517	40	concern	concern	NOUN
ihlr-16574	517	41	focusing	focus	VERB
ihlr-16574	517	42	on	on	ADP
ihlr-16574	517	43	the	the	DET
ihlr-16574	517	44	bene­	bene­	NOUN
ihlr-16574	517	45	fits	fit	VERB
ihlr-16574	517	46	european	european	ADJ
ihlr-16574	517	47	citizens	citizen	NOUN
ihlr-16574	517	48	will	will	AUX
ihlr-16574	517	49	receive	receive	VERB
ihlr-16574	517	50	from	from	ADP
ihlr-16574	517	51	nanotechnology	nanotechnology	NOUN
ihlr-16574	517	52	.	.	PUNCT
ihlr-16574	518	1	such	such	ADJ
ihlr-16574	518	2	benefits	benefit	NOUN
ihlr-16574	518	3	in­	in­	NOUN
ihlr-16574	518	4	clude	clude	VERB
ihlr-16574	518	5	not	not	PART
ihlr-16574	518	6	only	only	ADV
ihlr-16574	518	7	an	an	DET
ihlr-16574	518	8	enhanced	enhanced	ADJ
ihlr-16574	518	9	quality	quality	NOUN
ihlr-16574	518	10	of	of	ADP
ihlr-16574	518	11	life	life	NOUN
ihlr-16574	518	12	because	because	SCONJ
ihlr-16574	518	13	of	of	ADP
ihlr-16574	518	14	nanomedicine	nanomedicine	NOUN
ihlr-16574	518	15	,	,	PUNCT
ihlr-16574	518	16	but	but	CCONJ
ihlr-16574	518	17	that	that	SCONJ
ihlr-16574	518	18	this	this	DET
ihlr-16574	518	19	enhancement	enhancement	NOUN
ihlr-16574	518	20	of	of	ADP
ihlr-16574	518	21	life	life	NOUN
ihlr-16574	518	22	will	will	AUX
ihlr-16574	518	23	come	come	VERB
ihlr-16574	518	24	at	at	ADP
ihlr-16574	518	25	much	much	ADV
ihlr-16574	518	26	less	less	ADV
ihlr-16574	518	27	economic	economic	ADJ
ihlr-16574	518	28	and	and	CCONJ
ihlr-16574	518	29	societal	societal	ADJ
ihlr-16574	518	30	costs.t62	costs.t62	NOUN
ihlr-16574	518	31	the	the	DET
ihlr-16574	518	32	etc	etc	NOUN
ihlr-16574	518	33	has	have	AUX
ihlr-16574	518	34	also	also	ADV
ihlr-16574	518	35	discussed	discuss	VERB
ihlr-16574	518	36	the	the	DET
ihlr-16574	518	37	development	development	NOUN
ihlr-16574	518	38	of	of	ADP
ihlr-16574	518	39	intellectual	intellectual	ADJ
ihlr-16574	518	40	property	property	NOUN
ihlr-16574	518	41	rights	right	NOUN
ihlr-16574	518	42	for	for	ADP
ihlr-16574	518	43	nanomedicine	nanomedicine	NOUN
ihlr-16574	518	44	within	within	ADP
ihlr-16574	518	45	the	the	DET
ihlr-16574	518	46	general	general	ADJ
ihlr-16574	518	47	rules	rule	NOUN
ihlr-16574	518	48	in	in	ADP
ihlr-16574	518	49	the	the	DET
ihlr-16574	518	50	seventh	seventh	ADJ
ihlr-16574	518	51	framework	framework	NOUN
ihlr-16574	518	52	programme	programme	NOUN
ihlr-16574	518	53	(	(	PUNCT
ihlr-16574	518	54	fp7	fp7	PROPN
ihlr-16574	518	55	)	)	PUNCT
ihlr-16574	518	56	.	.	PUNCT
ihlr-16574	519	1	163	163	NUM
ihlr-16574	519	2	the	the	DET
ihlr-16574	519	3	fp7	fp7	PROPN
ihlr-16574	519	4	was	be	AUX
ihlr-16574	519	5	designed	design	VERB
ihlr-16574	519	6	to	to	PART
ihlr-16574	519	7	group	group	VERB
ihlr-16574	519	8	all	all	DET
ihlr-16574	519	9	research	research	NOUN
ihlr-16574	519	10	initia	initia	NOUN
ihlr-16574	519	11	..	..	PUNCT
ihlr-16574	519	12	;	;	PUNCT
ihlr-16574	519	13	tives	tive	NOUN
ihlr-16574	519	14	in	in	ADP
ihlr-16574	519	15	the	the	DET
ihlr-16574	519	16	eu	eu	PROPN
ihlr-16574	519	17	and	and	CCONJ
ihlr-16574	519	18	classify	classify	VERB
ihlr-16574	519	19	them	they	PRON
ihlr-16574	519	20	into	into	ADP
ihlr-16574	519	21	four	four	NUM
ihlr-16574	519	22	broad	broad	ADJ
ihlr-16574	519	23	categories	category	NOUN
ihlr-16574	519	24	:	:	PUNCT
ihlr-16574	519	25	cooperation	cooperation	NOUN
ihlr-16574	519	26	,	,	PUNCT
ihlr-16574	519	27	ideas	idea	NOUN
ihlr-16574	519	28	,	,	PUNCT
ihlr-16574	519	29	people	people	NOUN
ihlr-16574	519	30	,	,	PUNCT
ihlr-16574	519	31	and	and	CCONJ
ihlr-16574	519	32	capacities	capacity	NOUN
ihlr-16574	519	33	.	.	PUNCT
ihlr-16574	520	1	164	164	NUM
ihlr-16574	520	2	framework	framework	NOUN
ihlr-16574	520	3	programmes	programme	NOUN
ihlr-16574	520	4	are	be	AUX
ihlr-16574	520	5	proposed	propose	VERB
ihlr-16574	520	6	by	by	ADP
ihlr-16574	520	7	the	the	DET
ihlr-16574	520	8	european	european	PROPN
ihlr-16574	520	9	commission	commission	PROPN
ihlr-16574	520	10	and	and	CCONJ
ihlr-16574	520	11	once	once	ADV
ihlr-16574	520	12	approved	approve	VERB
ihlr-16574	520	13	by	by	ADP
ihlr-16574	520	14	the	the	DET
ihlr-16574	520	15	european	european	PROPN
ihlr-16574	520	16	parliament	parliament	NOUN
ihlr-16574	520	17	,	,	PUNCT
ihlr-16574	520	18	function	function	VERB
ihlr-16574	520	19	as	as	ADP
ihlr-16574	520	20	the	the	DET
ihlr-16574	520	21	primary	primary	ADJ
ihlr-16574	520	22	tool	tool	NOUN
ihlr-16574	520	23	through	through	ADP
ihlr-16574	520	24	which	which	PRON
ihlr-16574	520	25	the	the	DET
ihlr-16574	520	26	eu	eu	PROPN
ihlr-16574	520	27	funds	fund	NOUN
ihlr-16574	520	28	scientific	scientific	ADJ
ihlr-16574	520	29	research	research	NOUN
ihlr-16574	520	30	and	and	CCONJ
ihlr-16574	520	31	development.165	development.165	NOUN
ihlr-16574	520	32	~·a	~·a	NOUN
ihlr-16574	520	33	working	working	NOUN
ihlr-16574	520	34	group	group	NOUN
ihlr-16574	520	35	composed	compose	VERB
ihlr-16574	520	36	of	of	ADP
ihlr-16574	520	37	representatives	representative	NOUN
ihlr-16574	520	38	from	from	ADP
ihlr-16574	520	39	industry	industry	NOUN
ihlr-16574	520	40	,	,	PUNCT
ihlr-16574	520	41	acade­	acade­	PROPN
ihlr-16574	520	42	mia	mia	PROPN
ihlr-16574	520	43	,	,	PUNCT
ihlr-16574	520	44	and	and	CCONJ
ihlr-16574	520	45	public	public	ADJ
ihlr-16574	520	46	administration	administration	NOUN
ihlr-16574	520	47	has	have	AUX
ihlr-16574	520	48	been	be	AUX
ihlr-16574	520	49	established	establish	VERB
ihlr-16574	520	50	to	to	PART
ihlr-16574	520	51	further	far	ADV
ihlr-16574	520	52	elaborate	elaborate	VERB
ihlr-16574	520	53	the	the	DET
ihlr-16574	520	54	principles	principle	NOUN
ihlr-16574	520	55	of	of	ADP
ihlr-16574	520	56	th~	th~	PROPN
ihlr-16574	520	57	intellectual	intellectual	ADJ
ihlr-16574	520	58	property	property	NOUN
ihlr-16574	520	59	policy	policy	NOUN
ihlr-16574	520	60	of	of	ADP
ihlr-16574	520	61	the	the	DET
ihlr-16574	520	62	european	european	PROPN
ihlr-16574	520	63	technology	technology	PROPN
ihlr-16574	520	64	platform	platform	NOUN
ihlr-16574	520	65	on	on	ADP
ihlr-16574	520	66	nanomedicine	nanomedicine	NOUN
ihlr-16574	520	67	.	.	PUNCT
ihlr-16574	521	1	"166	"166	PROPN
ihlr-16574	521	2	as	as	ADP
ihlr-16574	521	3	of	of	ADP
ihlr-16574	521	4	2006	2006	NUM
ihlr-16574	521	5	,	,	PUNCT
ihlr-16574	521	6	this	this	DET
ihlr-16574	521	7	group	group	NOUN
ihlr-16574	521	8	enumerated	enumerate	VERB
ihlr-16574	521	9	three	three	NUM
ihlr-16574	521	10	"	"	PUNCT
ihlr-16574	521	11	model	model	NOUN
ihlr-16574	521	12	aims	aim	NOUN
ihlr-16574	521	13	"	"	PUNCT
ihlr-16574	521	14	to	to	PART
ihlr-16574	521	15	"	"	PUNCT
ihlr-16574	521	16	achieve	achieve	VERB
ihlr-16574	521	17	a	a	DET
ihlr-16574	521	18	large	large	ADJ
ihlr-16574	521	19	participation	participation	NOUN
ihlr-16574	521	20	in	in	ADP
ihlr-16574	521	21	the	the	DET
ihlr-16574	521	22	initiative	initiative	NOUN
ihlr-16574	521	23	and	and	CCONJ
ihlr-16574	521	24	a	a	DET
ihlr-16574	521	25	fair	fair	ADJ
ihlr-16574	521	26	158	158	NUM
ihlr-16574	521	27	.	.	PUNCT
ihlr-16574	522	1	i	i	PRON
ihlr-16574	522	2	d	d	PROPN
ihlr-16574	522	3	at	at	ADP
ihlr-16574	522	4	24	24	NUM
ihlr-16574	522	5	.	.	PUNCT
ihlr-16574	522	6	159	159	NUM
ihlr-16574	522	7	.	.	PUNCT
ihlr-16574	523	1	i	i	PRON
ihlr-16574	523	2	d	d	PROPN
ihlr-16574	523	3	160	160	NUM
ihlr-16574	523	4	.	.	PUNCT
ihlr-16574	524	1	i	i	PRON
ihlr-16574	524	2	d.	d.	PROPN
ihlr-16574	524	3	161	161	NUM
ihlr-16574	524	4	.	.	PUNCT
ihlr-16574	525	1	i	i	PRON
ihlr-16574	525	2	d	d	PROPN
ihlr-16574	525	3	at20	at20	PROPN
ihlr-16574	525	4	.	.	PUNCT
ihlr-16574	526	1	162	162	NUM
ihlr-16574	526	2	.	.	PUNCT
ihlr-16574	527	1	i	i	PRON
ihlr-16574	527	2	d.	d.	PROPN
ihlr-16574	527	3	at	at	ADP
ihlr-16574	527	4	11	11	NUM
ihlr-16574	527	5	-	-	SYM
ihlr-16574	527	6	14	14	NUM
ihlr-16574	527	7	.	.	PUNCT
ihlr-16574	527	8	163	163	NUM
ihlr-16574	527	9	.	.	PUNCT
ihlr-16574	528	1	i	i	PRON
ihlr-16574	528	2	d.	d.	PROPN
ihlr-16574	528	3	at	at	ADP
ihlr-16574	528	4	28	28	NUM
ihlr-16574	528	5	;	;	PUNCT
ihlr-16574	528	6	see	see	VERB
ihlr-16574	528	7	also	also	ADV
ihlr-16574	528	8	european	european	PROPN
ihlr-16574	528	9	commission	commission	PROPN
ihlr-16574	528	10	.	.	PUNCT
ihlr-16574	529	1	understand	understand	VERB
ihlr-16574	529	2	fp7	fp7	PROPN
ihlr-16574	529	3	,	,	PUNCT
ihlr-16574	529	4	available	available	ADJ
ihlr-16574	529	5	at	at	ADP
ihlr-16574	529	6	http://cordis.europa.eultp7	http://cordis.europa.eultp7	PROPN
ihlr-16574	529	7	/	/	SYM
ihlr-16574	529	8	understand_en.html	understand_en.html	PROPN
ihlr-16574	529	9	(	(	PUNCT
ihlr-16574	529	10	last	last	ADJ
ihlr-16574	529	11	visited	visit	VERB
ihlr-16574	529	12	feb	feb	PROPN
ihlr-16574	529	13	.	.	PROPN
ihlr-16574	529	14	12	12	NUM
ihlr-16574	529	15	,	,	PUNCT
ihlr-16574	529	16	2009	2009	NUM
ihlr-16574	529	17	)	)	PUNCT
ihlr-16574	529	18	.	.	PUNCT
ihlr-16574	530	1	164	164	NUM
ihlr-16574	530	2	.	.	PUNCT
ihlr-16574	531	1	i	i	PRON
ihlr-16574	531	2	d.	d.	PROPN
ihlr-16574	531	3	165	165	NUM
ihlr-16574	531	4	.	.	PUNCT
ihlr-16574	532	1	i	i	PRON
ihlr-16574	532	2	d.	d.	PROPN
ihlr-16574	532	3	166	166	NUM
ihlr-16574	532	4	.	.	PUNCT
ihlr-16574	533	1	etp	etp	PROPN
ihlr-16574	533	2	strategic	strategic	ADJ
ihlr-16574	533	3	research	research	NOUN
ihlr-16574	533	4	agenda	agenda	NOUN
ihlr-16574	533	5	,	,	PUNCT
ihlr-16574	533	6	supra	supra	PROPN
ihlr-16574	533	7	note	note	PROPN
ihlr-16574	533	8	133	133	NUM
ihlr-16574	533	9	.	.	PUNCT
ihlr-16574	534	1	2010	2010	NUM
ihlr-16574	534	2	]	]	PUNCT
ihlr-16574	534	3	nanomedicine	nanomedicine	NOUN
ihlr-16574	534	4	421	421	NUM
ihlr-16574	534	5	allocation	allocation	NOUN
ihlr-16574	534	6	of	of	ADP
ihlr-16574	534	7	rights	right	NOUN
ihlr-16574	534	8	on	on	ADP
ihlr-16574	534	9	generated	generate	VERB
ihlr-16574	534	10	intellectual	intellectual	ADJ
ihlr-16574	534	11	property	property	NOUN
ihlr-16574	534	12	"	"	PUNCT
ihlr-16574	534	13	in	in	ADP
ihlr-16574	534	14	nanomedicine.167	nanomedicine.167	PROPN
ihlr-16574	534	15	first	first	ADJ
ihlr-16574	534	16	,	,	PUNCT
ihlr-16574	534	17	they	they	PRON
ihlr-16574	534	18	articulated	articulate	VERB
ihlr-16574	534	19	the	the	DET
ihlr-16574	534	20	goal	goal	NOUN
ihlr-16574	534	21	to	to	PART
ihlr-16574	534	22	streamline	streamline	VERB
ihlr-16574	534	23	the	the	DET
ihlr-16574	534	24	application	application	NOUN
ihlr-16574	534	25	process	process	NOUN
ihlr-16574	534	26	for	for	ADP
ihlr-16574	534	27	in­	in­	DET
ihlr-16574	534	28	tellectual	tellectual	ADJ
ihlr-16574	534	29	property	property	NOUN
ihlr-16574	534	30	rights	right	NOUN
ihlr-16574	534	31	so	so	SCONJ
ihlr-16574	534	32	as	as	SCONJ
ihlr-16574	534	33	to	to	PART
ihlr-16574	534	34	diminish	diminish	VERB
ihlr-16574	534	35	administrative	administrative	ADJ
ihlr-16574	534	36	burdens	burden	NOUN
ihlr-16574	534	37	by	by	ADP
ihlr-16574	534	38	per­	per­	NOUN
ihlr-16574	534	39	mitting	mitte	VERB
ihlr-16574	534	40	only	only	ADV
ihlr-16574	534	41	one	one	NUM
ihlr-16574	534	42	applicant	applicant	NOUN
ihlr-16574	534	43	per	per	ADP
ihlr-16574	534	44	patent.168	patent.168	NOUN
ihlr-16574	534	45	the	the	DET
ihlr-16574	534	46	second	second	ADJ
ihlr-16574	534	47	aim	aim	NOUN
ihlr-16574	534	48	states	state	NOUN
ihlr-16574	534	49	that	that	SCONJ
ihlr-16574	534	50	all	all	DET
ihlr-16574	534	51	research	research	NOUN
ihlr-16574	534	52	trials	trial	NOUN
ihlr-16574	534	53	will	will	AUX
ihlr-16574	534	54	be	be	AUX
ihlr-16574	534	55	free	free	ADJ
ihlr-16574	534	56	from	from	ADP
ihlr-16574	534	57	royalties	royalty	NOUN
ihlr-16574	534	58	.	.	PUNCT
ihlr-16574	535	1	169	169	NUM
ihlr-16574	535	2	the	the	DET
ihlr-16574	535	3	third	third	ADJ
ihlr-16574	535	4	objective	objective	ADJ
ihlr-16574	535	5	sets	set	NOUN
ihlr-16574	535	6	forth	forth	ADP
ihlr-16574	535	7	general	general	ADJ
ihlr-16574	535	8	goals	goal	NOUN
ihlr-16574	535	9	for	for	ADP
ihlr-16574	535	10	commercial	commercial	ADJ
ihlr-16574	535	11	use	use	NOUN
ihlr-16574	535	12	of	of	ADP
ihlr-16574	535	13	the	the	DET
ihlr-16574	535	14	intellectual	intellectual	ADJ
ihlr-16574	535	15	property	property	NOUN
ihlr-16574	535	16	rights.170	rights.170	PROPN
ihlr-16574	535	17	b.	b.	PROPN
ihlr-16574	535	18	fixing	fix	VERB
ihlr-16574	535	19	the	the	DET
ihlr-16574	535	20	focus	focus	NOUN
ihlr-16574	535	21	on	on	ADP
ihlr-16574	535	22	research	research	NOUN
ihlr-16574	535	23	and	and	CCONJ
ihlr-16574	535	24	development	development	NOUN
ihlr-16574	535	25	the	the	DET
ihlr-16574	535	26	second	second	ADJ
ihlr-16574	535	27	step	step	NOUN
ihlr-16574	535	28	toward	toward	ADP
ihlr-16574	535	29	creating	create	VERB
ihlr-16574	535	30	meaningful	meaningful	ADJ
ihlr-16574	535	31	regulation	regulation	NOUN
ihlr-16574	535	32	for	for	ADP
ihlr-16574	535	33	nanomedi­	nanomedi­	PROPN
ihlr-16574	535	34	cine	cine	NOUN
ihlr-16574	535	35	will	will	AUX
ihlr-16574	535	36	be	be	AUX
ihlr-16574	535	37	to	to	PART
ihlr-16574	535	38	shift	shift	VERB
ihlr-16574	535	39	the	the	DET
ihlr-16574	535	40	current	current	ADJ
ihlr-16574	535	41	_	_	NOUN
ihlr-16574	535	42	focus	focus	VERB
ihlr-16574	535	43	firmly	firmly	ADV
ihlr-16574	535	44	on	on	ADP
ihlr-16574	535	45	research	research	NOUN
ihlr-16574	535	46	and	and	CCONJ
ihlr-16574	535	47	development	development	NOUN
ihlr-16574	535	48	of	of	ADP
ihlr-16574	535	49	nanotechnology	nanotechnology	NOUN
ihlr-16574	535	50	.	.	PUNCT
ihlr-16574	536	1	the	the	DET
ihlr-16574	536	2	eu	eu	PROPN
ihlr-16574	536	3	has	have	AUX
ihlr-16574	536	4	noted	note	VERB
ihlr-16574	536	5	"	"	PUNCT
ihlr-16574	536	6	a[]s	a[]s	ADJ
ihlr-16574	536	7	knowledge	knowledge	NOUN
ihlr-16574	536	8	becomes	become	VERB
ihlr-16574	536	9	the	the	DET
ihlr-16574	536	10	critical	critical	ADJ
ihlr-16574	536	11	factor	factor	NOUN
ihlr-16574	536	12	for	for	ADP
ihlr-16574	536	13	implementation	implementation	NOUN
ihlr-16574	536	14	and	and	CCONJ
ihlr-16574	536	15	,	,	PUNCT
ihlr-16574	536	16	eventually	eventually	ADV
ihlr-16574	536	17	,	,	PUNCT
ihlr-16574	536	18	legislation	legislation	NOUN
ihlr-16574	536	19	,	,	PUNCT
ihlr-16574	536	20	targeted	target	VERB
ihlr-16574	536	21	actions	action	NOUN
ihlr-16574	536	22	in	in	ADP
ihlr-16574	536	23	a	a	DET
ihlr-16574	536	24	number	number	NOUN
ihlr-16574	536	25	of	of	ADP
ihlr-16574	536	26	areas	area	NOUN
ihlr-16574	536	27	and	and	CCONJ
ihlr-16574	536	28	at	at	ADP
ihlr-16574	536	29	different	different	ADJ
ihlr-16574	536	30	levels	level	NOUN
ihlr-16574	536	31	,	,	PUNCT
ihlr-16574	536	32	particularly	particularly	ADV
ihlr-16574	536	33	in	in	ADP
ihlr-16574	536	34	the	the	DET
ihlr-16574	536	35	field	field	NOUN
ihlr-16574	536	36	of	of	ADP
ihlr-16574	536	37	research	research	NOUN
ihlr-16574	536	38	and	and	CCONJ
ihlr-16574	536	39	development	development	NOUN
ihlr-16574	536	40	...	...	PUNCT
ihlr-16574	537	1	[	[	X
ihlr-16574	537	2	are	be	AUX
ihlr-16574	537	3	]	]	X
ihlr-16574	537	4	a.matter	a.matter	ADJ
ihlr-16574	537	5	ofpriority	ofpriority	NOUN
ihlr-16574	537	6	.	.	PUNCT
ihlr-16574	538	1	"171	"171	PROPN
ihlr-16574	539	1	the	the	PRON
ihlr-16574	539	2	eu	eu	PROPN
ihlr-16574	539	3	further	further	ADJ
ihlr-16574	539	4	vows	vow	VERB
ihlr-16574	539	5	that	that	SCONJ
ihlr-16574	539	6	"	"	PUNCT
ihlr-16574	539	7	[	[	X
ihlr-16574	539	8	t]hey	t]hey	PRON
ihlr-16574	539	9	will	will	AUX
ihlr-16574	539	10	take	take	VERB
ihlr-16574	539	11	into	into	ADP
ihlr-16574	539	12	consideration	consideration	NOUN
ihlr-16574	539	13	work	work	NOUN
ihlr-16574	539	14	that	that	PRON
ihlr-16574	539	15	has	have	AUX
ihlr-16574	539	16	been	be	AUX
ihlr-16574	539	17	carried	carry	VERB
ihlr-16574	539	18	out	out	ADP
ihlr-16574	539	19	...	...	PUNCT
ihlr-16574	539	20	at	at	ADP
ihlr-16574	539	21	[	[	X
ihlr-16574	539	22	the	the	X
ihlr-16574	539	23	]	]	X
ihlr-16574	539	24	national	national	ADJ
ihlr-16574	539	25	and	and	CCONJ
ihlr-16574	539	26	internationallevel	internationallevel	NOUN
ihlr-16574	539	27	.	.	PUNCT
ihlr-16574	540	1	"172	"172	NOUN
ihlr-16574	540	2	by	by	ADP
ihlr-16574	540	3	not	not	PART
ihlr-16574	540	4	limiting	limit	VERB
ihlr-16574	540	5	its	its	PRON
ihlr-16574	540	6	focus	focus	NOUN
ihlr-16574	540	7	solely	solely	ADV
ihlr-16574	540	8	to	to	ADP
ihlr-16574	540	9	the	the	DET
ihlr-16574	540	10	research	research	NOUN
ihlr-16574	540	11	and	and	CCONJ
ihlr-16574	540	12	development	development	NOUN
ihlr-16574	540	13	of	of	ADP
ihlr-16574	540	14	nanomedicine	nanomedicine	NOUN
ihlr-16574	540	15	only	only	ADV
ihlr-16574	540	16	in	in	ADP
ihlr-16574	540	17	the	the	DET
ihlr-16574	540	18	eu	eu	PROPN
ihlr-16574	540	19	specifically	specifically	ADV
ihlr-16574	540	20	,	,	PUNCT
ihlr-16574	540	21	it	it	PRON
ihlr-16574	540	22	will	will	AUX
ihlr-16574	540	23	be	be	AUX
ihlr-16574	540	24	better	well	ADV
ihlr-16574	540	25	able	able	ADJ
ihlr-16574	540	26	to	to	PART
ihlr-16574	540	27	facilitate	facilitate	VERB
ihlr-16574	540	28	"	"	PUNCT
ihlr-16574	540	29	a	a	DET
ihlr-16574	540	30	rapid	rapid	ADJ
ihlr-16574	540	31	improvement	improvement	NOUN
ihlr-16574	540	32	of	of	ADP
ihlr-16574	540	33	the	the	DET
ihlr-16574	540	34	scientific	scientific	ADJ
ihlr-16574	540	35	know­	know­	NOUN
ihlr-16574	540	36	ledge	ledge	VERB
ihlr-16574	540	37	bas[e]."173	bas[e]."173	X
ihlr-16574	540	38	similarly	similarly	ADV
ihlr-16574	540	39	,	,	PUNCT
ihlr-16574	540	40	the	the	DET
ihlr-16574	540	41	fda	fda	PROPN
ihlr-16574	540	42	has	have	AUX
ihlr-16574	540	43	indicated	indicate	VERB
ihlr-16574	540	44	a	a	DET
ihlr-16574	540	45	focus	focus	NOUN
ihlr-16574	540	46	on	on	ADP
ihlr-16574	540	47	nanotechnology	nanotechnology	PROPN
ihlr-16574	540	48	research	research	NOUN
ihlr-16574	540	49	and	and	CCONJ
ihlr-16574	540	50	development	development	NOUN
ihlr-16574	540	51	in	in	ADP
ihlr-16574	540	52	the	the	DET
ihlr-16574	540	53	ntf	ntf	PROPN
ihlr-16574	540	54	report	report	NOUN
ihlr-16574	540	55	,	,	PUNCT
ihlr-16574	540	56	stating	state	VERB
ihlr-16574	540	57	"	"	PUNCT
ihlr-16574	540	58	[	[	X
ihlr-16574	540	59	r]apid	r]apid	ADJ
ihlr-16574	540	60	developments	development	NOUN
ihlr-16574	540	61	in	in	ADP
ihlr-16574	540	62	the	the	DET
ihlr-16574	540	63	field	field	NOUN
ihlr-16574	540	64	mean	mean	VERB
ihlr-16574	540	65	that	that	SCONJ
ihlr-16574	540	66	attention	attention	NOUN
ihlr-16574	540	67	to	to	ADP
ihlr-16574	540	68	·	·	PUNCT
ihlr-16574	540	69	the	the	DET
ihlr-16574	540	70	emerging	emerge	VERB
ihlr-16574	540	71	science	science	NOUN
ihlr-16574	540	72	is	be	AUX
ihlr-16574	540	73	needed	need	VERB
ihlr-16574	540	74	to	to	PART
ihlr-16574	540	75	enable	enable	VERB
ihlr-16574	540	76	the	the	DET
ihlr-16574	540	77	agency	agency	NOUN
ihlr-16574	540	78	to	to	PART
ihlr-16574	540	79	predict	predict	VERB
ihlr-16574	540	80	and	and	CCONJ
ihlr-16574	540	81	prepare	prepare	VERB
ihlr-16574	540	82	for	for	ADP
ihlr-16574	540	83	the	the	DET
ihlr-16574	540	84	types	type	NOUN
ihlr-16574	540	85	of	of	ADP
ihlr-16574	540	86	products	product	NOUN
ihlr-16574	540	87	..	..	PUNCT
ihlr-16574	540	88	.in	.in	PUNCT
ihlr-16574	541	1	the	the	DET
ihlr-16574	541	2	near	near	ADJ
ihlr-16574	541	3	fu­	fu­	PROPN
ihlr-16574	541	4	ture	ture	NOUN
ihlr-16574	541	5	.	.	PUNCT
ihlr-16574	542	1	"174	"174	PROPN
ihlr-16574	542	2	they	they	PRON
ihlr-16574	542	3	go	go	VERB
ihlr-16574	542	4	on	on	ADP
ihlr-16574	542	5	to	to	PART
ihlr-16574	542	6	describe	describe	VERB
ihlr-16574	542	7	"	"	PUNCT
ihlr-16574	542	8	the	the	DET
ihlr-16574	542	9	need	need	NOUN
ihlr-16574	542	10	for	for	ADP
ihlr-16574	542	11	timely	timely	ADJ
ihlr-16574	542	12	development	development	NOUN
ihlr-16574	542	13	of	of	ADP
ihlr-16574	542	14	a	a	DET
ihlr-16574	542	15	transparent	transparent	ADJ
ihlr-16574	542	16	,	,	PUNCT
ihlr-16574	542	17	consistent	consistent	ADJ
ihlr-16574	542	18	,	,	PUNCT
ihlr-16574	542	19	and	and	CCONJ
ihlr-16574	542	20	predictable	predictable	ADJ
ihlr-16574	542	21	regulatory	regulatory	ADJ
ihlr-16574	542	22	pathway	pathway	NOUN
ihlr-16574	542	23	.	.	PUNCT
ihlr-16574	543	1	"m	"m	VERB
ihlr-16574	543	2	the	the	DET
ihlr-16574	543	3	u.s	u.s	PROPN
ihlr-16574	543	4	.	.	PROPN
ihlr-16574	543	5	and	and	CCONJ
ihlr-16574	543	6	the	the	DET
ihlr-16574	543	7	eu	eu	PROPN
ihlr-16574	543	8	shotild	shotild	PROPN
ihlr-16574	543	9	proceed	proceed	VERB
ihlr-16574	543	10	cautiously	cautiously	ADV
ihlr-16574	543	11	,	,	PUNCT
ihlr-16574	543	12	though	though	ADV
ihlr-16574	543	13	,	,	PUNCT
ihlr-16574	543	14	to	to	PART
ihlr-16574	543	15	ensure	ensure	VERB
ihlr-16574	543	16	that	that	SCONJ
ihlr-16574	543	17	the	the	DET
ihlr-16574	543	18	emerging	emerge	VERB
ihlr-16574	543	19	science	science	NOUN
ihlr-16574	543	20	of	of	ADP
ihlr-16574	543	21	nanomedicine	nanomedicine	NOUN
ihlr-16574	543	22	is	be	AUX
ihlr-16574	543	23	more	more	ADV
ihlr-16574	543	24	completely	completely	ADV
ihlr-16574	543	25	understood	understand	VERB
ihlr-16574	543	26	be­	be­	PUNCT
ihlr-16574	543	27	fore	fore	NOUN
ihlr-16574	543	28	regulations	regulation	NOUN
ihlr-16574	543	29	are	be	AUX
ihlr-16574	543	30	crafted	craft	VERB
ihlr-16574	543	31	.	.	PUNCT
ihlr-16574	544	1	failing	fail	VERB
ihlr-16574	544	2	to	to	PART
ihlr-16574	544	3	comprehend	comprehend	VERB
ihlr-16574	544	4	the	the	DET
ihlr-16574	544	5	science	science	NOUN
ihlr-16574	544	6	learned	learn	VERB
ihlr-16574	544	7	through	through	ADP
ihlr-16574	544	8	nanomedicine	nanomedicine	ADJ
ihlr-16574	544	9	research	research	NOUN
ihlr-16574	544	10	and	and	CCONJ
ihlr-16574	544	11	development	development	NOUN
ihlr-16574	544	12	could	could	AUX
ihlr-16574	544	13	lead	lead	VERB
ihlr-16574	544	14	to	to	ADP
ihlr-16574	544	15	regulation	regulation	NOUN
ihlr-16574	544	16	that	that	PRON
ihlr-16574	544	17	arrives	arrive	VERB
ihlr-16574	544	18	too	too	ADV
ihlr-16574	544	19	early	early	ADV
ihlr-16574	544	20	.	.	PUNCT
ihlr-16574	545	1	this	this	DET
ihlr-16574	545	2	early	early	ADJ
ihlr-16574	545	3	arrival	arrival	NOUN
ihlr-16574	545	4	of	of	ADP
ihlr-16574	545	5	regulation	regulation	NOUN
ihlr-16574	545	6	could	could	AUX
ihlr-16574	545	7	potentially	potentially	ADV
ihlr-16574	545	8	in­	in­	VERB
ihlr-16574	545	9	hibit	hibit	NOUN
ihlr-16574	545	10	the	the	DET
ihlr-16574	545	11	future	future	NOUN
ihlr-16574	545	12	of	of	ADP
ihlr-16574	545	13	nanomedicine	nanomedicine	NOUN
ihlr-16574	545	14	and	and	CCONJ
ihlr-16574	545	15	stifle	stifle	VERB
ihlr-16574	545	16	its	its	PRON
ihlr-16574	545	17	development	development	NOUN
ihlr-16574	545	18	.	.	PUNCT
ihlr-16574	546	1	167	167	NUM
ihlr-16574	546	2	.	.	PUNCT
ihlr-16574	547	1	/d	/d	INTJ
ihlr-16574	547	2	.	.	PUNCT
ihlr-16574	548	1	168	168	NUM
ihlr-16574	548	2	.	.	PUNCT
ihlr-16574	549	1	/d	/d	INTJ
ihlr-16574	549	2	.	.	PUNCT
ihlr-16574	550	1	169	169	NUM
ihlr-16574	550	2	.	.	PUNCT
ihlr-16574	551	1	ld	ld	PROPN
ihlr-16574	551	2	.	.	PROPN
ihlr-16574	551	3	170	170	NUM
ihlr-16574	551	4	.	.	PUNCT
ihlr-16574	552	1	ld	ld	PROPN
ihlr-16574	552	2	.	.	PROPN
ihlr-16574	552	3	171	171	NUM
ihlr-16574	552	4	.	.	PUNCT
ihlr-16574	553	1	regulatory	regulatory	ADJ
ihlr-16574	553	2	aspects	aspect	NOUN
ihlr-16574	553	3	,	,	PUNCT
ihlr-16574	553	4	supra	supra	PROPN
ihlr-16574	553	5	note	note	NOUN
ihlr-16574	553	6	153	153	NUM
ihlr-16574	553	7	,	,	PUNCT
ihlr-16574	553	8	at	at	ADP
ihlr-16574	553	9	11	11	NUM
ihlr-16574	553	10	.	.	PUNCT
ihlr-16574	554	1	172	172	NUM
ihlr-16574	554	2	.	.	PUNCT
ihlr-16574	555	1	ld	ld	PROPN
ihlr-16574	555	2	.	.	PROPN
ihlr-16574	555	3	173	173	NUM
ihlr-16574	555	4	.	.	PUNCT
ihlr-16574	555	5	jdat	jdat	PROPN
ihlr-16574	555	6	8	8	NUM
ihlr-16574	555	7	.	.	NUM
ihlr-16574	555	8	174	174	NUM
ihlr-16574	555	9	.	.	PUNCT
ihlr-16574	556	1	ntf	ntf	PROPN
ihlr-16574	556	2	report	report	PROPN
ihlr-16574	556	3	,	,	PUNCT
ihlr-16574	556	4	supra	supra	PROPN
ihlr-16574	556	5	note	note	PROPN
ihlr-16574	556	6	80	80	NUM
ihlr-16574	556	7	,	,	PUNCT
ihlr-16574	556	8	at	at	ADP
ihlr-16574	556	9	ii	ii	PROPN
ihlr-16574	556	10	.	.	PROPN
ihlr-16574	557	1	175	175	NUM
ihlr-16574	557	2	.	.	PUNCT
ihlr-16574	558	1	ld	ld	PROPN
ihlr-16574	558	2	422	422	NUM
ihlr-16574	558	3	indiana	indiana	PROPN
ihlr-16574	558	4	heal	heal	PROPN
ihlr-16574	558	5	til	til	PROPN
ihlr-16574	558	6	law	law	NOUN
ihlr-16574	558	7	review	review	NOUN
ihlr-16574	558	8	[	[	X
ihlr-16574	558	9	vol	vol	NOUN
ihlr-16574	558	10	.	.	PUNCT
ihlr-16574	559	1	7:397	7:397	NUM
ihlr-16574	559	2	c.	c.	NOUN
ihlr-16574	559	3	dealing	deal	VERB
ihlr-16574	559	4	with	with	ADP
ihlr-16574	559	5	the	the	DET
ihlr-16574	559	6	ethical	ethical	ADJ
ihlr-16574	559	7	conundrum	conundrum	NOUN
ihlr-16574	559	8	surrounding	surround	VERB
ihlr-16574	559	9	the	the	DET
ihlr-16574	559	10	unknown	unknown	NOUN
ihlr-16574	559	11	in	in	ADP
ihlr-16574	559	12	na­	na­	PROPN
ihlr-16574	559	13	nomedicine	nomedicine	NOUN
ihlr-16574	559	14	the	the	DET
ihlr-16574	559	15	etp	etp	PROPN
ihlr-16574	559	16	raises	raise	VERB
ihlr-16574	559	17	the	the	DET
ihlr-16574	559	18	question	question	NOUN
ihlr-16574	559	19	of	of	ADP
ihlr-16574	559	20	a	a	DET
ihlr-16574	559	21	new	new	ADJ
ihlr-16574	559	22	line	line	NOUN
ihlr-16574	559	23	that	that	PRON
ihlr-16574	559	24	might	might	AUX
ihlr-16574	559	25	one	one	NUM
ihlr-16574	559	26	day	day	NOUN
ihlr-16574	559	27	need	need	VERB
ihlr-16574	559	28	to	to	PART
ihlr-16574	559	29	be	be	AUX
ihlr-16574	559	30	drawn	draw	VERB
ihlr-16574	559	31	between	between	ADP
ihlr-16574	559	32	medical	medical	ADJ
ihlr-16574	559	33	treatment	treatment	NOUN
ihlr-16574	559	34	and	and	CCONJ
ihlr-16574	559	35	human	human	NOUN
ihlr-16574	559	36	enhancement.176	enhancement.176	NOUN
ihlr-16574	559	37	the	the	DET
ihlr-16574	559	38	fda	fda	PROPN
ihlr-16574	559	39	has	have	AUX
ihlr-16574	559	40	also	also	ADV
ihlr-16574	559	41	recognized	recognize	VERB
ihlr-16574	559	42	the	the	DET
ihlr-16574	559	43	presence	presence	NOUN
ihlr-16574	559	44	of	of	ADP
ihlr-16574	559	45	such	such	ADJ
ihlr-16574	559	46	ethical	ethical	ADJ
ihlr-16574	559	47	considerations.177	considerations.177	ADJ
ihlr-16574	559	48	·	·	PUNCT
ihlr-16574	559	49	assume	assume	VERB
ihlr-16574	559	50	patient	patient	NOUN
ihlr-16574	559	51	x	x	PRON
ihlr-16574	559	52	suffered	suffer	VERB
ihlr-16574	559	53	some	some	DET
ihlr-16574	559	54	blindness	blindness	NOUN
ihlr-16574	559	55	as	as	ADP
ihlr-16574	559	56	a	a	DET
ihlr-16574	559	57	side	side	ADJ
ihlr-16574	559	58	effect	effect	NOUN
ihlr-16574	559	59	to	to	ADP
ihlr-16574	559	60	the	the	DET
ihlr-16574	559	61	tumor	tumor	NOUN
ihlr-16574	559	62	.	.	PUNCT
ihlr-16574	560	1	not	not	PART
ihlr-16574	560	2	only	only	ADV
ihlr-16574	560	3	can	can	AUX
ihlr-16574	560	4	patient	patient	VERB
ihlr-16574	560	5	x	x	PROPN
ihlr-16574	560	6	's	's	PART
ihlr-16574	560	7	tumor	tumor	NOUN
ihlr-16574	560	8	be	be	AUX
ihlr-16574	560	9	cured	cure	VERB
ihlr-16574	560	10	by	by	ADP
ihlr-16574	560	11	nanomedicine	nanomedicine	ADJ
ihlr-16574	560	12	,	,	PUNCT
ihlr-16574	560	13	so	so	ADV
ihlr-16574	560	14	too	too	ADV
ihlr-16574	560	15	can	can	AUX
ihlr-16574	560	16	her	her	PRON
ihlr-16574	560	17	blindness	blindness	NOUN
ihlr-16574	560	18	.	.	PUNCT
ihlr-16574	561	1	what	what	PRON
ihlr-16574	561	2	if	if	SCONJ
ihlr-16574	561	3	,	,	PUNCT
ihlr-16574	561	4	however	however	ADV
ihlr-16574	561	5	,	,	PUNCT
ihlr-16574	561	6	her	her	PRON
ihlr-16574	561	7	vision	vision	NOUN
ihlr-16574	561	8	is	be	AUX
ihlr-16574	561	9	not	not	PART
ihlr-16574	561	10	only	only	ADV
ihlr-16574	561	11	repaired	repair	VERB
ihlr-16574	561	12	by	by	ADP
ihlr-16574	561	13	the	the	DET
ihlr-16574	561	14	nanites	nanite	NOUN
ihlr-16574	561	15	,	,	PUNCT
ihlr-16574	561	16	but	but	CCONJ
ihlr-16574	561	17	also	also	ADV
ihlr-16574	561	18	enhanced	enhance	VERB
ihlr-16574	561	19	in	in	ADP
ihlr-16574	561	20	some	some	DET
ihlr-16574	561	21	way	way	NOUN
ihlr-16574	561	22	.	.	PUNCT
ihlr-16574	562	1	178	178	NUM
ihlr-16574	562	2	considerations	consideration	NOUN
ihlr-16574	562	3	such	such	ADJ
ihlr-16574	562	4	as	as	ADP
ihlr-16574	562	5	this	this	PRON
ihlr-16574	562	6	pose	pose	VERB
ihlr-16574	562	7	interesting	interesting	ADJ
ihlr-16574	562	8	and	and	CCONJ
ihlr-16574	562	9	complex	complex	ADJ
ihlr-16574	562	10	ethical	ethical	ADJ
ihlr-16574	562	11	issues	issue	NOUN
ihlr-16574	562	12	over	over	ADP
ihlr-16574	562	13	both	both	CCONJ
ihlr-16574	562	14	the	the	DET
ihlr-16574	562	15	technology	technology	NOUN
ihlr-16574	562	16	and	and	CCONJ
ihlr-16574	562	17	its	its	PRON
ihlr-16574	562	18	eventual	eventual	ADJ
ihlr-16574	562	19	uses	use	NOUN
ihlr-16574	562	20	.	.	PUNCT
ihlr-16574	563	1	1	1	X
ihlr-16574	563	2	.	.	X
ihlr-16574	563	3	contemporary	contemporary	ADJ
ihlr-16574	563	4	comparison	comparison	NOUN
ihlr-16574	563	5	to	to	ADP
ihlr-16574	563	6	a	a	DET
ihlr-16574	563	7	medical	medical	ADJ
ihlr-16574	563	8	and	and	CCONJ
ihlr-16574	563	9	ethical	ethical	ADJ
ihlr-16574	563	10	dilemma	dilemma	NOUN
ihlr-16574	563	11	nanomedicine	nanomedicine	NOUN
ihlr-16574	563	12	is	be	AUX
ihlr-16574	563	13	the	the	DET
ihlr-16574	563	14	most	most	ADV
ihlr-16574	563	15	recent	recent	ADJ
ihlr-16574	563	16	newcomer	newcomer	NOUN
ihlr-16574	563	17	in	in	ADP
ihlr-16574	563	18	a	a	DET
ihlr-16574	563	19	long	long	ADJ
ihlr-16574	563	20	line	line	NOUN
ihlr-16574	563	21	of	of	ADP
ihlr-16574	563	22	medical	medical	ADJ
ihlr-16574	563	23	topics	topic	NOUN
ihlr-16574	563	24	that	that	PRON
ihlr-16574	563	25	are	be	AUX
ihlr-16574	563	26	steeped	steep	VERB
ihlr-16574	563	27	in	in	ADP
ihlr-16574	563	28	ethical	ethical	ADJ
ihlr-16574	563	29	considerations	consideration	NOUN
ihlr-16574	563	30	.	.	PUNCT
ihlr-16574	564	1	the	the	DET
ihlr-16574	564	2	most	most	ADV
ihlr-16574	564	3	clear	clear	ADJ
ihlr-16574	564	4	ethical	ethical	PROPN
ihlr-16574	564	5	is­	is­	PROPN
ihlr-16574	564	6	sue	sue	VERB
ihlr-16574	564	7	to	to	PART
ihlr-16574	564	8	parallel	parallel	VERB
ihlr-16574	564	9	nanotechnology	nanotechnology	NOUN
ihlr-16574	564	10	is	be	AUX
ihlr-16574	564	11	stem	stem	NOUN
ihlr-16574	564	12	cell	cell	NOUN
ihlr-16574	564	13	research	research	NOUN
ihlr-16574	564	14	and	and	CCONJ
ihlr-16574	564	15	development	development	NOUN
ihlr-16574	564	16	.	.	PUNCT
ihlr-16574	565	1	stem	stem	NOUN
ihlr-16574	565	2	cell	cell	NOUN
ihlr-16574	565	3	research	research	NOUN
ihlr-16574	565	4	has	have	AUX
ihlr-16574	565	5	faced	face	VERB
ihlr-16574	565	6	a	a	DET
ihlr-16574	565	7	great	great	ADJ
ihlr-16574	565	8	deal	deal	NOUN
ihlr-16574	565	9	of	of	ADP
ihlr-16574	565	10	ethical	ethical	ADJ
ihlr-16574	565	11	backlash	backlash	NOUN
ihlr-16574	565	12	since	since	SCONJ
ihlr-16574	565	13	the	the	DET
ihlr-16574	565	14	first	first	ADJ
ihlr-16574	565	15	human	human	ADJ
ihlr-16574	565	16	embryonic	embryonic	ADJ
ihlr-16574	565	17	stem	stem	NOUN
ihlr-16574	565	18	cells	cell	NOUN
ihlr-16574	565	19	were	be	AUX
ihlr-16574	565	20	cultured	cultured	ADJ
ihlr-16574	565	21	in	in	ADP
ihlr-16574	565	22	1998.179	1998.179	NUM
ihlr-16574	565	23	like	like	ADP
ihlr-16574	565	24	nanomedicine	nanomedicine	NOUN
ihlr-16574	565	25	,	,	PUNCT
ihlr-16574	565	26	stem	stem	NOUN
ihlr-16574	565	27	cells	cell	NOUN
ihlr-16574	565	28	are	be	AUX
ihlr-16574	565	29	unique	unique	ADJ
ihlr-16574	565	30	and	and	CCONJ
ihlr-16574	565	31	beneficial	beneficial	ADJ
ihlr-16574	565	32	because	because	SCONJ
ihlr-16574	565	33	their	their	PRON
ihlr-16574	565	34	eventual	eventual	ADJ
ihlr-16574	565	35	use	use	NOUN
ihlr-16574	565	36	and	and	CCONJ
ihlr-16574	565	37	application	application	NOUN
ihlr-16574	565	38	in	in	ADP
ihlr-16574	565	39	the	the	DET
ihlr-16574	565	40	medical	medical	ADJ
ihlr-16574	565	41	environment	environment	NOUN
ihlr-16574	565	42	are	be	AUX
ihlr-16574	565	43	limitless	limitless	ADJ
ihlr-16574	565	44	.	.	PUNCT
ihlr-16574	566	1	180	180	NUM
ihlr-16574	566	2	stem	stem	NOUN
ihlr-16574	566	3	cells	cell	NOUN
ihlr-16574	566	4	,	,	PUNCT
ihlr-16574	566	5	particularly	particularly	ADV
ihlr-16574	566	6	embryonic	embryonic	ADJ
ihlr-16574	566	7	stem	stem	NOUN
ihlr-16574	566	8	cells	cell	NOUN
ihlr-16574	566	9	,	,	PUNCT
ihlr-16574	566	10	are	be	AUX
ihlr-16574	566	11	"	"	PUNCT
ihlr-16574	566	12	undifferentiated	undifferentiated	ADJ
ihlr-16574	566	13	cells	cell	NOUN
ihlr-16574	566	14	that	that	PRON
ihlr-16574	566	15	have	have	VERB
ihlr-16574	566	16	the	the	DET
ihlr-16574	566	17	ability	ability	NOUN
ihlr-16574	566	18	to	to	PART
ihlr-16574	566	19	form	form	VERB
ihlr-16574	566	20	any	any	DET
ihlr-16574	566	21	spe­	spe­	ADJ
ihlr-16574	566	22	cific	cific	NOUN
ihlr-16574	566	23	adult	adult	NOUN
ihlr-16574	566	24	cell	cell	NOUN
ihlr-16574	566	25	.	.	PUNCT
ihlr-16574	567	1	"181	"181	NOUN
ihlr-16574	567	2	furthermore	furthermore	ADV
ihlr-16574	567	3	,	,	PUNCT
ihlr-16574	567	4	stem	stem	NOUN
ihlr-16574	567	5	cells	cell	NOUN
ihlr-16574	567	6	offer	offer	VERB
ihlr-16574	567	7	insight	insight	NOUN
ihlr-16574	567	8	into	into	ADP
ihlr-16574	567	9	human	human	ADJ
ihlr-16574	567	10	developmental	developmental	ADJ
ihlr-16574	567	11	events	event	NOUN
ihlr-16574	567	12	that	that	PRON
ihlr-16574	567	13	can	can	AUX
ihlr-16574	567	14	not	not	PART
ihlr-16574	567	15	be	be	AUX
ihlr-16574	567	16	studied	study	VERB
ihlr-16574	567	17	directly	directly	ADV
ihlr-16574	567	18	.	.	PUNCT
ihlr-16574	568	1	this	this	DET
ihlr-16574	568	2	insight	insight	NOUN
ihlr-16574	568	3	could	could	AUX
ihlr-16574	568	4	provide	provide	VERB
ihlr-16574	568	5	medical	medical	ADJ
ihlr-16574	568	6	understanding	understanding	NOUN
ihlr-16574	568	7	of	of	ADP
ihlr-16574	568	8	human	human	ADJ
ihlr-16574	568	9	de­	de­	ADJ
ihlr-16574	568	10	velopment	velopment	NOUN
ihlr-16574	568	11	with	with	ADP
ihlr-16574	568	12	potential	potential	ADJ
ihlr-16574	568	13	clinical	clinical	ADJ
ihlr-16574	568	14	significance	significance	NOUN
ihlr-16574	568	15	for	for	ADP
ihlr-16574	568	16	pre­	pre­	NOUN
ihlr-16574	568	17	venting	venting	NOUN
ihlr-16574	568	18	or	or	CCONJ
ihlr-16574	568	19	treating	treat	VERB
ihlr-16574	568	20	birth	birth	NOUN
ihlr-16574	568	21	defects	defect	NOUN
ihlr-16574	568	22	,	,	PUNCT
ihlr-16574	568	23	infertility	infertility	NOUN
ihlr-16574	568	24	,	,	PUNCT
ihlr-16574	568	25	or	or	CCONJ
ihlr-16574	568	26	pregnancy	pregnancy	NOUN
ihlr-16574	568	27	loss	loss	NOUN
ihlr-16574	568	28	,	,	PUNCT
ihlr-16574	568	29	as	as	ADV
ihlr-16574	568	30	well	well	ADV
ihlr-16574	568	31	as	as	ADP
ihlr-16574	568	32	ultimately	ultimately	ADV
ihlr-16574	568	33	leading	lead	VERB
ihlr-16574	568	34	to	to	ADP
ihlr-16574	568	35	the	the	DET
ihlr-16574	568	36	prevention	prevention	NOUN
ihlr-16574	568	37	or	or	CCONJ
ihlr-16574	568	38	treatment	treatment	NOUN
ihlr-16574	568	39	of	of	ADP
ihlr-16574	568	40	abnormal	abnormal	ADJ
ihlr-16574	568	41	human	human	ADJ
ihlr-16574	568	42	develop­	develop­	PROPN
ihlr-16574	568	43	ment	ment	NOUN
ihlr-16574	568	44	.	.	PUNCT
ihlr-16574	569	1	finally	finally	ADV
ihlr-16574	569	2	,	,	PUNCT
ihlr-16574	569	3	stem	stem	NOUN
ihlr-16574	569	4	cells	cell	NOUN
ihlr-16574	569	5	could	could	AUX
ihlr-16574	569	6	provide	provide	VERB
ihlr-16574	569	7	a	a	DET
ihlr-16574	569	8	valuable	valuable	ADJ
ihlr-16574	569	9	source	source	NOUN
ihlr-16574	569	10	of	of	ADP
ihlr-16574	569	11	transplantable	transplantable	ADJ
ihlr-16574	569	12	cells	cell	NOUN
ihlr-16574	569	13	and	and	CCONJ
ihlr-16574	569	14	tissues	tissue	NOUN
ihlr-16574	569	15	for	for	ADP
ihlr-16574	569	16	repair	repair	NOUN
ihlr-16574	569	17	and	and	CCONJ
ihlr-16574	569	18	regeneration	regeneration	NOUN
ihlr-16574	569	19	,	,	PUNCT
ihlr-16574	569	20	ushering	usher	VERB
ihlr-16574	569	21	in	in	ADP
ihlr-16574	569	22	a	a	DET
ihlr-16574	569	23	brand	brand	NOUN
ihlr-16574	569	24	new	new	ADJ
ihlr-16574	569	25	era	era	NOUN
ihlr-16574	569	26	of	of	ADP
ihlr-16574	569	27	re176	re176	PROPN
ihlr-16574	569	28	.	.	PUNCT
ihlr-16574	570	1	etp	etp	PROPN
ihlr-16574	570	2	strategic	strategic	ADJ
ihlr-16574	570	3	research	research	NOUN
ihlr-16574	570	4	agenda	agenda	NOUN
ihlr-16574	570	5	,	,	PUNCT
ihlr-16574	570	6	supra	supra	PROPN
ihlr-16574	570	7	note	note	VERB
ihlr-16574	570	8	133	133	NUM
ihlr-16574	570	9	at	at	ADP
ihlr-16574	570	10	24	24	NUM
ihlr-16574	570	11	.	.	PUNCT
ihlr-16574	570	12	177	177	NUM
ihlr-16574	570	13	..	..	PUNCT
ihlr-16574	571	1	ntf	ntf	PROPN
ihlr-16574	571	2	report	report	PROPN
ihlr-16574	571	3	,	,	PUNCT
ihlr-16574	571	4	supra	supra	PROPN
ihlr-16574	571	5	note	note	PROPN
ihlr-16574	571	6	80	80	NUM
ihlr-16574	571	7	,	,	PUNCT
ihlr-16574	571	8	at	at	ADP
ihlr-16574	571	9	4	4	NUM
ihlr-16574	571	10	.	.	NOUN
ihlr-16574	571	11	178	178	NUM
ihlr-16574	571	12	.	.	PUNCT
ihlr-16574	572	1	see	see	VERB
ihlr-16574	572	2	etp	etp	PROPN
ihlr-16574	572	3	strategic	strategic	ADJ
ihlr-16574	572	4	research	research	NOUN
ihlr-16574	572	5	agenda	agenda	NOUN
ihlr-16574	572	6	,	,	PUNCT
ihlr-16574	572	7	supra	supra	PROPN
ihlr-16574	572	8	note	note	VERB
ihlr-16574	572	9	133	133	NUM
ihlr-16574	572	10	at	at	ADP
ihlr-16574	572	11	24	24	NUM
ihlr-16574	572	12	.	.	PUNCT
ihlr-16574	572	13	179	179	NUM
ihlr-16574	572	14	.	.	PUNCT
ihlr-16574	573	1	jordan	jordan	PROPN
ihlr-16574	573	2	saltzberg	saltzberg	PROPN
ihlr-16574	573	3	,	,	PUNCT
ihlr-16574	573	4	the	the	DET
ihlr-16574	573	5	current	current	ADJ
ihlr-16574	573	6	embryonic	embryonic	ADJ
ihlr-16574	573	7	stem	stem	NOUN
ihlr-16574	573	8	cell	cell	NOUN
ihlr-16574	573	9	research	research	NOUN
ihlr-16574	573	10	federal	federal	ADJ
ihlr-16574	573	11	funding	funding	NOUN
ihlr-16574	573	12	policy	policy	NOUN
ihlr-16574	573	13	:	:	PUNCT
ihlr-16574	573	14	undue	undue	ADJ
ihlr-16574	573	15	respect	respect	NOUN
ihlr-16574	573	16	to	to	ADP
ihlr-16574	573	17	minority	minority	NOUN
ihlr-16574	573	18	ethical	ethical	ADJ
ihlr-16574	573	19	considerations	consideration	NOUN
ihlr-16574	573	20	?	?	PUNCT
ihlr-16574	573	21	,	,	PUNCT
ihlr-16574	573	22	29	29	NUM
ihlr-16574	573	23	j.	j.	PROPN
ihlr-16574	573	24	legal	legal	PROPN
ihlr-16574	573	25	med	med	PROPN
ihlr-16574	573	26	.	.	PUNCT
ihlr-16574	574	1	505	505	NUM
ihlr-16574	574	2	,	,	PUNCT
ihlr-16574	574	3	505	505	NUM
ihlr-16574	574	4	(	(	PUNCT
ihlr-16574	574	5	2008	2008	NUM
ihlr-16574	574	6	)	)	PUNCT
ihlr-16574	574	7	.	.	PUNCT
ihlr-16574	575	1	180	180	NUM
ihlr-16574	575	2	.	.	PUNCT
ihlr-16574	575	3	/d	/d	INTJ
ihlr-16574	575	4	.	.	PUNCT
ihlr-16574	576	1	at	at	ADP
ihlr-16574	576	2	506	506	NUM
ihlr-16574	576	3	(	(	PUNCT
ihlr-16574	576	4	citing	cite	VERB
ihlr-16574	576	5	embryonic	embryonic	ADJ
ihlr-16574	576	6	stem	stem	NOUN
ihlr-16574	576	7	cell	cell	NOUN
ihlr-16574	576	8	research	research	NOUN
ihlr-16574	576	9	at	at	ADP
ihlr-16574	576	10	uw	uw	PROPN
ihlr-16574	576	11	-	-	PROPN
ihlr-16574	576	12	madison	madison	PROPN
ihlr-16574	576	13	,	,	PUNCT
ihlr-16574	576	14	available	available	ADJ
ihlr-16574	576	15	at	at	ADP
ihlr-16574	576	16	http://	http://	PROPN
ihlr-16574	576	17	www.news.wisc.edu/packages/stemcells/facts.html	www.news.wisc.edu/packages/stemcells/facts.html	PUNCT
ihlr-16574	576	18	(	(	PUNCT
ihlr-16574	576	19	last	last	ADJ
ihlr-16574	576	20	visited	visit	VERB
ihlr-16574	576	21	feb	feb	PROPN
ihlr-16574	576	22	.	.	PROPN
ihlr-16574	576	23	13	13	NUM
ihlr-16574	576	24	,	,	PUNCT
ihlr-16574	576	25	2008	2008	NUM
ihlr-16574	576	26	)	)	PUNCT
ihlr-16574	576	27	)	)	PUNCT
ihlr-16574	576	28	.	.	PUNCT
ihlr-16574	577	1	181	181	NUM
ihlr-16574	577	2	.	.	PUNCT
ihlr-16574	578	1	saltzberg	saltzberg	ADJ
ihlr-16574	578	2	,	,	PUNCT
ihlr-16574	578	3	supra	supra	PROPN
ihlr-16574	578	4	note	note	NOUN
ihlr-16574	578	5	179	179	NUM
ihlr-16574	578	6	,	,	PUNCT
ihlr-16574	578	7	at	at	ADP
ihlr-16574	578	8	506	506	NUM
ihlr-16574	578	9	(	(	PUNCT
ihlr-16574	578	10	stating	state	VERB
ihlr-16574	578	11	that	that	SCONJ
ihlr-16574	578	12	embryonic	embryonic	ADJ
ihlr-16574	578	13	stem	stem	NOUN
ihlr-16574	578	14	cells	cell	NOUN
ihlr-16574	578	15	could	could	AUX
ihlr-16574	578	16	theoreti­	theoreti­	PART
ihlr-16574	578	17	cally	cally	ADV
ihlr-16574	578	18	provide	provide	VERB
ihlr-16574	578	19	an	an	DET
ihlr-16574	578	20	unlimited	unlimited	ADJ
ihlr-16574	578	21	supply	supply	NOUN
ihlr-16574	578	22	of	of	ADP
ihlr-16574	578	23	adult	adult	NOUN
ihlr-16574	578	24	cells	cell	NOUN
ihlr-16574	578	25	for	for	ADP
ihlr-16574	578	26	a	a	DET
ihlr-16574	578	27	variety	variety	NOUN
ihlr-16574	578	28	of	of	ADP
ihlr-16574	578	29	uses	use	NOUN
ihlr-16574	578	30	)	)	PUNCT
ihlr-16574	578	31	.	.	PUNCT
ihlr-16574	579	1	2010	2010	NUM
ihlr-16574	579	2	]	]	PUNCT
ihlr-16574	579	3	nanomedicine	nanomedicine	NOUN
ihlr-16574	579	4	423	423	NUM
ihlr-16574	579	5	generative	generative	ADJ
ihlr-16574	579	6	medicine	medicine	NOUN
ihlr-16574	579	7	.	.	PUNCT
ihlr-16574	580	1	182	182	NUM
ihlr-16574	581	1	noting	note	VERB
ihlr-16574	581	2	the	the	DET
ihlr-16574	581	3	enormous	enormous	ADJ
ihlr-16574	581	4	benefits	benefit	NOUN
ihlr-16574	581	5	to	to	ADP
ihlr-16574	581	6	the	the	DET
ihlr-16574	581	7	overall	overall	ADJ
ihlr-16574	581	8	health	health	NOUN
ihlr-16574	581	9	of	of	ADP
ihlr-16574	581	10	society	society	NOUN
ihlr-16574	581	11	that	that	SCONJ
ihlr-16574	581	12	the	the	DET
ihlr-16574	581	13	stem	stem	NOUN
ihlr-16574	581	14	cell	cell	NOUN
ihlr-16574	581	15	research	research	NOUN
ihlr-16574	581	16	offers	offer	NOUN
ihlr-16574	581	17	,	,	PUNCT
ihlr-16574	581	18	it	it	PRON
ihlr-16574	581	19	important	important	ADJ
ihlr-16574	581	20	to	to	PART
ihlr-16574	581	21	identify	identify	VERB
ihlr-16574	581	22	precisely	precisely	ADV
ihlr-16574	581	23	what	what	PRON
ihlr-16574	581	24	opponents	opponent	NOUN
ihlr-16574	581	25	to	to	PART
ihlr-16574	581	26	stem	stem	VERB
ihlr-16574	581	27	cell	cell	NOUN
ihlr-16574	581	28	research	research	NOUN
ihlr-16574	581	29	find	find	VERB
ihlr-16574	581	30	so	so	ADV
ihlr-16574	581	31	ethically	ethically	ADV
ihlr-16574	581	32	repugnant	repugnant	ADJ
ihlr-16574	581	33	.	.	PUNCT
ihlr-16574	582	1	in	in	ADP
ihlr-16574	582	2	order	order	NOUN
ihlr-16574	582	3	for	for	SCONJ
ihlr-16574	582	4	a	a	DET
ihlr-16574	582	5	stem	stem	NOUN
ihlr-16574	582	6	cell	cell	NOUN
ihlr-16574	582	7	to	to	PART
ihlr-16574	582	8	be	be	AUX
ihlr-16574	582	9	obtained	obtain	VERB
ihlr-16574	582	10	from	from	ADP
ihlr-16574	582	11	an	an	DET
ihlr-16574	582	12	embryo	embryo	NOUN
ihlr-16574	582	13	,	,	PUNCT
ihlr-16574	582	14	the	the	DET
ihlr-16574	582	15	embryo	embryo	NOUN
ihlr-16574	582	16	must	must	AUX
ihlr-16574	582	17	be	be	AUX
ihlr-16574	582	18	destroyed	destroy	VERB
ihlr-16574	582	19	.	.	PUNCT
ihlr-16574	583	1	183	183	NUM
ihlr-16574	583	2	·	·	PUNCT
ihlr-16574	583	3	~once	~once	NOUN
ihlr-16574	583	4	the	the	DET
ihlr-16574	583	5	fertilized	fertilize	VERB
ihlr-16574	583	6	egg	egg	NOUN
ihlr-16574	583	7	is	be	AUX
ihlr-16574	583	8	formed	form	VERB
ihlr-16574	583	9	[	[	PUNCT
ihlr-16574	583	10	from	from	ADP
ihlr-16574	583	11	in	in	ADP
ihlr-16574	583	12	vitro	vitro	X
ihlr-16574	583	13	fertilization	fertilization	NOUN
ihlr-16574	583	14	]	]	X
ihlr-16574	583	15	;	;	PUNCT
ihlr-16574	583	16	natural	natural	ADJ
ihlr-16574	583	17	.	.	PUNCT
ihlr-16574	584	1	cell	cell	NOUN
ihlr-16574	584	2	divisions	division	NOUN
ihlr-16574	584	3	commence	commence	NOUN
ihlr-16574	584	4	...	...	PUNCT
ihlr-16574	585	1	[	[	X
ihlr-16574	585	2	r]oughly	r]oughly	ADV
ihlr-16574	585	3	five	five	NUM
ihlr-16574	585	4	to	to	PART
ihlr-16574	585	5	nine	nine	NUM
ihlr-16574	585	6	days	day	NOUN
ihlr-16574	585	7	...	...	PUNCT
ihlr-16574	586	1	[	[	X
ihlr-16574	586	2	later	later	ADV
ihlr-16574	586	3	]	]	X
ihlr-16574	586	4	,	,	PUNCT
ihlr-16574	586	5	stem	stem	NOUN
ihlr-16574	586	6	cells	cell	NOUN
ihlr-16574	586	7	can	can	AUX
ihlr-16574	586	8	be	be	AUX
ihlr-16574	586	9	derived	derive	VERB
ihlr-16574	586	10	from	from	ADP
ihlr-16574	586	11	the	the	DET
ihlr-16574	586	12	inner	inner	ADJ
ihlr-16574	586	13	cell	cell	NOUN
ihlr-16574	586	14	mass	mass	NOUN
ihlr-16574	586	15	of	of	ADP
ihlr-16574	586	16	the	the	DET
ihlr-16574	586	17	embryo	embryo	NOUN
ihlr-16574	586	18	,	,	PUNCT
ihlr-16574	586	19	...	...	PUNCT
ihlr-16574	586	20	thus	thus	ADV
ihlr-16574	586	21	destroying	destroy	VERB
ihlr-16574	586	22	the	the	DET
ihlr-16574	586	23	developing	develop	VERB
ihlr-16574	586	24	organism	organism	NOUN
ihlr-16574	586	25	and	and	CCONJ
ihlr-16574	586	26	any	any	DET
ihlr-16574	586	27	potential	potential	NOUN
ihlr-16574	586	28	for	for	ADP
ihlr-16574	586	29	independent	independent	ADJ
ihlr-16574	586	30	life	life	NOUN
ihlr-16574	586	31	it	it	PRON
ihlr-16574	586	32	may	may	AUX
ihlr-16574	586	33	have	have	AUX
ihlr-16574	586	34	possessed	possess	VERB
ihlr-16574	586	35	.	.	PUNCT
ihlr-16574	586	36	"184	"184	VERB
ihlr-16574	586	37	the	the	DET
ihlr-16574	586	38	destruction	destruction	NOUN
ihlr-16574	586	39	of	of	ADP
ihlr-16574	586	40	the	the	DET
ihlr-16574	586	41	·	·	SYM
ihlr-16574	586	42	embryo	embryo	NOUN
ihlr-16574	586	43	is	be	AUX
ihlr-16574	586	44	the	the	DET
ihlr-16574	586	45	basis	basis	NOUN
ihlr-16574	586	46	for	for	ADP
ihlr-16574	586	47	the	the	DET
ihlr-16574	586	48	opponent	opponent	NOUN
ihlr-16574	586	49	's	's	PART
ihlr-16574	586	50	argument	argument	NOUN
ihlr-16574	586	51	...	...	PUNCT
ihlr-16574	586	52	,	,	PUNCT
ihlr-16574	586	53	they	they	PRON
ihlr-16574	586	54	believe	believe	VERB
ihlr-16574	586	55	that	that	SCONJ
ihlr-16574	586	56	to	to	PART
ihlr-16574	586	57	end	end	VERB
ihlr-16574	586	58	the	the	DET
ihlr-16574	586	59	existence	existence	NOUN
ihlr-16574	586	60	of	of	ADP
ihlr-16574	586	61	the	the	DET
ihlr-16574	586	62	fertilized	fertilize	VERB
ihlr-16574	586	63	embryo	embryo	NOUN
ihlr-16574	586	64	is	be	AUX
ihlr-16574	586	65	to	to	PART
ihlr-16574	586	66	end	end	VERB
ihlr-16574	586	67	a	a	DET
ihlr-16574	586	68	life.185	life.185	NOUN
ihlr-16574	586	69	this	this	DET
ihlr-16574	586	70	life	life	NOUN
ihlr-16574	586	71	,	,	PUNCT
ihlr-16574	586	72	they	they	PRON
ihlr-16574	586	73	argue	argue	VERB
ihlr-16574	586	74	,	,	PUNCT
ihlr-16574	586	75	should	should	AUX
ihlr-16574	586	76	be	be	AUX
ihlr-16574	586	77	regarded	regard	VERB
ihlr-16574	586	78	with	with	ADP
ihlr-16574	586	79	the	the	DET
ihlr-16574	586	80	same	same	ADJ
ihlr-16574	586	81	protections	protection	NOUN
ihlr-16574	586	82	as	as	ADP
ihlr-16574	586	83	a	a	DET
ihlr-16574	586	84	newborn	newborn	ADJ
ihlr-16574	586	85	baby	baby	NOUN
ihlr-16574	586	86	or	or	CCONJ
ihlr-16574	586	87	adult	adult	NOUN
ihlr-16574	586	88	.	.	PUNCT
ihlr-16574	587	1	186	186	NUM
ihlr-16574	587	2	essentially	essentially	ADV
ihlr-16574	587	3	it	it	PRON
ihlr-16574	587	4	is	be	AUX
ihlr-16574	587	5	the	the	DET
ihlr-16574	587	6	same	same	ADJ
ihlr-16574	587	7	argument	argument	NOUN
ihlr-16574	587	8	used	use	VERB
ihlr-16574	587	9	by	by	ADP
ihlr-16574	587	10	opponents	opponent	NOUN
ihlr-16574	587	11	of	of	ADP
ihlr-16574	587	12	abortion	abortion	NOUN
ihlr-16574	587	13	does	do	AUX
ihlr-16574	587	14	stem	stem	VERB
ihlr-16574	587	15	cell	cell	NOUN
ihlr-16574	587	16	research	research	NOUN
ihlr-16574	587	17	promote	promote	NOUN
ihlr-16574	587	18	ending	end	VERB
ihlr-16574	587	19	the	the	DET
ihlr-16574	587	20	life	life	NOUN
ihlr-16574	587	21	of	of	ADP
ihlr-16574	587	22	a	a	DET
ihlr-16574	587	23	being	being	NOUN
ihlr-16574	587	24	that	that	PRON
ihlr-16574	587	25	deserves	deserve	VERB
ihlr-16574	587	26	the	the	DET
ihlr-16574	587	27	full	full	ADJ
ihlr-16574	587	28	protection	protection	NOUN
ihlr-16574	587	29	of	of	ADP
ihlr-16574	587	30	the	the	DET
ihlr-16574	587	31	law	law	NOUN
ihlr-16574	587	32	?	?	PUNCT
ihlr-16574	588	1	those	those	PRON
ihlr-16574	588	2	opposed	oppose	VERB
ihlr-16574	588	3	to	to	PART
ihlr-16574	588	4	stem	stem	VERB
ihlr-16574	588	5	cell	cell	NOUN
ihlr-16574	588	6	research	research	NOUN
ihlr-16574	588	7	would	would	AUX
ihlr-16574	588	8	argue	argue	VERB
ihlr-16574	588	9	that	that	SCONJ
ihlr-16574	588	10	if	if	SCONJ
ihlr-16574	588	11	that	that	DET
ihlr-16574	588	12	question	question	NOUN
ihlr-16574	588	13	can	can	AUX
ihlr-16574	588	14	not	not	PART
ihlr-16574	588	15	be	be	AUX
ihlr-16574	588	16	answered	answer	VERB
ihlr-16574	588	17	with	with	ADP
ihlr-16574	588	18	firm	firm	ADJ
ihlr-16574	588	19	certainty	certainty	NOUN
ihlr-16574	588	20	,	,	PUNCT
ihlr-16574	588	21	then	then	ADV
ihlr-16574	588	22	this	this	DET
ihlr-16574	588	23	research	research	NOUN
ihlr-16574	588	24	should	should	AUX
ihlr-16574	588	25	not	not	PART
ihlr-16574	588	26	receive	receive	VERB
ihlr-16574	588	27	federal	federal	ADJ
ihlr-16574	588	28	support	support	NOUN
ihlr-16574	588	29	.	.	PUNCT
ihlr-16574	589	1	not	not	PART
ihlr-16574	589	2	only	only	ADV
ihlr-16574	589	3	is	be	AUX
ihlr-16574	589	4	the	the	DET
ihlr-16574	589	5	topic	topic	NOUN
ihlr-16574	589	6	of	of	ADP
ihlr-16574	589	7	stem	stem	NOUN
ihlr-16574	589	8	cell	cell	NOUN
ihlr-16574	589	9	research	research	NOUN
ihlr-16574	589	10	sensitive	sensitive	ADJ
ihlr-16574	589	11	on	on	ADP
ihlr-16574	589	12	an	an	DET
ihlr-16574	589	13	ethical	ethical	ADJ
ihlr-16574	589	14	level	level	NOUN
ihlr-16574	589	15	,	,	PUNCT
ihlr-16574	589	16	it	it	PRON
ihlr-16574	589	17	is	be	AUX
ihlr-16574	589	18	also	also	ADV
ihlr-16574	589	19	a	a	DET
ihlr-16574	589	20	charged	charge	VERB
ihlr-16574	589	21	issue	issue	NOUN
ihlr-16574	589	22	because	because	SCONJ
ihlr-16574	589	23	many	many	ADJ
ihlr-16574	589	24	do	do	AUX
ihlr-16574	589	25	not	not	PART
ihlr-16574	589	26	believe	believe	VERB
ihlr-16574	589	27	that	that	SCONJ
ihlr-16574	589	28	stem	stem	NOUN
ihlr-16574	589	29	cell	cell	NOUN
ihlr-16574	589	30	re­	re­	NOUN
ihlr-16574	589	31	search	search	NOUN
ihlr-16574	589	32	and	and	CCONJ
ihlr-16574	589	33	development	development	NOUN
ihlr-16574	589	34	should	should	AUX
ihlr-16574	589	35	take	take	VERB
ihlr-16574	589	36	place	place	NOUN
ihlr-16574	589	37	with	with	ADP
ihlr-16574	589	38	federal	federal	ADJ
ihlr-16574	589	39	money.187	money.187	NOUN
ihlr-16574	589	40	stem	stem	NOUN
ihlr-16574	589	41	cell	cell	NOUN
ihlr-16574	589	42	research	research	NOUN
ihlr-16574	589	43	will	will	AUX
ihlr-16574	589	44	certainly	certainly	ADV
ihlr-16574	589	45	move	move	VERB
ihlr-16574	589	46	forward	forward	ADV
ihlr-16574	589	47	with	with	ADP
ihlr-16574	589	48	or	or	CCONJ
ihlr-16574	589	49	without	without	ADP
ihlr-16574	589	50	federal	federal	ADJ
ihlr-16574	589	51	money.188	money.188	NOUN
ihlr-16574	589	52	if	if	SCONJ
ihlr-16574	589	53	the	the	DET
ihlr-16574	589	54	government	government	NOUN
ihlr-16574	589	55	chooses	choose	VERB
ihlr-16574	589	56	to	to	PART
ihlr-16574	589	57	not	not	PART
ihlr-16574	589	58	invest	invest	VERB
ihlr-16574	589	59	in	in	ADP
ihlr-16574	589	60	the	the	DET
ihlr-16574	589	61	research	research	NOUN
ihlr-16574	589	62	and	and	CCONJ
ihlr-16574	589	63	development	development	NOUN
ihlr-16574	589	64	,	,	PUNCT
ihlr-16574	589	65	then	then	ADV
ihlr-16574	589	66	it	it	PRON
ihlr-16574	589	67	will	will	AUX
ihlr-16574	589	68	have	have	VERB
ihlr-16574	589	69	no	no	DET
ihlr-16574	589	70	ability	ability	NOUN
ihlr-16574	589	71	to	to	PART
ihlr-16574	589	72	regulate	regulate	VERB
ihlr-16574	589	73	the	the	DET
ihlr-16574	589	74	research	research	NOUN
ihlr-16574	589	75	essentially	essentially	ADV
ihlr-16574	589	76	handing	hand	VERB
ihlr-16574	589	77	over	over	ADP
ihlr-16574	589	78	all	all	DET
ihlr-16574	589	79	power	power	NOUN
ihlr-16574	589	80	to	to	ADP
ihlr-16574	589	81	the	the	DET
ihlr-16574	589	82	private	private	ADJ
ihlr-16574	589	83	sector.189	sector.189	NOUN
ihlr-16574	589	84	"	"	PUNCT
ihlr-16574	589	85	an	an	DET
ihlr-16574	589	86	'	'	PUNCT
ihlr-16574	589	87	unlegislated	unlegislated	ADJ
ihlr-16574	589	88	,	,	PUNCT
ihlr-16574	589	89	commercially	commercially	ADV
ihlr-16574	589	90	driven	drive	VERB
ihlr-16574	589	91	world	world	NOUN
ihlr-16574	589	92	'	'	PUNCT
ihlr-16574	589	93	of	of	ADP
ihlr-16574	589	94	hesc	hesc	NOUN
ihlr-16574	589	95	[	[	X
ihlr-16574	589	96	human	human	ADJ
ihlr-16574	589	97	embryonic	embryonic	ADJ
ihlr-16574	589	98	stem	stem	NOUN
ihlr-16574	589	99	cell	cell	NOUN
ihlr-16574	589	100	]	]	PUNCT
ihlr-16574	589	101	research	research	NOUN
ihlr-16574	589	102	could	could	AUX
ihlr-16574	589	103	lead	lead	VERB
ihlr-16574	589	104	to	to	ADP
ihlr-16574	589	105	'	'	PUNCT
ihlr-16574	589	106	un­	un­	ADV
ihlr-16574	589	107	safe	safe	ADJ
ihlr-16574	589	108	,	,	PUNCT
ihlr-16574	589	109	black	black	ADJ
ihlr-16574	589	110	market	market	NOUN
ihlr-16574	589	111	·	·	SYM
ihlr-16574	589	112	conditions	condition	NOUN
ihlr-16574	589	113	,	,	PUNCT
ihlr-16574	589	114	'	'	PUNCT
ihlr-16574	589	115	and	and	CCONJ
ihlr-16574	589	116	erode	erode	VERB
ihlr-16574	589	117	respect	respect	NOUN
ihlr-16574	589	118	for	for	ADP
ihlr-16574	589	119	human	human	ADJ
ihlr-16574	589	120	embryonic	embryonic	ADJ
ihlr-16574	589	121	stem	stem	NOUN
ihlr-16574	589	122	cells	cell	NOUN
ihlr-16574	589	123	,	,	PUNCT
ihlr-16574	589	124	the	the	DET
ihlr-16574	589	125	very	very	ADJ
ihlr-16574	589	126	respect	respect	NOUN
ihlr-16574	589	127	opponents	opponent	NOUN
ihlr-16574	589	128	of	of	ADP
ihlr-16574	589	129	such	such	ADJ
ihlr-16574	589	130	research	research	NOUN
ihlr-16574	589	131	stress	stress	NOUN
ihlr-16574	589	132	and	and	CCONJ
ihlr-16574	589	133	which	which	DET
ihlr-16574	589	134	erosion	erosion	NOUN
ihlr-16574	589	135	could	could	AUX
ihlr-16574	589	136	be	be	AUX
ihlr-16574	589	137	protected	protect	VERB
ihlr-16574	589	138	against	against	ADP
ihlr-16574	589	139	by	by	ADP
ihlr-16574	589	140	federal	federal	ADJ
ihlr-16574	589	141	regulation	regulation	NOUN
ihlr-16574	589	142	.	.	PUNCT
ihlr-16574	590	1	"190	"190	NOUN
ihlr-16574	590	2	182	182	NUM
ihlr-16574	590	3	.	.	PUNCT
ihlr-16574	591	1	i	i	PRON
ihlr-16574	591	2	d	d	PROPN
ihlr-16574	591	3	(	(	PUNCT
ihlr-16574	591	4	citations	citation	NOUN
ihlr-16574	591	5	omitted	omit	VERB
ihlr-16574	591	6	)	)	PUNCT
ihlr-16574	591	7	;	;	PUNCT
ihlr-16574	591	8	183	183	NUM
ihlr-16574	591	9	.	.	PUNCT
ihlr-16574	592	1	i	i	PRON
ihlr-16574	592	2	d	d	PROPN
ihlr-16574	592	3	184	184	NUM
ihlr-16574	592	4	.	.	PUNCT
ihlr-16574	593	1	i	i	PRON
ihlr-16574	593	2	d.	d.	PROPN
ihlr-16574	593	3	at	at	ADP
ihlr-16574	593	4	507	507	NUM
ihlr-16574	593	5	.	.	PUNCT
ihlr-16574	594	1	"	"	PUNCT
ihlr-16574	594	2	[	[	X
ihlr-16574	594	3	this	this	DET
ihlr-16574	594	4	report	report	NOUN
ihlr-16574	594	5	]	]	PUNCT
ihlr-16574	594	6	summarizes	summarize	VERB
ihlr-16574	594	7	some	some	PRON
ihlr-16574	594	8	of	of	ADP
ihlr-16574	594	9	the	the	DET
ihlr-16574	594	10	more	more	ADV
ihlr-16574	594	11	interesting	interesting	ADJ
ihlr-16574	594	12	and	and	CCONJ
ihlr-16574	594	13	significant	significant	ADJ
ihlr-16574	594	14	recent	recent	ADJ
ihlr-16574	594	15	developments	development	NOUN
ihlr-16574	594	16	.	.	PUNCT
ihlr-16574	594	17	.	.	PUNCT
ihlr-16574	595	1	.	.	PUNCT
ihlr-16574	596	1	both	both	PRON
ihlr-16574	596	2	in	in	ADP
ihlr-16574	596	3	the	the	DET
ihlr-16574	596	4	basic	basic	ADJ
ihlr-16574	596	5	science	science	NOUN
ihlr-16574	596	6	and	and	CCONJ
ihlr-16574	596	7	medical	medical	ADJ
ihlr-16574	596	8	applications	application	NOUN
ihlr-16574	596	9	of	of	ADP
ihlr-16574	596	10	stem	stem	NOUN
ihlr-16574	596	11	cell	cell	NOUN
ihlr-16574	596	12	research	research	NOUN
ihlr-16574	596	13	and	and	CCONJ
ihlr-16574	596	14	in	in	ADP
ihlr-16574	596	15	the	the	DET
ihlr-16574	596	16	related	related	ADJ
ihlr-16574	596	17	ethical	ethical	ADJ
ihlr-16574	596	18	,	,	PUNCT
ihlr-16574	596	19	legal	legal	ADJ
ihlr-16574	596	20	,	,	PUNCT
ihlr-16574	596	21	and	and	CCONJ
ihlr-16574	596	22	policy	policy	NOUN
ihlr-16574	596	23	discussions	discussion	NOUN
ihlr-16574	596	24	.	.	PUNCT
ihlr-16574	596	25	"	"	PUNCT
ihlr-16574	597	1	a	a	DET
ihlr-16574	597	2	report	report	NOUN
ihlr-16574	597	3	of	of	ADP
ihlr-16574	597	4	the	the	DET
ihlr-16574	597	5	president	president	NOUN
ihlr-16574	597	6	's	's	PART
ihlr-16574	597	7	council	council	NOUN
ihlr-16574	597	8	on	on	ADP
ihlr-16574	597	9	bioetidcs	bioetidc	NOUN
ihlr-16574	597	10	,	,	PUNCT
ihlr-16574	597	11	monitoring	monitor	VERB
ihlr-16574	597	12	stem	stem	NOUN
ihlr-16574	597	13	cell	cell	NOUN
ihlr-16574	597	14	research	research	NOUN
ihlr-16574	597	15	2	2	NUM
ihlr-16574	597	16	(	(	PUNCT
ihlr-16574	597	17	2004	2004	NUM
ihlr-16574	597	18	)	)	PUNCT
ihlr-16574	597	19	,	,	PUNCT
ihlr-16574	597	20	available	available	ADJ
ihlr-16574	597	21	at	at	ADP
ihlr-16574	597	22	http://www.bioethics.gov/reports/stemcell/pcbe	http://www.bioethics.gov/reports/stemcell/pcbe	NOUN
ihlr-16574	597	23	_	_	PUNCT
ihlr-16574	597	24	final	final	ADJ
ihlr-16574	597	25	_	_	PRON
ihlr-16574	597	26	version	version	NOUN
ihlr-16574	597	27	_	_	PUNCT
ihlr-16574	597	28	monitoring	monitor	VERB
ihlr-16574	597	29	_	_	PUNCT
ihlr-16574	597	30	stem	stem	NOUN
ihlr-16574	597	31	_	_	DET
ihlr-16574	597	32	cell	cell	NOUN
ihlr-16574	597	33	_	_	PUNCT
ihlr-16574	597	34	research	research	NOUN
ihlr-16574	597	35	.	.	PUNCT
ihlr-16574	598	1	pdf	pdf	NOUN
ihlr-16574	598	2	(	(	PUNCT
ihlr-16574	598	3	focusing	focus	VERB
ihlr-16574	598	4	on	on	ADP
ihlr-16574	598	5	the	the	DET
ihlr-16574	598	6	ethical	ethical	ADJ
ihlr-16574	598	7	,	,	PUNCT
ihlr-16574	598	8	legal	legal	ADJ
ihlr-16574	598	9	,	,	PUNCT
ihlr-16574	598	10	scientific	scientific	ADJ
ihlr-16574	598	11	,	,	PUNCT
ihlr-16574	598	12	and	and	CCONJ
ihlr-16574	598	13	medical	medical	ADJ
ihlr-16574	598	14	developments	development	NOUN
ihlr-16574	598	15	so	so	SCONJ
ihlr-16574	598	16	"	"	PUNCT
ihlr-16574	598	17	that	that	SCONJ
ihlr-16574	598	18	the	the	DET
ihlr-16574	598	19	president	president	NOUN
ihlr-16574	598	20	,	,	PUNCT
ihlr-16574	598	21	the	the	DET
ihlr-16574	598	22	congress	congress	PROPN
ihlr-16574	598	23	,	,	PUNCT
ihlr-16574	598	24	and	and	CCONJ
ihlr-16574	598	25	the	the	DET
ihlr-16574	598	26	nation	nation	NOUN
ihlr-16574	598	27	may	may	AUX
ihlr-16574	598	28	be	be	AUX
ihlr-16574	598	29	better	well	ADV
ihlr-16574	598	30	informed	inform	VERB
ihlr-16574	598	31	as	as	SCONJ
ihlr-16574	598	32	they	they	PRON
ihlr-16574	598	33	consider	consider	VERB
ihlr-16574	598	34	where	where	SCONJ
ihlr-16574	598	35	we	we	PRON
ihlr-16574	598	36	should	should	AUX
ihlr-16574	598	37	go	go	VERB
ihlr-16574	598	38	in	in	ADP
ihlr-16574	598	39	the	the	DET
ihlr-16574	598	40	future	future	NOUN
ihlr-16574	598	41	.	.	PUNCT
ihlr-16574	598	42	"	"	PUNCT
ihlr-16574	599	1	i	i	PRON
ihlr-16574	599	2	d.	d.	PROPN
ihlr-16574	599	3	)	)	PUNCT
ihlr-16574	599	4	185	185	NUM
ihlr-16574	599	5	.	.	PUNCT
ihlr-16574	600	1	saltzberg	saltzberg	ADJ
ihlr-16574	600	2	,	,	PUNCT
ihlr-16574	600	3	supra	supra	PROPN
ihlr-16574	600	4	note	note	NOUN
ihlr-16574	600	5	179	179	NUM
ihlr-16574	600	6	,	,	PUNCT
ihlr-16574	600	7	at	at	ADP
ihlr-16574	600	8	512	512	NUM
ihlr-16574	600	9	.	.	PUNCT
ihlr-16574	601	1	186	186	NUM
ihlr-16574	601	2	.	.	PUNCT
ihlr-16574	601	3	ld	ld	PROPN
ihlr-16574	601	4	187	187	NUM
ihlr-16574	601	5	.	.	PUNCT
ihlr-16574	602	1	i	i	PRON
ihlr-16574	602	2	d.	d.	PROPN
ihlr-16574	602	3	at	at	ADP
ihlr-16574	602	4	505	505	NUM
ihlr-16574	602	5	.	.	PUNCT
ihlr-16574	603	1	188	188	NUM
ihlr-16574	603	2	.	.	PUNCT
ihlr-16574	604	1	i	i	PRON
ihlr-16574	604	2	d.	d.	PROPN
ihlr-16574	604	3	at	at	ADP
ihlr-16574	604	4	517	517	NUM
ihlr-16574	604	5	.	.	PROPN
ihlr-16574	605	1	189	189	NUM
ihlr-16574	605	2	.	.	PUNCT
ihlr-16574	606	1	i	i	PRON
ihlr-16574	606	2	d	d	PROPN
ihlr-16574	606	3	190	190	NUM
ihlr-16574	606	4	.	.	PUNCT
ihlr-16574	607	1	i	i	PRON
ihlr-16574	607	2	d.	d.	PROPN
ihlr-16574	607	3	(	(	PUNCT
ihlr-16574	607	4	quoting	quote	VERB
ihlr-16574	607	5	carly	carly	PROPN
ihlr-16574	607	6	goldstein	goldstein	PROPN
ihlr-16574	607	7	,	,	PUNCT
ihlr-16574	607	8	note	note	VERB
ihlr-16574	607	9	;	;	PUNCT
ihlr-16574	607	10	dipping	dip	VERB
ihlr-16574	607	11	into	into	ADP
ihlr-16574	607	12	uncle	uncle	PROPN
ihlr-16574	607	13	sam	sam	PROPN
ihlr-16574	607	14	's	's	PART
ihlr-16574	607	15	pockets	pocket	NOUN
ihlr-16574	607	16	:	:	PUNCT
ihlr-16574	607	17	federal	federal	ADJ
ihlr-16574	607	18	funding	funding	NOUN
ihlr-16574	607	19	of	of	ADP
ihlr-16574	607	20	stem	stem	NOUN
ihlr-16574	607	21	cell	cell	NOUN
ihlr-16574	607	22	research	research	NOUN
ihlr-16574	607	23	:	:	PUNCT
ihlr-16574	607	24	is	be	AUX
ihlr-16574	607	25	it	it	PRON
ihlr-16574	607	26	legal	legal	ADJ
ihlr-16574	607	27	?	?	PUNCT
ihlr-16574	607	28	,	,	PUNCT
ihlr-16574	607	29	11	11	NUM
ihlr-16574	607	30	b.u	b.u	NOUN
ihlr-16574	607	31	.	.	PUNCT
ihlr-16574	607	32	pub	pub	NOUN
ihlr-16574	607	33	int	int	NOUN
ihlr-16574	607	34	.	.	PUNCT
ihlr-16574	608	1	lj	lj	PROPN
ihlr-16574	608	2	229	229	NUM
ihlr-16574	608	3	,	,	PUNCT
ihlr-16574	608	4	256	256	NUM
ihlr-16574	608	5	(	(	PUNCT
ihlr-16574	608	6	2002	2002	NUM
ihlr-16574	608	7	)	)	PUNCT
ihlr-16574	608	8	)	)	PUNCT
ihlr-16574	608	9	.	.	PUNCT
ihlr-16574	609	1	424	424	NUM
ihlr-16574	609	2	indiana	indiana	PROPN
ihlr-16574	609	3	health	health	PROPN
ihlr-16574	609	4	law	law	PROPN
ihlr-16574	609	5	review	review	NOUN
ihlr-16574	609	6	[	[	X
ihlr-16574	609	7	vol	vol	NOUN
ihlr-16574	609	8	.	.	PUNCT
ihlr-16574	610	1	7:397	7:397	NUM
ihlr-16574	610	2	2	2	NUM
ihlr-16574	610	3	.	.	PUNCT
ihlr-16574	610	4	creation	creation	NOUN
ihlr-16574	610	5	of	of	ADP
ihlr-16574	610	6	a	a	DET
ihlr-16574	610	7	task	task	NOUN
ihlr-16574	610	8	force	force	NOUN
ihlr-16574	610	9	on	on	ADP
ihlr-16574	610	10	ethical	ethical	ADJ
ihlr-16574	610	11	considerations	consideration	NOUN
ihlr-16574	610	12	the	the	DET
ihlr-16574	610	13	u.s	u.s	PROPN
ihlr-16574	610	14	.	.	PROPN
ihlr-16574	610	15	and	and	CCONJ
ihlr-16574	610	16	the	the	DET
ihlr-16574	610	17	eu	eu	PROPN
ihlr-16574	610	18	should	should	AUX
ihlr-16574	610	19	consider	consider	VERB
ihlr-16574	610	20	creating	create	VERB
ihlr-16574	610	21	task	task	NOUN
ihlr-16574	610	22	forces	force	NOUN
ihlr-16574	610	23	to	to	PART
ihlr-16574	610	24	analyze	analyze	VERB
ihlr-16574	610	25	and	and	CCONJ
ihlr-16574	610	26	monitor	monitor	VERB
ihlr-16574	610	27	the	the	DET
ihlr-16574	610	28	ethical	ethical	ADJ
ihlr-16574	610	29	considerations	consideration	NOUN
ihlr-16574	610	30	surrounding	surround	VERB
ihlr-16574	610	31	nanomedicine	nanomedicine	NOUN
ihlr-16574	610	32	.	.	PUNCT
ihlr-16574	611	1	as	as	ADP
ihlr-16574	611	2	with	with	ADP
ihlr-16574	611	3	stem	stem	NOUN
ihlr-16574	611	4	cell	cell	NOUN
ihlr-16574	611	5	research	research	NOUN
ihlr-16574	611	6	,	,	PUNCT
ihlr-16574	611	7	"	"	PUNCT
ihlr-16574	611	8	[	[	X
ihlr-16574	611	9	e]ven	e]ven	NOUN
ihlr-16574	611	10	...	...	PUNCT
ihlr-16574	611	11	those	those	PRON
ihlr-16574	611	12	who	who	PRON
ihlr-16574	611	13	favor	favor	VERB
ihlr-16574	612	1	[	[	X
ihlr-16574	612	2	the	the	X
ihlr-16574	612	3	]	]	X
ihlr-16574	612	4	research.~-	research.~-	X
ihlr-16574	612	5	.	.	PUNCT
ihlr-16574	613	1	[	[	X
ihlr-16574	613	2	have	have	VERB
ihlr-16574	613	3	]	]	X
ihlr-16574	613	4	questions	question	NOUN
ihlr-16574	613	5	about	about	ADP
ihlr-16574	613	6	its	its	PRON
ihlr-16574	613	7	proper	proper	ADJ
ihlr-16574	613	8	limits	limit	NOUN
ihlr-16574	613	9	and	and	CCONJ
ihlr-16574	613	10	the	the	DET
ihlr-16574	613	11	means	mean	NOUN
ihlr-16574	613	12	of	of	ADP
ihlr-16574	613	13	establishing	establish	VERB
ihlr-16574	613	14	and	and	CCONJ
ihlr-16574	613	15	enforc­	enforc­	VERB
ihlr-16574	613	16	ing	e	VERB
ihlr-16574	613	17	those	those	DET
ihlr-16574	613	18	limits	limit	NOUN
ihlr-16574	613	19	through	through	ADP
ihlr-16574	613	20	meaningful	meaningful	ADJ
ihlr-16574	613	21	regulation	regulation	NOUN
ihlr-16574	613	22	.	.	PUNCT
ihlr-16574	614	1	"191	"191	PROPN
ihlr-16574	615	1	these	these	DET
ihlr-16574	615	2	task	task	NOUN
ihlr-16574	615	3	forces	force	NOUN
ihlr-16574	615	4	should	should	AUX
ihlr-16574	615	5	be	be	AUX
ihlr-16574	615	6	charged	charge	VERB
ihlr-16574	615	7	with	with	ADP
ihlr-16574	615	8	determining	determine	VERB
ihlr-16574	615	9	what	what	PRON
ihlr-16574	615	10	these	these	DET
ihlr-16574	615	11	"	"	PUNCT
ihlr-16574	615	12	proper	proper	ADJ
ihlr-16574	615	13	limits	limit	NOUN
ihlr-16574	615	14	"	"	PUNCT
ihlr-16574	615	15	will	will	AUX
ihlr-16574	615	16	include	include	VERB
ihlr-16574	615	17	and	and	CCONJ
ihlr-16574	615	18	how	how	SCONJ
ihlr-16574	615	19	nanomedicine	nanomedicine	NOUN
ihlr-16574	615	20	can	can	AUX
ihlr-16574	615	21	be	be	AUX
ihlr-16574	615	22	developed	develop	VERB
ihlr-16574	615	23	and	and	CCONJ
ihlr-16574	615	24	implemented	implement	VERB
ihlr-16574	615	25	in	in	ADP
ihlr-16574	615	26	the	the	DET
ihlr-16574	615	27	future	future	NOUN
ihlr-16574	615	28	.	.	PUNCT
ihlr-16574	616	1	n.	n.	NOUN
ihlr-16574	616	2	conclusion	conclusion	NOUN
ihlr-16574	616	3	though	though	SCONJ
ihlr-16574	616	4	nanotechnology	nanotechnology	NOUN
ihlr-16574	616	5	and	and	CCONJ
ihlr-16574	616	6	nanomedicine	nanomedicine	NOUN
ihlr-16574	616	7	are	be	AUX
ihlr-16574	616	8	still	still	ADV
ihlr-16574	616	9	firmly	firmly	ADV
ihlr-16574	616	10	situated	situate	VERB
ihlr-16574	616	11	in	in	ADP
ihlr-16574	616	12	the	the	DET
ihlr-16574	616	13	research	research	NOUN
ihlr-16574	616	14	and	and	CCONJ
ihlr-16574	616	15	development	development	NOUN
ihlr-16574	616	16	phase	phase	NOUN
ihlr-16574	616	17	,	,	PUNCT
ihlr-16574	616	18	the	the	DET
ihlr-16574	616	19	united	united	PROPN
ihlr-16574	616	20	states	states	PROPN
ihlr-16574	616	21	and	and	CCONJ
ihlr-16574	616	22	the	the	DET
ihlr-16574	616	23	european	european	PROPN
ihlr-16574	616	24	union	union	PROPN
ihlr-16574	616	25	have	have	AUX
ihlr-16574	616	26	both	both	PRON
ihlr-16574	616	27	decided	decide	VERB
ihlr-16574	616	28	to	to	PART
ihlr-16574	616	29	preemptively	preemptively	ADV
ihlr-16574	616	30	examine	examine	VERB
ihlr-16574	616	31	this	this	PRON
ihlr-16574	616	32	emerging	emerge	VERB
ihlr-16574	616	33	technolo­	technolo­	X
ihlr-16574	616	34	gy	gy	NOUN
ihlr-16574	616	35	.	.	PUNCT
ihlr-16574	617	1	both	both	DET
ihlr-16574	617	2	countries	country	NOUN
ihlr-16574	617	3	are	be	AUX
ihlr-16574	617	4	proceeding	proceed	VERB
ihlr-16574	617	5	cautiously	cautiously	ADV
ihlr-16574	617	6	,	,	PUNCT
ihlr-16574	617	7	however	however	ADV
ihlr-16574	617	8	,	,	PUNCT
ihlr-16574	617	9	with	with	ADP
ihlr-16574	617	10	regard	regard	NOUN
ihlr-16574	617	11	to	to	ADP
ihlr-16574	617	12	regulation	regulation	NOUN
ihlr-16574	617	13	of	of	ADP
ihlr-16574	617	14	this	this	DET
ihlr-16574	617	15	new	new	ADJ
ihlr-16574	617	16	technology	technology	NOUN
ihlr-16574	617	17	.	.	PUNCT
ihlr-16574	618	1	through	through	ADP
ihlr-16574	618	2	adoption	adoption	NOUN
ihlr-16574	618	3	of	of	ADP
ihlr-16574	618	4	''	''	PUNCT
ihlr-16574	618	5	wait	wait	VERB
ihlr-16574	618	6	and	and	CCONJ
ihlr-16574	618	7	see	see	VERB
ihlr-16574	618	8	"	"	PUNCT
ihlr-16574	618	9	ap­	ap­	PROPN
ihlr-16574	618	10	proaches	proache	NOUN
ihlr-16574	618	11	,	,	PUNCT
ihlr-16574	618	12	the	the	DET
ihlr-16574	618	13	nations	nation	NOUN
ihlr-16574	618	14	will	will	AUX
ihlr-16574	618	15	be	be	AUX
ihlr-16574	618	16	better	well	ADV
ihlr-16574	618	17	situated	situated	ADJ
ihlr-16574	618	18	to	to	PART
ihlr-16574	618	19	meaningfully	meaningfully	ADV
ihlr-16574	618	20	deal	deal	VERB
ihlr-16574	618	21	with	with	ADP
ihlr-16574	618	22	and	and	CCONJ
ihlr-16574	618	23	regulate	regulate	VERB
ihlr-16574	618	24	the	the	DET
ihlr-16574	618	25	technology	technology	NOUN
ihlr-16574	618	26	once	once	SCONJ
ihlr-16574	618	27	the	the	DET
ihlr-16574	618	28	science	science	NOUN
ihlr-16574	618	29	is	be	AUX
ihlr-16574	618	30	fully	fully	ADV
ihlr-16574	618	31	understood	understand	VERB
ihlr-16574	618	32	,	,	PUNCT
ihlr-16574	618	33	and	and	CCONJ
ihlr-16574	618	34	there	there	PRON
ihlr-16574	618	35	is	be	VERB
ihlr-16574	618	36	a	a	DET
ihlr-16574	618	37	clear	clear	ADV
ihlr-16574	618	38	defined	define	VERB
ihlr-16574	618	39	direction	direction	NOUN
ihlr-16574	618	40	in	in	ADP
ihlr-16574	618	41	which	which	PRON
ihlr-16574	618	42	the	the	DET
ihlr-16574	618	43	technology	technology	NOUN
ihlr-16574	618	44	will	will	AUX
ihlr-16574	618	45	be	be	AUX
ihlr-16574	618	46	used	use	VERB
ihlr-16574	618	47	.	.	PUNCT
ihlr-16574	619	1	it	it	PRON
ihlr-16574	619	2	will	will	AUX
ihlr-16574	619	3	not	not	PART
ihlr-16574	619	4	be	be	AUX
ihlr-16574	619	5	until	until	SCONJ
ihlr-16574	619	6	these	these	DET
ihlr-16574	619	7	scientific	scientific	ADJ
ihlr-16574	619	8	advancements	advancement	NOUN
ihlr-16574	619	9	occur	occur	VERB
ihlr-16574	619	10	that	that	SCONJ
ihlr-16574	619	11	the	the	DET
ihlr-16574	619	12	gov­	gov­	NOUN
ihlr-16574	619	13	ernments	ernment	NOUN
ihlr-16574	619	14	will	will	AUX
ihlr-16574	619	15	be	be	AUX
ihlr-16574	619	16	able	able	ADJ
ihlr-16574	619	17	to	to	PART
ihlr-16574	619	18	adequately	adequately	ADV
ihlr-16574	619	19	see	see	VERB
ihlr-16574	619	20	the	the	DET
ihlr-16574	619	21	limitations	limitation	NOUN
ihlr-16574	619	22	of	of	ADP
ihlr-16574	619	23	the	the	DET
ihlr-16574	619	24	application	application	NOUN
ihlr-16574	619	25	of	of	ADP
ihlr-16574	619	26	current	current	ADJ
ihlr-16574	619	27	regulatory	regulatory	ADJ
ihlr-16574	619	28	structures	structure	NOUN
ihlr-16574	619	29	already	already	ADV
ihlr-16574	619	30	in	in	ADP
ihlr-16574	619	31	place	place	NOUN
ihlr-16574	619	32	as	as	SCONJ
ihlr-16574	619	33	they	they	PRON
ihlr-16574	619	34	apply	apply	VERB
ihlr-16574	619	35	to	to	ADP
ihlr-16574	619	36	nanotechnol­	nanotechnol­	VERB
ihlr-16574	619	37	ogy	ogy	NOUN
ihlr-16574	619	38	and	and	CCONJ
ihlr-16574	619	39	nanomedicine	nanomedicine	NOUN
ihlr-16574	619	40	.	.	PUNCT
ihlr-16574	620	1	once	once	SCONJ
ihlr-16574	620	2	these	these	DET
ihlr-16574	620	3	limitations	limitation	NOUN
ihlr-16574	620	4	are	be	AUX
ihlr-16574	620	5	adequately	adequately	ADV
ihlr-16574	620	6	realized	realize	VERB
ihlr-16574	620	7	,	,	PUNCT
ihlr-16574	620	8	it	it	PRON
ihlr-16574	620	9	will	will	AUX
ihlr-16574	620	10	be	be	AUX
ihlr-16574	620	11	possible	possible	ADJ
ihlr-16574	620	12	for	for	SCONJ
ihlr-16574	620	13	meaningful	meaningful	ADJ
ihlr-16574	620	14	regulation	regulation	NOUN
ihlr-16574	620	15	to	to	PART
ihlr-16574	620	16	follow	follow	VERB
ihlr-16574	620	17	.	.	PUNCT
ihlr-16574	621	1	the	the	DET
ihlr-16574	621	2	future	future	NOUN
ihlr-16574	621	3	of	of	ADP
ihlr-16574	621	4	mea­	mea­	PROPN
ihlr-16574	621	5	ningful	ningful	ADJ
ihlr-16574	621	6	regulation	regulation	NOUN
ihlr-16574	621	7	will	will	AUX
ihlr-16574	621	8	only	only	ADV
ihlr-16574	621	9	stem	stem	VERB
ihlr-16574	621	10	from	from	ADP
ihlr-16574	621	11	careful	careful	ADJ
ihlr-16574	621	12	monitoring	monitoring	NOUN
ihlr-16574	621	13	of	of	ADP
ihlr-16574	621	14	the	the	DET
ihlr-16574	621	15	research	research	NOUN
ihlr-16574	621	16	and	and	CCONJ
ihlr-16574	621	17	development	development	NOUN
ihlr-16574	621	18	of	of	ADP
ihlr-16574	621	19	nanotechnology	nanotechnology	PROPN
ihlr-16574	621	20	.	.	PUNCT
ihlr-16574	622	1	though	though	SCONJ
ihlr-16574	622	2	some	some	PRON
ihlr-16574	622	3	of	of	ADP
ihlr-16574	622	4	the	the	DET
ihlr-16574	622	5	current	current	ADJ
ihlr-16574	622	6	regula­	regula­	NOUN
ihlr-16574	622	7	tions	tion	NOUN
ihlr-16574	622	8	might	might	AUX
ihlr-16574	622	9	adequately	adequately	ADV
ihlr-16574	622	10	govern	govern	VERB
ihlr-16574	622	11	parts	part	NOUN
ihlr-16574	622	12	of	of	ADP
ihlr-16574	622	13	nanotechnology	nanotechnology	NOUN
ihlr-16574	622	14	and	and	CCONJ
ihlr-16574	622	15	nanomedicine	nanomedicine	NOUN
ihlr-16574	622	16	in	in	ADP
ihlr-16574	622	17	the	the	DET
ihlr-16574	622	18	future	future	NOUN
ihlr-16574	622	19	,	,	PUNCT
ihlr-16574	622	20	it	it	PRON
ihlr-16574	622	21	is	be	AUX
ihlr-16574	622	22	likely	likely	ADJ
ihlr-16574	622	23	that	that	SCONJ
ihlr-16574	622	24	these	these	DET
ihlr-16574	622	25	regulations	regulation	NOUN
ihlr-16574	622	26	will	will	AUX
ihlr-16574	622	27	not	not	PART
ihlr-16574	622	28	be	be	AUX
ihlr-16574	622	29	able	able	ADJ
ihlr-16574	622	30	to	to	PART
ihlr-16574	622	31	address	address	VERB
ihlr-16574	622	32	all	all	PRON
ihlr-16574	622	33	of	of	ADP
ihlr-16574	622	34	issues	issue	NOUN
ihlr-16574	622	35	as	as	ADP
ihlr-16574	622	36	most	most	ADJ
ihlr-16574	622	37	are	be	AUX
ihlr-16574	622	38	not	not	PART
ihlr-16574	622	39	yet	yet	ADV
ihlr-16574	622	40	known	know	VERB
ihlr-16574	622	41	.	.	PUNCT
ihlr-16574	623	1	in	in	ADP
ihlr-16574	623	2	addition	addition	NOUN
ihlr-16574	623	3	to	to	ADP
ihlr-16574	623	4	focusing	focus	VERB
ihlr-16574	623	5	on	on	ADP
ihlr-16574	623	6	the	the	DET
ihlr-16574	623	7	science	science	NOUN
ihlr-16574	623	8	of	of	ADP
ihlr-16574	623	9	nanomedicine	nanomedicine	NOUN
ihlr-16574	623	10	,	,	PUNCT
ihlr-16574	623	11	the	the	DET
ihlr-16574	623	12	united	united	PROPN
ihlr-16574	623	13	states	states	PROPN
ihlr-16574	623	14	and	and	CCONJ
ihlr-16574	623	15	the	the	DET
ihlr-16574	623	16	european	european	PROPN
ihlr-16574	623	17	union	union	PROPN
ihlr-16574	623	18	should	should	AUX
ihlr-16574	623	19	consider	consider	VERB
ihlr-16574	623	20	creating	create	VERB
ihlr-16574	623	21	ethical	ethical	ADJ
ihlr-16574	623	22	task	task	NOUN
ihlr-16574	623	23	forces	force	NOUN
ihlr-16574	623	24	.	.	PUNCT
ihlr-16574	624	1	these	these	DET
ihlr-16574	624	2	task	task	NOUN
ihlr-16574	624	3	forces	force	NOUN
ihlr-16574	624	4	would	would	AUX
ihlr-16574	624	5	be	be	AUX
ihlr-16574	624	6	charged	charge	VERB
ihlr-16574	624	7	with	with	ADP
ihlr-16574	624	8	monitoring	monitor	VERB
ihlr-16574	624	9	potential	potential	ADJ
ihlr-16574	624	10	ethical	ethical	ADJ
ihlr-16574	624	11	issues	issue	NOUN
ihlr-16574	624	12	surrounding	surround	VERB
ihlr-16574	624	13	the	the	DET
ihlr-16574	624	14	eventual	eventual	ADJ
ihlr-16574	624	15	uses	use	NOUN
ihlr-16574	624	16	for	for	ADP
ihlr-16574	624	17	nanotechnology	nanotechnology	NOUN
ihlr-16574	624	18	and	and	CCONJ
ihlr-16574	624	19	nanomedicine	nanomedicine	NOUN
ihlr-16574	624	20	.	.	PUNCT
ihlr-16574	625	1	they	they	PRON
ihlr-16574	625	2	will	will	AUX
ihlr-16574	625	3	likely	likely	ADV
ihlr-16574	625	4	have	have	VERB
ihlr-16574	625	5	to	to	PART
ihlr-16574	625	6	tackle	tackle	VERB
ihlr-16574	625	7	such	such	ADJ
ihlr-16574	625	8	issues	issue	NOUN
ihlr-16574	625	9	as	as	ADP
ihlr-16574	625	10	nanomedicine	nanomedicine	NOUN
ihlr-16574	625	11	uses	use	NOUN
ihlr-16574	625	12	for	for	ADP
ihlr-16574	625	13	human	human	ADJ
ihlr-16574	625	14	en­	en­	PROPN
ihlr-16574	625	15	hancement	hancement	NOUN
ihlr-16574	625	16	in	in	ADP
ihlr-16574	625	17	addition	addition	NOUN
ihlr-16574	625	18	to	to	ADP
ihlr-16574	625	19	countless	countless	ADJ
ihlr-16574	625	20	ethical	ethical	ADJ
ihlr-16574	625	21	considerations	consideration	NOUN
ihlr-16574	625	22	that	that	PRON
ihlr-16574	625	23	have	have	AUX
ihlr-16574	625	24	not	not	PART
ihlr-16574	625	25	been	be	AUX
ihlr-16574	625	26	191	191	NUM
ihlr-16574	625	27	.	.	PUNCT
ihlr-16574	626	1	a	a	DET
ihlr-16574	626	2	report	report	NOUN
ihlr-16574	626	3	of	of	ADP
ihlr-16574	626	4	the	the	DET
ihlr-16574	626	5	president	president	NOUN
ihlr-16574	626	6	's	's	PART
ihlr-16574	626	7	councll	councll	NOUN
ihlr-16574	626	8	.	.	PUNCT
ihlr-16574	627	1	on	on	ADP
ihlr-16574	627	2	bioetincs	bioetinc	NOUN
ihlr-16574	627	3	,	,	PUNCT
ihlr-16574	627	4	monitoring	monitor	VERB
ihlr-16574	627	5	stem	stem	NOUN
ihlr-16574	627	6	cell	cell	NOUN
ihlr-16574	627	7	research	research	NOUN
ihlr-16574	627	8	6	6	NUM
ihlr-16574	627	9	(	(	PUNCT
ihlr-16574	627	10	2004	2004	NUM
ihlr-16574	627	11	)	)	PUNCT
ihlr-16574	627	12	,	,	PUNCT
ihlr-16574	627	13	available	available	ADJ
ihlr-16574	627	14	at	at	ADP
ihlr-16574	627	15	htlp:/lwww.bioetbics.govfreports	htlp:/lwww.bioetbics.govfreport	NOUN
ihlr-16574	627	16	/	/	SYM
ihlr-16574	627	17	stemcelll	stemcelll	NOUN
ihlr-16574	627	18	pcbe_final_version_monitoring_stem_cell_research.pdf	pcbe_final_version_monitoring_stem_cell_research.pdf	NOUN
ihlr-16574	627	19	"	"	PUNCT
ihlr-16574	627	20	much	much	ADJ
ihlr-16574	627	21	basic	basic	ADJ
ihlr-16574	627	22	and	and	CCONJ
ihlr-16574	627	23	applied	apply	VERB
ihlr-16574	627	24	research	research	NOUN
ihlr-16574	627	25	re­	re­	PROPN
ihlr-16574	627	26	mains	main	NOUN
ihlr-16574	627	27	to	to	PART
ihlr-16574	627	28	be	be	AUX
ihlr-16574	627	29	done	do	VERB
ihlr-16574	627	30	if	if	SCONJ
ihlr-16574	627	31	human	human	ADJ
ihlr-16574	627	32	stem	stem	NOUN
ihlr-16574	627	33	cells	cell	NOUN
ihlr-16574	627	34	are	be	AUX
ihlr-16574	627	35	to	to	PART
ihlr-16574	627	36	achieve	achieve	VERB
ihlr-16574	627	37	their	their	PRON
ihlr-16574	627	38	promise	promise	NOUN
ihlr-16574	627	39	in	in	ADP
ihlr-16574	627	40	regenerative	regenerative	ADJ
ihlr-16574	627	41	medicine	medicine	NOUN
ihlr-16574	627	42	.	.	PUNCT
ihlr-16574	628	1	this	this	DET
ihlr-16574	628	2	research	research	NOUN
ihlr-16574	628	3	is	be	AUX
ihlr-16574	628	4	expensive	expensive	ADJ
ihlr-16574	628	5	and	and	CCONJ
ihlr-16574	628	6	technically	technically	ADV
ihlr-16574	628	7	challenging	challenging	ADJ
ihlr-16574	628	8	,	,	PUNCT
ihlr-16574	628	9	and	and	CCONJ
ihlr-16574	628	10	requires	require	VERB
ihlr-16574	628	11	scientists	scientist	NOUN
ihlr-16574	628	12	willing	willing	ADJ
ihlr-16574	628	13	to	to	PART
ihlr-16574	628	14	take	take	VERB
ihlr-16574	628	15	a	a	DET
ihlr-16574	628	16	long	long	ADJ
ihlr-16574	628	17	perspective	perspective	NOUN
ihlr-16574	628	18	in	in	ADP
ihlr-16574	628	19	order	order	NOUN
ihlr-16574	628	20	to	to	PART
ihlr-16574	628	21	discover	discover	VERB
ihlr-16574	628	22	,	,	PUNCT
ihlr-16574	628	23	through	through	ADP
ihlr-16574	628	24	painstaking	painstaking	ADJ
ihlr-16574	628	25	research	research	NOUN
ihlr-16574	628	26	,	,	PUNCT
ihlr-16574	628	27	which	which	DET
ihlr-16574	628	28	combinations	combination	NOUN
ihlr-16574	628	29	of	of	ADP
ihlr-16574	628	30	techniques	technique	NOUN
ihlr-16574	628	31	could	could	AUX
ihlr-16574	628	32	...	...	VERB
ihlr-16574	628	33	be	be	AUX
ihlr-16574	628	34	successful	successful	ADJ
ihlr-16574	628	35	.	.	PUNCT
ihlr-16574	628	36	"	"	PUNCT
ihlr-16574	629	1	i	i	PRON
ihlr-16574	629	2	d.	d.	PROPN
ihlr-16574	629	3	at	at	ADP
ihlr-16574	629	4	140	140	NUM
ihlr-16574	629	5	(	(	PUNCT
ihlr-16574	629	6	noting	note	VERB
ihlr-16574	629	7	that	that	SCONJ
ihlr-16574	629	8	this	this	PRON
ihlr-16574	629	9	could	could	AUX
ihlr-16574	629	10	not	not	PART
ihlr-16574	629	11	be	be	AUX
ihlr-16574	629	12	accomplished	accomplish	VERB
ihlr-16574	629	13	without	without	ADP
ihlr-16574	629	14	"	"	PUNCT
ihlr-16574	629	15	strong	strong	ADJ
ihlr-16574	629	16	financial	financial	ADJ
ihlr-16574	629	17	support	support	NOUN
ihlr-16574	629	18	"	"	PUNCT
ihlr-16574	629	19	from	from	ADP
ihlr-16574	629	20	both	both	CCONJ
ihlr-16574	629	21	public	public	ADJ
ihlr-16574	629	22	and	and	CCONJ
ihlr-16574	629	23	private	private	ADJ
ihlr-16574	629	24	sources	source	NOUN
ihlr-16574	629	25	)	)	PUNCT
ihlr-16574	629	26	.	.	PUNCT
ihlr-16574	630	1	2010	2010	NUM
ihlr-16574	630	2	]	]	PUNCT
ihlr-16574	630	3	nanomediclne	nanomediclne	NOUN
ihlr-16574	630	4	425	425	NUM
ihlr-16574	630	5	imagined	imagine	VERB
ihlr-16574	630	6	or	or	CCONJ
ihlr-16574	630	7	contemplated	contemplate	VERB
ihlr-16574	630	8	at	at	ADP
ihlr-16574	630	9	this	this	DET
ihlr-16574	630	10	point	point	NOUN
ihlr-16574	630	11	.	.	PUNCT
ihlr-16574	631	1	much	much	ADV
ihlr-16574	631	2	like	like	ADP
ihlr-16574	631	3	stem	stem	NOUN
ihlr-16574	631	4	cell	cell	NOUN
ihlr-16574	631	5	research	research	NOUN
ihlr-16574	631	6	,	,	PUNCT
ihlr-16574	631	7	nanomedicine	nanomedicine	ADJ
ihlr-16574	631	8	technology	technology	NOUN
ihlr-16574	631	9	raises	raise	VERB
ihlr-16574	631	10	specific	specific	ADJ
ihlr-16574	631	11	ethical	ethical	ADJ
ihlr-16574	631	12	considerations	consideration	NOUN
ihlr-16574	631	13	that	that	PRON
ihlr-16574	631	14	must	must	AUX
ihlr-16574	631	15	be	be	AUX
ihlr-16574	631	16	explored	explore	VERB
ihlr-16574	631	17	and	and	CCONJ
ihlr-16574	631	18	considered	consider	VERB
ihlr-16574	631	19	when	when	SCONJ
ihlr-16574	631	20	contem­	contem­	NOUN
ihlr-16574	631	21	plating	plate	VERB
ihlr-16574	631	22	the	the	DET
ihlr-16574	631	23	regulation	regulation	NOUN
ihlr-16574	631	24	of	of	ADP
ihlr-16574	631	25	not	not	PART
ihlr-16574	631	26	only	only	ADV
ihlr-16574	631	27	its	its	PRON
ihlr-16574	631	28	research	research	NOUN
ihlr-16574	631	29	and	and	CCONJ
ihlr-16574	631	30	development	development	NOUN
ihlr-16574	631	31	,	,	PUNCT
ihlr-16574	631	32	but	but	CCONJ
ihlr-16574	631	33	also	also	ADV
ihlr-16574	631	34	its	its	PRON
ihlr-16574	631	35	inevitable	inevitable	ADJ
ihlr-16574	631	36	use	use	NOUN
ihlr-16574	631	37	in	in	ADP
ihlr-16574	631	38	society	society	NOUN
ihlr-16574	631	39	.	.	PUNCT
ihlr-16574	632	1	the	the	DET
ihlr-16574	632	2	governments	government	NOUN
ihlr-16574	632	3	of	of	ADP
ihlr-16574	632	4	the	the	DET
ihlr-16574	632	5	united	united	PROPN
ihlr-16574	632	6	states	states	PROPN
ihlr-16574	632	7	and	and	CCONJ
ihlr-16574	632	8	the	the	DET
ihlr-16574	632	9	european	european	PROPN
ihlr-16574	632	10	union	union	PROPN
ihlr-16574	632	11	both	both	PRON
ihlr-16574	632	12	have	have	VERB
ihlr-16574	632	13	pivotal	pivotal	ADJ
ihlr-16574	632	14	roles	role	NOUN
ihlr-16574	632	15	to	to	PART
ihlr-16574	632	16	play	play	VERB
ihlr-16574	632	17	in	in	ADP
ihlr-16574	632	18	the	the	DET
ihlr-16574	632	19	regulation	regulation	NOUN
ihlr-16574	632	20	of	of	ADP
ihlr-16574	632	21	this	this	DET
ihlr-16574	632	22	re­	re­	PROPN
ihlr-16574	632	23	search	search	NOUN
ihlr-16574	632	24	.	.	PUNCT
ihlr-16574	633	1	this	this	DET
ihlr-16574	633	2	influence	influence	NOUN
ihlr-16574	633	3	will	will	AUX
ihlr-16574	633	4	ultimately	ultimately	ADV
ihlr-16574	633	5	determine	determine	VERB
ihlr-16574	633	6	how	how	SCONJ
ihlr-16574	633	7	nanotechnology	nanotechnology	NOUN
ihlr-16574	633	8	de­	de­	VERB
ihlr-16574	633	9	velops	velop	NOUN
ihlr-16574	633	10	and	and	CCONJ
ihlr-16574	633	11	is	be	AUX
ihlr-16574	633	12	eventually	eventually	ADV
ihlr-16574	633	13	used	use	VERB
ihlr-16574	633	14	in	in	ADP
ihlr-16574	633	15	society	society	NOUN
ihlr-16574	633	16	.	.	PUNCT
ihlr-16574	634	1	nanotechnology	nanotechnology	NOUN
ihlr-16574	634	2	and	and	CCONJ
ihlr-16574	634	3	nanomedicine	nanomedicine	NOUN
ihlr-16574	634	4	have	have	VERB
ihlr-16574	634	5	the	the	DET
ihlr-16574	634	6	potential	potential	NOUN
ihlr-16574	634	7	to	to	PART
ihlr-16574	634	8	revolutionize	revolutionize	VERB
ihlr-16574	634	9	the	the	DET
ihlr-16574	634	10	medical	medical	ADJ
ihlr-16574	634	11	field	field	NOUN
ihlr-16574	634	12	in	in	ADP
ihlr-16574	634	13	many	many	ADJ
ihlr-16574	634	14	beneficial	beneficial	ADJ
ihlr-16574	634	15	ways	way	NOUN
ihlr-16574	634	16	.	.	PUNCT
ihlr-16574	635	1	nanotechnology	nanotechnology	NOUN
ihlr-16574	635	2	is	be	AUX
ihlr-16574	635	3	quickly	quickly	ADV
ihlr-16574	635	4	moving	move	VERB
ihlr-16574	635	5	beyond	beyond	ADP
ihlr-16574	635	6	the	the	DET
ihlr-16574	635	7	walls	wall	NOUN
ihlr-16574	635	8	of	of	ADP
ihlr-16574	635	9	laboratories	laboratory	NOUN
ihlr-16574	635	10	,	,	PUNCT
ihlr-16574	635	11	where	where	SCONJ
ihlr-16574	635	12	it	it	PRON
ihlr-16574	635	13	is	be	AUX
ihlr-16574	635	14	constrained	constrain	VERB
ihlr-16574	635	15	by	by	ADP
ihlr-16574	635	16	theory	theory	NOUN
ihlr-16574	635	17	,	,	PUNCT
ihlr-16574	635	18	and	and	CCONJ
ihlr-16574	635	19	is	be	AUX
ihlr-16574	635	20	shifting	shift	VERB
ihlr-16574	635	21	ever	ever	ADV
ihlr-16574	635	22	closer	close	ADV
ihlr-16574	635	23	to	to	ADP
ihlr-16574	635	24	the	the	DET
ihlr-16574	635	25	realm	realm	NOUN
ihlr-16574	635	26	of	of	ADP
ihlr-16574	635	27	practical	practical	ADJ
ihlr-16574	635	28	applicability	applicability	NOUN
ihlr-16574	635	29	.	.	PUNCT
ihlr-16574	636	1	as	as	SCONJ
ihlr-16574	636	2	this	this	DET
ihlr-16574	636	3	shift	shift	NOUN
ihlr-16574	636	4	occurs	occur	VERB
ihlr-16574	636	5	,	,	PUNCT
ihlr-16574	636	6	governments	government	NOUN
ihlr-16574	636	7	of	of	ADP
ihlr-16574	636	8	leading	lead	VERB
ihlr-16574	636	9	nations	nation	NOUN
ihlr-16574	636	10	need	need	VERB
ihlr-16574	636	11	to	to	PART
ihlr-16574	636	12	remain	remain	VERB
ihlr-16574	636	13	watchful	watchful	ADJ
ihlr-16574	636	14	over	over	ADP
ihlr-16574	636	15	nanotechnology	nanotechnology	NOUN
ihlr-16574	636	16	and	and	CCONJ
ihlr-16574	636	17	nanomedicine	nanomedicine	ADJ
ihlr-16574	636	18	developments	development	NOUN
ihlr-16574	636	19	.	.	PUNCT
ihlr-16574	637	1	current	current	ADJ
ihlr-16574	637	2	regulatory	regulatory	ADJ
ihlr-16574	637	3	struc­	struc­	ADP
ihlr-16574	637	4	tures	ture	NOUN
ihlr-16574	637	5	for	for	ADP
ihlr-16574	637	6	medical	medical	ADJ
ihlr-16574	637	7	devices	device	NOUN
ihlr-16574	637	8	and	and	CCONJ
ihlr-16574	637	9	technology	technology	NOUN
ihlr-16574	637	10	may	may	AUX
ihlr-16574	637	11	initially	initially	ADV
ihlr-16574	637	12	be	be	AUX
ihlr-16574	637	13	an	an	DET
ihlr-16574	637	14	appropriate	appropriate	ADJ
ihlr-16574	637	15	platform	platform	NOUN
ihlr-16574	637	16	from	from	ADP
ihlr-16574	637	17	which	which	PRON
ihlr-16574	637	18	to	to	PART
ihlr-16574	637	19	govern	govern	VERB
ihlr-16574	637	20	nanomedicine	nanomedicine	NOUN
ihlr-16574	637	21	.	.	PUNCT
ihlr-16574	638	1	the	the	DET
ihlr-16574	638	2	technology	technology	NOUN
ihlr-16574	638	3	,	,	PUNCT
ihlr-16574	638	4	however	however	ADV
ihlr-16574	638	5	,	,	PUNCT
ihlr-16574	638	6	may	may	AUX
ihlr-16574	638	7	quickly	quickly	ADV
ihlr-16574	638	8	outgrow	outgrow	VERB
ihlr-16574	638	9	the	the	DET
ihlr-16574	638	10	effectiveness	effectiveness	NOUN
ihlr-16574	638	11	of	of	ADP
ihlr-16574	638	12	these	these	DET
ihlr-16574	638	13	regulations	regulation	NOUN
ihlr-16574	638	14	.	.	PUNCT
ihlr-16574	639	1	the	the	DET
ihlr-16574	639	2	united	united	PROPN
ihlr-16574	639	3	states	states	PROPN
ihlr-16574	639	4	and	and	CCONJ
ihlr-16574	639	5	the	the	DET
ihlr-16574	639	6	european	european	PROPN
ihlr-16574	639	7	union	union	PROPN
ihlr-16574	639	8	should	should	AUX
ihlr-16574	639	9	continue	continue	VERB
ihlr-16574	639	10	to	to	PART
ihlr-16574	639	11	employ	employ	VERB
ihlr-16574	639	12	the	the	DET
ihlr-16574	639	13	"	"	PUNCT
ihlr-16574	639	14	wait	wait	VERB
ihlr-16574	639	15	and	and	CCONJ
ihlr-16574	639	16	see	see	VERB
ihlr-16574	639	17	"	"	PUNCT
ihlr-16574	639	18	approach	approach	NOUN
ihlr-16574	639	19	to	to	ADP
ihlr-16574	639	20	nanotechnology	nanotechnology	NOUN
ihlr-16574	639	21	and	and	CCONJ
ihlr-16574	639	22	nanomedicine	nanomedicine	ADJ
ihlr-16574	639	23	regula­	regula­	PROPN
ihlr-16574	639	24	tion	tion	NOUN
ihlr-16574	639	25	until	until	SCONJ
ihlr-16574	639	26	more	more	ADV
ihlr-16574	639	27	is	be	AUX
ihlr-16574	639	28	learned	learn	VERB
ihlr-16574	639	29	from	from	ADP
ihlr-16574	639	30	research	research	NOUN
ihlr-16574	639	31	and	and	CCONJ
ihlr-16574	639	32	development	development	NOUN
ihlr-16574	639	33	.	.	PUNCT
ihlr-16574	640	1	as	as	SCONJ
ihlr-16574	640	2	the	the	DET
ihlr-16574	640	3	science	science	NOUN
ihlr-16574	640	4	takes	take	VERB
ihlr-16574	640	5	shape	shape	NOUN
ihlr-16574	640	6	,	,	PUNCT
ihlr-16574	640	7	the	the	DET
ihlr-16574	640	8	governments	government	NOUN
ihlr-16574	640	9	should	should	AUX
ihlr-16574	640	10	use	use	VERB
ihlr-16574	640	11	specific	specific	ADJ
ihlr-16574	640	12	task	task	NOUN
ihlr-16574	640	13	forces	force	NOUN
ihlr-16574	640	14	to	to	PART
ihlr-16574	640	15	pointedly	pointedly	ADV
ihlr-16574	640	16	consider	consider	VERB
ihlr-16574	640	17	the	the	DET
ihlr-16574	640	18	ethical	ethical	ADJ
ihlr-16574	640	19	issues	issue	NOUN
ihlr-16574	640	20	surrounding	surround	VERB
ihlr-16574	640	21	human	human	ADJ
ihlr-16574	640	22	enhancement	enhancement	NOUN
ihlr-16574	640	23	and	and	CCONJ
ihlr-16574	640	24	other	other	ADJ
ihlr-16574	640	25	ethi­	ethi­	NOUN
ihlr-16574	641	1	cal	cal	ADJ
ihlr-16574	641	2	issues	issue	NOUN
ihlr-16574	641	3	that	that	PRON
ihlr-16574	641	4	develop	develop	VERB
ihlr-16574	641	5	with	with	ADP
ihlr-16574	641	6	the	the	DET
ihlr-16574	641	7	technology	technology	NOUN
ihlr-16574	641	8	.	.	PUNCT
ihlr-16574	642	1	through	through	ADP
ihlr-16574	642	2	understanding	understanding	NOUN
ihlr-16574	642	3	and	and	CCONJ
ihlr-16574	642	4	preparation	preparation	NOUN
ihlr-16574	642	5	on	on	ADP
ihlr-16574	642	6	the	the	DET
ihlr-16574	642	7	ethical	ethical	ADJ
ihlr-16574	642	8	issues	issue	NOUN
ihlr-16574	642	9	involved	involve	VERB
ihlr-16574	642	10	,	,	PUNCT
ihlr-16574	642	11	governments	government	NOUN
ihlr-16574	642	12	will	will	AUX
ihlr-16574	642	13	be	be	AUX
ihlr-16574	642	14	better	well	ADV
ihlr-16574	642	15	able	able	ADJ
ihlr-16574	642	16	to	to	PART
ihlr-16574	642	17	frame	frame	VERB
ihlr-16574	642	18	a	a	DET
ihlr-16574	642	19	meaningful	meaningful	ADJ
ihlr-16574	642	20	regulatory	regulatory	ADJ
ihlr-16574	642	21	structure	structure	NOUN
ihlr-16574	642	22	for	for	ADP
ihlr-16574	642	23	nanotechnology	nanotechnology	NOUN
ihlr-16574	642	24	and	and	CCONJ
ihlr-16574	642	25	nano­	nano­	NUM
ihlr-16574	642	26	medicine	medicine	NOUN
ihlr-16574	642	27	.	.	PUNCT
ihlr-16574	643	1	this	this	DET
ihlr-16574	643	2	regulatory	regulatory	ADJ
ihlr-16574	643	3	structure	structure	NOUN
ihlr-16574	643	4	will	will	AUX
ihlr-16574	643	5	determine	determine	VERB
ihlr-16574	643	6	future	future	ADJ
ihlr-16574	643	7	societal	societal	ADJ
ihlr-16574	643	8	uses	use	NOUN
ihlr-16574	643	9	of	of	ADP
ihlr-16574	643	10	this	this	DET
ihlr-16574	643	11	technology	technology	NOUN
ihlr-16574	643	12	.	.	PUNCT
ihlr-16574	644	1	the	the	DET
ihlr-16574	644	2	governments	government	NOUN
ihlr-16574	644	3	of	of	ADP
ihlr-16574	644	4	the	the	DET
ihlr-16574	644	5	united	united	PROPN
ihlr-16574	644	6	states	states	PROPN
ihlr-16574	644	7	and	and	CCONJ
ihlr-16574	644	8	the	the	DET
ihlr-16574	644	9	european	european	PROPN
ihlr-16574	644	10	union	union	PROPN
ihlr-16574	644	11	must	must	AUX
ihlr-16574	644	12	remain	remain	VERB
ihlr-16574	644	13	mindful	mindful	ADJ
ihlr-16574	644	14	of	of	ADP
ihlr-16574	644	15	the	the	DET
ihlr-16574	644	16	critical	critical	ADJ
ihlr-16574	644	17	role	role	NOUN
ihlr-16574	644	18	they	they	PRON
ihlr-16574	644	19	are	be	AUX
ihlr-16574	644	20	to	to	PART
ihlr-16574	644	21	play	play	VERB
ihlr-16574	644	22	as	as	ADP
ihlr-16574	644	23	some	some	PRON
ihlr-16574	644	24	of	of	ADP
ihlr-16574	644	25	the	the	DET
ihlr-16574	644	26	most	most	ADV
ihlr-16574	644	27	important	important	ADJ
ihlr-16574	644	28	technology	technology	NOUN
ihlr-16574	644	29	of	of	ADP
ihlr-16574	644	30	the	the	DET
ihlr-16574	644	31	future	future	NOUN
ihlr-16574	644	32	begins	begin	VERB
ihlr-16574	644	33	to	to	PART
ihlr-16574	644	34	develop	develop	VERB
ihlr-16574	644	35	.	.	PUNCT
ihlr-16574	645	1	"	"	PUNCT
ihlr-16574	645	2	the	the	DET
ihlr-16574	645	3	deci­	deci­	ADJ
ihlr-16574	645	4	sion	sion	NOUN
ihlr-16574	645	5	...	...	PUNCT
ihlr-16574	646	1	reach[ed	reach[ed	PROPN
ihlr-16574	646	2	]	]	PUNCT
ihlr-16574	646	3	here	here	ADV
ihlr-16574	646	4	today	today	NOUN
ihlr-16574	646	5	will	will	AUX
ihlr-16574	646	6	determine	determine	VERB
ihlr-16574	646	7	how	how	SCONJ
ihlr-16574	646	8	we	we	PRON
ihlr-16574	646	9	will	will	AUX
ihlr-16574	646	10	regard	regard	VERB
ihlr-16574	646	11	this	this	DET
ihlr-16574	646	12	creation	creation	NOUN
ihlr-16574	646	13	of	of	ADP
ihlr-16574	646	14	our	our	PRON
ihlr-16574	646	15	genius	genius	NOUN
ihlr-16574	646	16	.	.	PUNCT
ihlr-16574	647	1	it	it	PRON
ihlr-16574	647	2	will	will	AUX
ihlr-16574	647	3	reveal	reveal	VERB
ihlr-16574	647	4	the	the	DET
ihlr-16574	647	5	kind	kind	NOUN
ihlr-16574	647	6	of	of	ADP
ihlr-16574	647	7	people	people	NOUN
ihlr-16574	647	8	we	we	PRON
ihlr-16574	647	9	are	be	AUX
ihlr-16574	647	10	;	;	PUNCT
ihlr-16574	647	11	what	what	PRON
ihlr-16574	647	12	...	...	PUNCT
ihlr-16574	648	1	[	[	X
ihlr-16574	648	2	we	we	PRON
ihlr-16574	648	3	are	be	AUX
ihlr-16574	648	4	]	]	PUNCT
ihlr-16574	648	5	des­	des­	NOUN
ihlr-16574	648	6	tined	tin	VERB
ihlr-16574	648	7	to	to	PART
ihlr-16574	648	8	be	be	AUX
ihlr-16574	648	9	.	.	PUNCT
ihlr-16574	648	10	"192	"192	NOUN
ihlr-16574	648	11	192	192	NUM
ihlr-16574	648	12	.	.	PUNCT
ihlr-16574	649	1	star	star	PROPN
ihlr-16574	649	2	trek	trek	NOUN
ihlr-16574	649	3	the	the	DET
ihlr-16574	649	4	next	next	ADJ
ihlr-16574	649	5	generation	generation	NOUN
ihlr-16574	649	6	:	:	PUNCT
ihlr-16574	649	7	the	the	DET
ihlr-16574	649	8	measure	measure	NOUN
ihlr-16574	649	9	of	of	ADP
ihlr-16574	649	10	a	a	DET
ihlr-16574	649	11	man	man	NOUN
ihlr-16574	649	12	(	(	PUNCT
ihlr-16574	649	13	paramount	paramount	ADJ
ihlr-16574	649	14	television	television	NOUN
ihlr-16574	649	15	broadcast	broadcast	VERB
ihlr-16574	649	16	february	february	PROPN
ihlr-16574	649	17	l3	l3	PROPN
ihlr-16574	649	18	,	,	PUNCT
ihlr-16574	649	19	1989	1989	NUM
ihlr-16574	649	20	)	)	PUNCT
ihlr-16574	649	21	.	.	PUNCT